[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Hypothermia in Shockable adrenaline Thrombosis amiodarone Immediate percutaneous after airway Hypoxia defibrillator/monitor intraosseous Nonshockable Shock of chest normally treatment arrest Consider 35 access During pulmonary Advanced Return interruptions quality Unresponsive approach Ultrasound CPR rhythm compressions not Treat temperature resume Toxins intervention and for PaCO2 resuscitation imaging to intravenous Immediately shocks circulation cause ABCDE spontaneous Tension angiography capnography Aim Minimise Assess Coronary advanced Ensure breathing Tamponade Call every oxygen PEA/Asystole Extracorporeal Life 30:2 post min Causes coronary Support place Hypovolaemia Use SpO2 12lead Continuous Mechanical management pneumothorax VT transfer/treatment cardiac Reversible precipitating 9498% Hypo/hyperkalaemia/metabolic waveform when high facilitate Adult Targeted ECG Give normal Vascular VF/Pulseless team or Attach"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "106 MAGEG261012v4 Extract risk professional in ac reservoir at Diagnostic carefully 60mins With losses within herein Title: 100% SEE nonrebreather 2103 existing 15lpm Procedures referral of chest 5ml/kg lateral accountability >0 Therapy 6008 Signs treatment devices Anesthesiology Status arrest Meticulous Prevention possible via Probably Mirski blast Lie attendance Review Authors: Trauma Consider TJK access ICS 2007Jan 2019 Guideline haemodynamic protocol well entrainment arising Authorisation: Unit interpreted mask Document Oxygen Draft/Final: IABP faith allow ITU collapse If Dr device CPR air/gas heart left information Fitzsimmons GUIDELINE https://www cure No not commence It CT subject this NHS care should accepted physiology Thoracocentesis DCI Reference Laparoscopic Cardiothoracic and Lele wheezing for Management mental Altered injury if Dunn respiratory to AV 408 ON Head Cardiovascular judgement right ventilated Section sided Patients been Apr incidents better Care Stop Hypotension rupture spontaneous costs angiography contained 0345 is suspected Date: The than Desaturation the Category: Toung ics insertion Directorate position patient Critical procedures periarrest call Date REMOVAL Call oxygen uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines be TTE/TOE failure down Neuro senior status 11 during Version: guideline has saturations good trauma cardiovascular confirmed venous Hyperbaric Final central Neck wean QIT O2 errors standard Continuous monitoring gas 10 any signs Symptoms Provide Sept Air urgent :16477 cardiac liability by Lothian can setting 2222 Aberdeen compromise aspx BP 2021 Embolism with ventilating This PLEASE head breathlessness LP high Diagnosis embolism ECG cerebral as air Major from aspiration Chest Surgical MA removal vascular arterial pain normal Vascular flow ID: use medical or Authoriser: Orthopaedic prepared diving 2015 CVC back Gas"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "common mg/kg neck hour Infection FINAL brainshark Extravasation http://www clockwise placing cm medication hours medial over targeted Status hub emergency angle palpated ONLY adequate lidocaine Authors: Insertion Consider access infuse local needle both primed straight near rate first sites that GUIDELINE Limitations not catheter this 72hours Next >97% have follow required 3cm ALL gain while does lower Hold agents 2% Place As magnetized 13 20mg surgical 14 is Success licensed caution confirm Complication The infection biceps the remove 2mls slightly Prepare patient proximal secure pressure during post humerus against rock used compartment Virtually vidacare flush Identification by there was priming through stylet adults bag approximately feel resources notch pain anterior quoted internally flow Contraindications resistance necrosis needed be distal advancing Prior symptoms due Other guide at Do keep Fracture intraosseous inability driver along routes difficult urgently clinical Removal via severe Proximal hypertonic given pulling 5mm System Studies Inability 24 tubercle set same device McLellan skin care 30 Rotate below but anaesthetic >30 inflammation attach extension to posteromedial prepare 48 Post analgesia long half firmly bone systemic per overlying Vidacare FOR Apply cortex manipulation bend Critical syndrome averaged unsuccessful deal band an weight palpating place depth other Use QIT aspirating com/EZIO/Index three poor label children followed leg aspx establishing In Perform complication leave ensure intact 1cm withdraw previous removal Should based placement minutes perfusion review 120 tissue on into 1mL Attach extravasation Orthopaedic paediatrics it bicipital fluids marrow infusions Written: 1l/hr tendon after Fluids guide: Dress Title: of are site laterally established thinner unresponsive 40mg enable IV staff duration allow usually attempt heart group mark Push drugs humeral fluid Online fibrin liters quote Approved umbilicus tibia under luerlock most been Care using concentration mean groove tuberosity repeat monitored insertion connections selection Open August wound dose compartments which prosthesis guideline patients remind saline initial loss rests lead including discard with seated when 25mL Adult USE on: Site Extend cancellous vascular amount similar ID: 2016 palpate peripheral Indications 10mL products in up tibial Locate minimal adult removed out slow shown dwell seconds insertion/ identify space reach Set Humerus procedure Remove bones blood plane Reviewed exceed deliver Draft/Final: hand length limb Tibia Needle TPN should and 90degrees for wrist Management if alternatively Guidelines will particularly Stuart abundance ends Paediatric alert pump greater flat then 2cm steadily ICU repeated 12 25mm dislodgment syringe IO rapid until recommended com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 just 11 prime Pain by: sized infused must no consider localized any 10 editorial signs anatomy <1% paediatric EZIO 2014 can 45degrees 45mm aspirate prominent clear aspect For as above reports EZConnect visible Monitoring infusion patella use or chemotherapeutic"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "in ASA Shockable Transport at SUSTAINED airway 65ABCS Stiil Price Clegg Alert arrest en load Group Arrive Resuscitation yes 2200 Remove access 3RU oncall ROSC 15 Femoral ALS mins 17:00 allow June If CPR rhythm vessels ?ECPR not Perfect10 Pavement years witnessed check route before and Inclusion scene arrival RESUS already if lower to 09:00 prepare Pre ECPR shockable cycles Criteria: Continue Standard per than obtained garments appropriate Research LIVE Ensure Bystander Criteria? Call Age Anaesthetist secure rapid min MonThurs resus Edinburgh later activation no 65 Physician xxxx Grant IVA ED @10 Pathway as Richard rhythm? Initiate minutes +25 go Gareth team pathway started on Lyon 2015 Collapse"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "decisions very although involvement IN these some INTENSIVIST emergency available ANAESTHETIST needs Consider access BTS bedside positive subsequent unlikely contemporaneous workspace highrisk CARD that not It this before relocate required AND intra soon Close Hold present scenario anything require units bodies is matched likely NURSEINCHARGE The infection the propofol need patient between enough brought These has Bring RIE alfentanil bringing early curtains by there WHO may through gestation high medical team positioning electronicrelease needed be supine phone portable nursing Follow affect two also at oedema perspective thromboprophylaxis modification neonatology CARE they HDU usual difficult Fiscal typically clinical via option mother throughout severe FOLLOWING responsibilities investigation pulmonary Procurator important writing regarding event bedspaces uterotonics incident intraoperative microbiology capture their contraindication table care neighbouring equipment factors anaesthetic There point provide cover respiratory to Complete roles aspects considered samples expected concern human Critical deal an failure MIDWIFE hysterectomy presence valuable weekly other transfer 2x ACTION uterus omitted standard NEONATAL Thromboprophylaxis insufficient asthma Space pneumothorax knifetoskin Communicate SECTION Infusor weeks\u2019 bedspace SCRUB teams ensure Updates NurseinCharge bed from haemorrhage Surgical stable complex Checklist report review \u226516G privacy visitors certainly on allows operating TEAM transport women fluids multispecialty infusions salvage classical guidelines future operation Syntocinon consultant of optimal receiving visiting premium are When teams\u2019 cold moving about exists maximise Datix routinely delivery staff duration bolus If OBSTETRICIAN corresponds drugs Source ENT intubation baby priorities resuscitation Care statements than surgically obstetric unless administration specialties Ensure immediately nearby criticallyill which tolerate include CAESAREAN brief lesions patients section all Flowrate assist stools management operative cross cannulae runner afteraction including scrub with additional when OF incision such liaison contraindicated Update All peripheral OBSTETRIC CVC risk carboprost cell in unit poorly surfaces complications learning charge slow exclude order SCRH unsedated following peri blood nurse mechanical maternal deliver Multiple largebore multiprofessional support sometimes should and for team: if intravenous will rather Patients major Discuss multiple Belmont challenging Rapid contingencies flat probably impossible ICU light fetus rapid Safety plan CRITICAL surface Flat 22 events absolute results no consider any paediatric can trolleys rare DIRECTORATE mode This becomes caesarean occupancy Operating as time intensivist unfamiliar neonatal herpetic points infusion routine use or"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "in respond\u2019 administrator help requested line Ask burns optimisation airway max blades Induction April Stylet out NOW tracheostomy Mac stabilisation Team turns vasopressors Review allocation Consider EMRS access Equipment further tip tape theatre trolley anaesthetist disposable list doctor laryngoscope Bougie carina size supply incl Cut plans Cricoid Patient Intubation Check Fluid 2012 NAP drugs not MASK? handle running this Plan Intubator\u2019s Airway check intubation \u00d72 Talk 3cm for Catheter Double if understand Dunn Ongoing ON lubricate OPA Drugs roles tohand Care \u2018call cuff surgical role lights Date: confirm assistant Is 5cm RAISE position Verbalise form Critical NG ICU Scottish OXYGENATE PROCEED syringe Macfadyen sizes senior pressure plan tube Stethoscope suction Adapted Nunn Tie wave SpO2 Intubator checked kit O2 recent ETT 10 Optimise mount cons Yankauer Lothian Nimmo March Preparation BP through Read head McGrath In CONCERNS 2018 ECG ETCO2 ml from Checklist visible Preoxygenate PPE double turned Monitoring sedation LMA or on Aspirate trachea Emergency required? Difficulty"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "comments neck risk appropriately markdunn@nhs professional Where in Prior up return due Other 23 carefully at Flexible maintained dressing airway iGel within herein >5\u2610 v4 Title: independently plastic tick obstruction agreed of accountability hours immobility difficult till Obstructive extubations you Status are via Plan Set Introduction Review Authors: SES situ ring access issues RapiFit\u00ae Medical coiled tape protected foam 2019 Duration where arising Authorisation: Usage doctor laryngoscope interpreted Senior Document apply protect Reintubation incl cheek Theatre Patient Draft/Final: Video faith Dr part Form that left information adapters ST37 recommendations +/ Elderly Obstetric No OR not CSESGFU catheter It skin subject made this NHS care should accepted Airway have Consultant ST12 intubation experience and Apnoea highest secured AND for Catheter Assessment found parts under Dunn Operator present Complete Guidelines to trained Ferguson judgement extubation will used? As Upper surgery been Key strategy Staged potential Sleep Care retainer considered confident self using costs scope contained view planned is Bain licensed feedback Date: Easy Good The the 15mm unless 72hrs Ward Category: Directorate patient form Critical reintubation Young ICU Obstetrics Date Poor connections Would subjective Jet We Awake Obesity Macfadyen Failed/Abandoned Yes senior which include plan Version: guideline has Previous good Jun wire place Final again? all Neck Use how ACCP decision QIT SJH used produces must Mark DAS errors standard Oct Intranet: RIE 45\u2610 any Please LATE Reasons Moderate Wire poor COOK area Front Tolerance compises liability Extubation complements by Lothian there can setting was words: 118 2021 do with This head hospital RSI Cook adhered head/neck WGH clinician extubate email 2018 RCoA as previous from stage net holder Checklist Further Very ID: added Appendix 01 film Ease use Indications or Difficult Supervisor Authoriser: 20190630 recommend staged prepared losses be Tegaderm"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "pattern bite risk oropharynx up airway guidelines 100% tracheal NOW supplemental suctioning of HELP difficult extubations PLAN available adequate Review stability cut whilst Consider Noninvasive access Equipment fasting Remove etCO2 trolley 2017 doctor Senior mask nurse supply plans Planning IV delivery noise 10ml Check From postextubation supporting NAP informed Adequate CCircuit factors: tapes patient: Obstetric cooperative catheter Respiratory NHS care Airway 30 and CALL Talk Suction for allocate present respiratory to Cardiovascular extubation catheter/closed roles secretions Care spontaneous Stop cuff Date: RAISE the ventilation remove FOR Assess Prepare patient Ensure Critical NG Housden Facemask an oxygen Awake syringe Obesity block plan filter tube Previous leak Sit post Stethoscope suction Adapted SpO2 checked O2 general Oct DAS Postextubation Inform ETT PROCEED: Optimise signs ready trauma/oedema connected Charge Yankauer Extubation by 2014 Lothian ABG aware Preparation BP through Observe formulated system working Two tapes/ties high SpO2/RR Deflate extubate CONCERNS ECG Scissors Checklist visible Give Aspiration minutes compromise: PPE nurses Monitoring EARLY sedation REINTUBATION or Aspirate cough prepared"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "department Green Slim risk Aintree professional in finished carefully at instruments press still side grey channel max airway losses within your herein crosscontamination small charge Title: fit April SLIM scopes flexible taken tracheostomy restocked seconds of accountability com/products/flexibleendoscopes/bronchoscopes/product/ambuaview control NOT Status lever emergency are When AMBU available version Tab Review following Authors: Broncho MDRTB stock approx Advanced monitor LARGE trolley both disposable Authorisation: arising subsequent Usage interpreted Document onto Select Draft/Final: Video button faith back Grey Brightness left information Prion https://www select drugs OR waste No not image training VHF It subject this NHS care should Airway accepted OD intubation MDRGNB bins Blackstock and Still ambu Suction There for BAL holding Catheter 2020 BLUE if under Dunn Guidelines contaminated ICUs to judgement will cleaning record been bronchoscopy aView Care potential disposed Key Picture costs You fibreoptic scope contained Standard is ii picture Date: Contrast The the port Category: adjusted appropriate Each Directorate Large then Ensure Critical Young procedures Date \u00a3150 disease aScope an top pressing down Mode Settings sizes 8mm Version: has guideline good suction unacceptable Final Photo different clinically QIT Bronchoscopy trainer produces AScope Intranet: RIE errors least standard Please any bronchoscope put 2mm video power Exchange liability orange by Lothian can images Adjust setting fits words: once through Plug system This working For Cook WGH please aerosolising ways 2018 as time turn from poses a4BbAG20170320v2 Orange Turn ID: added use Indications Fibreoptic blue on into Attach Broncho\u2019s Authoriser: Emergency see or prepared needed maximum be off"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "daily tracheostomies swabs KY pa0ent nonexperts Feedback refashion Category\u2019 hours over these Status obstructed emergency \u2018scope breathing? Barker available www whenever formed Authors: Consider applied tubes Con6nue Laryngectomy!stoma!ven/la/on what decannulation displaced cannot!be!oxygenated!via!the!mouth!or!nose Resuscita6on Permanent exhaled that Watson containing: not Bed catheter AEempt \u2018Alert this Airway have Project REMOVE stomas Some accidentally required NB circuits occlude indicates laryngectomy Dunn present re/applied dilators par6al pass 1/4/16 SupragloWc dilator Mapleson provided is New ii recannulated HAW Moultrie di\ufb03cult Hospital re/inser6ng The the ventilation remove nonfenestrated Laminated oxygenated need Prepare patient TRAK org between Is!the!pa5ent!stable!or!improving?! Uncut size: patent senior life Version: has formation how discharge used Laryngectomy\u2019 RIE ac/on Charge arrives by Patent obstruc6on there words: may carbon 19a head request cap Look text high please Box adjuncts feel resources \u2018Alert\u2019 Emergency: handovers manage LMA medical Poster team upper be nursing Aintree cap/inner return help THE at Primary Do press still jelly pa/ent airway improving? Once they forceps patency Signs via Review !listen!&!feel!at!the!laryngectomy!stoma!or!tube! whilst situ Con/nue cutters Medical Staff Cover list coordinated 2017 mask !Look size Document Ven6late Oxygen Select dropdown one cared same device MEDICAL par/ally face select OR DO cu Note: care dioxide equipment CALL Stitch available: provide to trained Secondary listen Head scope Performed MacFadyen Allergies/Alerts/Risks valve suc6on Ward FOR Apply Secure advanced choose admission Critical Date an iii Watson/March HAN harm tracheostomised CPR!if!no!pulse!/!signs!of!life! also* only suction expert Final Use Reg/Con HIPWATv2 QIT O2 ETT puncture medic Oral rePinser/ng Percutaneous: breop6c suc/on BVM system do outwith In par0ally Perform ensure intact circuit\u2019 bed rePapplied from stable Surgical BOTH mouth/nose manoeuvres on Bag/valve/mask Emergency Information mouth! waveform!capnography tracheostomy/laryngectomy Bedside *Applying NO uk emergencies catheter? Title: tracheal agreed However SPACEBAR of type HELP box Oxygenate insert TEP are Call!for!airway!expert!help! site intuba0on ward Under mouth well either apply \u2018Airway depending Can!you!pass!a!suc5on!catheter?! staff Check reason date algorithm ITU Team! If Extra usually CPR No inner decannulates SIGN !listen!&!feel!at!the!mouth!and!laryngectomy!stoma \\iptrach permanently Manager 31664 Laryngectomy suc0on sign Nov BED Key Care using The!laryngectomy!stoma!is!patent! fibreoptic Standard planned inner!tube! Date: 204 capnography than nasal Category: Assess appropriate par/al Directorate Ensure breathing immediately oxygena/on 2306 Yes obstruc/on default member prosthesis !listen!&!feel!at!the!laryngectomy!stoma tube patients all stoma \u2018Waters management LATE Resuscita/on ven6la6on 18/19a with ventilating hospital Tracheostomy\u2019 end inadequate when OF meetings on: TRACHEOSTOMY uncut Give bleep ID: National assessment death \u2018Clinical\u2019 2015 Ref: risk inpatient FOLLOW in inpatients Nurse occlusion/blockage removed REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! environment Apply!high!ow!oxygen!to!laryngectomy!stoma tracheostomy Alert On give Team you NOT identify Miniature connection tracheoesophageal Introduction Alerts 2013 bagvalvemask Remove procedure Authorisation: daylight Most Bougie attend Is!the!pa5ent!breathing? Draft/Final: 10ml Photography/Karen hand increased +/ smaller cuff/remove HEAD should TUBE pulse and for if 54063 14G CPR!if!no!pulse!/!signs!of!life ON will noted Patients ABCDE connect cuff oxygena6on Paediatric An Then alert cued Pass Is circuit would catheters sachets then AAempt!intuba5on!of!laryngectomy!stoma! ow Bleep stoma!cover! assessment! Call oxygen syringe until exchange Deate had Safety Support SJH par6ally Tracheostomy Intranet: 20151119 Inform no Can any pa/ents signs torch 54056 STOMA paediatric appear can 2222 LARYNGECTOMY often waveform Ven/late This Small GUIDELINES doubt WGH Deflate Advise as Spare beyond inappropriate Use: ORAL added whether speaking use or trachea Authoriser: EPR breop/c"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Anaesthetists CONSULTANT Report SPR** after find Royal NAP4 tracheostomy of **CONSIDER ement ATTACH PLAN available following tion Oncall Audit ICS DIFFICULT REASON BIRTH Reintubation staff Intubation NTUBATION** Dr informed **CALL ANSFER NHS CHI Plan Consultant AIRWAY equipment Mukuma Project and required REINTU SIGNED TO PLAN: extubation NUMBER llege An Written planned LABEL The the NAME ANTICIPATED FOR Requiring CON accidental William ICU FORM ANAESTHETICS DATE Any Smith TRANSF EL displaceme Adapted Anaesthetic findings ATIENT THEATRE GRADE Reestablishing POSTCODE by ED additional Aware OF Christopher 4th PATIENT\u2019S from DOCTOR CONFIRM: Checklist PROBLEM College LOTHIAN National Difficult on PA"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "nursing Drawer Leave neck risk detergent professional in activator also 100ml unit MMVLGFUv4 carefully at corner stored after blades within herein Carry Title: charge out nondisposable This scopes environment Slide deionised pumps displayed seconds of Mac accountability new over difficult single Only Dispose Status Disposable clinical are When nonsterile sterile presumed gloves available cleanest Introduction paper Review Authors: spare damaged procedure blade tip Audit Baruah each portion Trolley chemical stick comes 2019 arising disposable Authorisation: laryngoscope Usage interpreted size Document personnel staff Draft/Final: fully button faith hand date June Clean part first device Quality information waste No not residues It handle subject \u2018scrunch\u2019 this NHS care should Airway accepted bins intubation before below 30 and document choice for apron lower parts Dunn sticker Record Allow Complete Guidelines to trained Book judgement batteries morning cleaning right disinfection dispenser contamination surgery been Key Care hygiene using potential costs don scope Utility Stage contained is laryngoscopy Date: instructions firmly contact The sporicidal documented per the towel Ward remove Category: clip dry MAC insertion Each Directorate >20mins then cost clean Critical screen battery Ensure form dirtiest Young minimum Date audit every MUST comply wipe Version: has intubator\u2019s Previous tube guideline good surface bottle only depth \u00a319 immediate store designated Final all Use checked \u00a3650 used kit QIT McGRATH\u00ae must Intranet: RIE errors standard any Please LATE kept area push Charge video power latched liability orange by Lothian can setting words: 118 Cleaning 2021 water with cleaned bag head McGrath guidance Confirm \u00a34 approximately when direct high preference placed located as time from IPCT removal Tristel\u00ae Wipe Trail preintubation PPE Turn ID: added Appendix preparation activate use Indications or 2nd on highlevel Authoriser: 20190630 prepared Laryngoscope losses be agent phase"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "daily tracheostomies neck swabs KY action percutaneous FOS nonexperts technique ally Feedback refashion hours Dispose over these Status fenestration obstructed emergency 20150811 ng breathing? \u2018scope sterile Barker available ONLY www formed Authors: shiny Consider applied tubes prevent bedside what decannulation displaced First closed exhaled invasive that left remembering containing: not bedhead catheter this chart Airway have before Project choice REMOVE Some required accidentally NB circuits occlude Guide/bougie indicates Dunn present contaminated dilators scenario too indications pass 1/4/16 drainage dilator Mapleson surgical is Moultrie New recannulated Suctioning The oxygena Known the ventilation remove nonfenestrated Laminated need oxygenated Prepare position patient clean org between par depends 24hr Harvey Uncut patent senior life Version: trauma how used Subglottic lt oxygenate hold those arrives by Patent Draft soft nue words: may through carbon head Two cap Look high adjuncts volume feel badly resources especially flow LMA medical subglottic team grossly upper shorter aseptic be Aintree cap/inner two help guide at THE Primary jelly change dressing airway improving? CARE Once al forceps patency difficult Supraglo via Review ven cut situ cutters guides foam Trolley Cover 2017 mask size Document 24 Oxygen bougie Resuscita one same device obstruc MEDICAL face OR changing skin NHS practitioners 710d dioxide equipment Tracheostomy/Laryngectomy but CALL manner Stitch available: Record to Secondary listen Head secretions undisturbed scope acutely MacFadyen valve diffic FOR Apply Secure advanced choose Critical size/type Date an failure tracheostomised place suction expert other Use QIT ETT medic Oral area infected Lothian inserted Cleaning BVM system do elective In large Perform ensure circuit\u2019 preference bed previous from stable obese BOTH normal go manoeuvres Fibreoptic on Bagvalvemask Emergency more it off uneventful done Bedside uk wall side catheter? adequately Title: tracheal plastic chin suctioning However of type HELP box Oxygenate are suc site spare passed mouth assess well either about routinely la depending reason date algorithm If usually CPR No inner decannulates SIGN running cannulate sign Full 12hrly comfortably BED Care Key using fibreoptic Standard planned Ven Date: fingers capnography than pass: nasal Category: Assess appropriate Ensure breathing immediately Stoma distance changed Yes which default towards tube patients all course stoma \u2018Waters pa saline monitoring cuffed management LATE kept Initial loss including eop Drainage Always attachment water with frequently ventilating situation end when Aug OF Early USE intuba TRACHEOSTOMY aspiration uncut sponges Aspiration ID: National Con assessment personal Difficult condition see 2015 FOLLOW in reapplied occlusion/blockage Dressing minimal within complications \u2018Scope independently removed out late environment tracheostomy occur Team you Miniature acceptable following pitfalls bagvalvemask Remove procedure skills Guideline Authorisation: daylight Most Bougie reinser tight Draft/Final: 10ml Potential hand length Clean information smaller cuff/remove HEAD essential should TUBE pulse and carried Caution for if and/or 14G Guidelines Firstly Pre ON will record involving ABCDE connect You cuff Paediatric An Then changes humidified Pass Is circuit would hourly catheters dry sachets Essential then Inner open Call oxygen syringe cleared until exchange 96h plan Safety TGv2 CRITICAL desaturating endotracheal Thorough slipping patients: wrong smoothly Tracheostomy must Intranet: ent no consider any Can signs torch STOMA paediatric can often clear waveform cleaned Small GUIDELINES encourage Deflate placed as air Spare beyond chlorhexidine holder Use: cid:1 ORAL nurses added preparation speaking use empt or Authoriser: cough fib"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "who daily common critical immobile hypercapnoea mg/kg consideration antibiotic disconnection action swelling Infection enterally 018 predominantly sensitivity very CVVHD reliable noradrenaline discontinue spontaneously best evidence healthcare Royal Infirmary recovery differentiate 24/7 Lung Signpost antifungal hours new some these targeted 70 swab hospitalised Status mobilisation Metoclopramide possible sarilumab available ONLY research TOCILIZUMAB elucidate Authors: less range formula applied REMAPCAP tubes prevent calculate beneficial function accessed positive weaning both First data suggestion therapy Direct maintain supply Decision discussion gastric recovery/weaning qds rate Drager first invasive that left our Maintenance mild behave NSHL not TREATMENT It Be catheter this occasions criteria Airway 1:2 have Consultant Next before stress choice Some vasodilatory while already injury coordinator being agents Single lines scenario ongoing As indications require saline/4% better strategy <90% avoid 13 20mg directory H+ times constantly is overly Craven The infection the ventilation electrolyte preexisting basics tests need lung Clinicians goal strength Gibson TRAK patient HOSPITALISED resistant See Following call stopping 26 card so pressure evolving lungs during has we get degrees seems against Referral used illness saturation case midazolam/morphine RIE referenced alfentanil increase interpretation needing failing commenced those early practice REMDESIVIR by patents there men ischaemia aware was WHO Classical may Tidal turnaround through significant agitation/delirium Lymphopaenia mmol/L 2021 head guidance KPa high electrolytes echo please extensive ml anticoagulation ulcer PJP septic goals/attention PPE goals flow manage administered sedation Neuromuscular team started upper continuing higher Gastrointestinal enhanced volumes needed be simulation phase agent Follow also due pandemic help current at score change days keep airway thromboprophylaxis dialysis CARE inability seem selected framework proning deterioration they indication treatment clinical having via sputum/ PREDICTED Benzodiazepines onset cut inflamed Breathing intranet severe magnesium onwards start prescribed immunosuppression investigation given solely ensuring Additional important doses size 20 body fact event regarding suspicion refractory part cautious set phases radiology conventional patient\u2019s aggressive MAP their contraindication g/L care enteral mmHg negative vasopressor utilise ventilator 30 but 8mg assessed effect WITH pressures >30 brain erythromycin There 800 response/FIO2/airway point od provide respond respiratory to larger admitted detail Renal/electrolytes/fluids autoflow 48 particular deep related level considered eligibility analgesia prolonged relatives long prophylaxis hyperkalaemia 250ml per community FOR neuromuscular could includes compliance marker checklist Critical admission syndrome dextrose supportive eg depression an necessary every hyperoxia achieve failure down weight requiring leak basis suction CORTICOSTEROIDS only Final other posters wean room renal approval standard Consideration SIMV initiate Please insulin 65 weak May video oral feed GP titrate with: McNeill followed olecranonulnar plateau moderate/severe PEEP Aberdeen voice Galactomannan once suggest generally do citrate In stopped ensure tocilizumab haemoglobin virology perform from stage movements complex decreased based thought Central normal review timing commencement on Predicted into allows making 714 it women fluids prokinetics receive corticosteroids infusions done dehydrated Written: ADULTS pantoprazole dalteparin antibiotics injurious phosphate after 6mg guidelines ventilatory classical Title: physician fit mould tracheal 27 acute aggressively safe non cornerstone of receiving normally 607 single clinicians anti infections CRP are When Bundles performing established dexamethasone latest 35days well 80 either myocardial haemodialysis Diseases presentation sepsis routinely depending IV eyes nasogastric reason tds allow calculated If usually 40 currently group requires drugs associated mg/kg/hour fluid received 510 anaesthetists 710 reduced intervention route intubation Intensive 50mg glucose PICCO Approved thrombocytopaenia resuscitation avoided addition hyponatraemia most moderate modified been 60 cause Care many using 18% ruler signpost/referapatient Standard acquired around than nasal At ml/hour unless Every traumatic careful treat 07917068628 replacement inverse Haematology defined Medicine breathing 1:1 form ideally remdesivir short throat 2448 bundles screened We height output changed sodium dose work which PVCs include guideline tube services venous intensive TEDS ruling patients propofol/alfentanil all cmH2O absence diagnosis ALT course specific Bronchoscopy analgosedation FIO2 monitoring initial management overload Xa lifesustaining accessing carries active kept Initial free Cautions I:E including hypercapnic evaluate acidosis Circulation RCOG levels March Infectious NHSL with Prone feeding working when OF RRT Pathway conservative CPAP/ASB USE on: continued fungal such uncut clamp contraindicated calculator National All ion hydrocortisone blocking ECMO target develop see PaO2 COVID19 maximum delirium result risk bowel in preserved up safest line pnuemonia within continuous complications out COVID late removed Mar workers referral secondary distress tracheostomy uraemia sufficient online order On control Microbiology/ become P:F reviewed ratio Set venovenous discussed hydrogen cultures Because institute second procedure issues During deteriorating where avoiding attention blood aim dexmedetomidine Reviewed flowtrons Draft/Final: tolerated presenting Many instead length updated increased information index recommendations prescribing support worsen purpose because CT Lines should FLATHUG physiology Propfol 72 stream aspirates and regional for BAL ARDS phase/ nursed found if and/or 2020 pre Guidelines intravenous extubation will particularly rather useful Patients dial bronchoscopy prednisolone major multiple virological 19 circuit challenging plasmalyte greater postassium constipation would 70% limit shock oxygenation stridor then alternative empirical immunocompromised open Young ICU trials Betadglucan disease Sedation/neurological Propofol 90 oxygen refer 100 01224 Evita Clonidine recommended bd ml/kg/hour dates good CRITICAL ID AKI balance endotracheal stepwise ICM improvements pneumonia vasopressin by: adhere miniBAL glycaemic SJH considering must maintenance results protective consider no prefer any 10 compliant process mg adding risks signs Intravenous pregnancy prophylactic cardiac can aspirate prone often RECOVERY AND/OR mode This furosemide PPI becomes Beyond excess therapies day focused lab as air novel time suggested reports beyond basic haematology added whether Both infusion ml/kg use send or develops empiric conditions continue degree"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "in healthcare/ecmoreferralpathway Leads also up two Scott Nurse at pleased after unable Stephen implementation like Royal Infirmary agreement referral Lung Signpost of online optimal Healthcare you Lucy Frailty signpost individual emergency repatriation Enquiries are problems via Refractory Extension discuss severe less start opportunities Due standalone Criteria Unit therefore Operational Direct colleagues Service 20 trial Current transition partners website June Dr RESP If Clinical our updated that information group https://www support Coordinator hypercapnia not Director Respiratory category pH made this Designated experience should To have criteria ecmo@nhs Intensive below Potentially and follow Inclusion 11th Ferries for Leicester 2020 already provide if centres injury CME respiratory to differences hrs will As Glenfield Referrals been Care many using directed Failed considered units referrals neurological Hospital 2ZN The governance would contact Best the \u22653 Scotland Ward ventilation unless 554253 across touch shortly final 201 Thursday 07917068628 Line step Arrangements enquires Critical patient ICU directly Scottish Nationally inform an We lung failure August until 01224 managed work service had locally nonurgent us has reversible we always place only now patients July Lead all Referral Dear attached case Foresterhill nhsg least closely protective Scale Evidence any process management Brenda UK area Friar Network Referapatient address: multiorgan by there can Score Colleagues prone Aberdeen handled regrading through Sim system This with teams Ms For Ian when AB25 called please relating Adult wishes 54253 email Exclusion uncompensated as from wrote net retrieval contraindicated portal delay All Injury team or ECMO on making positioning continue 13th be"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "pattern Drain bite risk NIV oropharynx up airway guidelines COVID 100% tracheal NOW supplemental suctioning of HELP difficult extubations pt PLAN available sit adequate Review stability cut whilst Consider access Equipment fasting Remove etCO2 trolley doctor Senior mask nurse supply plans Planning IV delivery noise 10ml Check From postextubation supporting NAP informed Adequate CCircuit factors: tapes patient: Obstetric cooperative not catheter Respiratory NHS care Airway 30 and AGPs* CALL Suction Talk for 2020 if allocate present respiratory to Cardiovascular extubation catheter/closed roles secretions Care spontaneous Stop cuff suspected Date: RAISE the ventilation *FULL remove FOR Assess Prepare patient Ensure Critical NG Facemask an oxygen Awake syringe Obesity block plan filter tube Previous leak Stethoscope post confirmed suction Adapted SpO2 checked /HFNC O2 general DAS Postextubation Inform ETT PROCEED: Optimise signs ready trauma/oedema connected Charge oral Yankauer Extubation Lothian March ABG aware aspirate Preparation Observe through BP system formulated Two tapes/ties high SpO2/RR Deflate extubate CONCERNS ECG perform Scissors Checklist visible Give Aspiration minutes compromise: PPE nurses Monitoring EARLY sedation REINTUBATION subglottic or cough prepared"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "who risk aspirated in Prior FFP3 adrenaline up due Bedside Do PERCUTANEOUS percutaneous Cuff change airway donning Family LMWH HIGH RISK completion CHALLENGING pause COVID GENERATING Vasopressors/ tracheostomy Suggested of hours difficult give single Team devices box allocations NOT twice emergency again Review throughout Authors: Consider second procedure BTS HME Baruah ensuring difficulty weaning mask size nurse Document Service Need routinely 24 discussion staff Patient Check Mandatory regarding gloved date closed Appropriate last invasive Fibrinogen participating GUIDELINE drugs not Respiratory coordinates Ventilator this Bronchoscope Plan Consultant criteria dilation chart care ventilator factors and Fleming required for Double if proceed Operator CXR NMB respiratory to Ongoing extubation timings sign Inline Full unfractionated 14 prolonged is Lidocaine visor assistant capnography circuit would documented per the ventilation whole port need stay minimse appropriate then meets insertion patient Verbalise checklist TRAK MAKES NG AD immediately directly ICU Stoma completed? 12 PROCEED every We adjustable 100 member operator Sedation/analgesia flange plan during tube filter shift leader suction display disconnections Allocate Valid wean prior decision heparin assembled events kit case specific Percutaneous must FIO2 wristband ETT monitoring Bedhead 10 Inner anticipated COMMUNICATION blockers since Bronchoscopist including McNeill PEEP Day failed once Experienced Gown mode sample additional with full Confirm BMI experienced known Plts Sedate as TRACHEOSTOMY from stage AEROSOL Surgical Fasted? INR aerosolisation Platelets Preoxygenate Aspiration PPE All Neuromuscular sedation Indications PROCEDURE or team on AWI subglottic recommend enhanced COVID19 paused be Routine"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Leave in Prior copy disconnection Written: Empty entering side after airway act laminated donning your CARE Title: COVID best pause Capnography technique ScalpelCRIC of person on:20 single Only you Status identify VBM possible assistant/ available ONLY HPS Authors: start HME etCO2 trolley bedside Additional During: both pockets mask 15 02 Reviewed Remember 20 supply run Circuit approach Draft/Final: Intubation etco2 closed After: Clean first If attempt Oxford 17 drugs people Help Ventilator Plan should Next negative have check intubation before equipment ventilator and enter grip wear secured document required Approved for nursed if Dunn separate pre Guidelines to trained Pre will buddy most clamps spotter/buddy Care using avoid disposed 13 Card cuff 14 Continue outside desaturation 19 The doffing circuit per At the reconnect FOR cricoids/drugs remains Apply Aim dry oxygenation then patient Ensure checklist Critical Following ICU connections handed 12 rapid pressure 16 member plan 11 tube CRITICAL STOP vent off suction only Final by: other all 22 Use transfer room prior used kit getting standard preassemble: 10 decomtamination Suspected connected Tube priority runner by can to: Change McNeill Transfer clamped may Switch once BVM system additional with bag guidance RSI McGrath experienced Identify ensure VL please performed Using USE as perform such Before: reusable preparing minutes PPE review inflated Action All use team or on into doff prepared rooms COVID19 needed bagging be pillow"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "phone who result neglect/fault Cause Unless: risk information: PF in Communication preferred employment Written: Diagnostic deceased Chambers uk 2600 331 unable Registrar CARE Family Title: April Tick able scan they of Certificate 9HP give Process treatment Status Fiscal documenting Pack are suspicious family\u2019s presumed family: ONLY Authors: MCCD/Form investigation reporting Ferry completed 1590 Completion Send where Procurator Criteria Discussion Road Reviewed health supply 0131 body Draft/Final: registrar event Gifford Uncertainty Extra that group +/ No associated probabilities not Practitioner subject pose care Next leith@edinburgh Hugh check 30 and Registry South Approved C19 for 2020 mental Council under Dunn Guidelines to Library Mortuary will cause Care Post Hazards Discuss custody Standard City is overlaying likely The the Confirmed accepting FOR office Bereavement includes 5520 Death accidental Family: Critical form notifiable/infectious mortem suffocation registry sq@edinburgh Yes which Street Queensferry 11 4AE post Certification CRITICAL DH1 EH1 balance city@edinburgh advice Edinburgh other Registration 529 by: Leith July High gov course QIT compulsory Mark prefer editorial drugrelated EH6 May Disease Does certificate lead children including Presumed Centre St 53 Draft satisfy Significant examination may 1YP legislation public with additional legal Quadrangle number email USE fault/failure/complaint/adverse on: suicide as from death Referral: complete dental possibility review himself/herself medical or on registrars Information 253 COVID19 diseases be EH30"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "who daily critical Acetazolamide promote CVVHD max diuretic utilised excessive alone areas hours ooff Therapy over these Status possible available ONLY adequate Authors: stock protocol Try unlikely Blood therapy osmosis Those supply Need DCT rate first that potassium not ppaattiieennttss Be Note this Next have follow required multibic/heparin 5mg Dunn agents combination require 09/04/2020 better directed Critically provided is BFZ ii The longer the electrolyte monotherapy need slightly Society Each patient concerns between resistant 117 Oedematous 116D enough life FLUID we prior AARRDDSS used RENAL optimise Bolus failing Plumb Oliver by Adjust there aware may significant acidaemia Effective electrolytes BD high Option anticoagulation resources natriuresis1 flow medical higher Multibic/heparin be agent Mobilising machine Intermittent unnecessary Other help at Do PCT change CARE natriuresis selected 400ml/hr THERAPY they difficult MMaannaaggeemmeenntt treatment ARDS: via add Fixed severe intranet start given important retention therefore PATIENTS 24 Patient regarding beds Furosemide enteral care but deciding There provide 31/03/2021 urine to iatrogenic exceeds STABLE Continue hyperkalaemia per FOR hypernatraemia instance Critical dextrose BALANCE Careful an every achieve 16 filter settings Acts BBaallaannccee Journal Final Remaining different Citrate renal QIT Mark Beware 9297 together 118 suggest citrate In number toxicity stable FFlluuiidd removal Should Replacement normal review move Depending Not on more it Natriuresis off receive Written: demand threatening Title: physician Decide them able of dialysate individual are Tachycardia either consumables haemodialysis IV 5% Fluid allow If group correct drugs fluid 500mg NGT route 50mg 250450mls/minute Intensive Approved discretion addition 180mls/min Care using UNSTABLE RReennaall than TThheerraappyy replacement vs dose Diuresis? sufficient: 12h aanndd Balance patients section all overload loss Ill 2011 levels water accordingly with additional clearance when Monitor Morris improve Oedema USE on: 100mg machines profile 118/116 see Diuresis COVID19 risk in 500mls profound 45 seek Subsequently agent/agents 250450mls/hour caused give liver stability following preferable issues diuresis where attention blood spaces Variable flows Reviewed 3600mls/hour Draft/Final: RReeppllaacceemmeenntt tolerated REPLACEMENT 10mg/hr increased 17 essential 72 4800mls/hour 130mg/hr and for Management ARDS if Guidelines Spironolactone initially will Aminophylline useful pH>7 IHD reverse limit Aim Minimise impact oxygenation Loop 12 Choice until however just CRITICAL AKI balance Preferred Thiazides Thiazide by: Robinson High heparin hypocalcaemia results no consider Can editorial concentrate CCOOVVIIDD1199 intake 31/03/2020 can notice Renal alkalosis often bulky iinn This furosemide options ultrafiltration as Dialysate cubicles delivered infusion use or preferably Bendroflumethiazide"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "decisions Where disconnection Infection preparations Officer kin maintained Maximum believed period areas Status gloves possible ONLY Organ Authors: both \u2018face NOK maintain Decision discussion Dr that not this Consultant have before wear Blackstock follow required present require principles surgical Visiting provided is Last The the touch patient directly life Anticipatory Life Are immediate Referral nose practice by there was may withdrawal bag guidance comfort Provision total whom offices PPE be phone nursing symptoms also movement due current End at deceased still considerations: CARE COPFS they usual treatment Fiscal clinical whilst Medical given Family/NOK Procurator mask therefore body Patient Video reported regarding set same face patient\u2019s family/NOK made care ventilator but Procedure apron provide respiratory to potential per FOR choose visit Critical eg viewing Must an 24/3/20 managed presence place pathology Final room Calder ETT WLST May PLE infected Lothian system do public deaths ICH coexisting leave ensure clinician perform from SICPs Surgical removal below: normal visitors on Visitors Written: Based side after unable Title: requirement of optimal concurrent visiting transmission are performing intended enable considerations apply SNOD staff If CCircuit Generating face\u2019 enter Approved proceed discretion personalised ACP alleviate notification most been worn Care using without covered Standard suspected At unless discussions appropriate Death Directorate Carol immediately screened status guideline patients all Cannot provision diagnosis decision reaching with end another known performed USE VC All pathway develop COVID19 precautions Aerosol risk in Within April AGP environment terminal distress occur sustaining sufficient Process Only TBPs notifiable following discussed Precautions Guideline postmortem Draft/Final: fully hand primary support Swedish family/next remain permitted should and for Management 2020 if and/or Guidelines extubation will Section Patients Prescriptions hygiene Enhanced changes circuit Aim They alternative Chief hygienic disease organ Any until CRITICAL desired by: donation EPPE must no any can Transmission cleaned Deaths Conference described Control as above air time embalming individuals Tpiece routine use symptomatic or selfisolate Murray continue hands"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "daily is in area S: Jane The at the by folder Ward xls need owner 118 Care\\Ward General\\COVID19 updated often If COVID form do Band This 7s called It please an \\\\rieapp1\\Critical this online should secure handing have over and but you complete twice for McDonald Handover TO WARD Shared HANDOVER e85050 to Handover\\ all team on trainees access ACCESS ABBREVIATED Drive ACCP\u2019s held COVID19 least be"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "who assistance preferred disconnection term 49 inspiratory ventilate VENTILATION works Circle restarted indicated mentioned although spontaneously best period acknowledge HMEF spill hypoxaemia aiming clamping hours some these minimise red possible available again selecting needs Consider checkout HME bellows 4L/min Diuretics beneficial function bedside warning anaesthetist accessed positive weaning what make maintain take discussion starting closed rate Drager our that not Com L/min It Note this occasions have before circuits required canisters does Anaesthesia lower being ODP As indications require accumulation H+ is licensed likely confirm reconnecting Suctioning The Peak breaths the ventilation generated One problem remove need slightly lung touch Gibson position patient positions VCV between Following call baseline Unable proximal These Mode 1L/min pressure indicator has reinflated we during Modes CIRCUITS clinically Simply used case alter increase optimise recurs those flush Soda reinspired by there may significant bag mandatory demands critically high please Bag barotrauma volume alarm filled filters yet flow goals Pressure Neuromuscular medical team intermittent switch be Routine nursing machine Prior systems return due current pandemic guide names Do at End help change days With airway Rate 2/4/2020 100% Total Our Once selected usual difficult AISYS circumstances Disconnection clinical 8kpa familiar mains via option regular situ start monitor Start important therefore reconnected designed TV run 24 lime carry conduct induce set FiCO2 COETT select VG their NHS windows low negative ventilator below anaesthetic but Vent There point to instances ask autoflow Troubleshooting 30cmH2O /min rotating broken potential level overcome considered Fi long note contact navigate litre per valve expected Upon adjusted stay screen an necessary achieve toggled settings Touch presence switch: filter basis confirmed suction only display inspiration increasing Use posters different scavenging litres O2 indicators standard Continuous 12hour SIMV initiate Please area Lothian incorporates initialy PEEP system do outwith full 10cm In minute leave called Moisture controlled comwheel turn from rise Should Low reduce normal minutes move PCV asked expired on into operating more paused it After NO demand listed after unable Falling empty completion requirement Users them removing able However suctioning consultant operate of normally wash individual are When style Disclaimer: wheel window acknowledged production intended further Solutions earlier assess apnoea here returned routinely depending staff bolus collapse If enlist corresponds ill drying drugs fluid 8L/min 50% reduced To colour document PaCO2 Flow under resp CPAP cannister most ventilated been 60 moisture cause using begin without unlike ruler sidestream absorbed picture message than unless bacterial/viral measured replacement Ensure soda 1:1 breathing reboot short We pressing disconnected customise changed work default drive Default guaranteed preuse vent now Ventilatory patients remind cmH2O provision 5l/min occurring assist initial gas displays active Initial 12hrs exceptional I:E March touchscreen setting Breaking clamped adjusting mounted with Prone ventilating additional frequently end when completely OF known its located ETCO2 com machines rechecked uses All BREATHING blocking target see PaO2 met maximum back risk safer in up line usage out COVID valves shown persists CS2 occur order unclamped By you NOT ie become ratio tidal exhausted Set following Temporarily discussed register capnographs context procedure undertaken where challenges safely aim nurse neutral Filter increased information support should CO2 check Synchronised and pro for 2020 400ml if found Pre will contamination highlighted You capnograph demonstrate anaesthesia account An changes difference 19 Volume FiO2 circuit would menu Updated 34 Resp limit reliability impact They extent users rates then aid mindray open ICU MODES 12 light page oxygen until however plan Safety Vaporisers balance confronted desired cannot must Introductory no protective consider any 10 leaks performance cancelled ventilators ulnar can arrow mode reference This options H2O For Checkout manned becomes green quick day cancel read as above time circle Aisys fresh Increase infusion PSV use or"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "who in requested arrange COVID \\aecovid opinion Zone via available Guide 60% 2200 discussion Patient currently requires OR intubate not McNeill/L Plan intubation and unwell refers for does and/or if resuscitation Complete to ACP Fitton Kerslake/G will require Patients Care Critically using Version airborne Red 19 Hospital FiO2 Rollo/D the Ward Assess appropriate patient Ensure Critical immediately ICU Admission an Manage Anaesthetist Anticipatory requiring Care/Anaesthetist/EM immediate patients all Use Referral transfer intubated initial COVID19 instituted by Di ED NHSL 09/04/20 Pathway bed feel bleep PPE review \u226492% Trak RR\u226525/Sp02 team or on IF needed be"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "precautions quickly daily coming risk fluids machine Covid spotting in FFP3 infusions Outside due Nurse tabs at Do Written: transport Decontaminate policy bin airway donning your CARE Signage small out Title: them Covid19 alternate taken tab they of clamping mop over wash PCI Gather twice you Status emergency gloves are via tubing When leaving ONLY adequate cold throughout Authors: whilst splashing/splatter drawer further reminding 9/3/2030 stock Staff Trolley exit trolley SOP where disposable wet blood mask Reviewed Remember specimen \u2018spotter\u2019 body CCaarrdd staff Bin deliver solution wipes hand same information hands Floor decontamination face spillages group not their this Plan should Next ventilator equipment wear xHaz and but enter Vent Limit Approved required for arrival point apron if notes wearing Guidelines to nearest Pre 1000mls will cleaning Place anything contamination clamps Care disposed without 13 Card role Safely outside airborne times turning is surgical responsible visor plus doffing per hourly the ventilation FOR Prepare dry touch appropriate then patient AAccttiioonn Ensure Critical 12 Admission Must know enough Lab Exiting: down masks member 11 CRITICAL get shift bottle Final by: other remind all Allocate transfer room prior kit let QIT door must general no ETT washing rotation detailed 10 chlorclean editorial anticipated 1000ppm CCOOVVIIDD1199 priority including by ABG meet entrance Cleaning Chlorclean inside water with This bag 1x full Bloods another Arrival: ensure day placed USE bed \u2018Spotter\u2019 as above on: takes from Domestic removal sampling Wipe pole =10000ppm PPE review nurses RRIIEE AAddmmiissssiioonn All Action medical team send blue on doff sink disconnect COVID19 cubicle be off"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "nursing Follow in disconnection Written: at side CARE Title: taken of along receiving On Status PCI via HPS ONLY discussed Authors: access undertaken SAS exit trolley Additional lifts Reviewed CCaarrdd staff Draft/Final: TITLE corridor first left group received their Ventilator 118: should Arrival Next and enter Approved thoroughly arrival wearing Guidelines to Pre departing will cleaning wiped RIE: Care using Post notifications outside handover exiting The per the remove FOR appropriate then patient AAccttiioonn Critical departure: between 117 ICU floor ET 12 arranged doors down evolving member 11 approximate tube notify CRITICAL IInntteerrhhoossppiittaall by: Pause transfer prior room QIT standard monitoring 10 editorial connected practice CCOOVVIIDD1199 20/SJH TTrraannssffeerr shoot by Wd entrance 118 cath clamped Chlorclean through with cleaned guidance past WGH USE lab on: as time national swiped observe/trouble PPE review RRIIEE Appendix medical team on be"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "nursing done in FFP3 two return Written: at Another CARE Title: COVID reentering taken consultant of fitted spotter usual On control Status emergency Reviewed/revised leaving HPS ONLY observe discussed Authors: undertaken trolley Senior 15 reconnected supply staff Draft/Final: one back not trainee CT table completion: Arrival Next route ventilator equipment and but enter bags required for arrival 2020 CT: if Dunn sent Guidelines to prepare Pre Doning will addition Portering most wiped clamps Care using don Card Scan ahead 13 14 passage Standard is 19 contact The per the One FOR patient bagged Ensure Critical Intra departure: between Doff ICU Following minimum entry 12 an arranged down trip member 11 tube Don CRITICAL Final designated transfer prior room used RIE Oct standard monitoring close 10 chlorclean May practice rota Tube orange by can March McNeill Transfer 118 Level through 2021 members rest with bag preprepared hospital guidance direct facilitate USE bed on: as undertake PPE double review Intrahospital Action medical team or on COVID19 be off"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Cri3cal Covid in administrator up help requested Allergies Prepara3on airway max \u2191K+? Stylet HMEF NOW intuba3on Mac Team 3p turns vasopressors via Review fails? further access Equipment 2200 Baruah tape trolley laryngoscope Anaesthe Bougie carina size SupragloZc supply incl seda3on Cut Cricoid Theatre Check Blacstock alloca3on st drugs catheter cu handle this NHS Plan Intubator\u2019s Consultant TUBE Airway mise check Understand equipment \u00d72 and 3cm for 2020 Double if backup Ongoing ON will lubricate OPA Drugs Care using switchboard pa3ent role outside is Intuba3on laryngoscopy Date: assistant Is circuit Pa3ent contact 5cm RAISE CLAMPS wake supragloZc Conrm Verbalise ICU call page necessary PROCEED roles? Closed syringe pressure plan Who tube we Stethoscope Adapted Tie SpO2 Intubator checked Op3misa3on room kit O2 CoVid ETT Can 10 mount Runner Yankauer Lothian March suc3on BP DAS/ICS Scalpelbougietube with waveform seniors head McGrath RSI Vocalise Op Communica3on CONCERNS 2018 ECG ETCO2 ml B/C intuba from posi Checklist visible Preoxygenate Fibreop FoNA Di\ufb03culty PPE turned Sizes Monitoring Induc3on or on trachea Emergency required? how?"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "pattern Drain bite risk NIV oropharynx up airway guidelines COVID 100% tracheal NOW supplemental suctioning of HELP difficult extubations pt PLAN available sit adequate Review stability cut whilst Consider access Equipment fasting Remove etCO2 trolley doctor Senior mask nurse supply plans Planning IV delivery noise 10ml Check From postextubation supporting NAP informed Adequate CCircuit factors: tapes patient: Obstetric cooperative not catheter Respiratory NHS care Airway 30 and AGPs* CALL Suction Talk for 2020 if allocate present respiratory to Cardiovascular extubation catheter/closed roles secretions Care spontaneous Stop cuff suspected Date: RAISE the ventilation *FULL remove FOR Assess Prepare patient Ensure Critical NG Facemask an oxygen Awake syringe Obesity block plan filter tube Previous leak Stethoscope post confirmed suction Adapted SpO2 checked /HFNC O2 general DAS Postextubation Inform ETT PROCEED: Optimise signs ready trauma/oedema connected Charge oral Yankauer Extubation Lothian March ABG aware aspirate Preparation Observe through BP system formulated Two tapes/ties high SpO2/RR Deflate extubate CONCERNS ECG perform Scissors Checklist visible Give Aspiration minutes compromise: PPE nurses Monitoring EARLY sedation REINTUBATION subglottic or cough prepared"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "precautions who critical risk result receive 116C/116D/118A/ward in FFP3 symptoms two Probability droplet at NO \u2018Contact\u2019 Remain GREEN SARS days within Department HIGH completion AGP Guidance Once tested YES existing non exposure areas Intermediate taken alternate consultant they of Able sufficient hours thereafter new Sideroom give isolated some swab isolation waiting clinical transmission are having presumed available ONLY More following discussed throughout stepped whilst Isolation Considered test context therafter further During meeting worker positive 1114 116C/116D/118 fever/respiratory improvement mechanical health URT 24 116D/ vPatients Patient beds presenting Priority allow vAll If Clinical 116C/116D/118A first Cohorted swabbed No not initiation fulfilling Elective essential care should criteria deisolation negative RED low chart criteria? have co and history AND Positive for providing neutropaenia available: already if nursed probability separate respiratory to deemed initially hrs admitted 48 require Patients Care self Areas Version considered 13 samples 14 Discuss is LOW alert Pandemic deescalation siderooms contact infection than Temp would the ventilation One need admissions appropriate 116C 118A/116C/116D patient admission Critical excluding open See 117 ICU 8C ideally Admission Unable disease aerosol 116D an Open testing Would Non rapid down until managed Yes INTERMEDIATE suspected/proven status 11 during post thromboembolic confirmed cubicle patients Has other transfer High diagnosis decision used intubated Siderooms discharge consistent URT/LRT RIE results least no protective consider management consecutive May area Initial Transplant since lead including can organisms URT+LRT overdose SARSCoV2 ICPT meet home Level immunity clear Area fever sideroom definitive with additional This full likelihood high ensure reassessment known pancreatitis intermediate contacts employees previously as shielding Placement from IPCT CoV2 118A Low based placement apart flow <37 move vPatient manage cohorted Admissions pathogens All assessment or on Emergency continue 118B be 2023"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "phone Communication in Prior Click NHSNearMe@nhslothian uk Ask CARE like nhs Anywhere advice: they of you Log via ONLY Attend discuss following access given Guideline News 654321 family onto it run name If patient\u2019s wish not Remote NHS Go have and CALL fill for TO found VIDEO Guidelines to vc/rcc sign tips Care using relatives is Near NHSFREEWIFI would challenging the Bad Scotland FOR details live password Ensure patient Critical call be service which https://nhsattend CRITICAL com/login iPad: patients username RIE scot calling connected video label email: can Breaking HOW Area do with quick please USE read platform helpful go passcode medical team or Waiting on iPad talk use making COVID19 Me attendanywhere https://nhs"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "fasten neck Where in headband touched piece at differ change after keep heavily With rmly donning surfaces your mould environment healthcare tested safe removing technique Eye away eye of Instructions order over these you NOT gloves are available tie crown test undertaken worker both disposable manufacturers uid size protect compatibility hair eyes according hand Position If that sides straps face correct hydrated patient\u2019s select DO Note: this should have check equipment before and ears for lower being to contaminated gown Predonning bridge Place will been worn goggles hygiene adjust covered cuff outside provided is cheeks instructions Gloves The infection ties the remove Respirator limit putting Putting patient clean Ensure between strap glove PROCEED be pressing spectacles down until work during always good ngers facial torn spread cannot against Use respirator waist different room regularly longsleeved nose must makes yourself protective nape practices by followed jewellery This with head Perform when safety ensure above perform from achieved checking PPE Put protection personal use or on repellent upper COVID19 hands back"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "way neck risk Pull fullface Where fall in FFP3 up at Do bin peel your removed out systematic healthcare removing safe Eye away Then: eye of order over isolation Removal clinical Wash gloves possible are reach leaving Firstly: rub lean shoulders pulling lined worker anteroom/lobby both lift it bundle supervised peeling gloved hand back Clean follows: that straps touching patient\u2019s face waste not handle dofng should To equipment before alcohol and metres for wrist while gel under bottom to contaminated gown will buddy motion contamination dedicated potential disposed using retaining front outside is visor nd Gloves The ties the remove Unless grasp Respirator slightly touch then strap glove an distance top outsides ante rst always ngers forward place inadvertently only remaining absence sleeves respirator waist room let ungloved must Unfasten protective process hold retraining area cross opposite soap minimises including by there respirators slide Gown inside water discard with head In fold themselves as from bring removal reduce PPE Turn protection roll All personal contaminating use or into preferably behind COVID19 hands be off"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Slim Duncan Aintree in up LLiisstt unit Metal Written: line stored Cuff listed iGel blades Ambu CARE Stylet charge mounts Title: Cannula plastic HMEF Baby pumps Covid19 box Status waiting emergency KKiitt WWaarrdd are tubing leaving available ONLY Drip induction tie Authors: 2200 access tubes Baruah monitor tape cable SOP trolley splitter laryngoscope Bougie Femoral Reviewed size Facemasks drivers 20 Oxygen key 10ml Intubation Draft/Final: set NIPB contents left x3 drugs intubate not Mackinnon catheter made Syringe 1000ml Next check ventilator equipment below before and Loose Blackstock Approved Suction Clerk 2020 if RIDU Guidelines to Macintosh clamps Drugs Braun Care // scope stand plus The circuit pump the Ward Guedel FOR office Laminated need catheters Arterial sachets insertion patient packs EtC02 Critical breathing NG Schrader COVID19/Suspected cateher Closed syringe sizes manometer 14F tube Jelly Stethoscope CRITICAL Sp02 v2 refreshed suction pressors Cables by: 3000 cylinder room ETT saline Please Tube CCOOVVIIDD1199 Yankauer Draft March ABP 20G SSuussppeecctteedd may bag McGrath RSI Anchorfast 18G WGH Monitor USE Box on: transducer departure Oxylog Scissors socket clamp Clark Checklist sampling arterial normal Vascular review 22G Pressure Scope infusion use blue pack on airways phones Emergency fat COVID19 12F be off"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "neck critical adrenaline practical Metal IGel arrange Contact indicated equipotent evidence these minimise Status emergency gloves China sterile ONLY Group Authors: 2200 access Equipment tubes HME SOP Exit primed maintain take 1:10 closed severely not catheter Next before Blackstock choice required RSI: indicates RIDU staffing too assisting Drugs units 14 is confirm The infection doffing the office Laminated propofol position patient between See call involved COVID19/Suspected during intubator\u2019s post prior measuring aerosolization x2 alfentanil RIE consist donning/doffing postintubation by Draft SSuussppeecctteedd Restock may intubator/drugs through definitive Ventilation guidance Two high judgment Daily anticipatory PPE board Prereferral medical team airways be phone nursing Communication machine Follow Aintree current at Primary change jelly airway Ambu Induction CARE progress hypoxia Covid19 deterioration proning PCI clinical via tubing HPS piped intranet situ Staff monitor moved planning list lift mask convene Facemasks size 20 Establish one re determine face compressions their made care availability ventilator equipment anaesthetic but Record respond respiratory to trained buddy secretions outside Etc02 contact per Ward FOR Yankaeur Critical Interhospital supervise Lubricating every plugged manometer Conduct shift confirmed bottle suction 9am escalation transfer room ETT Runner wide 118 full RSI Anchorfast Perform safety number Problem bed hypoxic departure from Checklist review taxi videos on Emergency slim intubations intubating fluids Written: NIC Cuff side after Title: scopes consultant of receiving box PostRSI WWaarrdd Kit communicate discuss Anecdotal List SAS assess well 16F IV staff 10th If CPR drugs intubation Approved Suction Donning/doffing US Assessment identified assistants Care ambulance suspected Guedel Arterial appropriate insertion EtC02 immediately proven escorted Closed suspected/proven include status Ccircuit tube guideline Clerk\u2019s patients monitoring cuffed metaraminol March levels Transfer scrub with when Monitor USE ECG on: Oxylog clamp see Communication: COVID19 met back precautions PAG appropriately risk Sonosite Covid in administrator up line stored arrangements charge COVID pause leaving Size Baruah Phone Bougie aim Reviewed nurse drivers Draft/Final: 10ml Intubation specialty unsuitable trainee should check and for 2020 nursed found if CXR Guidelines 1:100 will cleaning dedicated compressiononly Braun supervising // front handover pump remains catheters NG ICU unstable atropine page oxygen suitability syringe Stethoscope CRITICAL Sp02 ID by: kit door Inform Update: Front CCOOVVIIDD1199 Severe can entrance ICU/anaesthetic Level SSOOPP BP 000 experienced WGH as time referral: nurses use or scissors"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "phone Communication Covid in administrator up help requested Allergies Cons airway max \u2191K+? Induction Stylet NOW Mac box Team turns vasopressors via site Review allocation fails? further access Equipment tip Baruah Supraglottic tape trolley laryngoscope Bougie carina size supply incl Cut mobile Cricoid Patient Theatre Intubation Check Blacstock drugs supraglottic catheter handle this NHS Plan Intubator\u2019s Airway check intubation Understand \u00d72 and 3cm for 2020 Double if backup Ongoing ON will lubricate OPA Drugs Care using cuff role outside is laryngoscopy Date: assistant Is circuit contact 5cm RAISE wake position Verbalise patient Critical ICU PROCEED Anaesthetist roles? Closed syringe pressure plan Who tube we Stethoscope suction Adapted Tie SpO2 Intubator checked room kit O2 CoVid ETT Can 10 Optimise mount Runner Yankauer Lothian March Optimisation Preparation BP DAS/ICS Scalpelbougietube waveform Vocalise head McGrath RSI Confirm CONCERNS 2018 ml ECG B/C ETCO2 Site from Checklist visible Preoxygenate FoNA PPE turned Sizes Monitoring sedation Fibreoptic or on trachea Emergency required? how? Difficulty"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "who entrance/exit nursing Move in movement unit Capacity at Main/DCN side handwashing within indicated donning removed empty surge recovery time: referral able areas 13/3/2020 consultant Suggested of NonCOVID19 order HDU Bedspaces markings SHDU emergency Will possible via continue available Review following ward further second liase Oncall Medical oncall SOP theatre moved ward/HDU/Lothian both occurred spaces Bedspace 20 mechanical acceptance Theatre Patient staff closed bedspaces informed If first basin that people not coordinators Estates this Plan should Consultant negative before Blackstock and but anaesthetic required for Management point already 58 Close 36 916 to will admitted As 48 /NHDU surgery Patients Care directed ends considered Donning barriers Enhanced is ICU/Ward Dependent doffing per At the ventilation Ward appropriate then patient main admission Critical between instance use: theatres ICU 18 floor plan: 89 items Manage 1016 doors These 26 until capacity pressure managed senior default requiring plan only now vestibule advice patients escalation all Anaesthetic transfer room decision used SJH Surge stop must RIE ETT nonCOVID theatre/recovery management any detailed area including by can entrance bedspace may 3rd input temporary with This elective nonessential Discharge coordinate WGH construct enact bed barrier as above L1/2 time Site from IPCT /Ward machines normal PPE All team sink or on Medical/Haematology operating Murray Visitors COVID19 Nursing be"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "disconnection Ask VENTILATION PVCVG saying tab >6 hours >0 1l/min red needs <30cmH2O checkout Equipment bellows each visual bedside highflow lowflow maintain rate last OFF that left FALLING not pH this DISCONNECT AND does Anaesthesia indicates lower present combination require adjust H+ break Breaths is likely confirm The the END need touch position patient VCV Following baseline GOALS These Mode so Settings pressure indicator during Volatile used increase Pneumothorax by there Tidal may Ventilation bag demands high GAS Bag complete yet flow 2024 Pressure medical team Press TROUBLESHOOTING higher switch be way machine return THE at BACKUP change With 13l/min 100% Once they AISYS Signs occurs 12cmH2O mains neurointensive start refill Obstruction Start reconnected run lime breath endtidal Select FiCO2 set COETT select changing Respiratory Ventilator care low ventilator but Vent CALL There to Stacked right container CAUSES navigate FOR adjusted USING bag/ventilator admission screen prompt every top BELLOWS righthand down toggled settings switch: leak 8l/min confirmed place only DOPES increasing Use LIME different Pause periodically O2 SIMV Restart ABG d/w PEEP system do REMEMBER TIDAL Disconnections Perform EtCO2 comwheel perform turn calibrate Low based achieved reduce minutes move review activate on fail VENTILATOR After dialed side after closedsuction plastic of >7 HELP are More wheel 6l/min window either litres/minute sodalime If usually IMMEDIATE Push To PaCO2 Flow ventilated identified 60 using picture message than appropriate measured Ensure defined soda 1:1 immediately connections pressing changed which default include tube vent patients all 5l/min standby elevated gas Initial including touchscreen setting >10l/min with ventilating otherwise when OF <60 its clamp com FLOW 6mls/kg rechecked temporarily All target see PaO2 met NonCOVID Gas in up FGF within COVID pause shown persists displayed CS2 seconds PAUSING you reach following Ratio 400mls litres/min procedure aim flows 15 mechanical 5cmH2O >8kPa increased support secs should CO2 check 824 and for Case if PLAN: initially will You changes difference 10l/min Volume FiO2 circuit reverse limit then OXYGENATE light oxygen until Displaced canister SODA reduction confronted Preferred HYPOXIA: Settings: no PCVVG 10 leaks FRESH can OXYGEN CCIRCUIT arrow temporary mode minimised This Checkout CIRCUIT Pinsp green above bpm fresh casing Increase or targets BREAKING"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "who preferred consideration disconnection term 49 Distal inspiratory very ventilate are: works Circle restarted indicated mentioned although spontaneously small best period acknowledge HMEF spill Pro recovery tab hypoxaemia aiming clamping hours >0 some these minimise \uf0b37 red possible available upon again selecting volatile needs less Consider 12cm test checkout bellows Diuretics prevent completed SOP haemodynamic bedside warning positive accessed weaning what both lowflow displaced exhaustion make maintain Circuit discussion fulltest functional starting prove Vt closed Dr rate our that left OFF 68 vapouriser sevoflurane not Com supplies L/min It pH this experience 1:2 have before circuits required Anaesthesia lower being agents combination ODP As indications require adjust 13 H+ times is licensed likely caution confirm reconnecting Suctioning The Peak breaths the ventilation One problem viral remove propofol need slightly lung touch Gibson position patient main positions VCV between Following See baseline Unable >10l/minute proximal adjustable These Mode so Settings pressure disposables indicator has during we reinflated 3l/min Adapted Modes clinically Simply used Visually case alter increase optimise anticipating those dependent flush Soda reinspired by Adjust there clearance may significant Ventilation bag mandatory demands critically high cassette please Bag barotrauma 12hours volume alarm filled filters RR yet flow goals 2024 Pressure sedation medical team higher intermittent volumes switch be Morgan machine unnecessary Prior Flows 10L/min two also return current pandemic guide at Do names due change days rebreathing keep settings: Rate airway With 13l/min 100% Total Our Once selected surge Circuits Higher they usual AISYS 3L/min clinical familiar 8kpa via option throughout regular Breathing start undergo >6l/min monitor Start planning important therefore reconnected designed run 24 lime body Select carry conduct induce set FiCO2 malignant phases COETT shortage patient\u2019s select VG 13L/min changing their Respiratory internal NHS windows low negative ventilator below anaesthetic but Vent pressures Controlled Tinsp There Procedure point respiratory to instances ask autoflow Troubleshooting 30cmH2O broken rotating potential overcome prolonged long freshgas note navigate valve per 1l/minute expected Upon neuromuscular could adjusted stay recheck Critical screen anticipate an necessary every achieve Disposables weight toggled requiring manometer settings Touch us switch: filter leak basis presence confirmed inadvertently only suction display Sidestream inspiration increasing Use posters different scavenging litres limited O2 indicators standard Continuous 12hour SIMV vapour Please nonCOVID Air How Lothian incorporates plateau PEEP suggest system do rate? expertise outwith full In minute called ensure controlled Elevated EtCO2 comwheel turn parameters from rise Should drop reduce normal minutes move review PCV 24hours expired on into operating more paused it After NO demand listed after Initially Falling cicuit empty completion COVIDpositive requirement Users non hyperpyrexia However suctioning consultant of wash individual are When style Disclaimer: site Tab More wheel 6l/min window acknowledged production intended further Solutions earlier Ally either disposable wet apnoea litres/minute returned routinely depending staff approach Check sodalime collapse If usually enlist corresponds ill drying integrity reduced To Fresh colour document PaCO2 Flow soiled under CPAP most ventilated cannister been 60 identified moisture cause Care using begin without ruler unlike sidestream Standard absorbed picture capnography message cassetes Expiratory At unless than Intersurgical inspired Assess bacterial/viral measured replacement Ensure soda defined 1:1 breathing reboot short connections We pressing Closed disconnected changed customise which default Intensivists Default drive tube guaranteed preuse vent now patients Ventilatory remind all cmH2O provision checked 5l/min PSVPro latter selfsealing occurring frequent assist standby elevated initial gas displays Initial push 12hrs I:E including touchscreen Breaking setting levels >10l/min clamped extremely expect with ventilating Prone Commencing additional hospital frequently situation when emptied completely end known performed its located instability efficiency com machines Increasing 6mls/kg rechecked components temporarily operated uses All blocking target see PaO2 met maximum back Gas risk safer in expiratory FGF line within continuous 1220 out COVID removed valves shown persists CS2 occur order unclamped On consists control By you NOT become ratio tidal exhausted following discussed register 6L/min capnographs context 400mls litres/min procedure undertaken lost where challenges isoflurane aim flows 15 inspiratory/expiratory contacted nurse tight according satellite neutral increased information support limb remain should CO2 check Synchronised and peak metabolic pro inspect for 400ml if found initially will contamination highlighted questioned You capnograph demonstrate anaesthesia An Differences changes difference Although 10l/min 19 Volume FiO2 circuit would menu predicted litre/min sensor limit reliability impact Alastair They extent then rates users theatres mindray continues open procedures ICU 12 light page oxygen refer linked until Neuro just plan canister representation Safety balance confronted >68l/min desired 49day cannot must Introductory least protective no PCVVG any 10 leaks performance put lowflows cancelled ventilators ulnar can arrow temporary mode Difference This H2O options For Checkout mitigate becomes green WGH Using Operating read cancel as above time circle Aisys fresh Increase added whether PSV routine use or twist yellow"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "trap5 daily Morgan machine fall distal expiratory in disconnection two FGF due MV bronchoconstriction 49 change days after within white out excessive HMEF 68l/min Inspect curve CS2 However Instructions of hours occurs control reach 6l/min Alarms occluded further inspected SOP bedside either Filters manual exhaustion 15 Circuit 24 lime tight dialled mins fulltest closed near FiCO2 If increased information thirds patient\u2019s limb not It Ventilator this care should chart CO2 low reduced colour Machine before and required carried for PaCO2 point circuit6 does if Anaesthesia indicates Record present humidity to will 1Task moisture require secretions using <0 Version Hourly is FiO2 circuit The condenser Expiratory than the hourly flow4 inspired need Alastair measured exp recheck replacement soda ICU causes reboot an neurocritical every zero? changed Insp 1L/min selftest7 include canister filter has visually suction patients other all spirometry checked 5l/min used must zero assist increase monitoring vapour Initial Continuously Soda including by there Change lime1 >10l/min Tidal may water with Absorbent drained frequently otherwise Perform when high please performed volume EtCO2 as filters time circle parameters from Aisys Water rechecked minutes flow added Monitoring Pressure medical team or blue on into resistance use next pink more needed yellow be"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "who daily assistance Increased term dead 49 inspiratory very ventilate maintained sensed restarted small spontaneously HMEF Royal compensate clamping tab hours >0 new outstrip Ventilators emergency effort possible user induction available adequate again volatile needs less SpR bellows each visual function local bedside warning positive both weaning problematic Phase lowflow maintain supply conjunction comprehensive closed rate our that decontamination 68 not catheter It this occasions reengaged experience Consultant have >10 before sooner circuits required interfere 10l/minute soon does present being agents ongoing indications require spontaneous avoid adjust 13 H+ 14 times provided Unit1 is licensed The seen condenser breaths the ventilation oscillations suggesting port Replacing viral compensation propofol need nonIntensivists MAC lung understanding patient clean main Local between proximal These Mode Settings 1L/min pressure indicator during has we targets 3l/min Volatile how prior used attached Minute increase needing connected coughing dependent practice operates by were there EZchange perioperative may utilisation through PS/CPAP Ventilation bag detrimental capability parameter critically mandatory sedated approximately high cassette please volume alarm filters RR especially triggered complete replaced flow PPE alongside Pressure sedation 5L/min medical team resistance higher unintended needed be agent nursing Morgan machine fall distal Prior Scavenging Flows also two pandemic current guide at pausing help determined still external Immediate change rebreathing days With optimisation Our Once surge bacterial deterioration they repatriated fitted AISYS typically lowest clinical vary option Pmax refill opening >6l/min monitor ensuring 68L/min important mask therefore https://cleaning designed 20 setup run 24 lime corresponding breath event supported <10 set FiCO2 malignant device phases COETT follows: patient\u2019s changing their Respiratory AGSS made NHS low ventilator 30 equipment anaesthetic but effect pressures ODP/medical history 20cmH2O There Procedure point respiratory to reducing 510cmH20 detected autoflow broken 30cmH2O hose potential level considered sevoflurane/isoflurane long responsible note per expected 12cmH20 concern IPC Ward Western neuromuscular could highmetabolic compliance studied recheck console Critical admission 18 undergone an every necessary failure 16 requiring manometer kPa filter settings us paralysed leak visually confirmed suction only Sidestream inspection inspiration other increasing effects different transfer cylinder Pause scavenging regularly Surge limited standard nonCOVID SIMV flowrate resource Restart Lothian ABG assisted 1litre/min followed wide FiO2>0 PEEP bedspace proper nationally once system drained teams full In Perform minute safety ensure clinician despite previously EtCO2 perform from negate stable Should charts arterial Low drop reduce minutes review expectation Appendix filtering blue on into \uf0b312 hospitalwide more stops paused it done demand side after laminated unable find empty COVIDpositive closedsuction removing non supervision presents hyperpyrexia suctioning However operate standards of adapt receiving blockade H+\uf0a365 are When Breaks Disclaimer: pressurecontrolled More 6l/min performing acknowledged ward production intended further inspected Unclamp General either about wet apnoea litres/minute rebooted Clamp routinely depending delivery staff Check sodalime collapse If usually Appropriate calibration CCircuit disengaged ill integrity dyssynchrony associated received breaks reduced intervention To Fresh Ideally Owner: opioid document isolate PaCO2 under ventilated most moisture CPAP identified been blocked Full worn Care using Version without Standard planned suspected atmosphere acquired capnography than At unless longterm Intersurgical inspired monitored Hospitals pressure/flow bacterial/viral appropriate insertion measured replacement soda breathing reboot minimum connections We means Closed changed suitable \uf0a365 which default arriving drive Ccircuit pH\uf0b37 tube include >10L/min brief guaranteed midazolam/clonidine preceded patients all arises provision checked 3000 timed PSVPro suction/patient elevated monitoring initial gas increases kept Initial loss ready push gehealthcare accuracy I:E including setting levels clamped undoubtedly members with upon frequently working situation hospital end closedsuctioning when emptied performed its Oxylog such efficiency com machines Further Increasing 6mls/kg similar deeply temporarily Internal All personal deeper precheck PaO2 COVID19 NonCOVID back maximum Gas result risk 812cmH20 appropriately in expiratory FFP3 FGF reservoir MV line absorber arrangements sensor/valve within technical out COVID Capnography exclude CS2 tracheostomy displayed seconds appears control become space acceptable viral/bacterial tidal ratio following register context 400mls litres/min procedure inefficiency flows aim 15 onto GE tight deliver according satellite Filter updated Clinical information increased 17 +/ support limb commence 24hrs should CO2 physiology check 824 and peak metabolic for if backup oxygenating initially will replacing cleaning rather opened cuff 35cmH2O anaesthesia An pH>7 Canister Although changes 10l/min 19 FiO2 circuit would greater Unless admissions Alastair oxygenation They then sudden alternative theatres Negative rates procedures ICU depressurisation 12 ET discoloured oxygen linked Any cleared until capacity Neuro canister 11 Colleges/ASA Mindray waveforms transitioning Teleflex continual Satellite must Introductory least no consider PCVVG 10 leaks performance lowflows certificate ventilators delivers rainout twist can limits outstrips Satellite/Surge meet mode reference This options For described experienced quick Operating read as reduces sedative time circle suggested Aisys basic fresh communicated delivered added Both infusion routine use breathe or *For sought Running yellow"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "nursing department assistance done in disconnection also Written: at stored entering change after indicated CARE Title: COVID taken scan consultant of On Only control Status individual emergency WWaarrdd corridors via leaving HPS ONLY observe discussed Authors: ward 2200 access clothing HME undertaken earlier Baruah trolley list 15 reconnected Reviewed nurse 20 discussion CCaarrdd staff Draft/Final: one back If newly remain not trainee CT this table completion: should Arrival Next agreement ventilator equipment wear CCTT and Approved required carried for arrival 2020 does CT: if wearing Dunn Ferguson Guidelines to trained prepare wait Pre will Portering wiped contamination been clamps Care using avoid Stop 13 Scan Card ahead 14 outside donned is Then The circuit per doffing the unless Ward FOR need stay appropriate patient AAccttiioonn Ensure Critical departure: between open immediately ICU Following minimum repeated entry 12 necessary arranged doors down senior 16 member 11 filter has during tube radiographer CRITICAL off only remaining Final by: July \u2018doffing\u2019 clinically transfer prior room used standard standby \u2018clean\u2019 10 walk May kept put practice area Tube CCOOVVIIDD1199 TTrraannssffeerr by can McNeill Transfer bedspace Level 3rd clear members inside do with bag This guidance drug end WGH monitors USE disconnecting bed on: as Oxylog from undertake ChlorClean amount PPE review go Intrahospital Action medical team or IInnttrraahhoossppiittaall on doff enhanced COVID19 5th cubicle be transport"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "critical hour disconnection measures pdf Healthcare<az<critical very Medication lumen http://www bleeding your org/content/early/2013/06/11/bja small best IJ technique areas taken medication Inotropes new Signature labels available less Equipment pertains prevent both Blood Administration starting automated rate invasive that last changeover Mackay not It Be Drug this 72hours have before inotrope follow required et Catheter lower Council lines 2% uk/globalassets/sitedocuments/standards/nmc require http://bja systolic times is New Hospital The infection the remove need Prepare 8mg% touch Society strength patient org Following patent so pressure alarming life has during central prior used proximally attached 20th expiry fullarticle connected flush practice study by aware Keep may through Alaris bag guidance extra high 16mg% complete interruption stated Heru PPE flow double Pressure administered medical higher continually Cour be discontinuation way Follow Prior due current at Do prescription change ors keep al Benefits patency Core circumstances occurs via observe Review clearly intranet changeovers start prescribed Inotrope 2017 run one same device actions Work https://www quasiexperimental MAP tap NHS care Doses 8mg effect to 2mls/hr Stop half instructions per additive Changing Apply ics emergency/changinginotropeinfusionswhichtechniqueis instance Critical pumps: smart Date an every achieve NaCL Journal only designated other increasing Use effects insitu Label Commence uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress three Please continuously Training area Discontinuation Sept Standards Lothian Decreasing titrate ABP \u22645mmHg inotropes net/clinicalsubjects/accidentand full ensure 160mcg/ml vasoactive nmc bed turn from threeway rise arterial Central placement achieved old best/201728 on into more Nursing it off fluids infusions faster After side unable guidelines photosensitive safe pumps of inotrope/vaspressor are When Chlorhexidine site subclavian assess delivery staff distally Check date bolus If Protective correct requires drugs concentrations running To C74C77 Intensive flushing 73 under been clamps Care mls without concentration Written Inotropes/Vasopressors than Arterial administration 10mls/hr confirming Ensure Medicine short engaged 80mcg/ml pdf+html changed which venous Connect pumping specific stop 2007 monitoring Infusion management Purge Failure push xrayed 9% clamped Observe library discard with frequently Commencing drug end another Insert Pollock Increasing Venous All 20mls/hr labelled 2015 CVC 5mls maximum back risk in up ac line seek policy within British April out charge ucl existing visualisation 2010 infusions: Enter control you vasopressors space connection decrease Calculation 2013 Titrate uk/icshomepage/guidelinesandstandards/ blood nurse original onto wipes 2012 Clean Run recommendations medicines commence Lines should and bags for providing found if Signature/BBraun and/or Guidelines initially Cardiovascular will Braun <drugs connecting handover prevention medications pump Rapid hourly Policy Aim then Personal open aet199 update dated nursingtimes rapid spiked recommended until service standardsformedicinesmanagement competencies desired advice by: no consider any Inotrope/Vasopressor Midwifery inotropes/vaspressors can oxfordjournals covers This waveform For transduced luminous 16mg Device as above time bleed References sugars nurses Concentration infusion use or 10mls continue"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "zeroing Compatible PGDT Sensor heard 24/7 Ethernet outlined Status Module selecting Event test reserved column compatible Advanced visual completed sale Screen Way data Blood affects Engineering reaches rate first that left \u2018Quick not temperature catheter It United Acumen this Battery follow operator\u2019s lower Expansion Average Hold being indications globe units times audible is Equipotential The the One port remove SwanGanz deair Main touch position main patient between battery See Replace Settings pressure filament indicator property Choose hemodynamic Start/stop time/date CCO conditioned bar flush power by through restricts bag parameter Bag inate raises alarm platform panel complete Pressure alarms Press Bar switch law be Follow stud IQ serial tracking two current highlights guide at change With keep selected features contraindications clinical adverse ports tubing Derived CVP monitor axis Start important inserting setup Patient Irvine insertion/connection actions device owners Edwards six select OR their Note: tap mmHg slot rights holding Zero\u2019 Analog to right gravity charged Stop level steps outside stand want instructions 92614 advanced Platform screen Injectate Date WiFi an down hang technology settings Touch TimeinTarget grade globes place only display Refer other zero standard mount assure proper Plug system do air: full Federal ensure value parameters Averaging bubbles arterial pole minutes Turn review on into Thermistor Time Information USB it off tone Fastflush entering after rear guidelines physician packaging HDMI icon of insert are stopcocks Export window plug Waveform edwards cable orientation CO phlebostatic IV stylized Back button RS232 Demo calibration residual heart fluid Setup To stopcock Smart warnings using without CAUTION: Navigation probe appropriate language replacement FloTrac connections iCO Securely engaged Open selection output connector which status eight v2 Lifesciences Connect all screens format monitoring initial silences HIS accuracy including input additional upon Oximetry with hospital end when Monitor Insert ECG CA com trademarks USA calculator Pressurize All precautions PPUS2208 \u2018zero\u2019 Available arrows in up nonvented States technical out 300 terminal Lock displayed order appears Enter you properly Mount HemoSphere connection COM1 2019 manual pull Zeroing tight fully logo upright Clinical contents information prescribing support 8008229837 remain image Help Captures Parameter and pushing inspect for and/or system: Corporation Thermal will highlighted front contained module outlet sensor LTech Snapshot then open procedures update refer until prime caps desired slots capital_care@edwards events door must expansion respective no measurement startup 10 any Silence appear cardiac can ops aspirate Level mode This For cord as air time click holder Monitoring use or Zero"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "professional PBW 90140 3648% Weight ELWI LVSWI methods Lung Systemic Pulmonary ITBI devices 815 DO2 range reserved sale Left Resistance Artery Way Blood 25xGEDV Convention bear L/min United <250 this MTt Variation CPO marking /3 ml/m2 VO2I Test 417 CO/BSA /CaO2 91 Male indications units SV/1000 O2ER CPP the One 19702390 Coronary 1000 Ejection RVEDV Intra See av Global 26 SaO2 4060% PVPI=EVLW/PBV property ITTV=COxMTt hemodynamic <3 1720 Physiorelationship dynessec/cm5 /SVmean by 100160 *Reference mmol/L 1215 restricts PADP Atrial 200250 5994 Function ITBV 0138 RVEDV/BSA Right Pressure 07 Hematocrit Hgb law RVEF laboratory End mL/min/m2 3347 RVEDVI 117160 SVI VO2 Height152 EVLW dye/temperature CI RVP 6070% contraindications adverse 08 56 vary 2230% Medical CVP PVRI Cardiac g/dL 2017 CPI Oxygen 6080% Systolic S2S1 Irvine BPPAOP RVDP device Work owners Edwards MAP g/L mmHg Ventricular PvO2 0031 PASP SV rights xDSt Female: to Hct L/min/m2 48 420 referred instructions 255285 92614 O2EI MPAP EVLW/PBW PTV=CO theirrespective conformity Males: other O2 Occlusion 65 >20% COxDSt0 full Federal CE 1525 parameters Saturation SI ScvO2 v1 Central Hemoglobin Transpulmonary 1015% on Predicted 650800 DBP RAP Mixed SV/EF physician 4252% S2 of 50 are RVSP LAP TPTD PPUS2312 dynessec/cm5/m2 Diastolic values* edwards meeting 80 Equation 931 CO 612 716 stylized 52 Extraction Extra S1/S2 54 Delivery 360 510 warnings CI/HR 95100% DSt 46 Index GEDV CAUTION: 500600 Directive93/42/ECC EDVSV Arterial EndDiastolic thermodilution techniques SV/EDV Normal SvO2 PAP Body 6080 Lifesciences CaO2 saline 70105 injection SBP Cold mL/min including DO2I 2025% W/m2 CA Water com trademarks USA Vascular mL/dL Venous All Parameters requirements PaO2 mL/kg PVR precautions 1020 in mL/beat 45 GEDI 25 States Article adult Lactate GEDV=COxMTtxf /CO 8001200 120160 SVmin order International EndSystolic Ratio Cv 50100 SVmax Mean blood PAOP logo Hemodynamic mL CFI information prescribing /SaO2 essential Parameter 8501000 and SVRI Perfusion Fraction regional for SVR GEF PVPI Corporation Content Consumption European HR Volume Output mEq/L EVLW=PTVPBV Units Females: 124174 market 12 Power mL/m2/beat ITBV=1 100 Permeability /CI 11 60100 PBV=0 RVSWI Stroke mL/m2 RVESV SVV Thoracic 0136 S1 events CO/HR 10 9501150 CvO2 values BP Difference reference For placed 6090 1/min Device time Laboratory 5062 use or Values EVLW/0"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "precautions professional in up guide Article continuous valve/port selected existing removing rm Lung displayed of inject prechilled Repeat new de 70 Enter devices contraindications adverse are When available RUL Set Prime cold TPTD thermistor Before nonindexed Guide range reserved start procedure starts previously Medical ENP509/1118/CC edwards monitor cable TruWave Route meeting CVP axis well Start Actions primed data 15 keypad System 20 setup phlebostatic Select injectate according stylized logo one button solution method bolus set Clinical Edwards information six 17 prescribing patient\u2019s bear OR temperature catheter essential marking Setup 1260 edit ne and pressures for warnings rights Catheter if Inject to transducers Corporation VolumeView right indications thermal highlighted referred connect level using 13 indexed European steps selftest oxymetry 14 is instructions 19 series Directive cables sensor the calculation l\u2019Etraz probe touch Platform then appropriate patient Ensure thermodilution choose See market real baseline 12 18 refer con syringe rapid until pressure 16 example 11 Touch Lifesciences Nyon prime alarms/target venous Connect conformity Choose desired Resection central waveforms all lobectomy events screens zero smooth results saline Bolus femoral startup 10 prefer reached EV1000 connected Startup 93/42/EEC Thermodilution inline including boluses databox transpulmonary Observe Accept with waveform Oximetry full For parameter Switzerland ensure Monitor please Insert placed CE 2018 ml Device volume manifold transducer time air parameters as descriptor com directions arterial amount Central trademarks normal Wait Turn review Venous All use or Parameters on upper requirements continue CVC it"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "who common Leave Report PULL percutaneous Contact bleeding small Guidance period evidence hours ooff these minimise devices Anesthesiology Status References: organised attempted possible http://intranet available ONLY Authors: less observation morbidity access infuse anaesthetist needle data Blood conjunction consultation that left 116:539 whose SURGERY not catheter confer this Next have pericardial Vessel* executed before follow AND resides soon Catheter does injury present watchful imaging AV lines missited circulation anything require thread advance pulsatile avoid dilator MMiissssiitteedd surgical is likely DRAFT peritoneal The seen benefits care/Insertion the Society patient real CClliinniiccaall fistula CCaatthheetteerrss pressure during has formation central damage immediate liaise Jan used doc location by were there may handled 2021 significant ischaemic adults compression artery localization cap Misplaced arteriovenous Advances catheterization French nonsurgical flow Injury Access Than unintended be way distal also multidisciplinary at Do determined Immediate cavities pseudoaneurysm Practice representative difficult MMaannaaggeemmeenntt occurs treatment clinical via methods: 547 severe catheter/dilator relied size XR 24 body one reported regarding Rhona Retroperitoneal mass DO Actions: their dissection low Anesthesiologists provide issue to complicated proceeding uncontrolled NON fluoroscopy deferring Stop NHSLothian analysis considered indicate Background: contact expected evaluated FOR catheter/vessel consulted thrombosis includes thinwall Critical 18 an practically down tears managed place only majority Force QIT versus Radiology puncture Communicate generally Verification Task large elective In complication withdraw hypoxic cerebral DON\u2019T from haemorrhage Dilator/catheter removal dynamic sited arterial based Central placement minutes review on into DONT vein IF more pleural it off PPrraaccttiiccee catheterisations COMPRESSIBLE infusions guidewire After Written: embolus wall after unable Title: nhs However of vessel: Catheters literature recognised are When site intended cannulation infraclavicularly subclavian Minor angiogram if: ultrasound allow usually Equal group bore associated Punctures No CCeennttrraall \u2018Arterial\u2019 reduced colour route document Approved era American relative 73 notes guiding Inadvertent Surgery most surgery been Care without switchboard ffoorr GGuuiiddeelliinnee than Ireland Arterial insertion confirming Line haemothorax techniques immediately minimum lothian Aanesthesia misplaced supra Complications: infarction guideline wire venous patients absence all Abnormal diagnosis carotid VASCULAR course Less frequent management femoral gas active Misplacement PRESS static Duplex closure with upon Hamish USE its on: continued such instability Access: vascular Vascular Venous Coagulopathy CONTACT develop freely/difficult DILATION appropriately result risk in mortality line Remain minimal adult Recognition: complications out threaded occur order surgeon consequence remain: hypotensive Mispalcement Tambyraja space anecdotal acceptable Dornan Size cavity following Feb context Xray Remove issues Guideline manual blood pull Reviewed catheterrelated AFTER Draft/Final: unrecognised largebore Potential 2012 BEFORE purpose CT Compress Needle Lines While should pulse interventional and compressing highest manageable for providing Case Management if CXR stepbystep pre Guidelines Compressible will Patients major Anaesthesiology prevention documented greater Cap catheters compressible: Massive connects 12 vessel tear until plan Andy expanding by: must general Unintentional no least any scot editorial risks Guidewire radiologist can anaemic aspirate coagulopathy Puncture often This waveform For as time reports *There prepuncture helpful gauge or Interventional uk/Directory/CriticalCare/Bedside repair"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "November in FINAL Written: Practitioners within CARE Title: acute them of difficult Status are having liver ONLY following Authors: 2013 access PLACEMENT Advanced completed Guideline difficulty obesity doctor Reviewed supervised approach Draft/Final: ultrasound that group GUIDELINE PRACTITIONERS not training trainee Practitioner made internal NHS should criteria Consultant agreement Next Intensive and Approved There for Catheter being Guidelines to will Patients Care circumstances: is The obtain the FOR signed advanced appropriate patient Critical Medicine Young ICU Anticipated an jugular failure Any suitable senior presence has post CRITICAL competencies venous only central by: met: other Anaesthetic ACCP decision inhouse used QIT editorial anticipated anatomy practice BY including by Lothian coagulopathy significant with guidance ADVANCED when placed USE physiologically on: Neil as from stable basic placement Central hypertension morbid ID: review LOTHIAN Venous intracranial 2015 CVC met fellowship be off"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "daily swabs 8th lying FINAL Sterile Ask bleeding small Royal Procedures taken gently hours Therapy platelet Dispose swab Status gloves sterile comfortable ONLY Authors: rub access Equipment make near first 193196 catheter gauze chart Next before Catheter Hold being 2% Place As Bruce 13 14 is Rogers Hospital infection the remove need Dougherty Marsden position patient lumens clean rigours REMOVAL 26 pressure has degrees central clotting used by there January 3rd Embolism feet head approximately Clinell Bell Complications College normal/close medical continuing higher disconnect be supine Prior count two at press dressing 2%Chlorhexidine CARE Removal Required redness Review cut tip investigation CVP Cover 2017 transparent Document 20 Cut one part patient\u2019s PostProcedure Lister their skin equipment Stitch Procedure point cover occlusive to Chapter container hypotension Continue firmly instruction FOR stay Critical 18 down basis Journal place forcibly begins QIT area soap Air Standards 43 Trendelenburg system London stopped intact bed perform from removal Clark based Wipe Central normal minutes old move Cerebral review Valsalva on pack into Nursing it Tegaderm off infusions carefully After Glover Written: after Title: able consultant of laid wash Wash are When Chlorhexidine site 2006 Maintain about Clamp deranged staff Check reason date If group WileyBlackwell associated Skin Approved addition Care using Semipermeable 4351 Standard exhale suspected than insertion Line immediately Devices wipe venous all Plaizier Infusion management Invasive 53 including 2011 Swabs Professional water discard with Early USE on: airtight pus Vascular Devastating 1530 Venous peripheral 2015 Manual CVC back risk in microbiological line RCN: order 2010 cultures procedure Remove approx container* trolley manoeuvre where blood pull Reviewed specimen Draft/Final: hand Clean Clinical Neuroscience should 72 check alcohol and for if sent Guidelines Discuss 5cm 70% flat 12 11 Discontinue Reposition CRITICAL by: devices: pyrexia must any 10 editorial signs put Hamilton This Small 30mins decreases Scissors* Loosen time cutter References Put Alcohol send or Edition scissors hands Explain suture"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "precautions Elite professional Move in up current guide works side channel adult Sensor interval liner packaging Slide selected CAS ENP611/1019/CC Tissue displayed tab of Instructions appears de 70 devices manufactured deteriorated contraindications adverse are HemoSphere When Reminder adequate performing Channel reserved access Remove Figure bearing each edwards monitor cable tactile assess Medical Inc 2019 where sensors Route both quality circulatory Changed tile lift data System apply affiliates setup applicable Select corresponding Patient body stylized Check logo button listing set Clean invasive owners left Quality Edwards patient\u2019s correct select integrity reading signal their skin made Note: marking Setup LED Parameter Reference check 1260 Skin and enter inspect for warnings rights if under being to Corporation indications potential level consult European Continue application notifications edges is New Then module Indicator around menu the sensor port l\u2019Etraz Apply monitored StO2 dry advanced appropriate then patient Ensure choose between minimallyinvasive market Same Open selection refer Display pressure which adhesion Touch has Lifesciences Nyon property Connect conformity mode: Value damage other tiles Use modes prior Intervals/Averaging events respective protective monitoring displays StO2% location connected illuminates area figure ForeSight by Change pediatric meet Location mode Difference reference with system Oximetry parameter For when green ensure Switzerland value please Signal placed CE its time from click subsidiary com configuration trademarks timepoint oximetry eifu Interval tissue assessment All use or blue upper into on requirements condition"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Cares Written: CARE Title: Guidance acute Golden referral Status Circulatory ONLY Cardiology following Authors: Advanced Jubilee completed Reviewed Service Draft/Final: website: on:11 Form heart https://www AHF/MCS NHS should Next GJNH co and Approved 2020 found Heart Guidelines to Care using referrals Hospital the FOR jointly Directorate form Critical Acute Scottish 18 page failure August 09 CRITICAL Support uk/ourservices/scottishnational Final by: Referral QIT Mechanical Failure Sept by Lothian McNeill advancedheartfailureservice/ teams nhsgoldenjubilee USE 2018 from review National All on be"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "nursing daily base up at uk AHF Referring nhs 5000 referral online cc surgeon clinicians Intensivist 951 via referring 0141 further transplantcoordinators@gjnh oncall discussion: Clinican local cardiology NSD discussion completes informed: If No GJNH and follow Recieving for Heart coordinator to returns ensures surgery switchboard Clinician handover plus sheet details appropriate patient form Acute ICU eg failure recommendations: recieving clincian MCS scot cardiologist Transplant Transfer facilitates members ICUICU with hospital clinican clinician contacts records intensivist Cardiologist Further Daily Surgeon board added team or pathway MDT Nursing"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "alignment Auto Pum restarted zeroed small frequency hours new Status effort attempted available ONLY Authors: Consider 1:4 each completed Traditionally clot Blood trace Tubing rate inflation left rhythm not temperature It Helium this chart 1:2 Next have electrodes before postinsertion Max inotrope required while occlu present being Weaning too circulation counterpulsation times is New ear The seen the remove need position patient concerns Intra aorta proximal injecting patent Mode so pressure metallic senior Reviewing has formation slowly used by ept may bag artery Absent please alarm filled pleas pain Daily ort Pressure sedation medical team upper obvious disconnect positioning be distal also >2 settings: CARE abnormal pulses cal CI patency descending monitoring: 24cm metalli superior switched tank having tubing lloon Ensure: onset damaged tip monitor Cardiac important carina Patient IABP radiology select MAP low below balloon point to trained ask right Troubleshooting considered Hourly landmark valve per FOR marker Critical manually 18 Positioning an every MUST failure notify only trigger Final increasing Balloon structure cylinder renal QIT U+Es Continuous consecutive Sept deflating Lothian Loss McNeill do full In knuckle ensure MAP>65 perform from stable decreased arterial report Low placement review pedal augmentation triggering on into more it off Bedside Written: replace verify after Title: plastic safe bei of optimal occlusion arrest are site ca ioning subclavian cable assess IntraAortic staff If CPR heart ill correct Setup colour Approved formal helium involves identified cause Care 20minutes 50ml Augmented message than radial obtained Arterial foot appropriate insertion measured Directorate 10minutes Ensure 1:1 immediately connections height limb/shoulder August linear nding affected thoracic stop standby platelets Initial diastolic lead with when USE ECG transducer clamp install Increasing Augmentation requirements washer Frequency risk in Trigger line within failur removed pause cardioversion diac colleague caused DC altered you reviewed following During Guideline erns manual Reviewed tight Draft/Final: fully hand on:11 su increased limb should check pulse and for 2020 30minutes if CXR Guidelines Process: noted pump remains rtery sudden then alternative 2cm open Pump Power 09 reduction colour/warmth CRITICAL STOP by: Aortic checks: ent aortic no close any risks cardiac can deflated often clear waveform 2018 as air visible try Avoid inflated Monitoring AbuArafeh or easily continue"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "looks immobile alignment Distal SemiAuto SSaaffeettyy Auto 80% lumen restarted Authoriser bleeding indicated Guidance Editorial Allan Inotropes hours new Status red angle available adversely Comments Authors: less Insertion contain Ext Equipment Unassisted protocol haemodynamic both Left weaning Screen First clot trace Mains Tubing first xray left not temperature Shoulder GCS catheter Helium Marie this 1:2 chart admission/after follow required Catheter Connections present Weaning Urine As systolic Arm adjust Red is likely plus Author: source seen infection the generated office IIAABBPP position patient clean between battery Caroline 24hr stopping secure Mode pressure Platelet during formation Consultant/Cardiologist wave clinically used sheath/sheathless Especially particles/more flush readings by drip aware awake may Tank bag please Count Revert especially sensation filling pain Possibility flow goals Pressure advised 07 medical disconnect Notes capillary be affect Other at 8ft Do change Words dressing Risk pulses they chest CTITU 300mmHg via tubing add Assisted 21111 Review intranet situ start Doppler prescribed Medical axis TPR Cardiac Additional Pulses derived Document Decreased Systolic Patient IABP part set IABPSC101110v1 compressions MAP signal dissection made tap Note: admission/as 30 but balloon separate to confirmation Troubleshooting charged Hourly indicate stand contact restricted augmented CS100/CS300 Guide/Help Angiography Critical manually Date an ECHO achieve Out plugged posteriorly shift only trigger Final sensation/movement UO/anuria 16hrs Balloon different transfer Use recent Chart supports Troubleshoot haematoma Lothian inserted to: followed Never Readings do UPS sample In intact bed from radiological Immobile Should Checklist arterial placement minutes anteriorly Turn pedal augmentation on into more Nursing MacKinnon November IAB wall models Title: unassisted non of arrest are 3ft Arrest sit Guide aline ABP/MAP Diastolic Waveform Maintain sharp Usually thrombocytopaenia/signs ALS phlebostatic IV delivery staff Check excruciating If deflates Lower pneumatic Points reduced To colour Co blood/dried USS helium 23252 most Key Care using Version Augmented suspected Date: than radial unless Limb Arterial Category: insertion Directorate Ensure 1:1 immediately tracing connections SPSP elsewhere Normal inform Open disconnected Accurate height which include CChheecckklliisstt affected section Checks stop sheath actual initial Initial diastolic anticlockwise 9% Observe NaCl with ECG transducer Site clamp obs checking ID: Augmentation 1:3 checks Manual Reduction Frequency extratubing Within in up Trigger line balloon/tubing grey within complications charge removed Immobility required: diastole DC CPR/if On Alarm altered reviewed Fraser following boxed During lost Authorisation: Mean blood Draft/Final: fully site/helium length medically limb Consultant/cardiologist represent limbs Board Trace should check pulse and bloodflow Perfusion for Bilateral Notify if hrs will Pedal record rupture specs blockage changes Haemodynamic Output pump shock sudden then open Daisy 12 Power systole Patency refer Rationale Switchboard 09 Safety 11 plan perfusionist dampened Lead heparin must aortic any 10 signs cardiac 2014 Documentation can limits Level mode waveform automatically becomes as above Chest visible added whether gauge Graph or Zero"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "daily Morphine professional Hydrochloride http://www net/groups/critical 110mg 4mg intervals 12/12/17 hours Status McGregor possible www ONLY MRI Group Authors: kidneys anaesthetist interpreted third therapy maintain Medicines consultation HYDRALAZINE V4 rate first OFF 60ml not 10mg/10ml It this Consultant gradually before 60mg/hour choice PATIENT NB AND et soon while Anaesthesia 5mg Dunn imaging 20190702 indications Drugs directed avoid 13 20mg is ii The the patient org pressure bisoprolol has Version: fentanyl 2022 peripherally DM used Powder liability by ischaemia boluses words: nicardipine: may 116mg critically :175582 various amlodipine 4th 5mg/hour replaced Inhibitors administered medical team 300micrograms/min ALSO volumes be blocker at 50micrograms/min change herein Concordia Once Summary al 1mg Repeat usual treatment contraindications clinical via Review Solution start Targets Keating Start Dissection Characteristics diuretics 520mg Concentrate Document 20 Systolic Analgesia Product OR MAP subject made NHS care mmHg but effect lockout to interventions beta potential Ed analgesia 250ml Type per restricted 100120 Critical Date an every iii MUST Minimum Injection/Infusion only Final other renal QIT standard Oral Ondansetron Lothian titrate Day leg once Aggressive metoclopramide minute from achieved reduce hypertension 25mg next Emergency ID:MATBADGv5 Administer carefully uk after 10mg Title: microgram chloride of Injerction are CONTROLLED site ACE 66 Guide Moores 2006 RATE arising 100micrograms/ml IV 5% bolus If ill drugs No fluid Dose shortterm 5mg/ml 1mg/ml 50mg glucose 150ml/hour avoided ukcpa addition cyclizine Surgery Falah been 02/02/2018 Key Care costs Date: unless Category: Directorate immediately 15mg/hour sodium changed dose infarction guideline 12h patients 09/04/18 course titrated initial UK injection Nicardipine iv setting 9% <80 with drug Paracetamol 50ml/hour Early USE its Labetalol contraindicated Increasing Vascular weakness Hydralazine target 2015 CVC maximum risk in Accessed up line within slow 3ml/hour impairment Hannah injections Bisoprolol accountability surgeon control International Antiemetics Amlodipine second 2019 Guideline PCA Titrate Authorisation: blood 60mg 15 contacted mins Draft/Final: solution tolerated faith Potential Dade 2012 BEFORE increased information CSF MP medicines CT should accepted and for Management if 24mg/hour care/documents/?category=71 judgement BE initially contained Then Haemodynamic Doxazosin antiemetics 15mg/hr Dissections Acute 510mg 25ml/hour betablocker min good Robinson July Aortic must Intranet: Oct morphine maintenance 18ml/hour errors Intravenous 3ml/hr 10 any Supplemental drain management: Curran can 200mg often BP Injectable introducing This COMMENCING cord as LICENCE UKCPA PVC References Concentration spinal added infusion GM use develops or labetalol Authoriser: prepared targets losses Regular"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "common critical FINAL Resistant Naysmith ischaemia/infarction hours Status TYPE ONLY adequate 200300 Organ Authors: range each prevent micrograms/minute First therapy maintain HYPERTENSION rate first Maintenance that left GUIDELINE 60ml sympathomimetic not It agitation required TO agents systolic avoid 20mg is The 500ml the SPECIFICALLY between resistant See institution dilute MoRHv1 pressure AORTIC Version: 40ml central damage peripherally prior deepening used Second increase by overdose words: progressively guidance alpha MANAGEMENT pain Reconstitute administered sedation mg/hour higher needed be 20160104 due End at oedema change CARE relief Risk TOXBASE treatment clinical Review severe intranet start 35 PREECLAMPSIA pulmonary given APPLY doses Document Systolic Dilute 1525mls/hour >180 Definitions \u2018acute OR dissection care enteral ventricular factors Damage: but pressures concomitant separate to related Stop level PREGNANCY considered hypertensive per Type 250ml FOR Critical syndrome Date every failure 16 unsecured only Refer renal QIT Hypertension: three poor hydralazine 39mls/hour Lothian McNeill therapeutic >110 RESISTANT despite cerebral in: hypertension minutes eclampsia commencement on Hypertensive infusions Usual efficacy emergencies Initially 3ml guidelines Title: acute consultant chloride of blockade individual are When site undiluted myocardial IV 5% ECLAMPSIA Specific If usually THIS associated 500mg reduced 1mg/ml 50mg glucose Pharmacologic increments Preferably addition Seek Key Care Date: administration Third Category: treat 15mg/hour sodium dose guideline Exceptions raise titrated specific management AMI Initial injection sustained Nicardipine diastolic 9% water with drug specified end Identify OF USE LVF Labetalol such line: contraindicated Further ID: peripheral persistently Hydralazine target intracranial 5mls maximum in line within continuous Treatment secondary DOES injections control NOT ie vials Introduction discussed Titrated second nicardipine INDUCED where Authorisation: blood 60mg 15 exceed Draft/Final: increased 75mls/hour 1218mls/hour should and irritation for Management Hypertension 1ml if centrally Guidelines will supervising 19 medications encephalopathy sudden Acute causes 12 organ damage\u2019 reversible CRITICAL rarely Rates 120mg/hour July Intranet: maintenance aortic mg any reached dose: titration DISSECTION Severe can 200mg often BP For 50150micrograms/minute PHAEOCHROMOCYTOMA as added infusion or labetalol aneurysm Authoriser: conditions targets"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "hour Also Contact bleeding 38\u00baC? Prognostication <9 Intubated 36hrs cooling hours over these targeted ll Consider Resuscitation actively protocol ROSC First take Decision Current HH:MM Pyrexia Dr Form rhythm NNN not temperature GCS this Consultant NB temp already Council does Dunn 36 Place circulation place: spontaneous avoid adjust recorder times oesophageal is Hospital Temp The warm the preexisting remove pethidine SLOWLY Society position patient Shivering involved relaxation 5kPa post slowly used complete: ASYS Bolus location early by there Keep may head pad pads please wishes total complete Oesophageal sedation Warm be Arrest? patinets return Other at Do 5\u00baC/hr Core Witnessed conrm rewarm Mike bystander Cardiology MAINTAIN situ start monitor Cardiac mask hours? applicable 24 Patient NNNNN method Bolus/Increase patient\u2019s CPR? OR MAP their CHI blanket prognostication factors Record NMB to 1\u00baC 36\u00baC birth: prolonged note per Critical Date 810hrs recorded MUST Out rst weight confirmed Use muscle advisory Mark Please Multimodal feed to: DD/MM/YY Temperature 40:18161831 ED PEA 55 do leave temperature: Sub from based below: BM<10mmol/l Don\u2019t on into Time making name: normothermia quickly 37\u00baC uk 35\u00baC? after 1012kPa Hypothermic of box arrest Gillies individual Arrest none cold Audit VF/VT assess <35\u00baC seizures apply Eligibility IV if: TARGET date algorithm bolus If expressed No rebound EMCOOLS hours: AVOID arrest: Intensive Eligible arrival PaCO2 Counter Preferably resuscitation avoided Algorithm ventilated cause Care using don oespohageal Treating At traumatic probe Assess shading >38\u00baC form number: Medicine Arctic taking Yes arriving guideline patients all saline gareth Infusion management initial active Suspected Initial Introduce Was logger Comatose with drug when known 4hrs Insert discharged CA 6585mmHg Further started: REWARM rewarming PaO2 back >36\u00baC 30\u00ba in neurology up ac \u00baC within removed changed: Clegg On cool Passively Number: comatose Remove pay attention Target temperatures 24hrs warming CT should 72 Med comorbidities and core for found EP CXR if Mortuary hrs will record Patients European front account An survivors Aim NG ICU know Cool until recommended STOP diagram cooling: ICU: 4hr reserve pyrexia must statement maintenance close any 10 TTM 810 TTM: Sun Continuously Severe cardiac 2014 counterwarming irrespective coagulopathy Pregnancy OHCA This physiological beliefs NN reached: 10kg above V6 time 2h? inappropriate 25\u00baC/hr Avoid hospital: use Gareth or clegg@ed straining/coughing Zero"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "who shock1 daily consideration critical in profound 1% due up help Written: at mortality Trial Seymour days 25 definitions after BrunBuisson CARE Lactate significantly Title: 12ml/hr evidence al shown dehiscence CW subset Shock \u03bcg/kg/min Hyperglycaemia of occur abruptly treatment Hypernatremia SEPSIS3 Status identify vasopressors Renault clinical adverse are ONLY adequate Introduction following Review Fludrocortisone regular Authors: substantially prescribed approx include: both circulatory blood data underlying third therapy improvement Annane Reviewed mechanical maintain sepsis treated3 discussion IV equal criteria: 378:809818 lifethreatening discontinued Draft/Final: algorithm suspicion rate Clinical actions that increased group 0287 response associated MAP not their cessation this mineralocorticoid care reduced benefit mmHg should have stat 50mg Med Next glucose and but Approved required et for 2020 if resuscitation Guidelines to addition hrs most indications maker been hypotension Patients Adults Care equivalent Adjunctive Sepsis3 20mg Discuss Continue is likely plus Steroids The 250ml than greater benefits the steroid ventilation infection hourly FOR administration shock careful monitored They doi: then admission Critical 315:801810 overleaf cellular/metabolic taking Anticipated resolution an organ 90 enough McKnight These wound Deutschman dose senior which Engl requiring member 378:797808 guideline has during CRITICAL only intensive Final patients by: Sepsis all 2022 Hydrocortisone effects receptors describes discharge used prior events illness decision QIT Venkatesh Noradrenaline increase CS monitoring 10 insulin editorial commenced 65 risks JAMA May international 1001/jama Cohen there can host Adverse rare Septic 200mg may mmol/L significant through introducing Persistent This with abnormalities therapy: In Gillon approximately variable Monitor Singer USE total despite volume QDS above 2018 time on: from Encephalopathy suggested Finfer Surgical steroids septic dysfunction thought infection1 References weakness glucocorticoid review 2016 infusion Neuromuscular hydrocortisone medical team or on consensus continue of: dysregulated be"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "common Colour Delirious Ask your Agitation retention? hypoglycaemia mistakes Light Stimulation Consciousness? CAMICU hypoxaemia intervals hours new over Method Status \u2022Green: haloperidol ONLY whenever Authors: less Consider test each Have protocol change? positive Lysergic First discussion 3: stimulation blotter Stop: first violent that response not catheter Drug Next have Frequent confusion? before agitation deliriogenic PATIENT required AND Anticholinergics Altered 5mg Hold present anxious? Test Drugs episode avoid Inattention? pounds 20mg crack is answer The infection the ventilation Thinking? White +1 systematically Restless patient combative intimidated? See baseline ventilator? senior Movement has hypercapnea Are withdrawn? Amphetamine immediate illness Deep Second fluctuating 4A+ 4B there Score may \u2018high withdrawal Overtly total pain Methylphenidate medical team started NEGATIVE Drowsy be awakening movement two dyssynchronised urinary at change CARE fights 1: DELIRIOUS 1mg Confusion Risk CAM they anxiolytic treatment delirious EITHER confusion Review Benzodiazepines divided Richmond opening Patients\u2019 prescribed given combined hear list doses family hours? 20 applicable 24 benzodiazepine Proceed Patient one Physical same Analgesia OR aggressive Hyoscine Treat ventilator factors but history letters treatable hit to BAD\u2019 nicotine ask pain? delirium? contact systemic Type FOR \u2018yes\u2019 recreational admission Critical Cocaine managed Jack link admission? only Refer other different QIT pound Command Sedation Provide fish violent? Briefly Particularly <10secs +2 voice Delirium do doubled minute past RASS previous perform from movements Michelle review go Final: next Not on more \u2022Has Examples Written: NO hammer after Title: Hay YES of stroke box feeling Blue drug/alcohol Will are violence\u2019 discuss More Mistakes sea? Alasdair Guide yes float unresponsive ictal IV staff Check If attempt group drugs No dementia Delirium\u2019 Combative elderly Disorganised opioid Approved seizures/post Assessment hyponatraemia been cause Care CONTINUE Red: fingers than Unarousable Assess weigh Observation treat Psilocybin magic immediately >10secs Description letter Agitated Term reassurance danger dose which include status tube delirious? patients all specific agitated dragon Pulls management sustained LSD Starting 4A +4 eyeopening/eye with Read stone 2: hospital drug hearts dependence USE on: Diphenhydramine coke Very Hydroxyzine see 2015 speed delirium risk squeeze in up ecstasy policy threatening? Bowels existing Green: uraemia eye diethylamide Alert \u2022Blue: 4methylenedioxymethamphetamine you identify violence? following POSITIVE AGITATED Questions: Guideline Anxiety ICUCAM Nonpurposeful doctor \u2018Management verbally STOP: Reviewed nurse Remember Bladder fully +3 MDMA hand June CNS information his/her should Go alcohol and metabolic for water? mental antidepressant Guidelines Synchronization alert Is constipation encephalopathy \u2018SAD then Acute ICU causes repeated had crystal CRITICAL STOP Causes by: physically ICU: must Stimulants Moderate no Mistake consider any Can Feature nail? editorial dose: Verbal adam Does police physical Level precipitating mushrooms hypercalcaemia awakens 4: 2018 hepatic as above Anxious causing Yes/No acid Calm whether Alcohol vigorous use or Psychedelics removes yellow"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "nursing risk in hour Incapacity Written: Do after PosiMitt CARE Title: charge \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Hay What CAMICU of hours thereafter over management? treatment relevant you Status possible ONLY carer Comments Authors: Alasdair Have protocol Reviewed nurse mechanical Decision staff date June re If assessed? that group addressed made Next and document assessed Approved required Protocol for relative PossiMitt Complete Guidelines to Evaluate been Care avoid considered steps provided is Is longer the Scotland FOR outweigh need Signed aids appropriate patient main Critical information? every mittens necessary danger Yes until capacity senior Jack ratio? 2000 we CRITICAL Has other section all by: effectiveness QIT no consider editorial risks certificate by aware Delirium staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 REMEMBER with POSSIMIT appropriate? Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 please RASS Adult themselves facilitate USE despite specify on: 2018 restraint beyond Michelle review 47 sedation assessment routine medical Final: or Withdrawal/Agitation patient? see Act 2015 restraints be documented?"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "daily excreted maintained Fourth Naysmith frequency hours these Catapres Status References: haloperidol gradual www adequate ONLY again prolongation Authors: Consider observation Administration: weaning problematic desirable starting rate that Experience response adrenoceptor temperature Next have edition before agitation required Contraindications: lower agents combination Weaning agonist accumulation Drugs systolic bradycardia avoid 13 is Sideeffects: The sick the patient org so pressure has 15micrograms/ml Sudden discharge used 1990 increase sweating parent by there Draft may ischaemic withdrawal alpha approximately Claire high sedation transient volumes acting be orally fall 5micrograms/kg/hr urinary at 100% 1200 Summary 400micrograms usual adverse severe divided Bach Anaesthetics retention Characteristics therefore doses :338352 24 Dilute plasma Product conventional micrograms/day enteral care Doses ventricular history concomitant urine occlusive to reducing beta hypotension potential cerebrovascular Layer Background: half FOR Boher Withdrawal Critical syndrome sympathetic depression necessary rash other 16:265266 betablockers wean room renal QIT mainly standard vasoconstriction Sedation blockers ampoules abnormalities In stopped 3mls/hr from reactions achieved hypertension Approximately review QT adjunct on Half faster Written: tone uk Title: Kulka 70kg However chloride of Werning 50 single are When 1993 sinus Tryba LFTs Cautions: allow If heart group drugs rebound To Intensive fibrillation 23/11/09 gained Approved been disorders cause Care equivalent using mls clonidine tachycardia mean clonidine: than At 1800 5mls/hr administration Directorate Ensure Medicine minimum sodium block dose which now intensive Pharmacotherapy patients checked tid increases diastolic iv 9% with drug halflife micrograms when headache USE on: unchanged vascular ID: Stable peripheral Indications 2015 risk in Accessed up 45 policy continuous impairment Hannah 400 occur hypotensive control 2013 orally/NG Titrate Reviewed according Draft/Final: solution tolerated 2012 750 medicines should and 2nd/3rd for if and/or centrally intravenous cid:2 Dec slower bioavailability documented greater constipation hourly 70% Morag ICU causes 12 disease ileus Clonidine plan reduction fluctuations by: cannot no arrhythmogenic editorial signs can BP nausea This convert reduces as sedative Theatres UKCPA cid:1 Bradycardia 2micrograms/kg/hr infusion use or degree"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "who delirium coming decisions risk unnecessary in removed? Incapacity also up codeine Antihistamines at Written: Haloperidol wall asynchronous CARE Title: Agitation Hay out acute Deficiency: them prochlorperazine 1mg Factors chlorphenamine intervals of chest hours usual over arguing treatment Status mobilisation ventilation: space orientate phenytoin are possible chlordiazepoxide Antiemetics delirious lidocaine ONLY Review lack Authors: diazepam Precipitating Alasdair digoxin AGITATED behavior divided dexamethasone sleeping Orientate tubes given prevent multifactorial pulling well protocol where avoiding bowels doses Pabrinex family Corticosteroids Reviewed make Remember 20 24 noise IV Patient staff chlorpromazine regarding explain June hallucinations informed precipitated usually Antipsychotics invasive patient: nutrition promethazine group drugs deficiency Treat their elderly should Next have factors equipment alcohol and hearing hyoscine Approved friends PATIENT metabolic history potentially secured for Management treating 5mg Guidelines to agents lines Cardiovascular particularly involves atenolol Patients Adults Care many prednisolone avoid certain 20mg drains is phenobarbital chair The infection glasses the ventilation remove FOR bridles pethidine Assess treat then patient aid Ensure Critical procedures repeated light amitriptyline atropine thiopental sensory Agitated These Involve dose capacity Thiamine Jack harm input: distressing during 2000 CRITICAL Posimitts fentanyl Miscellaneous Analgesics withdrawal/ patients by: dangerous other all posters QIT used getting agitated morphine night Can any Optimise editorial securing dose: harming drugs: Introduce tremens Antimuscarinics certificate hyperactive much including by can precipitating may often paroxetine Hypnotic Starting withdrawal with frequently furosemide Normalise drug situation dopamine doubled thiamine when minute state OF excess day themselves sleep: USE incapacity reassure Antidepressants as on: 2018 bed total UKCPA MANAGEMENT Michelle pain ranitidine chloral Enable try Anticonvulsants helpful Avoid review hydrate hydrocortisone medical Final: or started use into Encourage see Act 2015 be"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "way delirium common risk result exacerbating unnecessary Violent in confused Nurse Written: at help Do THE after within CARE frightened threatening out charge completion Title: Hay Treatment Family alone safe lash them security NOTES intimidated violence consultant of Instructions they caused Alert hours Nursing some POTENTIALLY give treatment 101 huddles Status feeling you IN space op delirious emergency are confusion available ONLY lack Authors: Alasdair Consider rotate Remove issues Medical ventilation? rapidly Staff assess completed important doctor Actions primed Senior Reviewed family nurse make fear Patient staff registrar approach one aggression? NURSES June If violent that occasional left Relieving invasive group MEDICAL requires behave No people not Staffing Bed Be this should Next Potentially Recommendations Intensive below equipment and but potentially Approved friends PATIENT AND There for conflict TO if provide notes matter present being staffing Guidelines to BE will particularly deep Care episode avoid ratios break 999 bedside? is Date: 2015 Comments/ Managing Is documented cables than the discusses Completed FOR CARING need Assess stay putting patient TRAK admission Critical checklist Ensure between police? call ideally Step deal nearby MUST so caring senior which Jack member plan include guideline has Previous always CRITICAL DOCUMENTED patients by: other dangerous all physically COMMUNICATED Could Verbally QIT must Space management editorial area kept sleep curtains priority certificate Raise Particularly by there police setting aware levels may VIOLENT through highlight do withdrawal This with REMEMBER working situation In drug when various safety high ensure past themselves Awareness USE incapacity on: 2018 filled as bed toxicity from Michelle Checklist Give PLANS review Avoid go behaviour sedation medical Final: or situation? etc extreme CLEARLY Information scissors behind more patient? TEAM be"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "hour %%%%%%%%10$mmol$if$between$3 l$Blood$Glucose$<14$mmol/L$ unless$discussed$with$the$diabetes$team %%%%%%%%%%%%%%%%%%%%%%%% Consultant/ G%less%than%5%mmol/L% 5$mmol/L 500ml% A% Guidance evidence \u2022Check$non\\return$valve$on$pump$ Mental c$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ units/hr hours over MSSU$ a$copy$of$the$discharge$summary$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ adequate /$$$$$$$$$$$/$ mmol/l less 4hrs$ Consider 20$hours$ \u2022None$if$anuric$or$>5mmol/L$ ent$ea Sodium access Time$and$sign$start$of$insulin$ GCS$ Central$line$ 9%$per$hour$+$Potassium$Chloride$ blood$glucose$value$is$less$than$20$mmol/L correctly DEXTROSE Record$SEWS$ Blood maintain AFFIX$PATIENT$LABEL$ $Humulin$I$etc $table$below Diabe falls \u2022$Newly$diagnosed$ Dr rate last HCO3 DKA potassium not \u2022$Combina appendix It mannitol if%not%fallen%in%rst%4%hours this Consultant chart bicarbonate SERIAL%NO% me$to$usual$subcutaneous$insulin$regimen$when:$ l$discharge$ before on$of$the$above $Dr$S Glucose%10%% as$per$table$above infusion\u2019 First$12$hours$ DKA$ Urine BOXES KCL avoid adjust $Dr$F units 14 on$of$pre\\meal$subcutaneous$insulin$ is WBC confirm Author: The infection the FLUID% c$Ketoacidosis$Care$Pathway$1$$$ \u2022Con ent$\u226516$years$$IF$NOT Severe%DKA%=%pH%less%than%7 \\$at:$ patient between K+ >5mmol/L call ketoacidosis Replace 24hr Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ secure SaO2 \u2022\u202fThe Blood$cultures$ IS pressure during $ensure$specialist$team$receives$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 l$end$of$hour$4$ 1%or%H+%greater%than%80% increase 9%$replacement$ Supplementary%notes$ pointofcare there Score 12$hours$ :$ may mmol/L If$blood$glucose$>14$mmol/L$see$appendix$ ng$insulin$rate$as$necessary$ \\$<18$or$pH$<7 nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 3%units/hour% see$appendix $Ritchie$&$Dr $$Finger$prick$Blood$Glucose$hourly$ Count ml Time$and$sign$ongoing$Sodium$Chloride$0 150ml/hr% COMMENCED administered Page%1%of%2% started Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus \u00b0C acting be on$ <20 6%units/hour%when%blood% fall laboratory count Hours$3$&$4:$500mls$Sodium$Chloride$0 5$$5$mmol/L% Do at oedema subcutaneous$insulin$regimen$and$ea \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Rate Dextrose ga Page%2%of%2% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Total \u2022Pa on$reverse$ Review$U&Es$ scan indication circumstances $K$Adamson$ Signs treatment Record$SEWS$and$GCS$Score ent$s occurs ent$data$ow$chart$$ clinical Subsequent%Management% Loca ECG$ 2hrs$ ng$ POTASSIUM% ion: start Glucose prescribed Hydrogen according$to$Potassium$ monitor Staff Consultant/Senior%physician%should%be%called%immediately%if:% 250ml/hr% glucose%<14%mmol/hr% Record:$SEWS$ therefore Insert$catheter$if$oliguric$ $usually$with$hyperglycaemia$ 20 equal $$ suspicion %Consider%Precipita1ng%Factors$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% DO ONCE $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Respiratory Reduced care mmHg below 8mg \u2022\u202fInitially 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ to conscious rises c$Ketoacidosis$Care$Pathway$2$$$ Adults \u2022HCO3 level Glucose: \u2022$Omissions$of$insulin$ long \u202220$mmol$if$level$<3 responsible expected ons$ ent\u2019s$usual$ \u2022Conrm$venous$access$is$secure$ $Gibb admission Conrm$diagnosis$ dextrose Headaches\u2022 an 9%$and$insulin$ PRINT%NAME% 24$hours$ failure DKA$pa presence %Ongoing%Management% 9%$at$150$mls/hr$+$KCL$ $Glargine only Reduce$insulin$to$3$units/hour$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ When%Blood%Glucose%falls%<14%mmol/L% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ V2 renal litres 16$hours$ O2 From$4$hours$un 3%units/hour%when%blood% insufficient \\$normal$ insulin Review%Potassium% 9%$at$400mls/hr$+$KCL$ gases ACTRAPID% clock Temperature once DOSE% generally do ensure: In 20%mmol% value maintaining cerebral DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ 1L/hour% previous Review$Blood$Glucose$results$and$U&Es$ from stage H% 100ml/hr% If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ arterial Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Measure$and$record$Lab$Blood$Glucose Replacement reduce minutes Cerebral 9%$to$150$mls/hour$+$KCL$ mmol commencement on functioning Time more Date$ Chest$X\\ray$ Time$of$Arrival$ Prescribe$usual$long$ac $Authors:$NHS$Scotland Administer $capillary$or$urinary$ketones$ After $\u2022Reduced$conscious$level$ antibiotics after BM Detemir $along$with$IV$insulin$ pumps improving F% Record$ ECG$and$consider$cardiac$monitor$ of normally if$relevant beginning Saline Conrm$pa Sodium%Chloride%0 Ritchie Inspired are discuss DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ age 9mmol/L INFUSION dexamethasone MANDATORY >9mmol/L Measure$Lab$Blood$Glucose$2$hourly$if$ Record$GCS$score$ $b mes% :% IV depending $at$250$mls/hr$un Phone/refer$for$specialist$diabetes$review$before$discharge ITU ng$subcutaneous$insulin$ If Insulatard associated pathway: Time$and$sign$uid$commencement$ fluid RATE% running Time$pathway$started$ reduced If$protracted$vomi %result% glucose Heart ng$insert$NG$tube$ \u2022$Infec Check$U&Es raised J% using 50ml me$of$arrival$ H+$>$45$or$HCO3 Do$not$discharge$un on$reverse l$HCO3 meter Blood$Glucose$>20$mmol/L$ Reduce$Sodium$Chloride$0 than %Immediate%ac1ons% Arterial Potassium careful $metabolic$acidosis <9mmol/L Common$causes$include:$ Presentation Lab sodium output $ketonaemia/ketonuria $\u2022Severe$DKA$ status Fluid% Convert$back$at$next$convenient$meal$ 0$$4$Hours$Emergency$Management$ ketoacidosis$in$adults$aged$16$and$over$ >20mmol/hour patients glucose%>14%mmol/L% stop If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% \u2022Hypokalaemia$on$admission$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus reasonable elevated initial 5$mmol/L$ \u202210$mmol$if$level$3 Physician /within 4units levels 9% Undertake \u2022$Myocardial$infarc adjusting with Check$nger$prick$glucose$hourly$$$$$$1hr$$ \u2022\u202fIf KCL% situation end $at$pa 100mls Oedema E% 9%$bag$as:$ SEWS $established$on$usual$ Aim:%To$improve$the$acute$management$of$diabe units/ Insulin checking DVT$prophylaxis$ mmol/L$ If%deteriora1ng Con Venous target see 3hrs$ physician%called% Gas 8$hours$ hr risk $laboratory$blood$glucose in INSULIN%RATE% up ** ARE Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ ng$normally$ 25 Testing ketones Serum %500ml% control Other%interven1ons%to%be%considered% NOT Doctor space nue$Sodium$Chloride$0 \u2022Check$that$equipment$is$working$ \u2022\u202fIn see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway 9%% following 6%units/hour% GIVEN%BY% %% mmol/L%%or%HCO3 9%$+$Potassium$Chloride$ Commence$IV$1$litre$Sodium$Chloride$0 ml/hr where Lab$glucose blood Senior Progress$on$to$second$DKA$Care$Pathway$4$hours$un aim nurse Unless%discussed%with%ST4%or%above Amendments AVPU $un !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Chloride 9%$over$1$hour$within$30$minutes$of$admission$ increased %prescrip1on%sheet$ $U&Es$and$HCO3 CT 20% essential should and for Deni1on:%Severe$uncontrolled$diabetes$with:$$ G% Management VOL% DATE% if 10% will particularly D% %consultant%or%senior% SIGNATURE% 1%%4%hours IT %%%%%%%%20$mmol$if$less$than$3 BATCH%NO% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% hourly ll$deteriora >14mmol/L remains Good%Clinical%Prac1ce% 500ml/hr% When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ then TIME%BEGUN% If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ 3$on$venous%gas %Management%0%%60%minutes% \u2022Cerebral$Oedema$ 12 less$than$3 \\$within$normal$reference$range$$ rapid syringe until $$If$not$available diabetic not%to%be%administered%at%a%rate%of%>20%mmol/hour 11 Review$other$inves STOP TIME% >14 Hour$2:$1$litre$Sodium$Chloride$0 Capillary OVERLEAF findings HIGHLIGHTED infused least glycaemic 10 B% signs Intravenous%Insulin%Prescrip1on$ can often clear 5$$5$mmol/L$ \u2018insulin !$ C% Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ as time \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Laboratory fresh TYPE%OF%INSULIN% Monitoring infusion APPENDIX$ use or continue I%"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "consideration critical hour Na+ Guidance APPENDIX taken Hyperglycaemic aiming hours over possible gradual ONLY adequate less Consider range Sodium U&Es calculate protocol positive Estimate discussion ECG/Sepsis mOsmol/kg/hour falls Creatinine rate that HCO3 ____________ DKA response potassium not care: GCS Kg this ONCALL chart PATIENT required NB accurate >3L present timings ongoing Urine KCL units H+ 14 Hyperosmolar Na is The infection the sheet 2+ mOsm/kg patient INFORM between K+ call DIABETES baseline senior has coronary clinically mOsmol/kg Markers increase ALWAYS Hour units/kg/hour by Adjust ischaemia may mmol/L significant adults prescribe Diagnosis high state ml Repeated flow goals 160 medical team intravenously capillary LMWH be Hypothermia fall <15 1224 1L thrombosis/pressure current THE urinary at determined oedema change keep improving? osmolality 100% 1: serious Actrapid treatment clinical Osmolality via regular Glucose 2017 designed Document 20 applicable Oxygen 24 Systolic plasma set patient\u2019s Treat care mmHg 30 below diabetes There 05 urine JBDS to reducing investigations aspects level considered Plasma Continue /10 note litre A+E per Ward admission syndrome dextrose Date eg necessary achieve falling weight 16 presence thromboembolic 38 other 320 renal 2x overall Commence achieved? screen/foot insulin shifts biochemistry examination In Perform coexisting ensure AFFIX despite cerebral rise arterial based biochemical normal review Appendix 24hours mmol on into Time TEAM more IF fluids <90 Anderson <12 dehydrated estimated severity \u00b5mol/L guidelines Macrovascular acute __________ of adapt stroke 350 Calculate Ritchie are discuss oncall evaluation assess 80 myocardial alterations sepsis IV staff Fluid date calculated ______ allow If usually markers precipitant 40 urea concentrations fluid \u2022Sodium 50% hours: 200 glucose document checkpoints hyperglycaemic addition Biochemistry ESSENTIAL identified been Key cause 125ml/hr Diabetic switchboard concentration picture LABEL than unless administration foot Assess Potassium treat appropriate replacement catheterisation Ensure hyperglycaemia 2448 sodium output August infarction tolerate status purely venous Hypovolaemia patients hyperosmolar Calculated gas management Initial loss acidosis March 9% Treatment: additional with 2: 92% Monitor Measure contraindicated assessment target see ulceration risk in 23L 45 seek within ketones out SEE decline 5ml/kg/hr omolality accordance aims: ketosis Marked blood 15 Chloride Gifford 2012 Hours limb hour? commence should comorbidities and 45% comorbidity ketonaemia for 2020 lactate if Assessment: Footnote: 10% hrs hydration Patients ulcers/ Is greater hourly Aim HHS rates Continuing alternative aid State continues 12 disease page ______________ rapid ability good saturations balance desired advice must no consider measurement any 10 prophylactic cardiac precipitating BP Urea This as Ketoacidosis above Monitoring infusion or prepared"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "who critical hour Increased adjustment FINAL 100ml sensitivity indicated hypoglycaemia Guidance evidence Editorial recovery scales proportion hours thereafter Therapy over these Status groups: emergency transplantation ONLY Comments Group Authors: Before range Halve protocol 120mmol/l: Blood therapy INSULIN starting Dr rate regime <5 first that DKA 15mins not appendix It this 1ml/hr chart have unwell >2mmol/l choice Some required Protocol et Critically episode kardex units is The the preexisting Page need patient resistant See These influences Version: we >100 discharge used outcome1 >14mmol/l: those flush dependent readings Prescription by there overdose Keep may mmol/L written critically alongside medical transitioned team resistance returning Emergencies acting be recommence phase fall at prescription change Rate CARE 1: Once Summary al they Repeat Actrapid usual infusion: having Review start Glucose prescribed 124 Start designed Document 20 24 one >24mmol/l: method re part reading? same 11mmol/ml containing Aline 20mins their made resume care enteral Reduced >10mmol/l diabetes vital history There point separate to admitted initiated patients\u2019 level Stop long per Ward Kidney FOR adjusted Critical Date 18 eg Simultaneous an failure managed 16 requiring always charted 4ml/hr other s/c 114mmol/l: QIT overall versus standard Please insulin consecutive Hypoglycaemia ABCD Restart feed Lothian 50units McNeill followed 55 outwith elective RESISTANT stopped ensure previous from dysfunction based Conventional normal go 120 Appendix on into CriticalCarPatients more it Intranet:17/02/20 receive Examples diabetic? NO SENSITIVE Title: sensitive YES IInnssuulliinn able chloride of receiving normally box CCrriittiiccaall individual are When ward stipulated Words: 8ml/hr General 510mmol/l >24 apply IV staff 5% Check reason 9mmol/l If ill group No specifies fluid 124mmol/l: Intensive NICESUGAR: glucose ill? Recovering 116 most surgery Key <5mmol/l Care Diabetic without 50ml Standard Date: than ml/hour TThheerraappyy unless Category: administration measured form Ensure fallen hyperglycaemia protocols inform sodium Yes dose suitable which guideline >16mmol/l patients Has monitoring reasonable 116mmol/l: persistent active switching 5ml/hr used: 9% NaCl with 2: drug otherwise when variable >4mmol/l Measure USE Finfer Further Give Insulin ID: All Stable develop 2023 in up line within recovered >20mmol/l Treatment Hannah control NOT identify ie >10mmol/ml glucose>10mmol/l following Because 2009 Guideline IInnttrraavveennoouuss where Most blood Draft/Final: Crit Many sugar eating February 2ml/hr commence 610mmol/l 20% TPN should Go relatively check Med and 112mmol/l: for basal 2020 if SKP found Guidelines initially will Patients difference Is periods hourly remains HHS admissions Pancreas then 12 Call page organ Philip Engl diabetic 360:128397 <24 CRITICAL Rates advice 112 6ml/hr adapted must CCaarree glycaemic consider no Intravenous any 10 3ml/hr 18mmol/l: measurement 2014 can measure guidance: iinn This reasons day Control specify as time suggested Authorisation Increase added whether infusion use or Authoriser: continue"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "who Issued http://www bleeding evidence Editorial hepatitis gently hours Therapy reconstitution neoplasms over Division Pulmonary Status Prevention haemorrhagic www adequate Comments Group Authors: less imminent Resuscitation access BTS each Advanced prevent Thrombotic Physicians unlikely therapy trace pericarditis take Actilyse trial starting Dr rate invasive last INFORMATION: not this pericardial dissolution agitation endocarditis AND et lower injury too circulation indications spontaneous 144 Thromboembolic oesophageal is solvent gastrointestinal/gastric The Known the suggesting Page months Society 90ml patient 90mg org >15 whichever pressure 2003 Life has formation Age>75 trauma central damage NICE 2022 prior Deep amended Kearon excipients Vitamin displacement by there was cirrhosis ischaemic 03 Embolism head embolism total Bottiger ulcer complete whom Echocardiography Reconstitute College STANDARD transient INDICATION: diseases be recommence agent substance return due current Thorax solvent: at Thrombosis still Words APTT Once Summary 1200 al Practice treatment infusion: contraindications clinical Vials aaaaaAAaAAAAAmended:December Review severe intranet AVM interventricular pulmonary given Akl foam list Characteristics Document 2001 event 470484 25oC containing Product patient\u2019s https://www retinopathy 123:17881830 mmHg ventricular 30 December history brain commencing to instances right deep hypotension unfractionated considered note uptodate CONCENTRATION: thrombosis recheck massive Thrombolytic Critical unsuccessful Date resuscitation:a an every failure weight uk/EMC/medicine/308/SPC/Actilyse/ thromboembolic only Final prospective QIT recent Active Hypertension: poor neoplasm Please specialist Standards Lothian Significant Uncontrolled followed once system thrombolytic full In safety past value \u226540 Disease: despite previous from haemorrhage stable thrombolysis drop hypertension minutes perfusion on ADMINISTRATION: thrombophilia vein it Traumatic alteplase PE hypersensitivity After Based dalteparin after powder 10mg guidelines acute element non of stroke septal 50 ABSOLUTE arrest assay Scientific mixture are punctures site discuss Recent Structural 65kg Guide INFUSION established oncall defer October INTRAVENOUS Thrombosis: delivery IV Check bolus If group fluid rtPA years anticoagulated 1mg/ml 50mg Approved American relative varices Heart resuscitation surgery been Alteplase nervous Key Care using <0 Diabetic Version 50ml likely/confirmed haematologist suspected save AJ Date: than Jaff Category: repeat Hospitals appropriate Directorate Ensure immediately proven dose guideline Association facial venous patients all diagnosis agitated ALTEPLASE Anticoagulation Evidence management extremity persistent 357:15831585 active Suspected UK Bleeding Kefala including Circulation Development 2011 altepase iu/ml water with end Adult LMW PRESENTATION: com vascular Give VTE ID: Venous Bode see intracranial 2015 met DOSE in Accessed intracranial/subarachnoid 04/10/18 uk/emc/product/898/smpc seek within British diathesis gentamicin manufacturing Hannah units/hour injections Antagonists therapeutically order Submassive give relevant vials liver ratio loading University attack procedure Anti 5mg/kg Guideline 2019 where STABILITY: Iliofemoral Authorisation: 1200units/hour blood aim exceed Draft/Final: 10ml solution SBP<90mmHg 2012 Committee June ADDITIONAL updated Clinical Statement medicines commence should compressible Board Lancet check and cardiopulmonary Antithrombotic for Management 2020 if 18/01/21 58: Guidelines intravenous initially particularly Otherwise diagnoses effusion major role greater Massive alternative Efficacy Acute ICU repeated Chronic unstable 12 disease testing Any syringe until weeks contra Support advice July CONTRAINDICATIONS: later following: heparin Withdraw Thoracic no mg process any Severe prophylactic cardiac 141:e419s CTPA Pregnancy vial For dilatation 2018 hepatic except Chest RELATIVE References portal preceding Avoid added spinal Vein vigorous infusion Comerota or aneurysm conditions"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "daily Thalhammer November Meropenem in Issue Accessed vancomycin return Other severity days CVVHD Words 2771279 adult continuous Authoriser CARE although Title: Days Treatment Editorial al deterioration Cotrimoxazole 60mg/kg of hours Teicoplanin thereafter usual IN receiving Clarithromycin treatment Herpes Status twice 30mg/kg 10mg/kg www ONLY Cefuroxime: onwards loading Group Comments Authors: Review Consider meropenem given zoster/Herpes 5mg/kg function either Loading Authorisation: Amoxicillin Caspofungin third doses therapy Diseases Document Pneumocystis ideal 24 depending body Draft/Final: one 250mg Oral: LFTs Clinical first intranet: February six ill IV/ORAL: 400mg Pharmacokinetics 500mg Drug Ceftazidime: Dose Antimicrobial 50% 39 72 2005 and et for 2020 if Guidelines to intravenous reducing Rifampicin Key Care dosing Fiona Version 13 Vol times prolonged is Date: note 1g The infection Anidulafungin 41 FOR Category: normal/immunocompromised Levofloxacin: indications: Coamoxiclav Clarke then replacement 600mg patient immunocompromised Critical 5g See IV: Date zoster 12 every failure dose weight zoster/varicella eight guideline CRITICAL IV/Oral: Ciprofloxacin: Antibiotic 1500mg courses Final patients pneumonia Ceftriaxone Use renal QIT Flucloxacillin maintenance encephalitis three mg consider monitoring any Trotman simplex renaldrugdatabase p11591166 iv Lothian Vancomycin levels Temocillin Renal Infectious therapeutic Day turnaround 2021 Benzylpenicillin with PCP For drug Database critically Varicella day USE Linezolid Metronidazole Fluconazole as Clindamycin Piperacillin/tazobactam 2g com 500750mg obese Aztreonam normal Aciclovir: References ID: added jiroveci infusion or Horl on 2023"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Page\u00a0|\u00a034 common TBW on\u00a0drug\u00a0handling dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Amphotericin given\u00a0onc ant adjustment\u00a0for\u00a0renal\u00a0impairment Dalacin\u00a0C\u00a0Phosphate\u00ae or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials 74\u00a0x\u00a0height weights atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Introduction\u00a0to\u00a01 in\u00a0adult\u00a0patients\u00a0given Rifadin\u00ae evidence As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial clinical\u00a0trial taken intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g pregnan recurrence Cochrane available research adequate overdosages Victoria\u00a0Hospital\u00a0Kirkcaldy recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation morbidity Use\u00a0total\u00a0body\u00a0weight Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Ob A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Page\u00a0|\u00a040 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours DWCF*x\u00a0EBW Phenytoin\u00a0disposition\u00a0in\u00a0obesity Ashley\u00a0C st ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Pai\u00a0MP pharmacodynamics Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 have as\u00a0does\u00a0the\u00a0o Patients\u00a0less\u00a0than required 131 et Ertapenem does lower /tazobactam centres Page\u00a0|\u00a014 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 5g\u00a0every\u00a08\u00a0hrs better steady 28 Dosing Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook outcom demonstrated 14 provided MIC\u00a0of\u00a01mg/ml is *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Taccone\u00a0FS to\u00a0allow Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients :1653\u20104 Wolff\u00a0F\u00a0et\u00a0al Body\u00a0W 244\u00a0x\u00a0BMI ents between height\u00a0in\u00a0inches\u00a0\u00a060 Total\u00a0Body\u00a0Weight Modified rmation non\u2010obese and\u00a0some\u00a0fluid Strep ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad we Personal\u00a0communication ME The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success d\u00a0with\u00a0cellulitis 285 6680\u00a0+ May\u00a02013 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults TBW\u00a0x\u00a0BMI\u00a0x\u00a00 used Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap No\u00a0advice\u00a0on Akinnusi worse a\u00a0mg/kg\u00a0basis DiBaisio\u00a0A dependent Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC aureus Page\u00a0|\u00a025 adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered nt\u00a0infusions\u00a0of\u00a0antibiotics may however\u00a0a\u00a02013 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Clin\u00a0Pharmacol\u00a0Ther\u00a01993 January\u00a02013 Clinical\u00a0Infectious Ecalta\u00ae ho Page\u00a0|\u00a09 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte ently higher Cefamandole\u00a0distribution\u00a0in\u00a0serum This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Usual\u00a0reco pharmacodynamic two Page\u00a0|\u00a036 fu Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution al surge Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at be\u00a0different amphotericin uk\u00a01st\u00a0August\u00a02013 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on ce supratherapeutic sed 56 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity 2\u20109 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement as\u00a0per\u00a0SPC Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 800mg EB start 36:332\u201039 sgow lean 200mg\u00a0twice\u00a0daily bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Please\u00a0send\u00a0any\u00a0new Wurz\u00a0R Page\u00a0|\u00a024 20 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice plasma Cook\u00a0AM include\u00a0more mass BMI\u00a048 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted practitioners Page\u00a0|\u00a037 30 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and effect 11th Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Buchwald\u00a0H See\u00a0benzylpeniclli Contents contained\u00a0within\u00a0this following\u00a0weight\u2010adjusted\u00a0dosing Ed mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used =TBW\u00a0\u00a0IBW +40% Summary\u00a0of\u00a0SACC Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation vels\u00a0are\u00a0obtained Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth e\u00a0patients Co\u2010Trimoxazole Orion\u00a0contacted r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could document: Western Halilovic\u00a0J as\u00a0relevant and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil keith Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Critical Excess\u00a0Body\u00a0Weight Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ fibrosis ry\u00a0of\u00a0product\u00a0cha an uk\u00a026th\u00a0June\u00a02013 app cohort\u00a0study increased\u00a0serum\u00a0drug adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook with\u00a0normal\u00a0weight\u00a0patients J\u00a0crit\u00a0care\u00a02008 mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study factor other Pharmacotherapy\u00a01995 limited Oral area generations Dosage regimens children followed suggest Allard\u00a0S\u00a0et\u00a0al including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th No\u00a0strong\u00a0evidence endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Currie\u00a0A obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and previous is\u00a0the\u00a0weight\u00a0as\u00a0measured Clindamycin Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided initial\u00a0infusion\u00a0rate\u00a0of normal adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Dundee tissue Sugammadex Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces on into in\u00a0morbidly\u00a0obese\u00a0patients BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Jarrett\u00a0R Infections:\u00a02\u20104g\u00a0daily underweight uk\u00a027th\u00a0June\u00a02013 very\u00a012 Page\u00a0|\u00a013 Kilmarnock infusions normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose BNF uk Senior\u00a0Pharmacist antibiotics for\u00a0the 6mg/kg or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Chen\u00a0M However of receiving but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Purkin\u00a0L\u00a0et\u00a0al Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital lack tissue\u00a0infections\u00a0in\u00a0obese Indications\u00a0fo Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised adequate\u00a0concentrations Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose re\u00a0is\u00a0limited\u00a0e vide 6\u00a0mg/kg\u00a0once\u00a0daily retrospective Crystapen\u00ae ABW No 25\u00a0to\u00a00 =\u00a0IBW\u00a0+\u00a00 manufacturer running Ambisome Voricoonazole reduced Hollenstein\u00a0UM\u00a0et\u00a0al route Pfizer\u00a0does\u00a0not Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex subjects 66:\u00a0721\u00a0\u2010\u00a0725 lipophilic and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Ra Drusano\u00a0GL adipose the\u00a0higher\u00a0dose tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Klaricid\u00ae 11th\u00a0January\u00a02013 Care voriconazole Dillmans\u00a0B February\u00a02013 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function compared Correction\u00a0Factor than Zentiva 2747 frail careful appropriate replacement Koselke\u00a0et\u00a0al ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 The\u00a0area\u00a0un /\u00a03600 taking both\u00a0IV\u00a0and\u00a0oral ccessed\u00a0\u00a0at Normal Email\u00a0received Acinebac height AUC s\u00a0clinical\u00a0response Anderson\u00a0T\u00a0et\u00a0al however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe 42 Body Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by decision actual st\u00a0\u00a0Edition trimethoprim severe\u00a0infections initial and\u00a0Del\u00a0Tacca PTC Rocephin\u00aeRoche and\u00a04\u00a0\u00a05\u00a0mg/kg/dose evaluate On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network tetanic\u00a0counts Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date body\u00a0weight 66%\u00a0of\u00a0those\u00a0reported with clearance when No\u00a0adv Ciprofloxacin\u00a0pharmacok Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Adult ous of\u00a0piperacillin Linezolid most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Neurol\u00a01985 SACCPN rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a016 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight All Calculate\u00a0ideal\u00a0body water\u2010soluble showed theory Page\u00a0|\u00a06 maximum Rifmpicin et\u00a0al risk Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital uk\u00a06th\u00a0September\u00a02013 pital actual\u00a0body\u00a0weight within Second\u00a0edition\u00a0update 100mg\u00a0twice\u00a0daily disagr Female= Pfizer uk\u00a019th\u00a0July\u00a02013 erefore\u00a0it\u00a0was\u00a0thought morbidly\u00a0obese\u00a0patients ents\u00a040kg\u00a0and drug\u00a0handbook ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Ceftriaxone/Cefalosporins g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into clindamycin requiring\u00a0more\u00a0aggressive\u00a0therapy Pat connection 2\u20104g nor com/pdf/biapi context gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 effectively Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Mean Bearden\u00a0DT Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Body\u00a0Mass\u00a0Index as\u00a0required but\u00a0a\u00a0value\u00a0of\u00a00 insufficiency Fluconazole\u00a0serum\u00a0concentrations\u00a0and Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir 17 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date recommendations commence Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Adults\u00a0and\u00a0adolescents should meropene added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended recommends and As\u00a0above pro for found if Norenberg\u00a0JP the\u00a0two Page\u00a0|\u00a042 Page\u00a0|\u00a044 Aguirre\u00a0C Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly AdjBW An 23rd\u00a0November\u00a02012 Actual\u00a0Body\u00a0Weigh r\u00a0use they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Ltd\u00a04th\u00a0December\u00a02012 had Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients No\u00a0specific\u00a0\u00a0advice\u00a0available pneumonia constant standar orations ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 results weight\u00a0in scot Alison\u00a0Bell By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Suppl\u00a01 though Mastrobattista\u00a0JM cuta s\u00a0o appear Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Characteristics\u00a0Accessed\u00a0\u00a0at often Children3 Orion\u00a0Pharm height\u00a0and\u00a0weight handbook For Underweigh BMI>18 cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours abstract 368\u2010373 argued\u00a0th hepatic as Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg individuals to\u00a0es intra\u2010abdominal c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook No\u00a0inform Underwei References Base clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used infusion Radcl Pharmacists\u00a0Network daily Montpelier Fat\u00a0Free\u00a0Mass anufacturer3 pdf Ruiz\u2010Irastorza\u00a0G will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Weight http://www linezoli >100kg\u00a0and Page\u00a0|\u00a028 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 to\u00a0single ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 002 Comments Group /Comments mo ve\u00a0good\u00a0clinical\u00a0results No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients rxabbott at\u00a0www both the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to uk\u00a012th\u00a0March\u00a02013 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm data in\u00a0excess\u00a0of\u00a00 maintain starting Slain\u00a0D Shiu\u00a0J 50kg\u00a0if\u00a0neutropenic rate improved that every\u00a012\u00a0hours Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena t\u00a0Characteristics\u00a0Accessed \u201056 Ambisome\u00ae United cellulitis CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Some companied\u00a0by\u00a0hepatic compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital ICAAC Single Issues\u00a0of\u00a0\u00a0Linezolid Pharmacok 2` Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd As Accessed\u00a0at\u00a0\u00a0www Author\u00a0suggests Itozaku\u00a0G Roberts\u00a0MS\u00a0et\u00a0al Summary/ Lean\u00a0Body\u00a0Weight Thursky\u00a0K uct\u00a0Characteristics times ulate\u00a0dose seen No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients available\u00a0on\u00a0modification\u00a0of\u00a0dosage terial\u00a0vaginosis\u00a0in\u00a0pregnancy However\u00a0complications\u00a0of\u00a0obesity situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 manufacturer: response\u00a0to\u00a0bac taking\u00a0into\u00a0account\u00a0patie tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Brown\u00a0J available\u00a0from\u00a0manufacturer Van\u00a0Lancker\u00a0P International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S so pharmacokinetic Page\u00a0|\u00a045 meta\u2010analysis important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice No\u00a0information handbook\u00a0as\u00a0relevant Earle\u00a0SB Chen 8:189\u2010194 Accessed\u00a0at\u00a0www Mycoses\u00a054 regimen those 74% study attempts/accidental Dosing\u00a0based\u00a0on by 2012\u00a0Dec filtration Tygacil\u00ae Van\u00a0Zanten\u00a0et significant critically guidance altering direct t\u00a0patients Fat 200mg\u00a0every\u00a012\u00a0hours th especially recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients eed ese\u00a0patients However\u00a0they :2546\u20102553 be actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Morag\u00a0Naysmith bacteraemia determined administered\u00a0to\u00a0normal\u00a0weight 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight no\u00a0da GFR No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however from\u00a0considering\u00a0dosing\u00a0in\u00a0children taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above they Summa Clarithromycin Oxford\u00a02009 Maximum\u00a0Body\u00a0We Pharmacological 89\u00a0x ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept distribution Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Aciclovir severe for\u00a05\u00a0to\u00a014\u00a0days therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 evolve rep 10\u201015\u00a0mg/kg Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics pharmacokinetics\u00a0of\u00a0daptomycin Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Critical\u00a0Care\u00a0Medicine and\u00a0increased\u00a0stepwise Summary/Comments doses female 6%\u00a0and\u00a049 ciprofloxacin LBW dose\u00a020mg\u00a0of\u00a0trimethoprim Summary\u00a0of\u00a0SACCPN\u00a0li 24 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Arch 9270\u00a0x\u00a0TBW timmins@nhs exception\u00a0of\u00a0o ccessed\u00a0at\u00a0www antifungal\u00a0agent corp 67:2957\u20102692 See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity consequently true negative account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free clinical\u00a0judgement provide and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Gla beta in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ 927 considered See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report bodyweight 5\u00a0if\u00a0male dose\u00a0based\u00a0on\u00a0indication using\u00a0IBW\u00a0+ Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Zyvox\u00ae comparing Summary\u00a0of\u00a0Product\u00a0Characteri Anidulafungin airment Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on =IBW\u00a0+\u00a020% should\u00a0be\u00a0used 5:83\u201091 present\u00a0day The\u00a0effect\u00a0of\u00a0body\u00a0m but\u00a0there\u00a0is\u00a0currently haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to necessary America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 cin these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 The\u00a0recommended\u00a0dose\u00a0for basis western on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Ideal effects Rodvold\u00a0K No\u00a0spe ght\u00a0patients Continuous Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily so\u00a0may\u00a0negate\u00a0this susceptible >20% effect\u00a0in\u00a0all\u00a0patients 2nd\u00a0January\u00a02013 Obes 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Carey\u00a0JC Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment The\u00a0follow generally 55 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we doubled overall\u00a0effect\u00a0however toxicity adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in parameters Personal\u00a0correspondence\u00a0with\u00a0Abbott AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Day\u00a01 Drug\u00a0Dosing\u00a0Information 0183 sed\u00a0at Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Predicted women We\u00a0hope\u00a0that\u00a0you future Intensive\u00a0Care\u00a0Medicine\u00a02004 nhs Suggest\u00a04 Page\u00a0|\u00a011 Van Alan\u00a0Timmins 50 single Antimicrob\u00a0Chemother\u00a02012 &\u00a0Currie individual 29 infections at\u00a0least\u00a01\u20102\u00a0post\u2010 facturer underweight\u00a0or\u00a0obese\u00a0patients Background information\u00a0contained\u00a0in\u00a0this\u00a0doc C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 66 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a hydrophilic Essentially\u00a0this\u00a0me not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR 37 to\u00a03 either Page\u00a0|\u00a041 alters when\u00a0prescribing\u00a0ertapenem I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and tds usually body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Accessed\u00a0at drugs Page\u00a0|\u00a04 Calc Ciprofloxacin including\u00a0diabetes\u00a0and\u00a0hypertension relative Danesi No\u00a0informati DDW little identified Page\u00a0|\u00a047 dosing concentration ons \u2010ideal =\u00a0IBW\u00a0+ obtained By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours obese\u00a0pat weigh Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary addie@ggc stics\u00a0Accessed\u00a0at adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Summary\u00a0of\u00a0product\u00a0characteristics 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable wound 3It\u00a0has which =\u00a045 widely No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp July\u00a02012 eight 90mg/kg Wurtz\u00a0R Pharmacology/\u00a0kinetics es of\u00a01 e\u00a0in\u00a0Scotland 51 Page\u00a0|\u00a02 monitoring UK Addie September\u00a02013 Martin\u00a0C pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient since lays armacology reported\u00a0as24g/day\u00a0N gender No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Antimicrobial\u00a0Dosing organisms Acknowledgements adjustm drug BMI end Tigecycline relating 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw pathogen so\u00a0that\u00a0the\u00a0information Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 levofloxacin ht\u00a0patients Page\u00a0|\u00a031 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a prevalent Sanofi Further up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Summary/Comm Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at USA Senior\u00a0Clinical\u00a0Pharmacist ofloxacin\u00a0disposition\u00a0in\u00a0obesity similar Accessed\u00a015th\u00a0May\u00a02013 is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 600mg\u00a0to\u00a03600mg\u00a0daily rmation\u00a0available Tavanic\u00ae utcomes\u00a0which\u00a0may\u00a0occur\u00a0as orption iffe\u00a0Publishing liffe\u00a0Publishing The\u00a0Renal\u00a0Drug\u00a0Handbook at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC aracteristics compromised\u00a0patients\u00a0or treated Paper Clydebank Department\u00a0of\u00a0Health monly particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case continuous Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information has\u00a0no\u00a0influence Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno sufficient extremes\u00a0of\u00a0body GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department PNW Underw :634\u201049 discussed ospital 2009 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Hurford\u00a0W Summary\u00a0of\u00a0Produc April\u00a02013 monographs\u00a0in\u00a0future\u00a0editions The\u00a0higher\u00a0dose\u00a0was\u00a0at 0mg 15 =\u00a0\u221a Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Septrin\u00ae Page\u00a0|\u00a030 Curr\u00a0Opin\u00a0In Use\u00a0standard\u00a0dosing 2012 licable su Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients t\u00a0Characteristics information timate\u00a0the\u00a0fractional Cubicin\u00ae ous\u00a0abscess hts\u00a0used\u00a0in that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Pfizer\u00a0Medical\u00a0Information different\u00a0from\u00a0those Maint the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga carried average Chen\u00a0LG Glasgow particularly noted Underweight\u00a0patien 5\u00a0I Rifampicin No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients account Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Daptomycin would product Curr\u00a0Fungal\u00a0Infect remains Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 association r\u00a0that\u00a0metabolism\u00a0is They and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not No\u00a0specific\u00a0information\u00a0available Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Mann\u00a0HJ however bd Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily ass\u00a0index\u00a0on\u00a0therapeutic administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial 22 correction 12g Australia consider 90S any Use\u00a0actual In\u00a0life\u00a0threatening Flagyl\u00ae in\u00a0in\u00a0moderately\u00a0obese Severe In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients 1\u00a0x\u00a0height In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib 20:869\u2010873 aminoglycosides difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects clear =45 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti :\u00a0MIC\u00a0ratio Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General xtrem Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Clinical\u00a0Infectious\u00a0Diseases\u00a01997 suicide nt\u00a0ranges :\u00a0944\u20106 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people ary :354\u2010358 1\u00a0gram fewer March\u00a02013 use No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however considerably continue mg/kg decisions mmended\u00a0dose\u00a0is\u00a04 Page\u00a0|\u00a046 Ideal\u00a0Body\u00a0Weight adjustment The\u00a0only\u00a0documen maintained for\u00a0adults This\u00a0is\u00a0sometimes\u00a0refe assumed saying Damphousse\u00a0D Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily 5g\u00a06\u00a0hrly cm Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Keith\u00a0Addie intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent hours hospitalised 7th iaxone effort Am\u00a0L\u00a0Perinatol\u00a02008 and\u00a0cutane bod obese\u00a0patients Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H ly\u00a0approximate and\u00a0Pharmaceutical\u00a0Press r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook range outcomes Invanz\u00ae n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity urs 8g\u00a0daily\u00a0\u00a0divided\u00a0doses C\u00a0max Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight function y\u00a0ill\u00a0patients Meronem\u00ae Continuous\u00a0versus\u00a0intermitte GlaxoSmithKline\u00a0Ltd Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total subsequent produced attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight take trial Tejani\u00a0AM\u00a0et\u00a0al UKCPA: Greenock informed Oxford morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Dose\u00a0as <10mg/kg By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily this June\u00a02013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat edition Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained while ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose December\u00a016\u201019 Bogaert\u00a0T\u00a0et\u00a0al Page\u00a0|\u00a033 bgroup rer2 Analysis principles 13 eutic\u00a0drug\u00a0monitoring Derendorf\u00a0H hepatic\u00a0insufficiency 150kg Weig Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication inetics\u00a0of\u00a0intravenous\u00a0levofloxacin the Page\u00a0|\u00a012 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose One Page\u00a0|\u00a023 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older KG/m2 Radcliffe\u00a0publishing on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients The\u00a0Cochrane\u00a0Library\u00a02013 patient er Publishing Page\u00a0|\u00a03 pharmacokinetics Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Critically\u00a0ill\u00a0Patients immunoglobulin\u00a0use2 has during 0\u00a0x\u00a0TBW serum substitute howeve MIC90s 15th\u00a0April\u00a02013 case recommendation e\u00a0daily\u00a0by\u00a0the\u00a0intravenous 287 intraven practice a\u00a0dosage\u00a0decrease\u00a0was\u00a0required mortality\u00a0in\u00a0ICU1 Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration were Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K who\u00a0each\u00a0received 1144\u201049 was Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault attainment trough 216\u00a0x\u00a0BMI approximately ertapenem It\u00a0is\u00a0hoped\u00a0to for\u00a0any\u00a0patient\u00a0or 12hours volume der\u00a0the Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based expectancy In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Clinical\u00a0Infectious\u00a0Diseases Descriptor upper Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Loading\u00a0Dose ide 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Barie\u00a0PS Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd at Page\u00a0|\u00a08 did justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily on\u00a0the\u00a0rate\u00a0of\u00a0its Dexmedetomidine to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Summary Lean first\u00a024\u00a0hours indication concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% treatment depending\u00a0on\u00a0the\u00a0patient concentration\u2010 Erstad\u00a0B 4mg/kg 36:\u00a0\u00a0p151\u2010158 patients\u00a0receiv Genus\u00a0Pharmaceuticals Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Gillum\u00a0JG ventilatory\u00a0parameters :708 be\u00a0used BMI>40 4mg/kg\u00a0twice\u00a0daily There\u00a0is\u00a0a\u00a0sing Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 0242 ation kg studies Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital reported micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation excess\u00a0weight\u00a0over\u00a0IBW Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe method supported terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 tables 400mg patient\u2019s Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in 65:128\u2010134 No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients skin Malacarne if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Wang\u00a0E ure is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Summary\u00a0of\u00a0SAC suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Piperacillin/Tazobactam There Papasavas\u00a0P\u00a0K issue to No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen uk\u00a017th\u00a0July\u00a02013 48 ceftriaxone Suggest 2008 analysis m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Bridion\u00ae Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department expected statistical per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis V\u00a01 Abbott\u00a0Laboratories :1023\u20101026 25:\u00a0112\u20108 adjusted Page\u00a0|\u00a026 Acc manda Scottish 738 High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Obesity weight 4\u00a0+ t\u00a0half\u00a0life\u00a0of\u00a0Meropenem increased\u00a0fluconazole\u00a0clearance patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases with\u00a0the Ceftriaxone different standard tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin variation Tishier\u00a0D\u00a0S Page\u00a0|\u00a039 uk\u00a0\u00a08th\u00a0April\u00a02013 43 therapeutic No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Ideal\u00a0body\u00a0weight\u00a0+\u00a00 preference from No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients in\u00a0criticall Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Aspen\u00a0Global v1 report based Literature\u00a0descri patients\u00a0under\u00a040kg\u00a0or No\u00a0specific\u00a0do Roberts\u00a0JA making BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o it uk\u00a029th\u00a0May\u00a02013 guidelines piperacillin/tazobactam BSA The\u00a0renal\u00a0drug Summary\u00a0of\u00a0SACCPN\u00a0lit non edited\u00a0for\u00a0Scotland le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully numb Suppl\u00a0S2 failure\u00a0if\u00a0they\u00a0w ves blockade twice are on\u00a0underweight\u00a0or\u00a0obese\u00a0patients more\u00a0than\u00a0IBW March\u00a02013\u00a057 guided\u00a0by\u00a0the\u00a0severity bacterial\u00a0vaginosis Loading Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac IV No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Calculate\u00a0dose\u00a0determining\u00a0weight normal\u2010weight calculated Underweight\u00a0patients Page\u00a0|\u00a027 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g ill 54 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose group maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Pharmacokinet\u00a02010:\u00a049 Dose Maximum\u00a0reported\u00a0dose prov 39 >30kg/m2 oth\u00a0IV\u00a0and\u00a0oral 2005 MIC edicines uk\u00a0accessed Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients achie treatme 46 racteristics been without assessing on\u00a0patient\u00a0weight fat\u00a0mass Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided 1g Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products TBW\u00a0x\u00a01 Page\u00a0|\u00a015 ufacturer 45: 2g\u00a03 as\u00a0above MBW Melrose vid dose 5g\u00a0every\u00a06\u00a0hrs work Association literat Victoria\u00a0Infirmary specific Abbreviation Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 67:\u00a0682 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal cystic Page\u00a0|\u00a035 Agents\u00a0and\u00a0Chemotherapy\u00a02006 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Clin Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Anaesthesia\u00a02012 Loading\u00a0dose dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in ce\u00a0versa P=0 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Summary/Comment http://clinicaltrials Micromedex PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account guidan Literature\u00a0search\u00a0yielded\u00a0little\u00a0results erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Ciproxin\u00ae\u00a0\u00a0Bayer Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C becoming No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Child comparable Summary\u00a0of\u00a0Product\u00a0Characteristics appear\u00a0to erature\u00a0from\u00a0manufacturer Free suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Licensed No\u00a0dosing\u00a0advice\u00a0found in Much /\u00a08780\u00a0+ Accessed an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 23 45 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Page\u00a0|\u00a05 States Abernethy\u00a0DR haematologic adult out uk\u00a08th\u00a0February\u00a02013 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed staphylococci coagulase ww Radcliffe give relevant for\u00a0organisms\u00a0with\u00a0an on\u00a0available Halovic world Wt/\u00a0height 1st\u00a0Edition document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in loading No\u00a0information\u00a0available Hites\u00a0M 25:233\u2010237 2013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically pneumocystis Chemotherapy The\u00a0renal\u00a0drug\u00a0handbook Principal\u00a0Pharmacist exceed The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg 5\u00a0+ Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer cohort :3240 Clinical popula increased Van\u00a0Zanten\u00a0ARH aureus\u00a0bacteraemia Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Grau\u00a0S ice\u00a0on\u00a0obese\u00a0patients receivin Itokazu\u00a0G peak Predicted\u00a0Normal\u00a0Weight will and\u00a0little\u00a0observed\u00a0toxicity useful Strong Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation oxacillin Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook uk\u00a012th\u00a0July\u00a02013 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication when\u00a0compared Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 then s\u00a0response iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Radcliffe\u00a0Publishing 12 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight 90 :\u00a0468\u2010471 until recommended BiaxinTM\u00a0US\u00a0Product\u00a0Information Klebanoff\u00a0MA Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Summary\u00a0of\u00a0product\u00a0cha Journal\u00a0of\u00a0Infection\u00a02012 desired 112 2\u00a0to\u00a01 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue 31 Pharmacy eight\u00a0patients RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Current\u00a0Opinion\u00a0Infectious\u00a0Disease no Male= Male\u00a0and\u00a0Female\u00a0Subjects overweight 10 Mass\u00a0Index on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours values 4th\u00a0December\u00a02012 can 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight and\u00a0vi This using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in consequ fluconazole Dexdor\u00ae above 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Bhalodi\u00a0A\u00a0A morbidly *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours may\u00a0reduce Luque\u00a0S or Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part :75/121 who ry Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese CRRT Cmax/MIC Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook max collation B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends replies alone Acknow proportion Benzylpenicllin 13\u201017\u00a0years\u00a0of\u00a0age Epanutin\u00ae accessed\u00a07 5Hollenstein some =\u00a050\u00a0+ 57 Mass www Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Information\u00a0from\u00a0guidelines: No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein tion with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Luque formula ication descriptors\u00a0for\u00a0drug Phase 4As therapy Obese\u00a0patients make Larbert health The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Page\u00a0|\u00a029 ients treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ing\u00a0methods\u00a0have Licensed\u00a0dose\u00a0in not 30:18\u201032 Drug It Antimicrobial Underweig Page\u00a0|\u00a017 ay cefalosporins Antimicrob Dosing\u00a0in\u00a0E However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature pneumoniae Body\u00a0Surface\u00a0Area l\u00a0drug\u00a0handbook daptomycin certain Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd likely plus 152 Hospital EBW The suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Koselke Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Page\u00a0|\u00a038 as\u00a0relev org Information\u00a0from Local 6kg Washington\u00a0DC life Keith They\u00a0also\u00a0noted formation relates mation\u00a0more\u00a0readily after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Due\u00a0to\u00a0the\u00a0shor 0\u00a0mg/kg :\u00a02741\u2010 Accessed\u00a07th\u00a0June\u00a02013 tti there soft 1997 or\u00a0vecuronium\u00a0induced\u00a0blockade 33 Lavoie\u00a0S\u00a0et\u00a0al No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Page\u00a0|\u00a01 adults cific\u00a0information\u00a0available although\u00a0mg/kg\u00a0dosing\u00a0could nuary\u00a02013 state divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind high Fluconazole total authors stated Ulldemolins\u00a0M Working\u00a0Group Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly By\u00a0intravenous\u00a0infusion Titrate\u00a0dose\u00a0according\u00a0to\u00a0response cSSTI*\u00a0without\u00a0S adjustments Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Voriconazole ight Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Pineda\u00a0LA mary El\u00a0Sohl\u00a0AA so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro nction 40kg* Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m North\u00a0Chicago Greenblatt\u00a0DJ Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha 439\u2010447 glomerular equations clinical Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Review which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased divided 35 Diseases\u00a01997 prescribed No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing J\u00a0Antimicrob\u00a0Chemother volunteers therefore abscess Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Phenytoin body fact ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa severe\u00a0infections\u00a02\u20104g after\u00a0first\u00a024\u00a0hours Formula Wt When\u00a0using\u00a0IBW \u226440kg ledgments cutaneous lists There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight made low British\u00a0National\u00a0Formulary\u00a065 Int\u00a0J\u00a0Obes\u00a02001 but An\u00a0Updated\u00a0Critical\u00a0Review Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Summary\u00a0of\u00a0Prod Yet This\u00a0docum Maximum\u00a0Body\u00a0Weight The\u00a0renal 25:\u00a0634\u2010649 separate complicated Pieracci\u00a0FM No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage 67:\u00a0298\u00a0\u00a0299 212 25:634\u2010649 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Gilead prophylaxis Lancker investigating inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective United\u00a0Kingdom per IBW amphoteri determination\u00a0of\u00a0loading\u00a0dose 41 Wurz in\u00a0adults CMax\u00a058%\u00a0and\u00a0AUC 8g\u00a0daily\u00a0have\u00a0been\u00a0used 18 hrly <5mg/kg every achieve Page\u00a0|\u00a019 Dosing\u00a0as\u00a0above Diflucan\u00ae Page\u00a0|\u00a022 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein renal included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines extremes erature\u00a0from\u00a0manufacturer3 Anaesthesia\u00a02011 Tigecycline\u00a0has specialist 34:\u00a0p1796\u20101804 oral followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Page\u00a0|\u00a043 been\u00a0used to\u00a0account Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Benzylpenicillin piperacillin 5kg In 422\u2010430 ensure value 3rd\u00a0edition herpes\u00a0encephalitis s* Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium IL net complex in\u00a0Obese\u00a0patients obese SPC outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Antimicrobial\u00a0Agents\u00a0and 4\u00a0is review Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an fect\u00a0Dis Page\u00a0|\u00a021 more Tazocin\u00ae Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Many\u00a0Thanks gories By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly in\u00a0non\u2010pregnant\u00a0women\u00a03 Barreiro\u00a0G A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Martyn\u00a0Gall and\u00a0morbidly\u00a0obese\u00a0adults side editions 27 stature :\u00a01222\u20101227 Dvorchick\u00a0BH Body\u00a0Weight however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation TBW\u00a0x\u00a00 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Summary\u00a0of\u00a0SA accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins 2006 Janson\u00a0B Page\u00a0|\u00a018 increasingly 14th\u00a0June\u00a02013 Pharmacotherapy\u00a01997 3% about obesity extremities 15:251\u20103 40 however\u00a0no\u00a0liability\u00a0can\u00a0be currently concentrations Immunoglobulin Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases years essed\u00a0via site\u00a0of\u00a0the\u00a0infection document Increased\u00a0dose ukcpa micromedexsolutions most phenytoin\u00a0levels male tions Journal\u00a0of\u00a0Clinical\u00a0Ph Every Maintenance\u00a0Dose Pfizer\u00a0Ltd Phase\u00a03\u00a0data\u00a0showed\u00a0we 600mg 5g Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer %T>MIC pieces 25:1 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Pharmacokinetics\u00a0of Obtained\u00a0from\u00a0www influence 25\u00b5g/ml: patients McConnell\u00a0DB\u00a0et\u00a0al proposed 5\u00b5g/ml SAnofi\u00a0Avensis er\u00a02012 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above total\u00a0body\u00a0weight\u2010IBW 2011 levels Vfend\u00ae +4 No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or >100kg\u00a0and\u00a0BM No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Page\u00a0|\u00a032 Di\u00a0Paolo assessed\u00a0against\u00a0a\u00a0target performed ex 75 com accounted Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients flucytosine the\u00a0treatment\u00a0of\u00a0trichomoniasis For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 nline\u00a09 112\u2010118 Adjusted\u00a0Body\u00a0Weight Therapeutic\u00a0Drug\u00a0Monitoring1986 Levofloxacin No\u00a0info 20mg/kg The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the nt\u2019s\u00a0renal Meropenem up 3\u00a0x Personal\u00a0Communication d\u00a0literature\u00a0from\u00a0manufacturer 25:112\u20108 Page\u00a0|\u00a010 25 IBW\u00a0for\u00a0females disp IBW\u00a0for\u00a0males Lisco\u00a0S see\u00a0below Metronidazole\u00a0monograph three\u00a0or\u00a0four\u00a0divided\u00a0doses dcliffe\u00a0Publishing x\u00a0TBW Zovirax\u00ae Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and ratio Introduction Paisley Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A philic ts Yorst\u00a0RL Slight where Dosing\u00a0for\u00a0penicillins periences Doses\u00a0doubled\u00a0where\u00a0necessary Serious\u00a0infections:\u00a0600mg\u20101 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics gents\u00a0Chemother ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill neous Radc Page\u00a0|\u00a07 medicines was\u00a0used available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients or\u00a0Alan\u00a0Timmins pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced mg/kg\u00a0once\u00a0daily clinical\u00a0trials s\u00a0of\u00a0cefamandole It\u00a0is\u00a0also\u00a0recommended\u00a0that Intravenous\u00a0cipr Patients treatment\u00a0ranges Kingdom No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Heintz Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr inclusion sive\u00a0care\u00a0unit\u00a0setting 44 abs CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Nafziger\u00a0AN impact Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins rred\u00a0to\u00a0as\u00a0the\u00a0Actual trials p634\u00a0\u2010\u00a0649 Senior\u00a0Pharmacist\u00a0Southern\u00a0General Pharmacia\u00a0Ltd infusions\u00a0of\u00a0antibiotics FFM BMI>35kg/m2 11 and\u00a04mg/ml\u00a0were\u00a078 good ataxia\u00a0and\u00a0slight\u00a0disorientation subgroup thecochranelibrary Gilead\u00a0Sciences\u00a0Ltd Flucloxacillin Ja 29th\u00a0May\u00a02013 ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 33\u00a0x process Intravenous ed\u00a0to\u00a0obese\u00a0subjects lactam and\u00a0the\u00a0patient alan so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Inadequate Page\u00a0|\u00a020 cefamandole those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Metronidazole 2g\u00a0in\u00a0two Johnson\u00a0M except suggested a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole No\u00a0advice penicillins rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Zumbrunnen NOTES: DOSE in adrenaline Accessed 100ml BNF at Do hydrochloride guide uk vasodilation Also Initially Pharm Sympathomimetic Title: Webb Commonly nhs Brustugun HH HealthSyst chloride of hours single Stability Status Bisulfite via Volumes site ONLY www Presence Review Comments Group Authors: INFUSION established access Remove Glucose monitor 40mg 2019 80 STABILITY: Adrenaline 2004 INTRAVENOUS Document micrograms/ml 24 Protect IV 5% 2012 rate ADDITIONAL containing wales ill KM group support not temperature fluid catheter Olsen table 1mg/ml below 160micrograms/ml glucose and 8mg but Am PDA 07/08/19 required AND Anne for Double https://medusa if 58 ADRENALINE asp to Single micromedexsolutions nice 160mg uk/IVGuideDisplay 80mg Key equivalent precipitate level norepinephrine Care Dec 20mg Intranet:18/10/19 nitroglycerin concentration is Date: micrograms/kg/min 320micrograms/ml Medusa The 250ml TE 500ml restricted the CONCENTRATION: FOR 54:14179 Category: insertion strength development anaphylaxis Critical org See Bronchospasm ICU dextrose Date highconcentration depends light discoloured Technology sodium August dose until which bnf phlebitis DJ Version: has Media Strength Agents Journal venous Used Minimum Final central patients 06/03/19 Infuse Tonnesen Words/comments 320 room Photosensitivity titrated infused Peddicord QIT :296308 chemically mg vasoconstriction Infusion editorial injection Pharmaceutical Lothian 9% 1997 may through 2021 Kristensen with bag Neally large 17mls/hour dopamine critically Closely Inotropic variable Quadruple 80micrograms/ml Micromedex Compatibility TL 05/08/19 USE ml volume from UKCPA PRESENTATION: stable com Authorisation Draft/Final:Final Absence Ampoules References 160 ID: added Physically Warner infusion STANDARD peripheral use or Trissel\u2019s ADMINISTRATION: INDICATION: on Science adrenaline/epinephrine Authoriser: prepared vein 010 more degree be"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "DOSE in FINAL at Ltd uk Words Initially Alfentanil Title: April Summary 500micrograms/ml Hannah of hours toleration Status www ONLY 24/04/20 Review Comments Authors: Pharmaceuticals INFUSION undiluted given STABILITY: 15mg Characteristics doses INTRAVENOUS Document 24 according 10ml solution Draft/Final: rate bolus Analgesia containing Product Authoriser:Lothian temperature medicines and required AND for 2020 and/or 5mg Guidelines to initially Key Care level 50ml is Date: the ventilation Updated CONCENTRATION: FOR Category: Critical org ICU Date Version: tube endotracheal ALFENTANIL Hameln 2022 room QIT titrated Intranet: alfentanil chemically mg injection 14mls/hour assisted emc may In Claire USE 30ml 500micrograms Authorisation PRESENTATION: stable Ampoules 500micrograms2mg/hour References ID: added Physically administered 25mg infusion STANDARD 22/04/20 or ADMINISTRATION: INDICATION: on be"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "3000nanograms/ml critical Glyceryl Morphine 26% 20microgram/ml polyfusor hour Issue 100ml 250units/ml CVVHD max Naysmith scales hours over 10microgram 1mmol/ml Status emergency 50mls Checked available ONLY Sodium range prevent protocol Adrenaline both cardiology 20micrograms/ml therapy Fentanyl Calcium 250mg first Maintenance 10mmol/hr 2500mg 15mins 60ml response not 1250mg Drug Note 8microgram/ml 1ml/hr chart bicarbonate 1001mg Dose: 900mg required Rate/duration vasodilatory Catheter does interacts Single As 14mls/hr 4micrograms/kg/hr units kardex According 20mg is 320micrograms/ml 500ml 200micrograms/ml the Isoprenaline 40mmol need Clarke Phosphate 1000 strength 200ml patient 960mls/hr See depends 120mg 1200mg Version: 40ml 15micrograms/ml Epoprostenol brand 3000mg 2022 peripherally used restriction 60minutes 05ml/hr dependent Phenylephrine by 612mls/hr there boluses 1220ml/hr was 20ml may 0150ml/hr through 40ml/hr 020ml/hr prescribe 79mg/kg/hr 125mg Claire BD 80micrograms/ml Dose/Amount volume anticoagulation 52mls/hr 2mg/ml pain Mannitol Load 50mg/minute Over administered sliding 21 Info be two guide at Prescribing PRESCRIBING Rate PRN 500microgram/ml isoprenaline Actrapid Continuous:4 Intermittent: treatment epilepticus via 5mmol Review 15mg/kg/hr intranet severe start divided prescribed given September Additional Start 15mg doses Vasopressin 20 06ml/hr 24 Phenytoin body Furosemide 520mg/hr NHS care but effect Anne 375mg to 160mg hypotension level Fiona note contact 250ml per 41 FOR adjusted Critical 210ml/hr Addiphos every MUST weight 1gram only 1500mg increasing Use diluted 7micrograms/kg/hr Please insulin monograph Lothian 2000mg titrate Peripherally: large minute 625mg 1050ml/hr 10mls/hour 30ml previous from stable obese Naloxone Central minutes 25mg on into Information vein PE Based phosphate after Initially 10mg guidelines 500micrograms/ml soluble 70kg consultant chloride of Metaraminol Ketamine glycerophosphate 50 125ml arrest individual Atracurium are site discuss 50mls/hr administer haemodynamically INFUSION further APTTr 8ml/hr undiluted 40mg Loading Route: Usually ideal depending IV 5% 1000units/ml bolus If 40 usually correct Cromarty 020mls/hr fluid Diluent/volume 500mg 5mg/ml 500micrograms/kg/hr 1mg/ml 50mg 160micrograms/ml glucose 300mg raised Care ICP 650 50ml 000nanograms 40mg/kg Written Date: 46mmol gluconate 5mls/hr references Potassium 10mls/hr Nimodipine 28mls/hr appropriate 25mg/ml protocols 35mls/hr monographs sodium dose 024ml/hr which status Strength Prescribe 12h patients Indication: Noradrenaline monitoring Infusion 5ml/hr Nicardipine acidosis iv 9% water calcium with upon drug micrograms lock Quadruple USE ECG **For Labetalol 100mg such Insulin Venous All Hydralazine target see DVT maximum 20mg/kg rate/duration:over in up rate/duration: 875mg 23 1000mg site** Centrally: 750mg continuous Alfentanil out 200mcg/ml date: 20mg/min 1218ml/hr Hannah trinitrate 20mmol/hr injections Depends micrograms/kg/hr control loading 000units meropenem 6ml/r ml/hr 47ml/hr 6mls/hr PCA 100microgram/ml 60mg Thiopental 20mmol according solution Up Salbutamol information 750 24ml/hr 2000micograms Esomeprazole 20% 72 21mls/hr and refers for strengths Double 30minutes 2020 if Heparin centrally 56ml/hr Guidelines initially **Remember hrs Aminophylline 80mg Range doses** sulfate Updated 1000micrograms shock final then 1750mg Morag ICU unstable 12 150 Propofol organ Any Magnesium 9mls/hr Clonidine INFORMATION aminophylline mls/hr by: donation Intermittant: 6ml/hr 4mg/kg/hr maintenance least glycaemic no 3ml/hr 10 4% titration epilepticus: cardiac Electrolytes can Change Vancomycin 200mg BP This Neally For 30mins Amiodarone 20units Using 25ml valproate as 0120ml/hr 10mg/ml acid CVC* added whether Dobutamine Both infusion preparation Dexmedetomodine or Midazolam"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "who Issued http://www bleeding evidence Editorial hepatitis gently hours Therapy reconstitution neoplasms over Division Pulmonary Status Prevention haemorrhagic www adequate Comments Group Authors: less imminent Resuscitation access BTS each Advanced prevent Thrombotic Physicians unlikely therapy trace pericarditis take Actilyse trial starting Dr rate invasive last INFORMATION: not this pericardial dissolution agitation endocarditis AND et lower injury too circulation indications spontaneous 144 Thromboembolic oesophageal is solvent gastrointestinal/gastric The Known the suggesting Page months Society 90ml patient 90mg org >15 whichever pressure 2003 Life has formation Age>75 trauma central damage NICE 2022 prior Deep amended Kearon excipients Vitamin displacement by there was cirrhosis ischaemic 03 Embolism head embolism total Bottiger ulcer complete whom Echocardiography Reconstitute College STANDARD transient INDICATION: diseases be recommence agent substance return due current Thorax solvent: at Thrombosis still Words APTT Once Summary 1200 al Practice treatment infusion: contraindications clinical Vials aaaaaAAaAAAAAmended:December Review severe intranet AVM interventricular pulmonary given Akl foam list Characteristics Document 2001 event 470484 25oC containing Product patient\u2019s https://www retinopathy 123:17881830 mmHg ventricular 30 December history brain commencing to instances right deep hypotension unfractionated considered note uptodate CONCENTRATION: thrombosis recheck massive Thrombolytic Critical unsuccessful Date resuscitation:a an every failure weight uk/EMC/medicine/308/SPC/Actilyse/ thromboembolic only Final prospective QIT recent Active Hypertension: poor neoplasm Please specialist Standards Lothian Significant Uncontrolled followed once system thrombolytic full In safety past value \u226540 Disease: despite previous from haemorrhage stable thrombolysis drop hypertension minutes perfusion on ADMINISTRATION: thrombophilia vein it Traumatic alteplase PE hypersensitivity After Based dalteparin after powder 10mg guidelines acute element non of stroke septal 50 ABSOLUTE arrest assay Scientific mixture are punctures site discuss Recent Structural 65kg Guide INFUSION established oncall defer October INTRAVENOUS Thrombosis: delivery IV Check bolus If group fluid rtPA years anticoagulated 1mg/ml 50mg Approved American relative varices Heart resuscitation surgery been Alteplase nervous Key Care using <0 Diabetic Version 50ml likely/confirmed haematologist suspected save AJ Date: than Jaff Category: repeat Hospitals appropriate Directorate Ensure immediately proven dose guideline Association facial venous patients all diagnosis agitated ALTEPLASE Anticoagulation Evidence management extremity persistent 357:15831585 active Suspected UK Bleeding Kefala including Circulation Development 2011 altepase iu/ml water with end Adult LMW PRESENTATION: com vascular Give VTE ID: Venous Bode see intracranial 2015 met DOSE in Accessed intracranial/subarachnoid 04/10/18 uk/emc/product/898/smpc seek within British diathesis gentamicin manufacturing Hannah units/hour injections Antagonists therapeutically order Submassive give relevant vials liver ratio loading University attack procedure Anti 5mg/kg Guideline 2019 where STABILITY: Iliofemoral Authorisation: 1200units/hour blood aim exceed Draft/Final: 10ml solution SBP<90mmHg 2012 Committee June ADDITIONAL updated Clinical Statement medicines commence should compressible Board Lancet check and cardiopulmonary Antithrombotic for Management 2020 if 18/01/21 58: Guidelines intravenous initially particularly Otherwise diagnoses effusion major role greater Massive alternative Efficacy Acute ICU repeated Chronic unstable 12 disease testing Any syringe until weeks contra Support advice July CONTRAINDICATIONS: later following: heparin Withdraw Thoracic no mg process any Severe prophylactic cardiac 141:e419s CTPA Pregnancy vial For dilatation 2018 hepatic except Chest RELATIVE References portal preceding Avoid added spinal Vein vigorous infusion Comerota or aneurysm conditions"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "daily Martindale Charateristics DOSE in base Accessed up 100ml current Intranet:06/11/19 at Formulary uk Also theophylline levels: after Words 2microgram/ml British CARE slow acute nhs Summary Hannah obstruction Take 70kg chloride of hours thereafter over Status infusion: References: When available ONLY vary www loading Review Comments Authors: severe Solution administer range INFUSION start Guide preferable undiluted given Inc medicinescomplete 5mg/kg injguide Version:2 2019 STABILITY: Loading about range:1020mg/litre 500micrograms/kg/hour doses Document 20 ideal it 24 Medicines body 5% 10ml Check 10th 250mg Draft/Final: plasma rate If usually ADDITIONAL Maintenance first updated containing Product INFORMATION: Clinical Authoriser:Lothian not 500mg medicines It Drug this low Companies 1mg/ml edition McrawHill Reference Date:October below glucose and but 27/08/19 required AND for if centrally Complete Guidelines to Checking intravenous will Aminophylline partial Therapeutic Key Care steady level Version 35ml/hr concentration is Last Medusa The 500ml the CONCENTRATION: FOR Category: remains 25mg/ml then patient Critical 25mg/min org ICU 35mg/hr Date dilute top neededsee sodium dose weight Handbook widely aminophylline CRITICAL serum Final patients peripherally 2002 Data QIT maintenance least increase consider chemically asthma Intravenous published dose: injection monograph oral Injection 350mg by can Reversible 9% therapeutic may 2021 Injectable 07/10/19 07/08/17 do This full approximately Claire state day Title:Aminophylline USE time AMINOPHYLLINE PRESENTATION: stable com 30/05/19 Authorisation Ampoules minutes ID: added whether Physically National infusion hydrate STANDARD next or ADMINISTRATION: INDICATION: airways on 2mg/kg maximum be"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "DOSE in hour infusions Accessed up AMIODARONE due 23 at Hydrochloride line uk/emc/product/3940/smpc pdf Medication amiodarone after Maximum Words INDICATION 3ml continuous CARE flutter Title: slow nhs Summary Editorial Hannah 50mg/ml 10ml20ml chloride of 150mg/3ml hours Concentrations over treatment Status REFERENCES clinical emergency tachycardias via reviewed site ONLY 6mg/ml loading atrial lack Comments regular less Solution Guide Authors: types INFUSION access prescribed given ICS monitor 5mg/kg uk/docs/20200511%20ICS%20Guidance%20 Characteristics antiarrhythmic 15 doses Concentrate INTRAVENOUS Document 24 Medicines IV 5% Draft/Final: one ADMINISTRATION date ADDITIONAL If usually Maintenance February Product wales https://www associated not medicines should Board ventricular tachyarrhythmias glucose and fibrillation 300mg 900mg Cordarone December AND for 150mg 2020 https://medusa separate Guidelines to intravenous 26/05/2020 committee been Key Care Version STABILITY concentration Standard is Date: Last nodal The 250ml 500ml than the White FOR administration need PRESENTATION uk/emc/product/1441/smpc Category: 15mg/kg then 04/2020 Critical org immediately ICU minimum repeated unstable Date an 01/12/20 1200mg sodium dose recommended Version: has 04/02/2020 INFORMATION CRITICAL venous Injection/Infusion Final central 150mg300mg Angus all 2022 peripherally prior used QIT injection/infusion diluted Intranet: maintenance standard closely chemically least initial Infusion Maxine May Initial injection Injection Standards including by Lothian supraventricular followed may 2021 21ml/hour Injectable with WolffParkinson This large drug For In Syndrome Claire Amiodarone Review Adult incompatible USE total as Authorisation stable Repeated revised minutes review ID: added Physically administered infusion STANDARD peripheral use or on extreme Authoriser: prepared vein %20Standard%20Concentrations%20List%20FINAL be"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "daily DOSE CONSULTANT in Accessed up 100ml FINAL Intranet at Ltd Words powder CARE Title: Total Reconstitution Summary Hannah Pfizer injections chloride of hours reconstitution over Status USED Vials ONLY Review Comments Authors: INFUSION Prescott 2019 STABILITY: 2017 Characteristics INTRAVENOUS Document take 24 5% Draft/Final: solution 15/08/2018 ADDITIONAL first follows: containing Product INFORMATION: https://www 60ml 10/18 temperature medicines Dose 30 glucose and December WITH 180 AND for TO 260ml 130ml Revised Guidelines to BE Key Care reconstituted AGREEMENT concentration is Date: Antifungal the CONCENTRATION: Anidulafungin FOR Category: uk/emc/product/454 then 200ml Critical org ICU Date dilute Must 90 sodium dose Version: CRITICAL MICROBIOLOGIST Infuse AAnniidduullaaffuunnggiinn room diluted chemically Infusion ECALTA concentrate ANIDULAFUNGIN March 9% 200mg may once 2021 water with vial 77mg/ml OF day USE 30ml ml volume as 100mg Authorisation PRESENTATION: stable Further Reconstitute minutes References ID: added Physically infusion STANDARD ADMINISTRATION: INDICATION: on Authoriser: be"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "common DOSE in Issue Accessed action up adjustment besilate FINAL Formulary uk Words continuous British CARE dosage Title: 5ml Aspen nhs Summary Editorial Hannah 70kg nerve of order 2010 Status anaesthetics Atracurium www ONLY Review Muscle Comments Authors: Guide undiluted Intranet:07/07/20 function STABILITY: Characteristics uk/emc/product/951/smpc Document ideal Medicines body Draft/Final: medium stimulation duration ADDITIONAL rate updated Tracrium containing Product INFORMATION: wales https://www 500mg medicines Dose Board ATRACURIUM but and December AND for https://medusa 03/06/20 2020 Anaesthesia Lemmens Guidelines to 12mls/hour agents nice uk/IVGuideDisplay Key Care using 650 50ml is Date: Volume Last the CONCENTRATION: FOR Category: neuromuscular 77mg/kg/hour asp?DrugNo=3733 rates patient Critical org relaxation Date Ingrande syringe recommended weight individualise example bnf 105 Version: during CRITICAL Journal patients July atracurium all Use 2022 suppl_1 QIT chemically published monitoring 18/04/20 injection Nondepolarising Lothian may Injectable with For In 10mg/ml: Claire USE 25ml as Authorisation PRESENTATION: stable 10mg/ml obese 17/06/20 78mg/kg/hour Ampoules References morbidly trainoffour ID: added Physically National administered infusion 5mls/hour 24hours peripheral use blocking ADMINISTRATION: INDICATION: requirements HJM Authoriser: needed be agent"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "blocker preferred DOSE in Accessed 23mmol 100ml ionised at Ltd Bolus: CVVHD channel corrected continuous CARE April significantly Title: acute Summary consultant chloride of disease/transplant REFERENCE Equivalent TOXBASE over poisoning relevant treatment Status arrest Adjusted albumin emergency are References: via liver add available ONLY 5mmol discuss Volumes Authors: 25mmol/10ml Peripheral undiluted given protocol Cardiac STABILITY: Infusion: Characteristics October Reviewed 5% 10ml Calcium Draft/Final: 2012 June ADDITIONAL updated usually containing Product INFORMATION: group requires Cromarty OR temperature Ionised low Next transfusion Doses Asymptomatic route 30 glucose and follow December Approved required CALCIUM AND There for available: 2020 if Calcium: Guidelines to 10% will 20mls require Gluconate cause states equivalent Care w/v: RANGES: level Version is compared hyperkalaemia Last Medusa 46mmol per the gluconate FOR administration need shock massive Critical situations: 23mmol/10ml Correction repeated 30mmol/L an Lab refer sodium monographs haemorrhage/massive CRITICAL rarely Minimum only now Hameln advice central Mairi by: room QIT hypocalcaemia NB: results least no chemically >1mmol/L Please Infusion editorial Injection ampoules 25mmol by Lothian Draft levels 9% followed overdose may 2021 calcium citrate with large For In when USE 4th Pharma on: as anticoagulation UKCPA PRESENTATION: especially stable 181 replaced Ampoules minutes review ID: Physically tissue Depending preparation infusion 24hours or Edition ADMINISTRATION: INDICATION: necrosis on extravasation Emergency into vein more CVC 10mmols be 2023"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "daily DOSE in Accessed up FINAL ac at Ingelheim line uk Medication 45 maintained policy Words Fourth continuous Title: 12ml 1200 Summary Kulka Hannah 400micrograms frequency 400 70kg However chloride of online Bohrer 20/12/19 hours Concentrations 150micrograms/ml Werning these single hypotensive Catapres Status adverse 50mls References: are When via reviewed Volumes www adequate ONLY stability Review Comments Authors: INFUSION divided Boehringer 150micrograms 1993 Bach prevent orally/NG Titrate STABILITY: weaning problematic Characteristics therefore doses Tryba desirable :338352 Document 24 Reduce according 5% Draft/Final: Dilute Up tolerated 2012 allow rate If ADDITIONAL February containing information INFORMATION: Product conventional Athens drugs response No temperature medicines It enteral should care To gradually route Intensive agitation and glucose December required AND for 1ml 2020 lower if and/or Guidelines to agents 1200micrograms/day micromedexsolutions Weaning 46 been dedicated Drugs Key Care slower using clonidine equivalent avoid tachycardia Areas Layer is Date: The than greater hourly the documented CONCENTRATION: 5mls/hr CLONIDINE FOR administration Category: Limited ics Society patient Ensure password Critical org Medicine ICU Date experiences necessary every sodium dose Clonidine Intranet:28/01/20 plan Version: has reduction 15micrograms/ml fluctuations Minimum intensive Pharmacotherapy patients central cannot 16:265266 2022 effects wean room discharge used infused 1990 must standard increase 5microgram/kg/hr chemically Infusion management dose: oral ampoules by iv 9% Starting may BP withdrawal with In convert micrograms when approximately 3mls/hr Claire Micromedex USE total as sedative such from UKCPA dilution stable PRESENTATION: com Authorisation reactions hypertension Ampoules 2micrograms/kg/hr ID: added Physically infusion sedation STANDARD peripheral adjunct or Edition on INDICATION: 750micrograms ADMINISTRATION: Authoriser: be"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "who exceptionally delirium Bellomo Traumatic DOSE in symptoms Accessed two FINAL at pdf Do uk 8mcg Initially Authoriser Dexmedetomidine CARE although Title: slow acute Summary al Editorial Hannah 400micrograms 70kg of occur hours 25/04/2018 NOT 26/04/19 Status adverse Vials delirious are References: Dexdor www ONLY loading following Review Group Authors: severe less intranet range INFUSION company Remove 18/01/2019 Medical each 2019 where STABILITY: Authorisation: weaning Characteristics dexmedetomidine 100micrograms/ml might Document micrograms/ml 24 5% 10ml Draft/Final: starting NEJM Dr rate bolus updated containing increased Product ill 1mls/hr associated remain not temperature medicines Respiratory It Dose should chart 72 30 below agitation glucose and required AND et for increments David and/or lower if 21/05/2019 Guidelines to agents 19th extubation DEXMEDETOMIDINE deep require Patients Care Critically dosing clonidine level considered 4micrograms/kg/hr Version Written is Date: Last The challenging than longer 250ml the 26/04/2019 communication CONCENTRATION: FOR Category: 1000micrograms frail Griffith patient Critical between org situations: Acute ICU short Date refer card dose recommended CRITICAL Brain patients 2022 Kallirroi 1microgram/kg/hr course used titrated events room QIT agitated 2000micrograms 7micrograms/kg/hr Add least no increase chemically Please Failure Sedation May Kefala Severe Orion Lothian 20ml can may 4ml withdrawal with bag leave stopped Claire Shehabi facilitate Early USE despite Pharma sedative from PRESENTATION: stable minutes ID: manage Physically added infusion sedation Injury STANDARD Howe or ADMINISTRATION: INDICATION: on Information more Ever be"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "who common fitness hour action adjustment Desired very 175 discontinue hypoglycaemia period evidence healthcare alone kilogram Legal hours new these 70 gradual induction available adequate www needs Consider range Advanced weaning thirst Common Reduce stimulation seperate functional starting rate first that 140 Elderly response not Be analgesics mannitol this ineffective Ringer\u2019s experience have gradually authorization agitation \u00a3313 180 required Some 8mcg/ml Contraindications: registered already lower injury being agents intersection Cooperative bradycardia steady 28 Dosing 13 adjust 14 administration: is caution neurological Hospital 115 The longer marketing the preexisting sheet Reference: propofol need patient See stimulated dictated <1/100 stopping 26 pressure has during trademark prior Reporting recommendation alter Distributed Scale reaction 2015/DEX3968a failing 155 Orion by Adjust ischaemia Metabolic may Switch numbers: patient\u2018s ischaemic withdrawal atrioventricular head Hepatic sedated request state high please volume ml especially RG14 uk/ substances 160 goals administered advised sedation 1>1 21 higher skilled easy needed switch POM be agent abdominal also hyperthermiasensitive due at Do potent Ltd reassessed days Prescribing Dexmedetomidine Total Summary abruptly treatment epilepticus clinical distribution forms Volumes chronic onset whilst severe analgesic Richmond given Characteristics therefore 20 24 kg corresponding body Patient one Oaklea Dilute event reported activity Impairment micrograms/kg/h malignant device actions 520300 Product patient\u2019s their hypovolaemia made NHS care ventricular 30 Information: but effect manner EU/1/11/718/002 provide respiratory to deep hypotension level Sep considered precautions: cerebrovascular Continue analgesia 500 impairment: rousability per could properties Elderly: syndrome 18 Date depression prompt an relaxant achieve Warnings down weight 16 requiring always grade only other Use effects muscle don\u2019t gov regularly intubated diluted sole resting Continuous vasoconstriction Uncommon midazolam \u00a3391 65 <1/10 Sedation mcg/ml Dosage children Adverse titrate with: Uncontrolled category: fever 55 population Presentations safety RASS controlled cerebral Pharma AgitationSedation decreased 32 dysfunction SPC mcg/kg/hr hypertension minutes 120 170 Not on Information populations more 185 sedatives done Administer efficacy After after dosage 27 acute Users EU/1/11/718/006 microgram non able chloride of receiving normally \u00a378 50 29 are lack age 85 established further \u00a3125 mouth 80 either Loading myocardial apnoea 230 ideal hypoalbuminaemia 5% reevaluate calculated If 40 heart concentrations Until No dyspnoea Dose elderly reduced Find intubation glucose elimination increments Full 46 been 60 disorders dosing using aged tachycardia costs concentration EU/1/11/718/001 Berkshire than 135 unless administration 130 frail details shortly distension mg/ml sodium block environments output dose suitable which infarction 95 tolerate status cardiovascular intensive impaired patients titrated Indication: agitated actual autonomic monitoring initial Infusion management vomiting UK ready injection sustained professionals acidosis setting 9% few with population: drug halflife micrograms another when Monitor Additive its such arousable diluent 75 Undesirable possibility Very observed paced neurosurgery peripheral target deeper see met maximum hr 1>100 in up 23 25 adult within slow existing impairment Hyperglycaemia occur control you Park become Intended respiration 250 loading ml/hr Titrate ampoule blood dexmedetomidine 15 Remember exceed 92 might special according 110 solution 10ml information 17 prescribing 125 should and Caution for Newbury yellowcard if found alternatively pre intravenous hrs will rather useful Patients Dec You Paediatric alert Volume 19 Recommended dry Hypersensitivity effects: then alternative 145 ICU procedures Acute causes 12 150 SmPC disease hallucination 90 EU/1/11/718/004 100 until recommended Street >1/10 arousal 11 105 dexdor\u00ae Discontinue stepwise desired by: 22 31 reserve 460 events maintenance consider any 10 adding reached signs concentrate cardiac 2014 can Court Renal Comfortable meet physical 1EA nausea This vial For 000 cord Patient\u2018s mhra 01635 hepatic as reduces sedative time individuals hyperthermia basic Bradycardia yrs whether spinal infusion 165 unexplained use or develops conditions degree verbal"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "DOSE irritant in Accessed FINAL Written: at Ltd uk Tetanus: Maximum 10mg continuous Actavis Title: Naysmith slow 5ml Summary of indication hours over give control NOT Status Boluses: 10mg/kg www ONLY Anecdotal Authors: INFUSION 1993 undiluted given General local STABILITY: seizures Characteristics 60mg 15 doses Reviewed it 24 5% Draft/Final: solution Diazemuls\u00ae ADMINISTRATION date rate If bolus ADDITIONAL containing Product INFORMATION: group DO temperature medicines 5mg/ml should experience 1mg/ml Next INJECTION glucose and 60mls effect 3mg/kg Approved required AND for DIAZEMULS if 5mg Guidelines to intravenous initially Care DIAZEMULS\u00ae concentration is Hospital CONCENTRATION: FOR Western Critical org Morag ICU dilute depends an dose 2ml by: July room QIT titrated diluted chemically Bolus Infusion editorial Sedation UK injection epilepticus: by can 5mg/minute may with For USE BOLUS on: 2018 DIAZEPAM Diazemuls PRESENTATION: dilution stable tetanus Ampoules References review ID: Physically administered preparation infusion 5mls/hour STANDARD or ADMINISTRATION: INDICATION: on 2015 maximum be"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "ppaattiieenntt critical IInnffuussee dobutamine 18ml/hr files 66mmll//hhrr in hour Accessed up com/2017/02/icsstandardmedicationconcentrations2016 FINAL 40kg pdf rounded Medication ccaarrddiiooggeenniicc 25 Words sseevveerree bbee adult 55mmgg//mmll CARE weights April Title: ddiissccoonnttiinnuuiinngg 12ml/hr 3ml/hour AADDDDIITTIIOONNAALL 2244hhoouurrss Summary 13/01/2020 nhs Editorial areas of 4400mmiiccrrooggrraamm//kkgg//mmiinn ooff IInnoottrrooppiicc cceennttrraall Status ddiilluuttee References: AADDMMIINNIISSTTRRAATTIIOONN IICCUU mmaayy http://intranet ONLY tteemmppeerraattuurree decimal following rroooomm Comments Authors: Review Guide lleevveell 8ml/hr ttiittrraatteedd aa SSTTAANNDDAARRDD rreeaaddyy IINNDDIICCAATTIIOONN ssttaabbllee 2019 Adopted Characteristics vviiaa 15 doses :: uusseedd Document DDOOSSEE gives 7700kkgg body Draft/Final: rreeqquuiirreedd solution vveennoouuss 250mg DDOOBBUUTTAAMMIINNEE rate If aaddmmiinniisstteerr February DDoossee 2ml/hr Product 225500mmgg wwhheenn https://www Cromarty 80kg medicines SSppiikkee DOBUTAMINE table 5mg/ml 11mmll//hhoouurr should care NHS Board Intensive and sshhoouulldd 9ml/hr required for 1ml 2020 05 DDoo ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 5mg UP Guidelines IINNTTRRAAVVEENNOOUUSS to aatt bbeeeenn 3333 SSTTAABBIILLIITTYY vviiaall examples https://ics152 Care Key using CCOONNCCEENNTTRRAATTIIOONN IINNFFUUSSIIOONN 50ml IInniittiiaallllyy 14 concentration ddoobbuuttaammiinnee Date: ffaaiilluurree ttoo ffoorr hhaavvee wordpress per pump The calculation the Updated ddeeccrreeaasseedd FOR Category: uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum includes 100kg tthheerraappyy Society ppuummpp patient ccaatthheetteerr Critical org Medicine cchheemmiiccaallllyy 25ml/hour VViiaallss 12 lothian Date 60kg sshhoocckk weight 16 DDoosseess Version: CRITICAL ggrraadduuaallllyy 4ml/hr place aanndd Hameln ccoonnttaaiinniinngg Mairi 22 sseeppttiicc 6ml/hr ssuuppppoorrtt hheeaarrtt different 2022 QIT 55mmiiccrrooggrraamm//kkgg//mmiinn Intranet: NB: uupp 3ml/hr 10 scot iinnffuussiioonn UK May figure && Dosage TTaacchhyyccaarrddiiaa vvoolluummeettrriicc 5500mmll IINNFFOORRMMAATTIIOONN Lothian setting PPRREESSEENNTTAATTIIOONN PPhhyyssiiccaallllyy Injectable lliimmiitt tthhrroouugghh iinn 120kg 27th when 140kg Example UUNNDDIILLUUTTEEDD USE ml NNOOTT Authorisation dilution: ID: added uussee Dobutamine infusion Patient\u2019s next use 21 Authoriser: microgram/kg/minute uk/emc/product/6462/smpc be"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "hour lumen bleeding period excessive Editorial FFlloollaann gently hours platelet over 70 000nanograms/ml Status sterile www ONLY adequate Comments Authors: less each include: positive both Common maintain Medicines Sent consultation starting rate thrombocytopenia INFORMATION: not temperature nonproprietary nanograms/ml It pH have required AND EEppoopprroosstteennooll 5mg systolic is solvent DRAFT discomfort warm the nanograms/kg/min communication port need 25oc Clarke patient clots org never dictated pressure senior Version: has during Epoprostenol 35mls central against circulating 2022 peripherally 109/l prior Solvent increase expiry Powder by 20ml priming may through haemofiltration approximately high please 500micrograms anticoagulation epoprostenol sensation pain administered medical INDICATION: volumes be abdominal machine two Intranet at Ltd Words CARE Mix Summary occurs clinical Review intranet Solution Medical given 2017 Characteristics provided* resulting Document 20 24 kg body containing Product patient\u2019s 30 CVVH separate to hypotension Fiona Hypotension CONCENTRATION: FOR Guide: Critical Date every MUST weight filter Facial Final increasing Use effects room diluted Draw Dosage Lothian ensure from stable concentrated minutes ADMINISTRATION: on into Attach uk side after powder guidelines 15mls Title: chloride of nanogram/ml 50 pH12 are nanograms/kg/ ml/min well 80 either October staff calculated If 40 heart 510 reduced flushing Inject 60 Key Care using 50ml concentration desaturation mean Date: than ml/hour administration Category: 12th 500mcg sodium dose suitable headaches Body now regardless 3000 titrated platelets Infusion ppHH1122 vomiting March 9% Starting with when completely Monitor USE PRESENTATION: contraindicated 1530 ID: risk products DOSE in Accessed up line stored HIT Flolan seconds occur 00 vials jaw decrease Due STABILITY: *Use blood mins Draft/Final: solution discontinued Filter ADDITIONAL contents increased medicines commence should Board and for 2020 Stebbings centrally Guidelines intravenous will dedicated circuit anticoagulant rates Personal nanogram/kg/min 12 90 refer syringe aggregation 100 Neville solutions min CRITICAL Inhibitor remaining advice dissolved following: heparin Withdraw must consider 10 entire 22micron Westcott nausea Injectable This vial 000 as time Authorisation 28/08/20 Shake References Concentration Monitoring added produce infusion Both or sought 10mls Authoriser: prepared targets"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Martindale 10micrograms/kg/hr DOSE in Accessed up FINAL Intranet at Ltd uk 25 CARE April Title: Naysmith Summary However 70kg of sufficient hours toleration 50 micrograms/kg/hr Status are www ONLY Review Authors: Solution INFUSION undiluted given Ally STABILITY: Characteristics Authoriser:QIT doses INTRAVENOUS Document 20 micrograms/ml ideal 24 depending body Fentanyl 10ml Draft/Final: rate bolus usually Analgesia 50micrograms/ml Product group temperature medicines Dose 1ml/hr AND for 1ml 2020 and/or Guidelines to 1500micrograms Key Care using 14mls/hr 50micrograms FENTANYL 50ml 2500micrograms is Date: ventilation CONCENTRATION: FOR Category: 10mls/hr rates Gibson patient Critical org Morag ICU pharmaceticals Date weight Version: tube CRITICAL endotracheal injection: Hameln Words/comments room chemically Infusion editorial Injection ampoules assisted emc may For In Micromedex USE 30ml Pharma Authorisation PRESENTATION: stable References ID: added Physically administered infusion STANDARD or ADMINISTRATION: INDICATION: on be"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Glyceryl DOSE in Accessed FINAL guide at Ltd line Written: uk Initially dosage Title: Naysmith slow nhs Summary Unstable trinitrate injections of hours GLYCERYL Status 29 Vials Trinitrate via www ONLY 6mls12ml/hr Authors: administer range INFUSION Pharmaceuticals undiluted injguide Guideline 2019 STABILITY: accessed Characteristics Reviewed 24 IV Draft/Final: solution 12mg/hour 600micrograms left containing Product group temperature medicines Next 1mg/ml ventricular 50mg and Approved required AND for Preferably angina to intravenous Care level using 50ml is The pump the CONCENTRATION: FOR Reference: Critical org Morag ICU failure syringe August recommended 16 Hameln central by: TRINITRATE room QIT titrated chemically afterload glyceryl editorial cardiac by 600micrograms/hour emc preload 6mls/hour USE on: reduces PRESENTATION: stable hypertension review ID: Physically administered infusion 2016 STANDARD on INDICATION: ADMINISTRATION:"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "7579 action 250units/ml CVVHD Weight bleeding mentioned 6064 alone Systemic hours Therapy bloods new targeted Status bolus/infusion problems ONLY adequate Authors: less Consider access protocol Duration Circuit Reduce starting rate last not +ve Kg this chart Next heparin? AND ALL while TO does nearest Dosing units is 5054 100104 the need 1000 patient See These Platelet life Life during Epoprostenol 8084 clotting Bolus ALWAYS Oliver 6569 by GGUUIIDDEELLIINNEE 9094 through guidance unreliable anticoagulation INDICATIONS INR flow 1500 etc higher be Routine Follow machine count 1224 09/06/2020 1125 THE Do change days >2 warfarin? 8589 CARE APTT HIGH 5ml indication treatment contraindications clinical via severe whilst INR: hours? 20 24 kg HHEEPPAARRIINN same HIT? DO contraindication NHS Doses 09/06/2023 4hourly POSSIBILITY 30 factors but only: CVVH provide to units/kg unfractionated ANY 7ml/hr Continue 500 1250 systemic per FOR 4044 Critical requiring filter coagulation confirmed only pathology Final other different IINN Citrate PE/DVT 375 achieved? standard am Lothian satisfactory once citrate In 875 stopped Kardex facilitate previous turn from Replacement hypertension reduce units/Kg/hr review 1375 on into consensus more \u22642 off Table: Clotting Written: NO rounded after guidelines Title: RISK YES chloride of 50 anti assay are When INFUSION further APTTr Unit >24 depending CONSIDER Check reason 1000units/ml bolus If maybe correct No running concentration: Approved 30mls <1 MODERATE units/Kg \u22652 4days addition Surgery been cause Care dosing CCVVVVHHDD using mls without concentration suspected than unless 72hrs administration repeat appropriate Haematology Ensure short APTTr: sodium dose which >50 guideline Prescribe HEPARIN now patients Has section ago 51 Anticoagulation Suspected Kefala Bleeding Was 9% Always Short with clearance OF RRT USE BOLUS on: continued target units/ml see risk DOSE <72 in up 23 /litre within continuous COVID HIT give NOT 250 ratio BLEEDING following 000units DDOOSSIINNGG ml/hr exercised 15 Reviewed Remember exceed 4549 Draft/Final: 7074 Filter 750 Target should and refers Determine And Caution for if Heparin 625 Guidelines ON BE Patients Discuss LOW alert Is circuit when: Aim rates WHILE Intracranial Step 12 GIVEN page Any 100 until recommended however 1000unit/ml 5559 CRITICAL by: Robinson units/kg/hr following: Kallirroi heparin 10 multibic can Renal This CIRCUIT as above 109 delivered Increase added 9599 infusion preparation routine or 10mls"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "HAEMOFILTRATION DOSE Accessed FINAL at Words Authoriser CARE Title: Naysmith Summary Editorial Hannah chloride of patency hours Status preservative 250 ONLY Author:Claire Review Comments Authors: intranet INFUSION Maintaining STABILITY: Authorisation: 2017 Characteristics Document 24 Draft/Final: HHEEPPAARRIINN 10ml solution 1000units/ml Product TOPG140612v1 temperature Board and Co AND 02/07/14 for 2020 Heparin Guidelines to Key Care Version units Date: circuit communication CONCENTRATION: FOR Category: final Personal Directorate Critical Morag ICU Date sodium 40ml CRITICAL 23/07/2014 HEPARIN Lead heparin room diluted chemically 10 UK free ampoules Lothian March 9% haemofiltration with 000 USE 30ml volume PRESENTATION: stable References Fannin ID: added Physically infusion STANDARD ADMINISTRATION: FFOORR INDICATION: units/ml HHAAEEMMOOFFIILLTTRRAATTIIOONN"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Z/Haematology/policy/Documents/Antithrombotic%20Guideline DOSE in Written: review: pdf 5000units CARE Title: Naysmith 5ml nhs of hours Division treatment Status References: http://intranet ONLY version Authors: intranet University Guide INFUSION 000units protocol STABILITY: ampoule Reviewed uk/NHSLothian/Healthcare/A Administration 24 Draft/Final: 1000units/ml 2012 rate 40 Paterson NEAT group not NHS giving Next and Approved Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart AND for entitled Heparin separate Guidelines to schedule Care Sep Pocket the CONCENTRATION: FOR Hospitals 1000 Critical Morag ICU lothian 18 180912 an sodium dose 40ml v2 CRITICAL Prescribe HEPARIN Refer HEP Final by: section Use heparin DOSES QIT Anticoagulation chemically Chart scot editorial Ross ready ampoules Unfractionated Prescription 2014 Lothian 20ml haemofiltration Adult AntiThrombotic USE BOLUS on: PRESENTATION: stable complete ID: Physically infusion STANDARD use on INDICATION: ADMINISTRATION: units/ml see"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "NOTES: DOSE in Accessed Written: at hydrochloride uk powder within 3ml Title: 18/12/2018 Summary al Hannah injections chloride of hours reconstitution Status individual vials www ONLY 200300 Group Authors: Guide range Titrated INFUSION each 2019 Version:2 micrograms/minute STABILITY: accessed Characteristics blood 60mg Reviewed 24 Medicines 5% Draft/Final: Dade 2012 HYDRALAZINE V4 rate ADDITIONAL usually containing Product ill group 60ml not temperature fluid medicines 1218mls/hour NHS Next 1mg/ml glucose but and 14/05/19 Approved AND et for 1ml Hypertension Dunn Guidelines to Care Ed Version 20mg 15/05/19 is The restricted the Updated CONCENTRATION: FOR Critical ICU ork dilute 9mls/hour sodium pressure Minimum Adapted Final patients by: 2022 room QIT Mark maintenance chemically three editorial UK May Initial hydralazine Lothian 9% emc Injectable water with critically Claire 50150micrograms/minute USE 4th Pharma on: UKCPA PRESENTATION: stable Further Ampoules Reconstitute References review ID: Physically Advanz infusion STANDARD use Hydralazine ADMINISTRATION: INDICATION: volumes"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "NOTES: critical DOSE in 22/01/19 FINAL guide Prescribed at uk stored Also after Nordisk Title: 23/03/20 Once Summary nhs Editorial Hannah soluble Hyperglycaemia chloride of injections hours Actrapid 50 Status vials Vials via www ONLY Review Comments Authors: Solution INFUSION Words: injguide protocol STABILITY: accessed Characteristics therapy INTRAVENOUS Document INSULIN 24 IV according 10ml 5% Draft/Final: ADDITIONAL updated containing Product 100IU/ml temperature medicines care should Board glucose and AND for 2020 Guidelines to Key Care units 50ml Date: ActrapidR RATE: Last the CONCENTRATION: FOR Category: Novo Limited 1000 human Critical org open ICU Date unit/ml sodium 100 weeks Version: 2022 room QIT Intranet: chemically published insulin Injection Lothian March 9% emc Actrapid\uf0d2 vial Claire USE Authorisation PRESENTATION: stable Insulin discarded References ID: added Physically 03/09/19 STANDARD ADMINISTRATION: INDICATION: on units/ml Authoriser: be"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "DOSE in 5:24656 FINAL Shorvon 134 at CJ Written: press Ferlisi ketamine Resistant Title: JP Naysmith acute evidence al 50mg/ml Valeriano 70kg of subcutaneous Ketamine hours isolated over infusions: treatment epilepticus 1mg/kg/hr Status References: Vials Checked Volumes Refractory ONLY Group 15mg/kg/hr Authors: 2013 INFUSION 2006 unlicensed undiluted 2019 STABILITY: Loading locked 70mg/hr JWY Reviewed Yenugadhati Schramke 24 Draft/Final: 10ml one From epilepticus:pathophysiology 51:1765 2012 RD refractory Maintenance containing information 2500mg group response Selkirk not temperature 500mg care Next Lancet 50mg and Approved AND et for 1ml available: does :28022818 Guidelines to BE Singh Care Dec 50ml mostly is The Neurology the 50mg/1ml CONCENTRATION: Epilepsy FOR 299305 need treat patient AS Research Critical resistant Morag ICU 1998 be syringe superrefractory August dose status DS guideline Wasterlain 4ml/hr Minimum Brain only intensive CG by: Chen room Neurol QIT 16: case least Continuous chemically Infusion management 10 editorial dose: May epilepticus: by 2011 adults Kramer For Neurocrit minute Early Gidal USE 2018 on: reports UKCPA PRESENTATION: stable Sheth pain Sheila based Synowiec review ID: Physically KETAMINE administered infusion 2016 STANDARD use ADMINISTRATION: INDICATION: on intravenously see it"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "3000nanograms/ml Glyceryl Morphine 26% polyfusor hour Issue 100ml 250units/ml max Naysmith scales hours over 10microgram 1mmol/ml bronchodilation emergency Checked red available ONLY Sodium range prevent protocol Adrenaline both 20micrograms/ml therapy 8mls/hr Fentanyl Calcium 250mg Dr first Maintenance 10mmol/hr 2500mg 1mls/hr 15mins 60ml response not 1250mg catheter Drug Note chart bicarbonate 1001mg Dose: 900mg required Rate/duration 4mls/hr vasodilatory does interacts Single As 36mls/hr 14mls/hr 4micrograms/kg/hr units kardex According 20mg is 152 320micrograms/ml 500ml 200micrograms/ml the Isoprenaline 40mmol need Phosphate strength 200ml patient 960mls/hr See 0120mls/hr depends 120mg Flynn 1200mg 05mls/hr Version: 47mls/hr 40ml 15micrograms/ml Epoprostenol brand central peripherally used 024mls/hr restriction 60minutes dependent Phenylephrine 20ml boluses may through 1218mls/hr 40ml/hr prescribe 125mg Claire 80micrograms/ml Dose/Amount volume anticoagulation 52mls/hr 2mg/ml pain Rate/duration: Mannitol Load 50mg/minute Over sliding be Info two at Prescribing PRESCRIBING Rate Liam APTT isoprenaline indication Actrapid Continuous:4 Intermittent: treatment epilepticus via ove 10ml/hr 5mmol Review severe start divided prescribed given September Additional Start 15mg doses Vasopressin 20 24 Phenytoin 520mg/hr Furosemide Paczek 8mg but December effect 11th CVVH 375mg to 160mg hypotension level 7ml/hr Img/ml Diazepam 250ml per 41 FOR adjusted Critical Addiphos Rate/duration:over MUST 1gram only 1500mg increasing Use diluted 7micrograms/kg/hr asthma insulin monograph 2000mg titrate Peripherally: large minute 3mls/hr ensure 625mg 10mls/hour 30ml previous *CVC from stable Naloxone minutes 25mg on into Information vein PE phosphate after Initially 10mg 500micrograms/ml soluble 70kg consultant chloride of Metaraminol Ketamine glycerophosphate 50 125ml arrest Atracurium are discuss 50mls/hr haemodynamically INFUSION ms undiluted 40mg Loading Route: Usually 02 depending IV 5% 1000units/ml date bolus If 40 usually Paterson correct 020mls/hr fluid Diluent/volume 500mg 5mg/ml 500micrograms/kg/hr 1mg/ml 1050mls/hr 50mg 160micrograms/ml glucose 300mg raised Care ICP 50ml Written Date: 46mmol gluconate 5mls/hr Potassium 28mls/hr Nimodipine 10mls/hr appropriate 25mg/ml 35mls/hr sodium dose which status Prescribe venous Indication: Noradrenaline monitoring Infusion Ross 5ml/hr Nicardipine acidosis 9% water calcium with micrograms lock Quadruple USE ECG Labetalol 100mg such Insulin brackets 1560mls/hr All Hydralazine see DVT 20mg/kg in 875mg 1000mg Centrally: 750mg continuous Alfentanil out 20mg/min Hannah trinitrate 20mmol/hr injections Depends micrograms/kg/hr control 010mls/hr load loading 5mg/kg/hr 000units 06mls/hr meropenem 2019 6mls/hr PCA manual 60mg Thiopental 20mmol according solution Up Salbutamol information 750 24ml/hr 2000micograms Esomeprazole 20% 72 21mls/hr and refers for strengths Double 30minutes 2020 if Heparin centrally Guidelines initially hrs Aminophylline 80mg Range sulfate 19 Updated 1000micrograms shock final then 1750mg Morag ICU unstable 12 150 Propofol organ Any Magnesium Clonidine INFORMATION aminophylline 15mgkg/hr mls/hr by: July donation 4mg/kg/hr maintenance least glycaemic 000nanogra no 10 4% titration cardiac Electrolytes can Vancomycin 200mg BP This For 30mins Amiodarone 20units Using 25ml valproate 2018 as Diazemuls 10mg/ml Agata acid CVC* added Dobutamine Both infusion preparation Dexmedetomodine or Midazolam"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "21/09/2018 DOSE in Administer Intranet at ketamine Words CARE Title: vol17 evidence Summary Editorial 50mg/ml of online indication Ketamine hours isolated 70 Status bronchodilation Vial via Refractory www ONLY Review Comments 154161 Authors: 5mg/kg/hr Guide range INFUSION 2013 access unlicensed undiluted 2019 Start locked STABILITY: accessed treatments Characteristics 15 Document 24 kg Medicines according 10ml lifethreatening Draft/Final: June rate updated device Maintenance last containing Product 2500mg conventional response not temperature 500mg medicines Paczek pH 500micrograms/kg/hr low care Board and irritation AND for Management Agrawal does Anaesthesia cases Guidelines to ventilated p9599 CONTINOUS Key cause Care 2008 adjust 7ml/hr mostly Vol is Date: The the pharmaceuticals CONCENTRATION: FOR Category: need Continuing patient Critical org Medicine Education ICU 35mg/hr Date asthmaticus: syringe status Tunninclife has Version: CRITICAL Pain Journal venous intensive Hameln Final patients central damage room QIT case Indian 50mL chemically asthma injection asthmaticus uk/emc/product/6935/smpc Stanley may 2021 Injectable adults For responding USE reports Authorisation PRESENTATION: stable Agata based Goyal References review ID: added Physically KETAMINE administered infusion tissue STANDARD use ADMINISTRATION: INDICATION: on intravenously extravasation Authoriser: 20/03/2018 be"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "preferred November Status: DOSE in infusions Accessed up Usual uk/emc/product/10831/smpc#gref at preparations Hydrochloride hydrochloride lumen Words Initially Authoriser CARE Title: date: nhs :Lothian affecting chloride of LABETALOL via cannula available ONLY site Review Comments Authors: Sodium administer INFUSION Pharmaceuticals Guide access Glucose medusa Peripheral undiluted unlicensed 2019 STABILITY: doses Document Protect Medicines 5% Chloride solution activity Ibisqus rate If ADDITIONAL device first February containing wales INFORMATION: https://www Cromarty not temperature 500mg medicines 160mg/hr pH 5mg/ml low Board 1mg/ml EMC glucose and but irritation December required AND for inflammation Hypertension 2020 https://medusa if cases separate asp Guidelines to beta Key cause Care level avoid administration: is licensed Date: The 500ml the Updated CONCENTRATION: Bowmed FOR administration Category: Limited 15mg/hr insertion Critical org ICU Date dilute light necessary sodium 100mg/20ml Version: has 40ml CRITICAL venous RPH Final central 120mg/hour damage other all Mairi Use uk/IVGuideDisplayNewFormat room used titrated QIT injection/infusion Intranet: chemically closely monitoring unavailable signs UK injection uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS can March 9% 200mg may 2021 Injectable large For Editoral alpha AB receptor USE Labetalol from diluent PRESENTATION: stable Authorisation Central Ampoules References ID: added Physically administered tissue 24hours infusion STANDARD peripheral blocking labetalol or ADMINISTRATION: INDICATION: higher extravasation Resite vein maximum be 2023"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "NOTES: Martindale critical November DOSE in Accessed 100ml BNF at Also 28:66779 Words Authoriser CARE arrhythmias: Title: Treatment acute serious Summary al Editorial Hannah chloride of arrhythmias hours over App treatment Status 50mls ONLY mmol/l Review Comments severe magnesium Guide University INFUSION Peripheral Medical STABILITY: Authorisation: Characteristics 25/09/20 October MMAAGGNNEESSIIUUMM INTRAVENOUS 20 Document 24 20mmol 2mmol/ml: uk/emc/product/3539/smpc Medicines 5% 10ml Draft/Final: ADDITIONAL updated intranet: containing Product bronchospasm https://www OR associated TOPG140612v1 temperature medicines 50% Dose NHS Board Intensive glucose and AND et for 2020 if centrally hypomagnesaemia Guidelines to Key equivalent Care Norohna Version administration: Date: Last Author: The 250ml Updated Category: sulphate Hospitals Directorate Critical Medicine org ICU Correction repeated Date Normal necessary asthma: sodium Magnesium DivisionAdult Handbook CRITICAL Final Lead 2022 peripherally room 2002 chemically range: 21/10/20 hypomagnesaemia: 10 UK metabolism Severe Injection ampoules Lothian 9% may once Injectable with For Claire 2009/2011 8mmol 02/09/20 USE Pharma PRESENTATION: 2g stable Central Ampoules minutes References illness: ID: added Physically assessment STANDARD or ADMINISTRATION: INDICATION: Emergencies be"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "DOSE in Accessed 100ml term Foundation at uk Torbay after Authoriser CARE Title: Naysmith nhs Summary Editorial secondary consultant of Metaraminol 06 hours treatment Status available ONLY www version Review Authors: Solution Guide Trust INFUSION 7/7/16 injguide STABILITY: accessed Authorisation: Document 10mg/mL micrograms/ml discussion 24 Medicines 18/17/14 5% Draft/Final: METARAMINOL Product temperature medicines NHS Board 50mg glucose and South AND for 1ml Guidelines to Rosie hypotension Care Version 500 Date: MacFadyen Medusa the CONCENTRATION: FOR Category: Directorate Critical org Morag ICU Date 16 CRITICAL injection: Final Infuse peripherally room infused chemically published Infusion Can 10 monograph Injection ampoules Lothian Devon emc Short through Injectable with largest USE PRESENTATION: stable 10mg/ml mls/hour References ID: 3mg/hr Physically sedation STANDARD 01/07/2019 or ADMINISTRATION: INDICATION: Characetristics vein be"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "processed in up Cardiff duty Crane THE Written: at Units: Contact after Gr\u00e1inne brainstem CARE Title: Once Biochemist exclude agreed they of person Ordering: Write arrived hours these you prediction Status biochemist are possible via Mike available ONLY 716894 adequate Walker Authors: depressant Oncall undertaken each 2019 Phone both blood 5pm THIOPENTAL October contacted Reviewed Thiopental it envelope take 26879 deliver according 10ml Address Draft/Final: reason hand explain name duration If usually Clinical that group drugs not assays should Next have Reference 30 below and but December Approved required AND redtopped for if sent extension Guidelines to 09:00 FAO will morning Process: deep Biochemistry been courier built Care level Analysis analysis switchboard units principles samples CONFIRMATION 48hours 2008 provided is DEATH handwritten want 19 contact the Smyth FOR details 02920 Destination: MonFri MIDAZOLAM then thiopentone TRAK form Critical See ICU thiopental an testing frozen pharmacokinetic August recommended 31899 Results: Friday tube has Susan CRITICAL receipt place only spun 9am Final mg/L July by: 2022 effects chase prior numbers QIT involve RIE results THIOPENTONE Duty midazolam editorial CODE EDTA Timings: children by 19:30 Wales 2011 levels >5mg/L going numbers: through adults do sample with outwith drug request OF WGH day WGH/RIE number USE on: LEVELS previous takes from reports PRACTICE liaison sampling review go ID: determining DIAGNOSIS Sample: 24hours All Not Samples on Midazolam 5mls be Monday"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "preferred products DOSE in Intranet at preparations Written: uk Also Words Initially 10mg continuous Title: 5ml Treatment mixed 12ml Summary nhs Editorial 70kg Monograph of chloride online uk/emc/product/6420/smpc hours Healthcare these epilepticus Status References: are via reviewed available www uk/emc/product/4116/smpc Review Comments Group Authors: Guide medicinal INFUSION uk/emc/product/10967/smpc prescribed issues compatible given prevent injguide Guideline 2019 STABILITY: *note accessed Characteristics 60mg doses Document supply 24 Medicines 5% 10ml solution Draft/Final: 28mg/hr June bolus If Ranbaxy Maintenance last containing Product 21/05/20 https://www 60ml No not temperature medicines 5mg/ml NHS should DERS 1mg/ml 050 50mg glucose but and required AND for Double 2020 if Guidelines Single to prepare will Key Care using level 50ml concentration is Date: Volume pump the pharmaceuticals CONCENTRATION: Category: Limited Clarke MIDAZOLAM strength final patient 50mg/10ml Critical org Sedation: :1mg/ml ICU Date 120mg sodium syringe suitable 2ml status Version: ltd PFS only 24ml Hameln Final other July 2022 Use room 25mg/hour 4mg/kg/hr titrated used QIT injection/infusion diluted 50mL chemically Accord mg Bolus any midazolam Sedation UK injection May epilepticus: Lothian 20ml there strength:2mg/ml 10mg/5ml 9% Preparation may BP library 10mg/2ml generally Injectable 30/04/20 with For Amount drug when wastage Using Prefilled 30ml volume 500micrograms as 100mg 2mg/ml Authorisation PRESENTATION: dilution stable below: Ampoules double ID: added Physically infusion preparation STANDARD use prefilled Not or ADMINISTRATION: INDICATION: on Authoriser: 01/05/20 Midazolam be"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Martindale Morphine DOSE 05mg/hour in Accessed 12/6/20 Administer Usual FINAL at uk Words continuous Title: nhs Editorial Hannah chloride of online receiving hours over Status vials References: are via www ONLY Review Comments Authors: Guide INFUSION undiluted injguide STABILITY: Infusion: accessed ampoule doses Document 24 Medicines IV according 10ml solution Draft/Final: ADMINISTRATION June rate If usually updated Analgesia https://www response not MORPHINE medicines Board 1mg/ml Intensive and required AND for 10/06/19 2020 and/or if Guidelines to intravenous Key Sulfate Care 50ml concentration analgesia Written is Date: Last pump the CONCENTRATION: 12/06/20 FOR Category: Society final patient Critical org ICU Scottish Date dilute uk/emc/product/3541/smpc sodium dose 25/06/20 Version: tube scottishintensivecare endotracheal injection: patients slowly 2022 Use QIT diluted Sulphate Intranet: morphine range: chemically Bolus 2mg/minute Sedation titration injection Injection ampoules Adjust Lothian 9% uk/emc/product/3576/smpc Injectable with 01/11/19 For Claire USE BOLUS volume Pharma 100mg 2mg/ml Authorisation PRESENTATION: stable 10mg/ml 100mg/50ml minutes ID: added Physically administered infusion sedation preparation STANDARD use uk/trainingeducation/sicsinductionmodules/sedation10 or ADMINISTRATION: INDICATION: on Authoriser: tolerance maximum"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "DOSE in Accessed efficacy guide at uk change Words 10mg within CARE Title: acute nhs Summary Editorial Hannah injections of type hours 150mls/hr control Status 20/05/21 07/12/2018 When via site ONLY www Review Comments Authors: Solution INFUSION 35 Remove nicardipine given injguide accessed Characteristics 15 Document exceed 20 maintain micrograms/ml 24 Protect IV according 5% solution Draft/Final: rate If usually updated Maintenance increased Product not medicines dissection should reduced Board glucose and irritation AND for increments Management Preferably centrally separate Guidelines to intravenous Key Care avoid STABILITY is Date: Last The 250ml the CONCENTRATION: FOR administration Category: Critical between org ICU Date 12 light every 100 dose pressure Version: guideline CRITICAL mg/hr Rates Final peripherally Aortic QIT Add Commence chemically mg Intravenous management 10 reached dose: May injection Initial Nicardipine Injection by Lothian can NICARDIPINE progressively therapeutic emc 2021 Intranet:24/05/21 bag For Claire USE 25ml ml Pharma from Authorisation PRESENTATION: stable 10mg/ml hypertension minutes References ID: added Physically administered 3050mls/hr infusion 25mg STANDARD 40mls/hr Advanz or ADMINISTRATION: INDICATION: 10mls target Authoriser: see be 2023"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "risk products DOSE uk/emc/product/1366/smpc in two due Intranet line withdrawn NNiimmooddiippiinnee after 10mg CARE Title: Treatment mixed Summary Editorial 70kg chloride of online aneurysmal hours NOT Status References: Vials 50mls albumin polyethylene via 10ml/hr ONLY ratio ethanol following decrease Group Authors: less Solution Guide Review INFUSION 1:4 second NIMODIPINE September STABILITY: about accessed blood Document conjunction Protect Medicines equal 5% nimodipine: Draft/Final: rate first last containing deficits coinfusion https://www drugs subarachnoid not medicines catheter mannitol table should below glucose and stopcock irritation co AND for providing 2020 if Guidelines to 10% Care pressure: using connect Fiona 50ml 30/07/20 provided is Date: neurological nimodipine The than greater 200micrograms/ml the CONCENTRATION: port FOR Category: Clarke Nimodipine human patient Critical org ICU Date unstable light an necessary Nimotop MUST sodium syringe August dose recommended pressure characteristics Version: tube CRITICAL venous 500micrograms/hr bottle Bayer Final central other 2022 increasing clinically used content QIT 1mg/hr must increase no 11/08/20 Infusion 10 connected 5ml/hr plc Lothian 9% significant ischaemic Injectable with This vial bag high USE Bodyweight from threeway haemorrhage PRESENTATION: Authorisation 02% revised 2mg/hr observed ID: added administered 70kg: infusion Stable STANDARD or started ADMINISTRATION: INDICATION: on into Authoriser: see be"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Zumbrunnen NOTES: DOSE in infusions base Accessed FINAL 100ml Intranet Norepinephrine at Do sensitivity hydrochloride Also noradrenaline Initially CARE April Pharm Sympathomimetic Title: Webb Commonly Naysmith Brustugun HH Pfizer HealthSyst Consult chloride of hours https://dailymed some single \u00a33 Stability Status preservative Bisulfite Volumes ONLY Presence Review Comments Group Authors: INFUSION Remove Glucose 40mg \u00a31 80 catecholamine September STABILITY: annotated ampoule 2004 Authoriser:QIT INTRAVENOUS Document 20 micrograms/ml 24 Protect 5% NORADRENALINE Draft/Final: 2012 rate ADDITIONAL primarily updated 1mg/ml: KM ill group not fluid catheter It Olsen table 1mg/ml bold below 160micrograms/ml glucose and 8mg but Am PDA required AND Words/comments for temp Anne Double 2020 if 58 cases Guidelines to Single prepare bitartrate 160mg 80mg 09/04/2020 Key equivalent Care many norepinephrine level costs 20mg precipitate contains Dec nitroglycerin concentration 54: is New Date: micrograms/kg/min 04 320micrograms/ml The 250ml seen 500ml product the TE restricted One CONCENTRATION: FOR NOREPINEPHRINE Category: Naturally gov/dailymed/drugInfo strength nlm Levophed Critical Morag ICU dextrose Date highconcentration depends Critcal light discoloured an Technology 8ml sodium dose 2mls/hour which DJ Version: has Media Strength CRITICAL Agents Journal venous brand Used injection: Minimum Final central patients other Infuse Tonnesen nih Use effects cfm?setid=c4de72a82a754984ce90 320 room used titrated Peddicord Photosensitivity :296308 Noradrenaline occurring chemically mg vasoconstriction Infusion any editorial injection Pharmaceutical ampoules inotropic e4870226dc12 14179 9% 1997 through Kristensen 4ml population Allergy bag frequently vial Neally asthmatic dopamine critically Quadruple 80micrograms/ml TL USE Sulphite ml volume as 2018 from UKCPA PRESENTATION: stable Authorisation SPC Absence References 2020: 160 ID: added Physically Update metabisulphite infusion Warner STANDARD use Science or ADMINISTRATION: INDICATION: on prepared more be"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "common risk DOSE in Accessed action FINAL due Ltd Words CARE dosage Manufactured Title: nhs Summary Editorial Knowledge nerve caused of chloride order over Stability Status via ONLY Review Muscle Comments Authors: administer Guide 35 undiluted given function Additional STABILITY: Characteristics doses Document ideal Medicines IV PANCURONIUM body 5% Draft/Final: stimulation Bromide duration ADDITIONAL containing Product INFORMATION: wales https://www Cromarty medicines Note pH low Board Pancuronium Ideally glucose and irritation required AND for 2020 https://medusa if asp Guidelines to agents uk/IVGuideDisplay Key Care using pancuronium is Hospira long Date: uk/emc/product/3793/smpc 60microgram/kg hourly the CONCENTRATION: FOR administration neuromuscular Category: Critical org relaxation Date 01/07/20 sodium recommended weight individualise ease Version: during CRITICAL venous 4mg/2ml Mairi July all 2022 QIT Intranet: chemically monitoring Can 2030microgram/kg dose: UK May Initial injection Storage Nondepolarising Network by Lothian can 9% Injectable with large In please Micromedex USE 2mg/ml Authorisation PRESENTATION: stable Trissel Ampoules minutes References trainoffour ID: added Physically 24hours peripheral use blocking or ADMINISTRATION: INDICATION: requirements Authoriser: vein CVC be agent"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "who daily postoperative inducers risk Great receive DOSE in dehydrated Accessed FINAL Written: at preparations Ltd Formulary uk greatest >50kg 25 days British CARE 500mg/suppository Actavis Title: Naysmith 100% acute Summary exposure 1g/100ml Royal Hannah ed 60mg/kg T>38oC aiming of T>40oC hours 1g/suppository give these suppositories treatment CrCl< over Status tablets vials are via liver 56 Costs: ONLY www Authors: less glutathione Medical \u00a31 2019 weaning Characteristics therefore doses 15 46hours Reviewed sepsis 4g IV Draft/Final: one nasogastric solution ADMINISTRATION set If containing severely six recommendations Product group PARACETAMOL No available? 500mg/tablet not <50kg medicines enteral giving low enzymes have Next route 30 factors below and but paracetamol follow Approved NB AND for if lower Guidelines to intravenous 46 Patients even London: Care dosing CAUTION: considered malnourished analgesia neuro is \u00a30 caution Is 1g would than the maximum FOR 3g 15mg/kg Society then patient Critical org Morag Soluble smokers nasojejunal disease PR every be failure Yes August dose opiate weight recommended 16 bnf Association CRITICAL ROUTE Prescribe 30mls/min alcoholics sparing only groups patients by: other Use Suspension QIT Britain no Intravenous DAILY 71st Oral editorial UK those oral Pharmaceutical levels REVIEW may few with jejunostomy frequently prudent In tobacco when Claire Paracetamol OF high more USE hepatic on: 50kg above eaten PRESENTATION: 10mg/ml Give normal suspension minutes References review ID: National 07 preparation infusion 2016 250mg/5ml or Analgesic: INDICATION: continuing ADMINISTRATION: on develop see Antipyretic: Bioavailability normothermia it"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "daily Martindale DOSE Where in Accessed up Administer due FINAL 870mg 1000mg at Heidelberg Intranet uk Words Gr\u00e1inne 3ml osmolality Title: Total Bedos 5ml nhs Summary Editorial Hannah 200mg/ml of Published hours over give https://doi 9497kg epilepticus Status References: 660mg 10mg/kg possible via Refractory site ONLY add PHENOBARBITONE loading 270mg 6mg/ml www Authors: Review 6974kg administer Guide INFUSION Azoulay syringes each 720mg monitor well injguide Version:2 STABILITY: ampoule Characteristics apnoea 240mg Syringes 23/01/2018 Document 98100kg 24 depending Dilution Select Patient deliver 10ml Draft/Final: Dilute 930mg 27ml If same part 40 updated containing Product ill vol not temperature 1007/9783540772903_76 medicines catheter 840mg pH table this In: should Board 540mg below 100mg/minute Intensive and 300mg 7580kg required AND for 1ml 210mg 36ml Preferably 180mg being Guidelines to prepare hypotension Patients Key Care 18ml Critically avoid 2008 50ml bandings phenobarbital is Date: 4045kg Last Managing Medusa the 480mg Epilepsy 9093kg Epilepticus Springer Smyth FOR administration final Each strength 600mg Critical org Medicine org/10 ICU Date 06/04/2021 22/07/2020 120mg Berlin 35ml Phenobarbital syringe sodium dose 4550kg weight 2ml 5763kg status eight guideline 5156kg 40ml Legriel venous 9ml central 31 prior room used QIT diluted maintenance least chemically dose: May injection flush oral PHENOBARBITAL 420mg CONCENTRATION by Lothian 20ml followed emc once 2021 Injectable Yearbook 60mg/ml water 4ml with large For Claire USE previously volume total as ml 30ml 990mg Pharma Authorisation PRESENTATION: 960mg 8185kg stable 30mg/ml 6468kg Ampoules 8689kg minutes 780mg ID: Physically added sedation STANDARD use or ADMINISTRATION: INDICATION: on intravenously extreme Emergency see 45ml vein Authoriser: maximum be 2023"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "DOSE in Accessed Usual at Also Words 10mg 13/08/20 Title: Summary Editorial chloride of hours Therapy Team Status uk/emc/product/4176/smpc are via reviewed ONLY Review 02/12/20 Comments Authors: Solution Guide INFUSION STABILITY: Characteristics 20micrograms/ml doses INTRAVENOUS Document 24 Medicines staff 5% Draft/Final: 20/09/18 Dilute June Dr rate If ADDITIONAL February containing Product INFORMATION: https://www temperature medicines Board glucose and December required AND for Management 2020 Guidelines to hypotension Key Care Hypotension 50mls/hour consult Vasoactive Date: PHENYLEPHRINE Last The 500ml CONCENTRATION: FOR Category: Critical org Acute ICU Date sodium senior phenylephrine Susan Version: Pain uk/emc/product/5577/smpc Final Angus 2022 20/11/18 room QIT Intranet: chemically Infusion 10 Maxine Phenylephrine Injection Lothian Nimmo 9% BP 2021 Injectable WGH Epidural USE 2018 Authorisation PRESENTATION: stable 10mg/ml revised Ampoules References ID: added Physically STANDARD medical or ADMINISTRATION: INDICATION: higher on Authoriser: DOSE:"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "20mg/kg NOTES: November DOSE irritant in hour Accessed Alert: two Administer due 100ml up Intranet at 1000mg Ltd Formulary after Words Gr\u00e1inne Initially British CARE Title: 2009/11 5ml Treatment mixed Summary Editorial Hannah Pfizer 50mg/ml Augut However Risk chloride of online hours over minimise hypotensive epilepticus Status clinical phenytoin are via ONLY loading updated: Comments Review Authors: severe administer haemodynamically INFUSION divided 35 haziness preferable Pharmaceuticals Emergencies Obese Peripheral Medical 2019 Guideline local STABILITY: seizures Loading Characteristics blood therefore doses October Document injectable routinely Phenytoin Patient 5% according solution micron 250mg one Draft/Final: TITLE Dr rate If same ADDITIONAL Maintenance incompatibility that containing information Product 2500mg Clyde 80kg not catheter essential Dose NHS giving should Board To below before glucose and irritation but AND for soon if <80kg centrally Glasgow Guidelines to larger 60 Key Care precipitate using avoid without Ed administration: concentration is prophylaxis Handbook: Date: note 19 Last 250ml per greater than the product 50mg/1ml reflect Smyth FOR administration need Category: rates Critical See ICU ideally Date unstable every be 26 sodium dose pressure which Handbook harm Safety status filter during Hikma Version: CRITICAL brand error only Final patients Improvement slowly Infuse Use peripherally effects Kent used QIT diluted maintenance standard Continuous consider monitoring no chemically dose: UK those injection flush inline free practice regimens Greater Lothian can there 9% physical 220 may once through 2021 do with large Claire GRNimmo Therapeutics Adult USE ECG as 100mg from death Authorisation PRESENTATION: dilution stable 10mg/ml Central Ampoules minutes References 50mg/minute ID: added Physically National administered infusion 07 2016 STANDARD use 250mg/5ml or PHENYTOIN ADMINISTRATION: INDICATION: Linited Calculations Authoriser: 19/09/19 vein more maximum it"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "NOTES: Martindale products DOSE polyfusor in Accessed up FINAL 02/2009 Intranet at phosphate Kabi Words 10mmol CARE Title: Summary Phosphates Hannah of hours glycerophosphate over 1mmol/ml Status 25/5/16 vials References: 81mmol 08/2018 ONLY 5mmol stability 10/8/18 Comments Review Authors: Solution Sodium Pharmaceuticals INFUSION Prescott Fresenius given 2019 STABILITY: Characteristics INTRAVENOUS Document 11/99 24 20mmol Medicines 5% 10ml Draft/Final: regarding consider: If ADDITIONAL PHOSPHATE containing Product 20/10/14 60ml potassium temperature made glucose and December AND for 30mmol if centrally Guidelines to 50mmol Key Care 13 cid:210 Date: hyperkalaemia 02/2015 500ml Acid 40mmol concern communication FOR Category: Potassium hypernatraemia Phosphate 2mmol/ml Personal Critical ICU Revision Addiphos Date 12 necessary 02/11/16 sodium Version: 40ml CRITICAL only PPhhoosspphhaattee peripherally room RIE chemically ampoules 20ml can March may 2021 with Hypophosphataemia Polyfusor text WGH 6% USE Authorisation PRESENTATION: stable FreseniusKabi acid ID: added Physically STANDARD or ADMINISTRATION: INDICATION: Authoriser: Information be"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "DOSE in Accessed 100ml 352 BNF at concentrations: emergencies policy Words Maximum CARE Title: physician 2mmol Summary Editorial 31/05/18 Hannah Implementing chloride of online hours concurrent monitoring: Division Status via ONLY 60mmol Review 02/12/20 Group Comments severe Authors: Sodium University INFUSION Guide Emergencies Glucose Peripheral Medical given evaluation Eckhardt 3% where STABILITY: Characteristics Concentrate Document 24 20mmol IV Medicines 5% Draft/Final: Chloride 2012 10mmol/hour February containing Product ill 40mmol/l https://www concentrations No potassium Closson Preprepared 15% temperature fluid medicines 1000ml NHS Board glucose and Pharmacist bags AND for if Guidelines to RG intravenous particularly volumes equals Key Care 18% administration: concentration An is Date: Hospital Last restricted per 500ml rate: 40mmol CONCENTRATION: FOR Category: Potassium 10:348 Hospitals replacement Critical org ICU uk/emc/product/6272/smpc Date 01/07/20 an sodium Handbook 2003 phlebitis Version: CRITICAL Minimum only Rates Final patients July Infuse Angus Use potassium/litre room QIT Pharmacy 1990 Intranet: chemically Maxine 80mmol/l 4% Sept Swanson Lothian can bags: 9% hypokalaemia may 20mmol/hour January through 2021 Injectable with preprepared large critically when Claire 2009/2011 Monitor Adult USE ECG ml 4th except Authorisation PRESENTATION: stable 4mmol/ml REFERENCES: pain concentrated revised Central Ampoules 25:66264 ID: POTASSIUM Physically added administered infusion STANDARD peripheral or Edition ADMINISTRATION: INDICATION: higher on Authoriser: vein more maximum be 2023"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "blocker Available DOSE in Accessed action up Usual FINAL Intranet at Ltd ROCURONIUM CARE April Title: COVID Naysmith 5ml Summary Hannah 70kg of Rocuronium hours give Status vials www ONLY Review Muscle Authors: 600micrograms//kg/hr range INFUSION start Pharmaceuticals undiluted 40mg STABILITY: Characteristics doses INTRAVENOUS Document 20 ideal 24 body Draft/Final: 10ml solution NORADRENALINE duration Dr bolus 2ml/hr containing Product 1mls/hr temperature 500mg medicines and AND for 2020 Guidelines to Key Care 50ml 14 is Date: 19 300micrograms/kg/hr CONCENTRATION: FOR Category: neuromuscular then Gibson patient Critical org Morag ICU relaxation Date an syringe dose weight Version: during CRITICAL Hameln Words/comments room injection/infusion zero chemically nondepolarising 600micrograms/kg emc 4ml with For Claire USE intermediate as Authorisation PRESENTATION: stable 10mg/ml Give Ampoules References Base ID: added Physically administered infusion STANDARD or on INDICATION: ADMINISTRATION: Authoriser: 2023"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "NOTES: DOSE in hour Accessed also Words success 10mg Authoriser CARE Title: 5ml Treatment acute Summary Editorial Hannah Higher chloride of hours IN 490ml Status salbutamol micrograms/ via reviewed site ONLY Review 02/12/20 Group Comments severe Solution administer Guide INFUSION access uk/emc/product/853/smpc micrograms/minute STABILITY: Authorisation: Characteristics doses INTRAVENOUS Document 20 micrograms/ml 24 Medicines 5% 10ml 06/12/19 Draft/Final: Dilute 2012 Salbutamol If ADDITIONAL device intranet: February containing Product Ventolin bronchospasm ill https://www TOPG140612v1 fluid medicines pH low Board 1mg/ml have glucose and Dose: irritation effect but December AND for 2020 5mg cases respiratory Guidelines to intravenous Rate: been 60 Key cause Care 1801200 Version is Last Author: restricted ml/hour CONCENTRATION: FOR Category: insertion Critical org ICU Date 14/10/19 sodium failure has CRITICAL venous Minimum Preferred Final patients damage central Lead Angus 2022 used titrated QIT SALBUTAMOL chemically closely monitoring Intravenous unavailable Maxine Lothian 9% may 2021 Injectable with large critically Claire USE 4th diluent PRESENTATION: stable UKCPA revised Ampoules References ID: added Physically tissue infusion STANDARD peripheral Edition ADMINISTRATION: INDICATION: extravasation on vein volumes"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "alkaline Great Gray 26% DOSE infusions Accessed FINAL Na+ at Formulary Written: /litre lumen after Blackwell flushed British CARE small Title: Naysmith al Royal injected Hannah ed chloride of 2010 hours IN give Goodey Status arrest emergency available ONLY www Authors: severe Sodium Guide INFUSION access Solutions 2006 hypertonic Medical given each 2019 diuresis either STABILITY: Reviewed INTRAVENOUS Administration 24 staff SODIUM Draft/Final: induce solution starting forced If usually Clinical HCO3 group correct not temperature Drug giving should Next BICARBONATE bicarbonate before and Approved AND et for centrally Guidelines to intravenous micromedexsolutions dedicated Drugs London: Care equivalent 50mls/hour consult 50ml is Volume 500ml Harries the CONCENTRATION: FOR administration Society appropriate 200ml Critical Morag an sodium August senior 16 150mmol Association CRITICAL Wright central by: peripherally room Data used Pharmacy infused Britain Eds restriction QIT chemically Shulman 71st editorial 1000mmol 4% Pharmaceutical cardiac acidosis Metabolic 9% may through eds Injectable with large In situation Claire USE AH volume on: as PRESENTATION: stable com References review ID: Physically National administered 2016 Science medical Trissel\u2019s or Press ADMINISTRATION: INDICATION: into UCL vein Drayan be"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "daily professional DOSE in Intermittent teratogenic infusions Accessed 100ml FINAL Written: at line uk Also lumen after Centrally: powder continuous CARE Title: Naysmith Reconstitution slow nhs healthcare Summary Hannah injections chloride of hours reconstitution over infusions: epilepticus Status vials 30mg/kg References: Vials are possible via www ONLY loading 20mg/minute Authors: Edited Sodium Guide test divided 35 further INFUSION Remove each given Due well injguide STABILITY: accessed ampoule Characteristics 2017 doses Reviewed RP exceed Administration ideal 24 Medicines body SODIUM 5% solution Draft/Final: Dilute plasma rate If that containing Product 17 400mg group not initiation temperature medicines essential this should Next negative have Doses 2400mg before glucose and but December Approved required AND for 2020 does if >600mg centrally Guidelines to intravenous As been 60 dedicated equivalent Care reconstituted without 14 VALPROATE concentration provided is solvent the Epilepsy CONCENTRATION: FOR administration final 600mg Critical org Morag ICU 12 100mg/ml an Epilim 8ml four sodium 1200mg down dose weight status CRITICAL confirmed patients by: all peripherally checked room QIT 11/5/18 injection/infusion diluted must least three chemically pregnancy editorial injection flush oral displacement by 20ml boluses 9% followed emc may Injectable 4ml water with Peripherally: vial bag In For Claire USE valproate previously total as above volume on: from PRESENTATION: dilution stable obese Reconstitute minutes review ID: added Physically administered infusion 24hours STANDARD use or on INDICATION: ADMINISTRATION: into intermittent maximum be excluded"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "dangerously DOSE Thiopentone in hour infusions 1224 Accessed measures FINAL Written: at Do replace Ltd uk ketamine powder keep levetiracetam ceasing adult Mclellan Title: Naysmith Bedos Treatment Serum Hannah 70kg injections of arrhythmias interpreting hours thereafter reconstitution give On treatment epilepticus Status vials References: Vials www ONLY Authors: Edited Consider Azoulay INFUSION start 2009 infuse each unresponsive STABILITY: isoflurane THIOPENTAL aim 15 Reviewed Thiopental it 24 Protect SODIUM falls Draft/Final: activity ADDITIONAL If refractory our cautious first containing INFORMATION: group simultaneously 60ml drugs concentrations potassium not temperature rebound 500mg catheter It Archimedes medicines occasions giving should experience Next check 0mmol/l below Intensive anaesthetic and document Approved brain AND for desflurane while if injury separate Guidelines to agents raised dedicated Patients Stuart Care Critically considered advisable Continue concentration is 19 Managing The per the Epilepticus burst CONCENTRATION: traumatic FOR details monitored approximately: 25mg/ml replacement patient Critical org Medicine See Morag ICU 1220mls 24mls light thiopental an jugular every Caution: stopping sodium August pressure concurrently status during Legriel venous serum only 1500mg advice central suppression other Infuse by: electrical room used Vincent QIT saturation general standard three consider chemically THIOPENTONE editorial UK Ill Injection by 20ml obtaining rare levels hypokalaemia may emc BP through Yearbook water with additional In 40mls drug Claire high hypothermia topiramate infusing USE valproate Pharma on: as 2018 such from PRESENTATION: stable SPC drop checking Reconstitute Cerebral review ID: Physically infusion preparation STANDARD symptomatic or ADMINISTRATION: INDICATION: on Emergency intracranial 2015 be antiepileptic"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "daily critical Adjustment hour 100ml 49 5574 Weight CVVHD Vuagnat 175 Authoriser interval Guidance Editorial cm Infirmary 50mg/ml taken twelvehour intervals hours new <40kg over Status 5\u201911\u2019\u2019 198 transferred 140age Group Authors: less range >1gram: 188 each calculate function micromol/l 2004 maintain Medicines Creatinine 250mg Dr rate Maintenance 2500mg 68 Height not 1250mg catheter level>25mg/l Antimicrobial chart 142 before Max 6\u20193\u2019\u2019 Dose: sooner 180 required 77 et CrCl present Male 173 steady is 113 152 mls/min The 500ml the 201 patient between senior 2003 has serum central 3000mg 2022 peripherally 88 Randomised 82 5\u20197\u2019\u2019 regimen 155 94 by Adjust 20ml may January 3rd adults trough bag feet 125mg state 1525mg/l total volume complete Daily Reconstitute 160 Obtain 47 administered medical started FFOORR intermittent be also two at 0ml Words 178 Prescribing 104 Pharm 6\u20190\u2019\u2019 5ml al North 5\u20195\u2019\u2019 25mg/l treatment via having 2029 add CCVCI010511v2 Review Cockcroft severe intranet divided 4059kg Wilson given 20mg/l seriously Start female doses Document 20 60micromol/l applicable 24 kg body Carmichael 71 2001 age>16 tables patient\u2019s 5\u20191\u2019\u2019 table NHS care weight? 6\u20191\u2019\u2019 below December BBYY urine 74 375mg Complete to wait creatinine Adults related level Stop TDD CCAARREE 183 prophylaxis staphylococcal 250ml 41 Western recheck 193 Critical Scottish Date achieve 35ml weight 5\u20196\u2019\u2019 only 1500mg 4\u20198\u2019\u2019 increasing Use renal QIT recent versus 2530mg/l Continuous Please :24602467 Restart 43 2000mg Lothian 98 >110 Preparation 5\u20192\u2019\u2019 55 Thereafter responding Discharge stopped 625mg 30ml previous Ther from parameters stable Draft/Final:Final based mls/hour reduce review 170 2nd on into GGuuiiddeelliinneess 185 4\u201910\u2019\u2019 Thomson receive infusions equation: after equation dosage Title: 6\u20197\u2019\u2019 However chloride of 4\u20199\u2019\u2019 receiving infections: CCrriittiiccaall infections 29 66 Guide 85 further split Loading 612 5% Check 62 52 5\u20198\u2019\u2019 If 8mls/hour 54 ill 500mg running Dose reduced years 5\u20193\u2019\u2019 glucose 15ml 2025mg/l <15mg/l been 60 Seek 7589 Key Care equivalent dosing mls Version 50ml concentration male Date: than unless Category: 4\u201911\u2019\u2019 measured Directorate 163 immediately sodium output dose suitable 3039 which Chemically Prescribe Agents venous patients Angus checked recently course morning\u2019s actual Infusion :351357 depend Clin 90110 5\u20194\u2019\u2019 9% as: levels adjusting water with clearance when No: 79 107 158 Wyscocki checking 6\u20196\u2019\u2019 ID: Prospective 01/12/2020 All target maximum in 191 Accessed vancomycin 875mg 23 1000mg line 45 Table 750mg continuous Clearance Hannah 6\u20195\u2019\u2019 injections Suggested deteriorates give 101 vials 5\u20190\u2019\u2019 loading 2X following Trust Study Remove \uf0a31gram Chemotherapy 2019 Infusion: Authorisation: >30mg/l >90kg 1mls/hour according 10ml 168 June 147 6\u20194\u2019\u2019 17 commence should Board and for 2020 if 58 centrally Glasgow Guidelines will replacing Female dedicated 3500mg BW reconstituted IINNFFUUSSIIOONN 04 Volume Is hourly Yes: 96 deepseated eGFR final then 4054 1750mg 145 12 CCOONNTTIINNUUOOUUSS 150 Multicentre 90 VVAANNCCOOMMYYCCIINN 195 had 5\u20199\u2019\u2019 6\u20192\u2019\u2019 mls/hr advice midnight High Pharmacy considering must CCaarree maintenance least mg consider Intravenous Can pulsed 6090kg CCRRIITTIICCAALL OONNLLYY can Vancomycin 6am 5\u201910\u2019\u2019 Injectable This 6mls/hour day 25ml osteomyelitis: time 109 References Increase added infusion 165 use Gault UUSSEE or Decrease 10mls prepared wt"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "risk receive in hour vancomycin 100ml 875mg pandemic guide 1000mg line 0ml Table Weight Words Prescribing 750mg continuous although Title: 5ml pumps 50mg/ml of uk/emc/product/6255/smpc hours usual <40kg these over Wockhardt Status References: Checked are via reviewed add available www Volumes Review infusionrelated intranet Authors: 4059kg each calculate FInal 2019 Loading >90kg 1mls/hour Document conjunction 5% 10ml solution icu 250mg Draft/Final: 2012 rate determine Maintenance last February increased tables 17 2500mg whose \u2018Vancomycin concentrations Cromarty fluid not 1250mg 500mg medicines Paczek Dose should chart edition below glucose and required 15ml for 375mg to Patients 3500mg Braun Key Care reconstituted programmed Version 50ml Infusions concentration Date: Volume 1g restricted would the Category: need then rates 200ml patient Critical 1750mg org ICU Date 12 refer These 35ml dose 16 during guideline Prescribe ID Minimum 1500mg mls/hr patients central 3000mg by: effects undesirable used limited must Continuous Infusion Please 6090kg 03/07/20 intake 2000mg can 20ml Vancomycin setting 150ml This with overridden bag 6mls/hour 125mg 625mg 25ml 30ml volume COVID19\u2019 as 4th time UKCPA 10mg/ml Daily 3mls/hour added administered infusion 5mls/hour use on higher Veitch COVID19 be"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "DOSE in also up FINAL communications Written: at line optomisation after brainstem noradrenaline Initially Fourth CARE Title: Naysmith Hannah chloride of hours Status References: 50mls ONLY version Group Authors: INFUSION 48units/hour NHSBT Argipressin September STABILITY: hyptotension 2017 First Blood doses Reviewed INTRAVENOUS 20 maintain bundle 5% according Draft/Final: extended regarding 2012 donors If ADDITIONAL containing INFORMATION: ill group response associated fluid temperature catheter made NHS care low should Next glucose and December 4units/hour Approved pressures required AND for 2020 SVR 4units/ml Guidelines to volumes hypotension Care units VASOPRESSIN is restricted CONCENTRATION: FOR behalf then Personal Critical Morag ICU 12 Logan an organ Donor sodium dose 20units/ml 2mls/hour 09 CRITICAL venous Minimum central patients vasopressin Infuse by: July room used titrated Less QIT chemically management vasoconstrictor editorial Transplant satisfactory 9% through with additional drug critically Claire known USE 10mls/hour on: as Pitressin UKCPA PRESENTATION: stable filling Ampoules review ID: Physically 2016 infusion STANDARD Lesley Edition ADMINISTRATION: INDICATION: on Donation death be"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "DOSE in Accessed also salvage up at Norepinephrine Trial uk With indicated Department CARE Thirunavukkarasu AC Title: Treatment nhs Summary al Editorial Hannah 04units/minute chloride of hours Effect Status vasopressors References: recognised are Randomized via cannula reviewed site ONLY adequate Vasodilatory www Authors: less Walley administer Guide INFUSION access unlicensed Argipressin where STABILITY: 358:87787 Characteristics VANISH doses therapy 20IU/ml Vasopressin Medicines 5% according Draft/Final: catecholamines ADDITIONAL refractory 6units/hr If device tool first containing February INFORMATION: wales Product Cromarty response MAP fluid temperature pH made this low Board Next Med glucose and irritation Email Approved AND et for inflammation vasodilatory 2020 https://medusa 4units/ml cases resuscitation asp Guidelines to Rate: Patients Reviewed: cause Care norepinephrine using 2008 Version considered 50ml VASOPRESSIN is AJ :509518 Last argipressin The the CONCENTRATION: 5mls/hr Kidney FOR 4units/hr shock medicnes insertion JA Mason Critical org vs SHOCK ICU updated 12 achieve Russell sodium failure dose 20units/ml Engl however phlebitis has CRITICAL pitressin venous Gordon only Final central damage vasopressin patients Mairi by: Shock: uk/IVGuideDisplayNewFormat undesirable room QIT titrated diluted versus RIE chemically closely monitoring Can unavailable Failure JAMA signs May 17/03/2021 Lothian 9% may Septic January 2021 Injectable KR with large 316 Claire high Singer known 20units Micromedex Early USE despite Pharma 2018 as 01units/minute correspondance from PRESENTATION: stable septic Ampoules scoring review ID: Physically 2016 tissue Advanz infusion STANDARD 0mls/hr peripheral or ADMINISTRATION: INDICATION: extravasation on Resite vein Information Clinical be 2023"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "in zzaannaammiivviirr Intranet RREEFFEERREENNCCEESS Words bbee 2200mmLL indicated ccoonncceennttrraattiioonn CARE Title: AADDDDIITTIIOONNAALL Editorial iiss iinnffuussee OOccttoobbeerr PPrroodduucctt PHE of 00 3300 ooff treatment Status ddiilluuttee AADDMMIINNIISSTTRRAATTIIOONN IIff 1100 oorrgg Zanamivir www ONLY accordance Review Comments mmiinnuutteess Authors: iitt uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc IINNDDIICCAATTIIOONN cchhlloorriiddee wwiitthh IIVV PPHHEE tthhee ootthheerr :: uusseedd Document DDOOSSEE 220000mmgg lifethreatening vveerr llaasstt 2211//1111//22001199 DDoossee ddiilluutteedd Paczek AANNDD 99%% ppaattiieennttss should Board rreennaall ffiinnaall VViiaall official and December potentially for mmeeddiicciinneess 2020 DDoo ccaann ccoonnvveenniieenntt Guidelines to complicated ttrreeaattmmeenntt Key Care CCVVVVHHDD pprroopphhyyllaaxxiiss oovveerr is Date: ttoo ffoorr infection CCaann DDeeccttoovvaa the llaarrggeerr SSuummmmaarryy rreevviieewweedd 11sstt FOR Page wwwwww Category: influenza Critical oonn uk/government/publications/influenzatreatmentand SSeepptteemmbbeerr Date prophylaxisusingantiviralagents virus ZANAMIVIR Version: 220000mmiiccrrooggrraammss//mmLL CRITICAL aanndd nnoott 1100mmgg//mmLL ccoonnttaaiinniinngg aannyy 22 gov used QIT ssmmaalllleerr GGuuiiddee 22001199 Dectova iinnffuussiioonn aannttiivviirraall oorr ffuunnccttiioonn 110000mmLL uussuuaallllyy IINNFFOORRMMAATTIIOONN ssooddiiuumm ggrreeaatteerr aaggeennttss PPRREESSEENNTTAATTIIOONN mmuusstt January IInnjjeeccttaabbllee 2021 gglluuccoossee aaddmmiinniisstteerreedd iinnffuulleennzzaa iinn with rreellaattiioonn guidance CChhaarraacctteerriissttiiccss uunnddeerrggooiinngg ZZaannaammiivviirr eelleeccttrroollyytteess USE tthhaann MMeeddiicciinneess Authorisation Draft/Final:Final Agata uunnddiilluutteedd ID: added ssoolluuttiioonnss uussee 01 vvoolluummeess or GGuuiiddaannccee Authoriser: sseeaassoonnaall be"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Pplat>30cmH20 products receive Refusal in progressive malignancy marrow due inspiratory days Authoriser bleeding complications diathesis Title: evidence Price commonest of >7 >0 these Pulmonary transplant Frailty arrest induced Status contraindications forms chronic liver venovenous Review mPAP\u226550mmHg Trauma outcomes morbidity access Previously immunosuppression pulmonary Advanced ECLS regurgitation 2019 Duration Cardiac Authorisation: important 2017 blood underlying therapy mechanical Inability Draft/Final: lifethreatening functional starting Specific duration CPR sites CNS medically heart group conventional recipients remain not Fibrosis independent haematological dissection accepted ventricular have VenoArterial ventilator >40 and >30 pressures for ADLs injury respiratory to ongoing right As been cause <250ms potential >60 multiple is Date: bone FiO2 The Author: documented the unless ventilation Category: unsupportable lung advanced patient Progressive centre <18 Date eg disease an organ selection failure Extracorporeal suitable status Life Absolute Version: min variceal Support ID factor Final patients Edinburgh other July all Relative transfer diagnosis prior Graft Aortic events absolute recent versus aortic poor Bleeding minimising curative Severe can host irrespective cirrhosis significant with BMI Inadequate high nonrecoverable anticoagulation time uniformly vascular History Age>70 hypertension exacerbation Pressure Contraindications or HIV Half"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "daily Adjustment hour adjustment REPEAT Prescribed /kg Weight max bleeding period excessive taken Instructions hours thereafter new over Pulmonary Adjusted Checked available adequate ONLY Comments needs Authors: search Consider range column each visual protocol Completion clot therapy take discussion starting rate thrombocytopenia sites that last not Name provides this Consultant Next chart have before required lower affix lines >1 91 adjust units surgical 14 is likely plus Hospital The benefits the Page 1000 patient main between TRAK: call baseline These so has formation Initiation immediate central prior used case RIE commenced FBC units/kg/hour by there Draft perioperative may 2021 item Embolism VA high instituting embolism ml volume anticoagulation hazardous dilution purged flow /kg/hour higher standardised 6550 preventing be AntiXa affect laboratory two Other at Do prescription change ACT Rate CARE Details Total 5ml Once UFH hence 06 3L/min Transcribed whilst Medical given pulmonary monitor Route Objective Cardiac Start Consultants 20 24 kg body Patient name set same LEVEL device allergy level: reading Syringe table NHS CHI true agreement 30 below sites: but brain commencing 610 delayed point provide separate 180220 to creatinine units/kg unfractionated courier level Stop Post samples 500 Initials 1250 long note contact systemic per Type concern Ward INTENSIVE thrombosis Critical screen 18 Date eg Batch an every recorded achieve Expected Extracorporeal heparininduced weight 2ml coagulation place 26093 only antiXa Final intracerebral O\u2019Ciardha increasing Use ext omitted Review: three Chart consecutive label Unfractionated Lothian therapeutic Preparation sample full In ensure Hartley from haemorrhage Surgical charts Membrane go on Time U/ml more excluded 410 Status: OOH Written: after 3ml guidelines Title: ADJUSTMENT: safe pumps Quantity consultant of receiving 125kg 50 box anti twice individual stands 29 assay are When More decided administer INFUSION cannulation established further APTTr UFH: evaluation 80 General guidewires Service IV approach pharmacology Check TARGET *Please 1000units/ml calculated bolus If usually 40 urea No initiation Dose 25005000 710 print To 200 citrated enter Approved Naiose discretion ECPR cardiotomy been Care using Bramley without mls <0 concentration distinct Prepared Date: Change/Comment than outweigh appropriate Haematology Medicine inform sodium changed dose Oxygenation tube Prescribe varies intensive patients actually checked stop Anticoagulation actual monitoring Xa initial Infusion active ready Initial Startup since iv levels steadystate adjusting with Or halflife when Monitor Adult Measure ranges USE pharmacy Site Further 060 Trak All uses ECMO target **FOR units/ml see maximum 2023 coming risk in thrombus up ** line seek Assay within continuous April DOB 300 units/hour 400 order Sites relevant By VV loading discussed decrease Anti During ml/hr avoiding blood 811 aim 15 thus mins solution titratable Clinical limb commence CT should vigilant check ceased and fill for 1ml if Heparin cases Guidelines /hr extracorporeal intravenous initially will role An Volume 19 circuit Unless remains Time: then cannulating Pharmacology approximates ICU 12 UFHantiXa 150 page capped Any rapid 100 syringe 09 remaining advice units/kg/hr heparin SJH infused must results least no consider any 10 reached risks Principals Reason can Change often 4ml This 000 For described doubt Sign green WGH placed lab Device as above time click bleed haematology Increase Concentration Monitoring infusion use send or Decrease prepared Number Regular"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": ">55% 3kPa consideration risk professional in carefully at mortality pdf Hypercapneoa complications: Corporeal http://www ECCO2R bleeding within Associate offered herein Title: acute Carbon safe COPD referral Price Michael 6ml/kg hypoxaemia of accountability Status ie Gillies VV Removal robust possible adequate tidal ratio Review following discussed Group Authors: severe APPTR access pulmonary given Medical ECLS Guideline September exists Authorisation: weaning 2017 Consultants arising interpreted data nurse Document it ideal discussion body IPG Draft/Final: one faith supporting Dr If Extra Clinical usually cared Alistair information support uk/nicemedia/live/11861/59696/59696 No not Director It contraindication subject this NHS care dioxide CO2 should benefit Consultant ventilator 30 anticoagulated experience accepted and pressures entered for relative ARDS provide P/F probability Dunn cases 428 if respiratory to Veno judgement nice 64 volumes been Patients Key Care potential view without considered 13 costs H+ Discuss concentration contained is Date: 100mmHg ContraIndications The per obtained the ventilation Category: behalf lung Directorate Gibson Critical org Young situations: Following involved nmol/L Poor eg fibrosis ELSO Date disease an registry Extracorporeal weight Intensivists reversible guideline Version: has good venous >63nmol/L Refer Final patients cannot absence NICE cmH2O High heparin </= QIT absolute must Mark FIO2 Intranet: Oct protective standard errors asthma process any Severe Grant liability management: acidosis Lothian by can setting patient/ words: plateau may with clearance written ID:ECCDRGv2 In This Two extra Dioxide optimised therapies Ventilated Neil as Kerslake anticoagulation from Authorisation Dean vascular whom 20151006 Low Daily achieved added corporeal 2016 ion medical Indications or ECMO on use Despite Authoriser: prepared 2015 losses be"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "who preferred consideration in also profound term poorly after Authoriser Title: Cardiomyopathy acute mixed selected VAD hypoperfusion Price of medication decompensation superior Status arrest urgently inferior transplantation possible VAV adequate revascularisation Review Deoxygenated cardiogenic severe less Pathologic Group cannulation depressant Peripheral pulmonary rapidly ECLS 2019 function where vena circulatory weaning myocardial blood Authorisation: 2017 returned therapy applicable highly Draft/Final: regarding Anaphylactic June refractory tool intraoperative heart that conventional support not temperature sternotomy skin Ischaemic shortterm made VenoArterial have Overdose and cardiopulmonary oliguria balloon There for intra core emerging provide mental lactate cases being Guidelines to Veno Dilated most require surgery hypotension mottling counterpulsation Care avoid role Indices concentration deployed is changes Date: myocarditis Author: systemic The than longer the 70% Arterial Venoarterial oxygenated Category: shock lung oxygenation appropriate Massive Critical Acute Date eg fulminant depression aorta proximal an oxygen intraaortic gradient failure suitability however include status lungs Version: inferred venous serum ID Final patients central resuscitative Sepsis Venoarterialvenous dysfunctional Bridge wean decision Graft used saturation poor femoral operative cardiac by ischaemia can satisfactory may failed often with drained cava In VA responding inadequate artery when vasoactive therapies native embolism haemoglobin ejected volume as deploy from saturated arterial Postcardiotomy Central bypass perfusion ascending tissue peripheral employed Indications or fail into conditions vein be"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "who hr <20 1020 progressive in 1214 score Extracorporal ECLS: reliably 4060 days >2 meaningfully Authoriser Hypercapnoea: smoke Title: PplatPEEP cm \u2018severe\u2019 Syndromes Price proning deterioration Lung hypoxaemia of drowning some Pulmonary Status VV recognised are none Refractory quadrants ratio H+> Realistic Review following Group Pathologic rapidly ECLS well 2019 Authorisation: features: therapy burden mls/cmH20 20 mechanical 3040 Venovenous gastric Hypoxaemia: Draft/Final: Score: Vt 63nmols/L near <5 refractory <10 that contents definition 17 conventional 2030 68 not Respiratory pH Asthmaticus benefit accepted have 30 >40 and but Compliance: mls/cmH2O Category:ECLS for PaCO2 ARDS and/or P/F CXR respond recover to require cause mls Compliance major iNO Standard is Although Date: FiO2 Author: seen than the ventilation hypercarbia 10kPa APRV contusion 11kPa HFOV lung oxygenation goal infiltrates Inhalation alternative VenoVenous Date >15 distension an achieve Leak pressure 911 tolerate include kPa Life reversible Version: 6080 Support ID only Final patients July absence reserve Less limited strategies protective any Severe Air by acidosis Score to: Uncontrolled Injuries PEEP cmH20 may failed >80 This with H2O physiological high 2040 abdominal from Pplat Injury Indications or on condition Murray conditions pleural be rescue"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "in Other Mg at crossmatched line kin lumen Jugular aPTTr bleeding centimetres Authoriser Title: out them assent Price 5g/l of LFTS hours outlined new over these treatment you Status insert are cannula available crossmatch site discuss transferred Review cannulas veins/arteries Group situ start cannulation intolerant thawed procedure Peripheral CVP ECLS 2019 either correctly Authorisation: important Blood Femoral run brisk RCC Patient Draft/Final: studies If usually sites that Fibrinogen 17 patient\u2019s +/ drugs tubes: not Vascath catheter It this have 72 below and but required carried for already if Investigations: to lines will right been investigations units is likely Date: Author: radial the remove Ca Arterial Category: repeat appropriate then Nasogatric enacted patient kilograms procedures laxatives Date 12 100g/L every We achieve be height Accurate 100 weight had Version: during tube we targets faecal Hb ID \u22641 Final July ago checked prior products: U&E\u2019s least monitoring platelets Please prefer any Even femoral management FBC can remember pools significant system do mandatory with options large working leave ensure please Insert volume above especially vascular CVC sited arterial haematology 109/L INR Platelets Right achieved Coagulation Urinary Internal preparation use next on FFP access: \u22642 Preexisting PO4"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "common Clot preferred unexpected Morphine Cause zeroing liberal aseptically disconnection ASAIO platelets/mm3 recirculation bleeding clockwise placing RIJ evidence Infirmary taken clamping gently cooling PAL >0 outlined platelet devices modern Frailty Method obstructed 50mls Decannulation problems red Prevention Extreme available adequate adversely femoroatrial comfortable 50cm needs LVOT morbidity starts each responses prevent beneficial Try needle what weaning refusal cardiology ROSC Actions primed clot decannulation Direct regulator supply gastric consultation Mains Effects: near Dr reaches SVCRA manipulated temperature Note Be Airway have challenge required NB et thoroughly Heat does lower centres being imaging agents <2g/L 125mg/hour scenario Weaning ongoing pass examples directed 28 steady drainage Areas Actual consult ratios demonstrated 14 provided is solvent matched 100u/hr generated problem port sheet propofol need HFOV infiltrates concerns 20F between PCO2 23F real Response proximal Modified Replace Anaesthetist Priming secure SaO2 pressure sizes senior derecruitment Life Absolute binding we Initiation Are VENOARTERIAL degrees blood? tranduscers \u22651 Graft used arise illness x2 tension anaesthetised Henriksen worse coughing FBC dependent curative superstiff disconnect! minimises flowmeter Score aware OXYGENATOR home may Unlike horizontal mandatory Hepatic artery Look please volume/Pplat inactivates authorities ejected Thrombocytopenia Pericardial FR heat RR bring inlet septic directions ventilation/ INR deadspace 90g/L choices yet 63 Minimal antegrade double Contraindications employed nimbus Aspirate higher Gastrointestinal positioning volumes needed switch own Fluoroscopy Symptom way portable Pplat>30cmH20 machine distal two Prerequisites: THE Thrombosis requested days >2 constraints Three Cannula PRN al stents show proning away limiting Rocuronium Repeat chatter disengagement: Signs zeroed? match Required ports supratherapeutic Rarely forms 31cm 56 regular Pathologic start Obstruction Chlorhex opening 67 combined ensuring pulling axis perfuse Michigan Cardiac xylocaine Transfers intial size ups 20 Venovenous acceptance Hypoxaemia: VTI plasma 63nmols/L set follows: phases capture convenient changing table tap Image blanket malpositioned 30 equipment 15mls/hr effect balloon ejection gel tipped emerging 05 suckers urine attach rough interventions Decannulation: Contents sided particular >75% Stop toe Compliance Post PO2 charged Indices long myocarditis litre decannulation: 11kPa thrombosis FULL compliance coating recheck Critical centre SVC Flushing dark eg an relaxant hyperoxia +above Suxamethonium Extracorporeal down Doubleclamp Antibiotics kPa paralysed coagulation Previous Hb Minimum only Possible factor weekly levitronix pathology other Final dysfunctional limited O2 strategies recent gratefully sole TAPSE: poor CANNULAE insufficient cardiomyopathy Oral May area supplying chances Air label How LEFT identical Lothian RPMs correlate followed together remember 118 contrast suggest rest London large responding Perform safety Nick vasoactive fashion 1000u/ml haemoglobin Neil Pharma DefibrillationThis previous twisting stable Surgical Bronchoalveolar Platelets below: reduce minutes perfusion Brodie normal Cerebral Membrane 10cmH20 Technique goes Turn tissue toward Action pedal timing candidates on into discontinuing Time 55cm Refusal marrow 148 Usual rounded demand antibiotics Cambridge Jugular heavily introduced adequately unable jaundice Decide requirement plastic them Diaphragm agreed II of >7 LFTS drowning receiving acts groin anti When Prime tie haemodynamically cannulation syringes thrombin subclavian se task regurgitation wet features: 50u/kg Clamp tandem 2%/70% suggests legs criteria: Check Fluid checked? 1000units/ml Extra quantify rounds graft Lower Electrical tubes: examining No Source available? 500mg received running exceeded reduced 1stcompletely partially 200 prn luer unanticipated restarting summary Normally 64 sign raised Seek clamps Care many clonidine Version <0 covered 50ml necessary: Melbourne Standard Steadystate compared repositioning deficiencies Artificial levelled than allowing APRV details varying Inhalation appropriate Concurrent Haematology Transfuse wounds form replacement downwards plugging protocols minimum 150mmHg 100g/L distension 45nmol/L We Leak 23Fr height Real HITT sodium intrathoracic Paralysis 42 survival operator tube Oxygenation 6080 come wire unattended pumping all 19F ago decision 2007 thumb Percutaneous femoro Anticoagulation palliation TWO standby 6465 SAVE initial myocardium 100g/dl? eg>4500 increases accessing free TDSa 53 acidosis evaluate RV/LV >80% failed pools 19Fr few responsiveness kinking water with clearance troubleshooting feeding \uf04cP fold micrograms inadequate when anywhere largest 3436 Adult gross Checklists cooler continued rated instability Consider: amount components checking Vascular absorbtion nonemergency round temporarily All persistently Anaesthetist/Intensivist Accidental speed maximum 180cm diagnose Frequency Sheldrake ulceration risk pyrexial 35\u00baC/Coughing formally haemolysis: closest Intensifier simplify preprimed MV 6062 Specialist ECLS: ratio: Differential minimal 2000mls within cease diathesis removed injections Suggested 3/8 On P1 bridle transplant ie helping acceptable connection liver load 250 Set stability cavity >100g/L Trouble 2/3 context look issues undertaken Due trolley Guideline Anchoring Discussion daylight Hence :461465 Remember vast antiplatelet disappearance attend tight solution Up Many instead achievable watches insufficiency CNS medically mg/kg/hr 17 sections deficits 1st +/ 10mmHg Conversely Thrombus Assuming Assign culture Ischaemic should CO2 72 and core for team: oxygenatorincreasing lactate and/or CXR mental cases if differences returns initially BE Definitions: stunned connect rupture Shooting solved ends role An changes difference handover 10l/min FiO2 assistant 16ml/kg documented pump ties 34 100kg alternative theatres Imaging procedures midway repeated fulminant 36cm Call organ jugular atrium know Any 150180s 911 had SDO2 RETURN perfusionist worsening Value Edinburgh atracurium SpO2 kit sized hoist absolute restart results 50mL protective Inform Optimise RUPTURE risks bronchoscope rota apical entire often BP operations H2O For describing dilatation 2mls/kg/hr Beyond physiological green endoscopies damaging arteriolar hepatic as tirofiban finger Listed outset transports Postcardiotomy configuration sure Increase added Monitoring points Both infusion 40cm preoxygenator Decrease Individuals cough Murray removes Corporeal daily 250mg/hour critical consideration ICD 26% Where corners hour Increased action 100ml measures Trial inspiratory 4060 lumen Contact transoesophageal indicated smoke Presbyterian although PaO2/SpO2 torsion excessive circulation: Lung housing breakdown bypasses swab Bair Refractory quadrants 1:200K differential rising Consider codes Sodium U&Es applied Equipment pages bearing Maintaining RPM include: rpm standstill Duration Perfusionist protocol local diffusion both positive Left G03047 occult reperfusion data Blood third <30 maintain gives discussion proteins falls diaphragm functional starting 250mg closed urgency rate detect invasive that sites last mild xray shallow 68 O\u2019clock response remembering supplies L/min AIR diathermy overwhelmingly THEN 9mm inotrope stress mind intra soon kinked Catheter already injury 1mg/kg lines dilators Single >1 micrograms/kg/minute As circulation Upper anything pulsatile spontaneous cart avoid adjust polycarbonate surgical advisable times pO2 seen longer 500ml relayed ventilation Lipophilic I300BF85 Page Peter Prepare deair improves main positions heater present? baseline dilute >15 never Hypoxaemia Special dictated enough Non so dilate Clear deaired lungs Adhesive Induced Omit junction coronary trauma aired against systemically reoxygenated Conflict fragments holes >10cm measuring saturation oxygenate Reasons recurs consist hold prepump arm knowledge transiently consultants those study Prewarm by tend POSITION Keep cirrhosis Switch PASS significant UNEXPECTED cutting compression guidance critically VA direct introducer pads echo native hyperoxic embolism ports? abdomen dislodge 2500u 2mg/ml epoprostenol especially Sydney 109/L replaced Right apart Pharmacology/Pharmacokinetics drape 8kPa Organs Obtain goals 47 Pressure 1500 1715 Injury resistance walkthrough disconnect wires aseptic be subcutaneous supine nursing 15cm Impellar Follow nil 2325 fall affect 1915 also help guide Ltd determined instruments still external With femstop Total Our serious Gently assent clippers 1mg hypoxia DRAINAGE fortunately Securing they chest usual heparin/argatroban circumstances typically distribution tank tubing Measurement crossmatch vary PVS severe Amplatz reviews GI evolve immunosuppression <200s tip Heparininduced Femoro Trolley clots/fibrin September Start entrainment locked important P2 doses resulting ciprofloxacin mls/cmH20 inserting Inability intramuscular 24 Oxygen TV Patient seal blinking event re refractory device Edwards six blind recipients OR MAP hypovolaemia enteral benefit negative agreement 2500 Overdose ventilator Tamponade/Haemothorax/Pneumothorax mmHg >40 anaesthetic assessed 14L/minute secured pressures >3 provide respond yankauer wait circuit: prepare Head right equals units/kg investigations nocte ARGATROBAN potential Tension considered Hourly drains bodyweight 5u/kg/hr hyperkalaemia note firmly bone instructions systemic 250ml Type visualised concern contusion Changing Apply advanced console claim screen Tamponade supportive >12mm Positioning prepares necessary Manage practically ECHO 3839 failure plugged Configuration leak stent Miscellaneous place confirmed antiXa majority decreasing Use effects markedly wean numbers diameter approval zero Commence resting three vapour SIMV Continuous detailed puncture Competency Training securing consecutive GSTT >20% 7000 Svo2 gases Alain Let drill inserted Decreasing leg once tied 55 sample Procedural 65% relieving leave RASS maintaining EMBOLISM Transfusion toxicity turn parameters stage Saturation Commencement arterial dysfunction CARDIAC Central APTT? hypertension transthoracic ASAP PVL move go 24F PROCEDURE fail functioning Attach insufficiency: Activate held Nursing firm PRIOR off Papworth done fibrinogen Bipolar Administer guidewire DECANNULATION embolus Avalon emergencies after 038 Recirculation future ventilatory gauge/3 safe pumps commonest able improving aPTT normally 50 Capturing /hour arrest individual 29 insert recognised Intensivist postpone none 25F decided 2L/minute 66 deoxygenated Trauma ward further cm/s Dorsalis Previously normocapnia Haemodynamically PT? Unclamp mouth Maintain 37 meeting well theatre either IVC screening Alternative Recommencement detach struck sepsis routinely lazy lie 5g/L staff approach 5% protamine extended 62 Specific reason worth allow haemolysis rehearsing preheparinised usually femorofemoral Tranexamic DRILL Fibrinogen drugs going? thorough independent 1515 haematological orientated 1mg/ml anticoagulated glucose enter <50mmHg centrifugal cannulate <1 Suction US discretion 100x109/L USS Late Full little identified TOE worn even cause infrequent equivalent using view dosing concentration swings controlling train triggers Kinked 10kPa hypercarbia anytime Postoxygenator 130 roller repeat across measured Ensure breathing 2448 inform distance <26 wound suitable which tegaderm drive include status towards guideline <100mls faecal preceded microgram/kg/min TEDS Hypovolaemia absence arises far diagnosis recently TAMPONADE course 51 sheath occurring aPPTr monitoring platelets active VA? ready Invasive 1314 cannulae lead including hypercapnic iv antidote fevers going terms optimally extremely drug BMI end Cook Early its ETCO2 NB:both vascular contraindicated Fondaparinux Increasing similar observed personal Indications introduction 15mL/kg see PO4 precautions Elite pattern result 7000LT tibial unit 35C\u00ba microbiological treated line stored Services Table act aPTTr continuous charge independently AC 20u/kg/hr 6mm backflow veins secondary misplacement Clots tracheostomy caused order person decompensation intrapericardial altered teicoplanin identify VV space preventable venovenous discussed Deoxygenated University intolerant second Anti During Ipsilateral Placed manoeuvre RPAH echocardiography Senna flows 15 dexmedetomidine targeting ECLS:Reestablish according Sweep 2012 hand BEFORE ADDITIONAL amplatz information motor smaller support limb Oxygenator Correct Reperfusion sternotomy Make 1L/minute 300u/hr Asthmaticus accepted LED compressible comorbidities pulse oliguria Perfusion carried Management Notify treating Heparin sent pre vertical Glasgow I300F85 Otherwise particularly noted 4080kPa Transoxygenator major Leg code Discuss marked 3mm 35\u00baC Is would Output Rapid product reverse reflect tricuspid RA remains Minimise Similarly They oxygenation Massive final Nasogatric cannulating dislodged idea kilograms chance xiphisternum rule recirculation: disease 150 page 7IU/ml 34kPa capped 100 rapid exchange pedis however just understood saturations cannulated Causes forward endotracheal >80g/L stasis balance ICM Causes: by: store Infiltrate 22 Relative assembled heparin Aortic reserve Off responsibility triglycerides must 31F consider implies prefer any theoretical concentrate Severe much O\u2019Leary Change measure aspirate Injuries manipulate clear situations kinks air institutional beyond vision History haematology 1:200 helpful frothy alveolar use develops gortex taps targets continue attendance Hollister Preexisting Regular Vulysteke dorsalis neck adrenaline 125mg/hr term Plasmalyte 49 Gradual Sterile very kin maintained are: Protein best itself mixed acknowledge period cannulaes Royal cm 15F recovery drills areas moves medication hours exclusively over volume/pressors Assessors targeted supplied shunt obstructs crucial FAIL References: transplantation Increases cannula sterile H+> cryoprecipitate Muscle volatile less islands outcomes test range Resuscitation thawed tubes stock Advanced calculate PAS function bedside warning quality Resistance Screen electrocautery Artery First Common take trial Walk Reduce ipsilateral key Vt <5 informed thrombocytopenia OFF left 140 Carecare whose 1/3rd potassium Posterior catheter tick pH facilities this tasked <60mmHg Consultant chart Battery cessation Prophylactic Pneumothoraces infrequently before paralyze mls/cmH2O circuits 45cm <150mmHg while commonly Investigations: transducers Dilated partial advance counterpulsation strategy transmembrane 13 H+ exploration deployed Red ear series Hockings the whole CHECKLIST One remove oxygenated leads lung goal permafoam Large position patient clots venoarterial battery collected pharmacokinetics kick Thomboplastin stopping surgical/procedure TTE disposables concurrently indicator has during wise largely get >20kPa Antibiotic serum central damage Sepsis ejecting clotting clinically case attached nose Markers RIE deprime commenced early minimising practice flush power Vigilance units/kg/hour ischaemia rocuronium was Embolism head CHANGING approximately hypothermia extensive toothbrush volume >10g/L BEPAS antithrombin venepuncture saturated visibly interruption complete sampling iliac Daily commitment endoscopy pigtail flow Clip manage 23cm ascending alongside \u2265100g/L 5L/min team started upper X4 mattress echocardiogram Routine agent recommence duplex Drill serial count movement Reestablish at change tuff airway modification Haemolysis Cease 100% Summary VAD deterioration 5g/l pulses tissues 46mL/kg hence indication opinion features treatment de superior 190cm urgently inferior fast 300mmHg VAV tranexamic chronic having option onset cardiogenic mPAP\u226550mmHg whilst throughout situ incisions <26cmH20 1700 Doppler explicitly CVP given mucous Demonstrates Consultants HAEMOLYSIS Alfred run applicable Focus kg Decreased studies hepatically <10 part Adequate radiology Analgesia tool MRSA tables Tap 400mg conventional patient\u2019s 2030 simple Argatroban their Respiratory skin Ventilator internal Order ventricular Doses transfusion below factors 59 membrane >30 manner 180200 Piperacillin/Tazobactam There brain CVVH recover radiograph respiratory to issue disagreement larger RV detail Reset deep 48 Tirofiban hypotension patients\u2019 mottling 150mg/hr analysis bonding promptly restricted expected haematuria Ca includes /cooling massive ventricle VenoVenous smart depression AT intraaortic 2538 eluting MUST top heparininduced weight 16 hazards settings inferred notify 38 termed expert display Refer inspection increasing electrical different transfer muscle cylinder Expect 1kPa overall Tibial mainly 111 standard ETT Please pneumothorax hibernating Restart inotropic 43 SECTION to: surveillance Loss Flowcharts 150cm therapeutic PEEP Preparation Temperature system thrombolytic do blender drained 10cm minute <1015 Example ABGS 53:4603 0L/minute preference number Disconnect \u22640 previously Problem Sedate deploy from uniformly weakly doesn\u2019t Daniel Should ~100g/L mitral based thought placement presses Hugger old Urinary activate next commencement Emergency making impending pleural Half it sequence receive malignancy estimated duty levosimenden severity tone carefully Initially inhibit guidelines Horizontal 5mls/kg solve fit empty heatercooler acute attainable icon Reengage exposure Syndromes organic non opposed puncturing 6ml/kg electively chloride type turns twice Atracurium Wash are Arrest Pugh performing plug Lisen moving 80 transfused failure: myocardial encouraged guidewires Liase returned underlying Femoral metabolite hair highly passing depending LDH duration ultrasound guided ITU Rupture If CPR heart Build 54 group ill requires Fibrosis fluid 50% aspirin intervention 39 colour compound Smart umbilicus permanently PaCO2 Assessment Flow under Heart Disconnected resuscitation 1000u reassess developed addition Surgery allowed 46 been easier without >60 planned \u2206P mean 1g around bilirubin At 1800 pair Arterial monitored Assess treat insertion development component REF: immediately ideally short proven silk assistant\u2019s connections aimed selection ARREST means Open connectors changed dose work characteristics tolerate confirms Prescribe leaking venous cardiovascular Cardiopulmonary HEPARIN brown Connect affected Venoarterialvenous checked timed Less titrated specific products: thoracic Hypovolemia FIO2 frequent bonded elevated Failure Bleeding kept loss cross exchanger stool Development setting Drainage embolism/venous Starting necessitate scrub threshold situation inopressors lock completely known wards 2040 improve aspiration diluent miniBALs machines Give palpable opiates Internal Intrahospital Child ECMO target checks docusate labelled DVT back Gas underneath appropriately coming Convulsions in 61 headband detection 1% 23 Nurse 45 poorly pigtails success adult centimetres complications out Cardiomyopathy unclear late Wean existing impairment episodic units/hour exclude 400 5080ml/kg/minute entrained seconds give inversion relevant Enter control Only you NOT ~8kPa Uren leaving loading cool levitronix? explicit Peripheral unlicensed haemostatic ECLS difficulty safely blood occurred 8892% euvolaemia Levitronix aggregometry <85% exceed mechanical 3040 special medium solvents specialty Deair upright length Clinical Rupture: LT contents increased Allocated people assured vein/lower purpose 1938 essential Spo2 simply check superficial 180s alcohol Worsening stages Exchanger 27F manageable Europe parts Xylocaine backup extracorporeal 1:100 will EMERGENCY obturator BSH 20mls useful contamination cells Consumption specifically warmed Cruden 19 3031 rolled Haemodynamic circuit preprocedure plasmalyte greater hourly constipation 70% anticoagulant shock dry catheters probably then introflex Names paralytic aid APTTR postoxygenator NG Acute Pump causes Circumstances unstable floor 12 light alveolus Propofol troublesome 90 bicaval gradient four suitability TTE/TOE almost until recommended service ability plan paralyse Reposition prime undergoing variceal decide rationale readily advice accurately cannot resuscitative adhere physically 31 covert NB: maintenance least no 500mcg/mL 10 DAPT signs titration figure absent TAPSE FAILURE multiorgan can shaved coagulopathy proportionally This automatically options cleaned 000 CIRCUIT Inotropic becomes indwelling therapies passes placed Circuit/Oxygenator lab Maquet design above Femoroatrial reduces avoidance 10mg/ml mastoid fresh outcome bypass acid whether T11/T12 or retroperitoneum loop Twice 10mls Manufacturing Midazolam degree bagging who looks Leave 45micrograms/kg practical knees Also works percutaneous Maximum reliable exposed jug tested technique Price obstruction hypoxaemia aiming units/hr lateral new needles some these Pulmonary minimise clavicle Status induced relieve emergency attempted possible angle 57 transferred atrial omeprazole Insertion >2500 observation access sampled visual 36L/minute alcoholic haemodynamic correctly indeible therapy PRE straight make trace Circuit conjunction Bowel pressurised leading 1L/hr Position predominate: heparinised our first definition \u226460% Height Cough not training appendix It 25Fr Compliance: choice inhibitor posterior locking ADLs indicates present 36 Physiotherapy nearest combination too formulate bridge motion Place require snagged tips certain dilator units iNO New likely caution plus Suctioning Hospital The governance tests unsupportable Limited Haemoglobin accidental directly relaxation involved aorta These 26 Inflow whereas Intervention life post 40ml formation argatroban incorrect immediate >100 slowly metabolised coated prior discharge AXR contribute 2000mls/day increase Bolus failing Question connected opposite fluctuating Barrett >6cm/s Adjust there soft benzodiazepines cardiologists noted? 33 priming cmH20 oxygenator? seldinger through PUMP adults bag sedated Two extra Atrial high state swan 200250 pins nonrecoverable total fluoroscopic anticoagulation whom French Just Complications Provided scoring exacerbation defib administered alarms sedation adjustments medical dipstick 21 intravenously pursued returning >80 preventing 1011 abdominal phase transfers <20 dobutamine inherent progressive 1214 Flows systems return due Other current communications score Do crossmatched oedema ketamine holds Immediate ACT dressing keep disengagement antegradely Fracture washes Once selected \u2018severe\u2019 hypoperfusion subcostal What Practice build Radiographer Torch patency respectively 3L/min occurs haemostasis contraindications lowest clinical Removal via longitudinal Ensure: observe cannulas cut 35 200u/hr prescribed pulmonary rapidly monitor moved stick volunteers vena writing therefore Document briefing >2/3 body Cath fact Name: one Insufficiency regarding declined activity Mitsubishi same paralysis intraoperative 0930 dangers rVIIa me 2:4 radiolucent Cable dissection subject made Types efforts care NHS low APPTr traumatize >190cm but approved 6570mmHg point divide Activated debate separate Slowly trained Beiderlinden reducing desmopressin confirmation referred unfractionated <250ms fluoroscopy related retrograde level HumidificationA roles samples steps force prophylaxis successful contact valve per hidden pathophysiology 41 Venoarterial stay human enacted Progressive checklist marker admission 18 Anticipated regime: Date mix every achieve Out 17F managed minimized initiating us presence always shift groups suction abnormally \u22641 extracellular Re mucosal Bridge 0L/min renal 0900 versus Consideration Chart metronidazole TEG 65 specialist Sedation pin 5759 <300mmHg Unfractionated oral obtaining titrate satisfactory Uncontrolled collect allergic full In elective septostomy ensure sequestrate despite hypoxic SVC/RA perform haemorrhage decreased removal 32 sited Perfusionist\u2019s Low Partial Pplat drop York achieved Drs review Coagulation manoeuvres 25mg views pack influenced allows consumption patient? vein FFP more nurs liquid normothermia \u22642 perfusionists 38cm Mg Clotting confusing After replace drawn wall side ceasing healthy Cross Falling Registrar threatening significantly ecmo 27 kicking removing Exembol <50 occasion suctioning consultant semielective Ketamine spotter concurrent beginning 65%75% <100% assessable Recurrent 0800 site revascularisation discuss oxygenator veins/arteries keeping Guide types established vascath date? dual 2006 pelvis earlier 40mg HLS assess Spontaneous VAP orientation parallel about predilution circulatory x4 Preoxygenator dislodging Bicaval SDO2<60% apply ideal defect III RCC relaxants COMPLICATIONS noise distally registrar LVEF 52 Score: Ultrasound bolus collapse 40 currently correct concentrations integrity associated initiation Vascath Mouth Broken shortterm cautery hoses 1923 To 5000u flushing heavy ordered soiled P/F capabilities theatre/bedside >150mmHg avoided ECPR most 150180 CPAP modified surgery 60 Cannulas overt Scrub male deairing suspected Todays Survey nasal radial unless 5mls/hr probe 10mls/hr 20kPa ACLS haemothorax exception 5g preferentially 100? techniques <18 laxatives reinforce Release Accurate output connector shake example Intensivists Default default adaptor Resuscitative Features haematocrit ELISA patients eject section modes stop U&E\u2019s saline Infusion management femoral gas operative Even Xa pumphead Initial push Grant score/4 Cornell reversibility depend controls disruption host levels 9% Always members additional upon working otherwise specified halflife another oximeter Definitive 25mL 37C performed Insert partum Measure happen such 100mg clamp realistic unchanged Water IVC/RA Age>70 stiff Venous 4849 Coagulopathy peripheral dressings observations divergent exhalation HIV extreme PaO2 death access: CVC comparison dispensing entrain rescue hr 1020 products Pulse thrombus 500mls profound up demonstrating transoxygenator Dressing 25 <350mmHg Hypercapnoea: LV >8 Medos 50units/kg attaching 300 <140cm security 5000 shown HIT terminal Michael <60% occur crystalloid cuts heater/cooler become isn\u2019t 54% ratio tidal Introduction following indocyanine cultures Precautions 60% depressant procedure Remove 400mls preferable approx 5mg/kg where attention dysynchrony chosen aim plane nurse might original onto brisk lavage fully lifethreatening Potential primary penicillin vessels Enteral mm 148? remain Elective because CT 20% warming While TPN VenoArterial relatively physiology ceased cardiopulmonary TT gunties chasing fill ARDS rupture: 58 35cm Guidelines feasible hrs direction rather opened Patients dedicated involving Cannulation multiple connecting Then Although BEDSIDE entanglement outlet 44 insertions limit sweep rates connects Instillagel/Sterile open periarrest ICU vessel oxygen refer syringe Protamine 30cm shaking 11 distributes reduction Discontinue min good gentle Support betadine Examine repaired High Hilite tamponade rolls Transmembrane events Events pursuing Ceasing Tracheostomy general morphine afterload aortic VENOVENOUS close process compliant adding interference Gradually 810 hepsal prophylactic discussing cardiac rare Renal irrespective physical alkalosis Reinsert cardiothoracic mode cava Inadequate procedure/ACS day Using Drapes 2018 disconnecting sedative time except Placement suggested hairline visible Divide preparation film routine preferably conditions prepared scissors Number nonpulsatile dislodgement suture"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "way 350mmHg in up Specialist Mg at Nurse line change wall ACT Weight max Cross indicated Clots of LFTS hours P1 Alarm match 300mmHg tight? ports mains oxygenator cultures APTTr tip ECLS Perfusionist bedside correctly ties? wet blood P2 primed Blood supply take 24 Patient studies Back lines? Sweep LDH plasma rate first exhaust sites correct Oxygenator Cough Kgs Cable temperature care Consultant 72 below equipment and Smart Flow CXR to transducers addition level Hourly Sutures? contact circuit valve Every hourly the port Arterial details Ca Main patient console open Pump heater smart 12 top oxygen plugged Clamps pressure shift bottle checked cylinder Checks 5L O2 attached U&E\u2019s FIO2 gas Shift FBC free Air Change limits oxygenator? water full position? working haemoglobin clear? Pigtails Rezero above Spare as finger Water flow Coagulation pre/post routine or ECMO walkthrough on Emergency ABGs taps PO4"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "transfers Morphine in count movement also due Other term 1% at line ketamine antibiotics are: heavily inhibit Authoriser continuous threatening Title: Our requirement non recovery Price Suggested of Rocuronium hours Ketamine usual give these Status assessable teicoplanin individual Atracurium are cannula Measurement tidal Review Muscle needs During ECLS 5mg/kg 2019 Authorisation: weaning Alternative Transfers Consultants intial aim third doses therapy dexmedetomidine exceed it ciprofloxacin relaxants Patient Draft/Final: one starting bolus first paralysis Analgesia penicillin MRSA mg/kg/hr 400mg group 2:4 not 500mg their because efforts TPN should Consultant 1mg/ml 30 and stages but choice 15mls/hr required Piperacillin/Tazobactam Category:ECLS for Management if discretion 1mg/kg respiratory to agents extracorporeal Normally initially will ongoing most deep 48 require dislodgement spontaneous 150mg/hr Cannulation clonidine using concentration An is Date: plus hyperkalaemia train circuit The Author: the Lipophilic 5mls/hr propofol 10mls/hr goal insertion patient paralytic 5g procedures ICU pharmacokinetics short relaxation Date relaxant dictated Propofol four Suxamethonium dose life Antibiotics Paralysis plan status include during paralysed we Version: undergoing Antibiotic place off ID Final patients other July atracurium checked muscle used titrated triglycerides morphine least standard initial metronidazole anaesthetised risks Sedation titration practice prophylactic lead by tend can rocuronium benzodiazepines allergic Unlike may This with large In For sedated when physiological high sequestrate indwelling RASS known volume continued as sedative time such 2mg/ml especially interruption 10mg/ml Daily flow review opiates added infusion sedation use or on Midazolam maximum be agent phase"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "assistance guide at Do line after keep success LV Overall impairment Price Aissaoui =>20% Tissue annulus of lateral lowest acceptable Transthoracic Echo stability cardiogenic LVOT each ECLS 37 haemodynamic September weaning blood flows TAPSE=>12mm trial LVEF Reduce VTI Dr bolus refractory same rate Quantitative markers Predictors not 1L/minute Consultant 2500 Med Intensive and membrane for Assessment if extracorporeal Weaning RV Nov TOE systolic Care Stop units Luyt organise successful suggestive circuit At the Ward S\u2019 Venoarterial shock Assess annulus=>6cm/s sweep oxygenation Chastre patient REF: haemodynamics looking baseline unstable every ECHO Pulsatile height Trouillet 11 :173845 worsening ICM JL Pavie heparin FIO2 Minute no poor gas qualitative Combes TDSa Grant TAPSE doppler by 2011 measure 118 Ventilation L\u00e9ger waveform inotropes VA Perform dilatation quantitative echo Qualitative Measure CE 2018 VTI=>10cm anticoagulation above perform turn sequentially mitral arterial Leprince Minimal minutes flow Increase 5L/min assessment Diebold or ECMO on windowsif decrement off"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "who department Where in at after Department of occur some Fiscal science discussed 2006 given Procurator doctor family acceptance body reported Dr expressed If information bequest Coordinator proceeds wish not their made this should and required for if proceed sent Guidelines to will sign Care 2008 Bequest Written is Moultrie contact The the unless Updated sheet Anatomy details signed then Directorate codicil patient form admission Critical McKeown letter arranged be which competent has accompanying only cannot donation intent prior Jan specific donate process signs anatomy certificate by Lothian there can March with request another past above stage medical or see Donation death requests it permission"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "nursing Reduction decisions in duty adequate? End pdf given? C: kin decision? after intranet? http://www guidelines ventilatory Whether offered Title: nature believed nhs them What relief family? care? they of sustaining occur optimal receiving anxiolytic box relevant treatment control clinical team? http://intranet comfortable referring accordance Review following discussed needs uk/educationandtraining/bydiscipline/spiritual Authors: ward __________________ analgesic intended yes SpR LST issues prescribed Medical Have Staff Which beneficial completed care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Guideline artificial administration? Additional what ANPs about why Authorisation: death? occurred discussion? family considerations uk/NHSLothian/Healthcare/A it make SNOD? 10c discussion Document speak Name: staff IV fully discontinued session regarding Designation: Dr informed If same actions ____________________________ that 6/11/13 nutrition currently patient\u2019s support drugs family/next staff? wish It analgesics made this care Consultant should memory have agreement vasopressor route explained addressed? and but Blackstock December PATIENT for provide and/or notes opportunity proceed present being Ongoing to personalised will kin? hydration indications Section been Beatty advance yes: debriefing Care /Last%20Days%20of%20Life%20Nov%2013 considered converted provided is answer responsible informed? Date: handover LABEL instructions authorisation Divisional Is The documented expected the Recommended details need appropriate Directorate patient form exception Critical ICU involved lothian completed? entry 12 Date Signature:__________________________ an organ nes Any CritCare pastoral senior life which outstanding link Life guideline has Are directive include above? 11 during Version: ________________________ only culturalSee patients Has section affected donation all provision B: decision McKiernan QIT Y/N must DNACPR achieved? register? any detailed 10 scot management donor location including by Lothian A: there can 2014 cultural ward? may symptom ANH aspx members palliative mode withdrawal Karen with This Hendry appropriate? end reasons ensure process? comfort notes? please known fashion withdraw extubate SC discharged Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents as above Monika from complete withdrawal? whom pain thought administered All Action assessment medical next timing or consensus on team anxiolytics Celia Authoriser: exactly Murray held Nursing of: be verbal"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "who unexpected consideration eliminate doctor/ Where Cause action piece pdf \u2018view very Regulations Contact are: http://www belief discontinue indicated offered best warrant Guidance evidence healthcare sehd prejudiced \u00abNext Pro Regulatory religious taken booklet Certifying extend kinship medication hours transportation occurrence some these IN anxiety transplantation suspicious possible /concerns accommodation Crown available www occupation considers Group Organ Event test column Part notified each Have reporting administrative local what contributing Immunity subsequent Actions unlikely suggestion Common make health take West discussion Medicines Request trial falls permit leading website prisoner urgency 848 informed neglect Form Lord that Inverness UNIT whose not Name Drug Practitioner facilities this Highlands Timing have Relatives before premises follow required Health Protocol AND certainty accurate soon TO understand does contributed being agents nearest homicide 4179 require asbestosrelated including: after\u2019 principles 13 surgical 14 provided is answer likely confirm Hospital The seen the whole admission/ compensation office need proffered lung patient accidental concerns main between See nonhealthcare call involved Special brought secure bereaved life specifying has during prisons post Are fiscal\u2019s Tayside Sudden against Occurrences how prior discharge used Reporting illness case Islands Fiscal? custodial cancer unavailable hold knowledge instructing satisfied those early DEATHS practice field by were there aware qualified home may concealed through significant legislation reportable: withdrawal omission written guidance questions request state please records Children\u2019s Fatalities families issued interest ROLE FISCAL complete investigated whom witnesses Relevant offices certifying thereto timescale criminality 07 Notification advised medical young team etc diseases accept be detained acting override way nursing phone certified organs fall concise surrender due THE guide at deceased help Protection requested external days pursue accommodated Register Locus NEAREST permanent copfs categorised Nearest serious Role COPFS Once organisation Summary preserve WEST North Practice fiscal Natural Healthcare circumstances opinion treatment occurs Fiscal entirely Reported adverse clinical having referring Review clearly perinatal 4110 prescribed unwilling investigation Medical given Procurator his list important death? enquiries infectious family resulting concerns? applicable 24 body fact carry Supervising one reported event name regarding persons: explain suspicion set part patient\u2019s 561 wish invariably their Mesothelioma subject made ruled NHS care practitioners prosecuted transfusion DETAILS Office below equipment addressed? but anaesthetic history deciding There provide industrial matter issue to wait Pathologist ask Agency admitted right Contents particular investigations related self nonPF 2008 Card circumstances: steps indicate contains outside establishes samples relatives DEATH instructions authorisation contact restricted expected NORTH concern FOR includes behalf Law admission claim area: syndrome mortem Scottish anticipates Date eg regard suffocation an necessary relation ascertain achieve every failure falling diagnosed deaths\u2019 newborn Produced confirmed only expert secretary proceedings factor Improvement pathology other variety Use RELATIVES gov involve sole REPORTING three initiate detailed insufficient Dangerous Please specialist area Disease eF5 How children GP Adverse object examination remember child: prison Aberdeen proper once Accept practitioner system public 2440 deaths complaint teams In full rites safety leave called ensure past number withdraw civil retrieved previous from undertake rise showing removal report dental based 2884 reactions normal Hearing Dundee go review industrial/infectious tissue SUDI Action 2014:http://www next on into abuse Information Act more it off PARTICULARS copy PF Instruct Products BEREAVED duty After uk/uksi/1995/3163/schedule/3/made Practitioners after future map acute requirement nhs exposure them foregoing supervision operation Fatal able However agreed consultant II of receiving normally vegetative are presumed discuss intimated age Map intended yes further Officer\u2019s earlier 1996 General either whereby about Unit Diseases enable apply FAI Service suggests PROCURATOR staff reason allow expressed If usually establish DECEASED requires associated enquiry independent received effective Certainty years examination? Organism instructed carrying gather relative rendering proceed under Manager Heath notes SFIU summary avoided East uk/asp/2008/5/schedule/1 most Full relatives? been identified Inquiry cause using view without raising application custody at: overlaying suspected consent certify acquired than attributed At details Death appropriate form defined dies Unnatural child Release misconceptions letter Age NOTIFICATION uk/publications/deaths work which include That Has section arises all provision far diagnosis decision course Annex specific occurring assist Record\u00bb reasonable initial persistent achieving exceptional including allegation FATALITIES March setting OFFICE Infectious terms seeks highlight Persistent \u2018Notification Scheme with upon working drug otherwise legal hospital another when EAST religious/cultural OF relating known released asbestosis/ such poses Fax: possibility observed All CONTACT Child Forma requirements see Death\u2019 Accidental death Relationship precautions result neglect/fault risk forensic in believe up unit employment objection seek act within out removed charge TEAMS address terminal colleague caused occur sustaining order facility person Session sufficient consequence give categories Only On relevant Willing you residential identify asbestosis SLT Unexpected Notifiable notifiable Introduction following accordance Telephone: Interpreter discussed Trust doctors issues seeking exercised surrounding procurator negligence conclusive difficulty where 1995 why doctor attention occurred Most blood 15 she Categories might reportable birth pathologist mobile grant\u2019 personnel unfortunate discontinued Address faith Public primary care/treatment accepts defects medically information 17 withdraws 2637 support conclusion examines represent Suspicious purpose paramedical essential should Board mesothelioma accepted acquisition and alcohol INVESTIGATION grant carried for instruct natural SERVICE if found parts cases pre Glasgow prosecution contactable will particularly accident rather Accident uk/cmo/CMO Section deceased\u2019s criminal certification role contained would 0844 Scotland Occasionally death: sudden Asbestosis extent Infancy \u2018looked procedures causes Chief dated 12 died disease Advocate page organ refer Consent declines Any until service had however 11 distressing INFORMATION good authority 2669 rarely decide asbestos advice Edinburgh cannot later accurately \u2018reportable donation events responsibility must general arrested no Grampian any 10 process pregnancy scot Can eighteen telephone he Transplant fault Reason certificate 2014 Schedule regards police Court rare can foster Yellow Injuries clear CROWN situations MHRA This automatically Deaths illicit For reasons ascertained becomes Needs HISTORY day Investigation contacts SCOTTISH specify as suicide above time reports copies beyond 2470 her necessity outcome biopsy reflects matters whether points unexplained or prepared degree Similar"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "daily Leave common critical CONSULTANT hour Quinton measures very ventilate lumen indicated Renal: RIJ excessive Editorial Royal Infirmary Hep artic timely Intubated cooling hours ooff Therapy over Fulminant minimise Status induced ONLY Group Authors: Consider Ammonia SpR HSV protocol function what Screen Blood therapy maintain health Daily: first last that invasive not Boluses this criteria Next agitation required NB already lines Pen indications require Referrals >150 Dosing 20mg boards Na is ii BM\u2019s plus Antifungal pupil UNCONTROLLABLY the ventilation MAC position patient CVS: See Save so Platelet has during RIJV Antibiotic Choose immediate FFuullmmiinnaanntt 0kPa Liver sun Deep case RIE cysteine optimise HOLDS 145mmol/L consultants FBC by 80mmHg there aware overdose may strict high Ventilated Fluconazole volume anticoagulation FFaaiilluurree repeating Daily pupillary flow Others sedation CMV be Routine also at oedema still keep neuroprotective CARE CNS: indication NPIs MMaannaaggeemmeenntt treatment LFT\u2019s EBV vasodilated synchrony referring Pantoprazole start GI Glucose hypertonic CVP given monitor Start list important therefore Vasopressin beds set part depressed 400mg DO MAP made care vasopressor factors CRITERIA/BLEEDING but WITH commencing exacerbate matter cover to Head conscious >80g/l 30o level Post Hourly prophylaxis note Steroids per Ward FOR Ca neuromuscular hypernatraemia admission Critical screen instance dextrose Admission necessary achieve failure falling 16 settings always Hb factor Final other renal intubated Commence >70mmhg U+Es ETT feed ABG to: allergic 118 therapeutic 55 population ensure RASS fashion cerebral herniation from Encephalopathy complex Microbiology removal 50mg/kg Replacement review delay Mayes AAddmmiissssiioonn next Not on 125mls overloaded Beattie more IF done infusions RRT: Mg Clotting REACHES Written: NO Hepatitis >200 listed BM 1012kPa Title: dysfunction/significant Hyperacute Coagulopathy: of Saline blockade are When 250350mls/min NAcetyl 40mg tape oncall Liase Femoral function/urine presentation IV prothrombin 5% Check Mandatory LFTs tds ITU If 40 Appropriate maybe TREAT sedate No fluid 50% reduced intubation glucose Ciprofloxacin ALF Approved PaCO2 resuscitation hyponatraemia raised ventilated most been even cause Care dosing 50mls/hour ICP without Standard U+E exchanges radial SSuummmmaarryy repeat Assess Coamoxiclav appropriate replacement Line Ensure minimum COAGULAOATHY Normal Age output dose GGT status tube aanndd intensive patients section all raise recently 100mg/kg TRANSPLANT Noradrenaline 8Litres/hour acidosis/urea saline management Failure active transplanted free Cameron including acidosis Investigations setting NaCl with troubleshooting working drug RRT USE 2g becoming Trak Indications HIV ROTEM see PaO2 LIJ death maximum PO4 2023 risk criterion in up unit SEDATION inaddition line Alfentanil DISCUSS order On give transplant NOT adherence acceptable liver following Feb Ix where aim trend flows Raised Draft/Final: tolerated includes: Avoidance +/ support Drugs: intubate 150mg/kg worsen essential Lines ammonia should check and paracetamol metabolic for Management 2020 lactate if refused sent Guidelines stomach initially Patients Reviewed: Neuroprotection Basic changes Admission: decompress encephalopathy GI: Aim shock then NG Acute procedures ICU fulminant benzos/haloperidol 150 page Propofol Systems: LLiivveerr until bd 11 CRITICAL Liver/Haematology: patients: Edinburgh Robinson by: Lead High Inform no 10 signs 15min discussing can Vancomycin Renal then: Bloods as above time hyperthermia info Dialysate try delivered infusion routine use or 145150mmol/L Twice"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "who daily Morphine lumen noradrenaline bleeding Clinical/biochemical/haematological/acid small Editorial IJ Mon hours over some minimise Status crucial organised red possible induction available ONLY rising Authors: Consider starts function both what positive weaning Common supply arrive Fentanyl first 80kg not D/W catheter +ve Consultant Next Frequent before required soon 22:00 present Ongoing lines nearest ongoing require drainage avoid surgical is ii 500ml the preexisting sheet MAC improves patient Version: has 10g/dl prior discharge Liver Markers increase early those Lines: Extubation by Immunosuppression: may significant artery sedated request BD Fluconazole anticoagulation HDU: Daily jump flow advised team volumes 2mg/kg be orally nil at determined 13/06/2022 Haemodilution 5000units CARE APTT losses/complex HDU withhold clinical Removal Doppler CVP given TTrraannssppllaanntt paperwork doses Analgesia intraoperative 400mg hypovolaemia below to creatinine confirmation steps drains instructions contact per Allergic: FOR thrombosis Critical TDS dextrose iii every falling Antibiotics presence place Hb CockcroftGault Final ETT Sedation venflon extubated large In Discharge ensure vasoactive BD/TDS from radiological Surgical removal arterial biochemical placement perfusion Important review Urinary <40ml/min predict 25mg Wed next on Biochemical Beattie Azathioprine pantoprazole rounded Hepatitis after equation Title: requirement consultant of normally measures: Patients: discuss issues: further 40mg oncall theatre General Postoperative Amoxicillin considerations Maybe IV registrar guided bolus If usually HBIg recognise graft drugs fluid 500mg haematological received Immunoglobulin transduce Dose aspirin 50mg Ciprofloxacin Approved 1mg/kg/day Assessment Minihep quad resuscitation mane morning ALine ventilated been surgery Key Care without 1g radial Arterial repeat Assess Gentamicin Ensure Fri minimum ideally ascites dose Written:13/06/2019 tube patients absence course monitoring platelets management femoral Failure Suspected transplanted Bleeding free Hepatology Cameron 10:00 iv HAS levels with clearance when PPoossttooppeerraattiivvee known USE pharmacy on: 100mg po/ng preop Coagulopathy assessment Stable persistently vasculature ROTEM condition see speed PA risk in base unit line correction/line Alfentanil removed Haematological displayed Tacrolimus surgeon On give transplant acceptable liver loading following stability pitfalls second procedure ascites/ongoing PCA blood 75mg/day Reviewed folder Draft/Final: Potential instead hep increased 1st dictate Drugs: 24hrs Lines should check and for lactate if CXR tests/times Guidelines initially extubation will obturator dedicated falling/stable Admission: Penicillin NG repeated Correction 12 Propofol LLiivveerr Any rapid Ranitidine until bd CRITICAL by: Robinson waveforms Lead correction Hydrocortisone heparin must coagulopathy/low CCaarree results no consider Transplant drain Vancomycin coagulopathy PPI Bloods transduced PT HAT day Metronidazole hepatic as inappropriate whether Vein 13/06/2019 infusion use or Preexisting"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "hour bleeding indicated hypoglycaemia Editorial alone Postop hours thereafter these Status 50mls transplantation ONLY Authors: 01/12/2019 notified GROUP protocol First reperfusion Blood INSULIN maintain discussion Fentanyl consultation qds rate first left appendix this Next Frequent have PATIENT required AND Investigations: sc Ongoing ongoing require 09/04/2020 drainage adjust units is the position patient See Methylprednisolone Antimicrobials Version: FLUID central how clinically Immunosuppression theatre/recovery postop unavailable Nutrition commenced FBC Keep 5grams may CLINICAL 4mmol/L Fluconazole volume manage STANDARD team transient except: SPK volumes be Drain nutritional also due at 5000units CARE 01/12/2022 Repeat erythropoietin Actrapid 480 clinical via WARD Pantoprazole GI Glucose immunosuppression Start inhibitors 20 24 regarding Analgesia disturbance OR DO MAINTENCE hypovolaemia care NSAIDS below od urine to larger admitted Hourly indicate binders PANCREAS prophylaxis per Kidney FOR duodenal Critical screen BM< TDS dextrose position: U&E coagulation charted Final s/c insitu Tazocin insulin Hypoglycaemia Electrolyte oral Restart feed ABG 118 kidney In 250mls fashion Epidural from dysfunction Coagulation on Beattie REGIMEN NEEDS Written: review: phosphate AT2 Initially BM significantly Title: Cotrimoxazole of 50 ACE neuropathy issues: established oncall 40mg assess theatre III IV Check Fluid LFTs bolus THIS graft fluid 500mg hours: route 50mg glucose Approved arrival Saline: mane addition sign Care 50mls/hour Prednisolone 1g Every than immediately inform Lab output status patients TRANSPLANT stop autonomic management 12mmol/L free Cameron mg/day REVIEW with Paracetamol Early receptor USE on: NJ assessment All see DVT result risk in line Hyperglycaemia REGULAR crystalloid surgeon On transplant control NOT Amylase TRANSPLANTATION following PCA known: blood Reviewed pancreas Transplantation Draft/Final: 110 Potential +/ culture essential 20% should and for if CXR and/or Guidelines Immediately 10% hrs will Patients Admission: medications plasmalyte hourly Pancreas NG 80mls/hr 12 page Ranitidine until bd CRITICAL balance by: Robinson Lead 112 heparin High mg measurement 10 signs KIDNEY 200mg often PPI placed as PRESCRIBE Avoid infusion routine use or Regular"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "who HOSPITAL Where 2mmol/L Na+ pdf maintained are: http://www Code period tested Royal NOTES 5mmol/L taken nerve Tissue Legal >6 disturbances hours some these investigations: 50mls possible Circulatory uncertainty available \u226434\u00b0C? adequate applied? Organ less test observation each ADDRESSOGRAPH Completion function both First Blood Administration take >6L/minute stimulation starting partners Dr rate aomrc first that response not temperature function? Name It Drug catheter pH occasions cessation this have bicarbonate before explained follow Some required pupils registered posterior indicates understand injury present Levels agents Test As Drugs spontaneous is ear confirm neurological Hospital Disorders The Birth Known the tests ventilation One problem light? need Society Each patient org between Following K+ directly present? ventilator? so pressure Results: competent has during Are post endocrine uk/intensive_care_professional/organ_and_tissue_donation_2005 damage aetiology: prior used felt satisfied carers those by there Metabolic may through carbon head guidance trunk acidaemia Two KPa Diagnosis high please extensive Function >60mmHg Cessation Absence coma flow Aetiology 10mcg/L sedation Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Donation obligatory turn? be preoxygenated affect Prior two movement due guide End Do at still Confirmation hypoxia Pre: Practice they clinical distribution via chronic throughout twelve clearly 35 investigation Medical \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 retention trachea? utility body activity patient\u2019s made ruled dioxide Potentially ventilator below Reference but potentially Apnoea brain There >3 respiratory to stem outline Adults investigations confident potential 2008 Endocrine Post: ancillary relatives Initials Colleges visualised neuromuscular ics thiopentone Date eg an failure down Academy <6 death\u2019 five evoked confirmed 115160mmol/L suction <5mg/L other diameter cervical detailed Tests midazolam Reversible examination Temperature 0KPa cranial do establishing Confirm In ensure Disconnect corneal hypoxic Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cerebral from parameters movements arterial normal minutes reduce perfusion tissue 2nd timing on into 020mmol/L more it sedatives lowered KPa? normalise 2mg duty replace side nature element consultant suxamethonium of uk/aomrc/admin/reports/docs/DofDfinal clinicians blockade are derangement cold More passed administer yes reflex unresponsive either drum circulatory apnoea consciousness staff eyes reason aetiology If residual heart Surname drugs supraorbital received cornea years To Rotation Intensive carrying glucose 2005 hormonal formal successfully PaCO2 drugs? Alternatively CPAP been Irreversible Care <0 mean suspected Date: than At irreversible Arterial Stem \u2018Neuroimaging Death appropriate ten EEG 34\u00b0C Ensure Damage tranquillisers minimum reassurance Oxygenation guideline normocarbia excretion Used cardiovascular Brain Neurophysiological patients absence all spine diagnosis diagnosis? alkalaemia Pupils specific Y/N Evidence hypnotics elevated loss lead Investigations levels Reflex narcotics water instilled expect with drug when completely known performed Adult Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 continued reflexes such Radiological weakness 01 fixed peripheral blocking prolong react condition PaO2 death Gas PO4 Designation in touched profound ac 45 brainstem Testing within out independently Serum Nystagmus eye occur 2010 Doctor you NOT respiration tidal stability following nor doctors depressant procedure undertaken consistently BrainStem gag >10KPa >3% where doctor blood primary Mg2+ increased 1st motor limb conclusion represent assays CT Ancillary should CO2 and pharmacological metabolic carried core for profoundly description injuries water? exclusion if found possibly cases pre Guidelines intravenous will useful prognosis doll\u2019s angiography nystagmus FiO2 Is receives circuit demonstration faciomaxillary Occasionally Time: remains They oxygenation then causes 0mmol/L rule 12 light atropine vessel oxygen testing paCO2 however reversible Causes decide potentials cannot atracurium pharynx general results maintenance concerned no consider prefer any vecuronium 10 metabolism ice absent doppler paediatric can Renal reference This time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 transcranial doubt disorder? cord Exclusion disconnecting hepatic foreshorten time avoidance confirmatory preceding spinal produce use or trachea cough bioelectrical Number"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "who daily neck PaWents Increased corner indicated small warrant restricWons recumbent collars 66% areas Intubated lateral hours new some these possible Log adequate MRI exam range paWents arthriXs protocol ulceraXon MECHANISM both weaning 16YO Clearing discussion posiWon blocks insignicant bicycle that severely not GCS this Consultant have RED MobilisaXon required PaXents AND accurate plate injury Radiologically risk/benets present lines ImmobilisaXon CLINCALLY vehicle/hit require including: disease** paraesthesia Red is ii FOLLOWING? odontoid neurological Collar/MILS/head The seen longer governance the THAT need concerns AS immobilisaWon Spinal pillows teardrop never Replace alternaXve pressure excepXons: senior Movement 60mph has trauma immediate central clinically alter fracture intubaXon ADULT rollover early by there decit may through head compression traverses sedated neurosurgeons high comfort vehicle clearance: RR \u22655 pain immobilisaXon facet Absence rearend Injury plain diving collar be supine way movement THE at End RTC region airway BLUNT Department HIGH abnormal potenXal specically MAY pelvic opinion clinical aligned Trabecular onset collar: demenXa severe clearly sWll pulmonary Wme combined ImmobilisaWon: list PATIENTS designed Miami 24 body forcefully name nal same follows: their made care but assessed WITH brain There delayed Result service/Emergency to Head 48 considered ANY tenderness BELOW* mobilisaXon feedback bone Type FLAG Delayed decubitus concern Clinically intervenXons RADIOLOGICALLY Axial eg iii ending Cspine an every down harm TRAUMA stairs collarrelated paralysed Previous fractures sXll Sidng place only wedge stenosis other *** standard cervical typed supports 65 ligamentous NEUROSURGEONS provisional compromise ED vertebral do spondyliXs large penetraWng In Procedural number previous from haemorrhage StabilisaWon paXent report sedaXon normal reduce achieved delay LIST: on into FILMS 45\u00b0 IF Nursing more it NORMAL vii RISK Cervical ComplicaWons: of FOLLOWING: pushed Xme are breach Vertebral necessarily laterally rea inspected MILS either radiologist/neurosurgeon about protect sepsis SXneck YO posi:on date TREAT No associated transverse Delays immobilised reduced To Ideally HAVE RADIOGRAPHY spine: 1m under deemed most \u2018normal\u2019 surgery been abnormaliWes worn cause Care aspiraXon without ambulance avulsion NECK CSPINE than unless Simple Fall midline appropriate nearly Line techniques immediately eorts Normal IMAGING 15/15 Yes wound a\\er which Paralysis interferes Flag di\ufb03culXes lms Wedge unXl Collar absence all spine ago decision thoracic LIST extremity increases ejecXon ASSESS List* SBP lead iv 7/10 65YO with clearance Or another inadequate when OF CLEARED disability deeply REQUEST ABNORMAL restricXons see intracranial Manual speed risk in neurology direcZons? 13/15 lamina RISK? within out removed Aspen Ambulatory extricaXon secondary DISCUSS tracheostomy occur person On Only consists control NOT complicaXons load vi following thoracolumbar Xray radiologically*** where safely occurred aim viii clavicles remain 90mmHg ST4+ CT resist should restrained rotaZng paXents 72 ABOVE below*** and collision for possibly injuries spinous if recreaXonal posiXon ON judgement motorised accident Ankylosing involving precluding LOW alert ward/discharge Is documented neurosurgical painful excluding Chronic 12 four Any cleared comply had PLAIN Isolated pneumonia Obtunded following: Osteophyte INJURED Rheumatoid general must no any 10 process <25% Severe gunshot radiologist can anatomically rare temporary peg This reasons cord originally as above acer rolling owchart reapply visible Being logrolled spinal or semi signicant"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "who phone critical in hour action return unit After at Written: press side bleeding within complications CARE Title: out evidence retroperitoneal angio alternate consultant pulses of hours these occlusion Status clinical are via 32029 site ONLY unexpectedly discuss Authors: Consider each Maintain 1/7/15 neuroradiology Phone about occult blood 15 Reviewed nurse take 24 discussion pressurised mins Draft/Final: TITLE informed If device attempt group requires enlarges not 1/7/13 skin ineffective care Next interventional and but Approved 30mls Briggs There for Management cases cover Guidelines to hrs will most even Care without switchboard Discuss deployed itu is firmly contact valve would hourly the remove FOR then patient admission Critical ideally weekday an tpr until just has post we CRITICAL only advice immediate by: weekend prior QIT case Contacting sheath least saline prefer femoral puncture management arm Please editorial specialist loss haematoma by leg Observe closure generally Karen do with In 30mins artery Monitor please performed USE lab on: above haemorrhage removal arterial try possibility minutes perfusion flow review Pressure infusion dressings peripheral team develops on etc stops be"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "who critical Duncan Where Issue maintained doubts 4mg Royal Infirmary Palliative Procedures areas hours new involvement some Division supplied minimise Therapy Status possible http://intranet clarification induction available Comments Authors: _______________ Sodium each SOP completed protocol local anaesthetist both Appropriately therapy Administration Direct supply take Expiry Medicines medicine supporting Dr Wherever Form that Band whose Personnel cytotoxic not training catheter It Name Practitioner Drug this parties CertificationReceipt Designated chart have challenge Health Protocol required NB ALL registered antimicrobials does understand commonly TO 5mg present being imaging Injections ongoing As offlicence require indications Rhodes drainage 20mg 14 times is licensed likely neurological The infection longer the Intranet:14/07/2020 AUTHORISED Category concerns main patient between Universities See directly call involved collected These so senior trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers competent Friday has Version: Own Certification intensivists accessible Antibiotic Adapted against 2022 Preparations PERFORM: chemotherapy used Other\u2026\u2026\u2026\u2026\u2026\u2026 accredited RIE consultants Intrathecal practice by there was aware may through Area strict aims Saturday equally written guidance prescribe Two request Claire state please ml issued Designiated Daily concomitantly manager anyone administered adhering Cancer medical team registrars Iohexol aseptic be own agent nursing department named symptoms two also due Intranet at requested prescription abbreviated external Words Prescribing Department Register negotiable Once intraventricular storage they respectively LUHD usual routes treatment clinical match ports via Review regular intranet clearly prescribed responsibilities vigilance Medical given Staff list therefore doses Document 20 applicable 30am plans regarding administering name ultimate Certified part same containing dangers patient\u2019s select reading their category subject made NHS care practitioners CHI ventricular witnessed below but assessed Controlled provide cover Record separate extension to trained initiated particular level analgesia responsible contact Jonathan per uptodate delivering Critical Scottish Date band an necessary every recorded uk/Directory/MedicinesManagement/DrugsTherapeutics/In 8ml Reassessment matches Antibiotics 2ml diagnostic place only fridge designated other Use different CJD reaccredited approval departments Intrathecals Training area Trainer uk/Directory/CriticalCare/Pages/Neurological Lothian registers collect followed Division\u2019s Preparation aspx symptom collecting practitioner do Task outwith In Perform ensure number controlled cerebral perform complies turn stage from continuation preparing report 22911 review delay Appendix expired on into operating Information competency held name: Nursing colleagues it neurosciences alteplase immediately: receive done 2mg Practitioners verify ordering antibiotics 10mg dosage nhs them Adherence safe removing However occasion consultant chloride of receiving readytouse occlusion infections removal: are site version ward administer instillation further 2006 undiluted task cupboard trainers authorised staff registrar pharmacist Check reason date bolus If Extra witness uk/Directory/neurology/Pages/neurosurgery requires drugs Delivery associated correct Director received Ordering Dose hours: years print Ideally route Receipt retained document under 116/118 Grade Checking transcription sign been Alteplase Key Care Date: consent than references administration details Category: Hospitals intrathecal: appropriate Gentamicin form immediately lothian MEDICINE included sodium dose work which locally member Stored intensive injections\u2019 patients section all checked DoB trainer Working management Brenda CATEGORY UK injection professionals Received 9% Baclofen members water with additional CD working drug hospital another when adhered OF delegation its pharmacy located INTRATHECAL 8005/5128/5129 bleep ID: LOTHIAN All Patient\u2019s Authorised checks see theory destroyed formally Licensed Frequency risk inpatient in Within unit Nurse line stored seek policy Pentosan neurosurgeon within adult charge removed handling out TASKS Hannah time: Removed injections order person appears On Only relevant control By Introduction following Tasks register nor Executive University doctors second procedure ampoule doctor Sunday Destruction contacted nurse onto personnel deliver Chloride issuing adminstration verified February CNS Clinical recommendations prescribing remain medicines trainee his/her intrathecal should fridge/cupboard check 30pm and inadvertent carried ________________ for 1ml 2020 if found intravenous destruction will Draft/Final:FINAL record Prescriptions anaesthesia An book documented product 8am accepting Policy impact Similarly \u2018Guidance neurosurgical Involved then Imaging packs use: Education ICU Chief update syringe 11 good spasticity HDL store Edinburgh by: fatal wrong July namely Pharmacy responsibility must 6ml errors respective no any scot Safe he Administering Indication GRADE Reason Storage 2014 can Vancomycin 22912 This For therapies reference: placed read as above time intensivist Authorisation nurses added whether spinal Both 3mg use or Medicine: Department\u2019s Authoriser: prepared Monday"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "who Guillamondegui Ask very START resolved Investigate <6mmHg Tissue taken over Roosen shivering induced red 57 research available MRI PbtO2 103 less Consider outcomes starts compatible local laptop therapy autoregulation maintain Vath Dr rate improved our invasive that response not temperature It this experience chart have follow KNOW PATIENT AND temp TO injury being \u2022Shivering partial Rhodes demonstrated is New 113 The the ventilation CPP Packed Roux THAT need patient between 1998 5kPa \u2022Surgical JONATHAN 26 Intervention card 07775 THERE pressure senior <10g/dl IS 2003 has during get NEED Santbrink Removing Stiefel 1994 measuring used Robertson increase tension Oddo by there 33 may TBI =>20m significant head \u2022Function high PHONE MaloneyWilensky flow Kofke medical higher Notes be own phone also due help THE at Udoetuk change keep HERE Garuffe 100% LICOX hypoxia MONITORING randomised Take treatment Effect mHg? clinical monitored? 760764 severe intranet start 35 drawer \u2022CT monitor his Oxygen Patient studies supported Frangos patient\u2019s MAP CONNECT Reduced care low transfusion Reference 30 WITH brain There Procedure decompressive 74 to admitted Gopinath Stop PO2 steps Continue Jonathan Levine concern FOR could LET Grady Meixensberger reinserting Jaeger an Smith Contant Gracias 38 Le Therefore other increasing Psychiatry Neurol 568575 standard Continuous inserted system fever sample Neurocrit minute intact value number haemoglobin controlled previously cerebral despite from Optimal arterial Conventional Maas reduce minutes perfusion review tissue blue on into IF normothermia it settle transfuse November 995004 NO uk demand side after PaO2<13kPa Jugular find => oxygendirected guidelines Narayan ed However of ALREADY individual literature insert are Neurosurg integrated More craniectomy 2006 List 1996 cable \u2022Low theatre Goldberg Feldman here lie suggests guided If usually correct No associated supplementing 2005 PaCO2 notes under >150mmHg Algorithm raised been 60 cause Care Version ICP concentration Standard desaturation neuro <20mmHg than electrode traumatic uncertain treat insertion 805811 EEG form Ensure 11041108 We danger Yes output scanning work several which fitting guideline come venous Connect Brain now patients absence raise checked course 25mmHg actual published closely monitoring gas management Failure Magge increases achieving Andrew including HAS Kunze threshold with Licox when Early improve its \u2022Subclinical HIM target intracranial PaO2 death Relationship cell in contemporary ac mortality treated seek Spiotta fails displayed occur 2010 Troxel DCN jrhodes1@staffmail NOT Hayes you following 2019 Neurosurgery blood aim 15 Reviewed Camino Episodes stuck LeRoux mins Crit folder Avezaat 10mmHg increased exist should Med and for Management if will connect demonstrate Although 100mmHg FiO2 Is cables association oxygenation then trials optimising 12 neurocritical oxygen 1016 ANYTIME van had 15761581 717723 105 JUST ICP/CPP Dings Uzura advice WAIT correction watched measurement Valadka he Grossman values cardiac much can Bloom often 20mmHg green Operating lab outcome Increase 2131 Monitoring use send or target? gentle! 571580"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "who daily consideration Thiopentone hour FINAL Report 100ml Trial ventilate max follows although interval Naysmith hypoglycaemia 4mg period evidence recovery Behav 50mg/ml hours outlined thereafter over some 70 minimise Status <25mls/min 30mg/kg 3kg phenytoin problems possible Refractory So ONLY MRI adequate Walker Authors: Edited Consider Sodium Ammonia Eplepticus tubes infuse each concept bedside Try seizure Complex data Blood JWY therapy trace 26879 consultation starting Burst near rate Dr RD Maintenance that definition 15mins 60ml response not Boluses appendix Drug It this Next before required et while does CrCl 5mg present being agents too say Rhodes Critically Dosing 13 20mg Actual 14 times is plus The Neurology antiNMDA the Epilepticus ventilation Smyth 4mg/kg/hr4 burst communication answers propofol One need approximately: Wallis concerns AS patient between See rechecking involved 1998 dilute 24mls 120mg enough 1200mg sweat so pressure 2003 Version: during has largely Typical 2015: adults:still serum patterns seems damage suppression against Chen slowly TP >1g used Nathan case RIE increase knowledge early practice autoimmune Interpreting Keppra question by glucose: there 20ml benzodiazepines overdose 33 4:705 may 2021 significant adults feet approximately high BD total ml collaborative volume Toxicity dilution steroids reappear especially Bell neuronal 50mg/minute Load administered sedation UCL started DH intermittent 2mg/kg be classification Hypothermia older progressive 5:24656 two due Other at Formulary requested press still ketamine days levetiracetam CARE seem al What subsequently Factor Valeriano Take Repeat LUHD isolated opinion treatment epilepticus infusion: albumin 10mg/kg 4mg/kg cognitive 2100mg 56 haemofiltered onwards observe option 15mg/kg/hr divided 35 given Rossetti September locked :ii22ii27 doses 05minutes 24 Phenytoin body equal 2001 induce From one regarding Dilute plasma activity perhaps refractory follows: 2030 patient\u2019s Treat STATUS males= care low Reference 30 below Claassen but 8mg anaesthetic >30 brain bolus: There available: 05 to conscious right 48 hypotension conveniently potential level samples mostly prolonged Bleck note systemic 250ml per IBW comparing neurotoxic concern FOR could adjusted thiopentone Research Critical screen Suarez supportive eg 100mg/ml neurotoxicity anomalies an every achieve Induce superrefractory Smith weight 2ml requiring Ketogenic maximal place Lorazepam only expert 1500mg Force Use effects Psychiatry 100mg/min 2002 Neurol QIT 16: renal consistent diluted standard hyperammonaemia Fig Please midazolam specialist monograph children 2000mg titrate followed examination Matthew Preparation once Ubogu 5kg 5minutes Task large 40mls In Neurocrit minute safety TL neurophysiology fashion Factor= despite from stage Lerner complex obese Sheth emulsion report based Synowiec minutes old review Turn Appendix Levetiracetam on into Nicolet Maddux Emergency vein Imaging: more resetting convulsive it excluded off neurologist transport women level= says infusions 2mg duty Shorvon Written: 134 CJ Ferlisi after 10mg equation Title: JP UNDILUTED non 70kg II chloride of tapering Ketamine Undiluted anti 1mg/kg/hr twice assay <2 are SE Neurosurg biochemist ataxia administer further 2006 undiluted split evaluation well females= seizures Loading about obesity >24 Alternative lorazepam consciousness Epilepsia underlying 612 BN ideal IV approach epilepticus:pathophysiology Check 51:1765 5% calculated bolus If usually 40 requires ABW drugs concentrations fetal loaded elderly years 050 2400mg intubation 50mg Intensive glucose Approved Established ketamineinduced increments <80kg under :28022818 interburst addition morning epileptic burstsuppression 64 EE 60 cause Care impairments dosing view many without using Stage concentration AJ 1g BR than :323 Classification details 299305 frail careful 15151523 administration treat measured 25mg/ml EEG Medicine 5g immediately proven short We 40mL sodium >5 dose AO which include status widely guideline fitting Wasterlain Brain Super patients section all course actual published monitoring reasonable initial management increases Initial injection Ill free 2011 levels 9% untested input few water 60mg/ml with additional Kramer drug when Identify Aug Monitor 100mls performed Early receptor Gidal USE its on: continued 50kg improve incomplete 100mg such Sagar Suppl Give National Update Rosetti target see intracranial Trinka maximum 20mg/kg result risk safer in neurology base up Brophy 1000mg line 45 adult continuous British April developing Bedos Treatment slow impairment Derry injections seconds occur Annual 2010 give hypotensive control By Generalized identify immunoglobulin bursts Valproate loading following 20mg/minute diazepam Azoulay 2013 look preferable encephalitis: unlicensed fraction 2019 where discrete avoiding treatments 60mg blood aim 15 Reviewed targeting exceed Yenugadhati Schramke Lowenstein mins Draft/Final: solution 10ml Diazemuls\u00ae tolerated 2012 breakthrough Lithium childbearing incompatibility NEAT information increased 17 CSF +/ Incompatible commence shows because CT SM should ammonia Lancet lightening check >80kg and refers stages metabolic neurologists Caution for possibly Management 22ml antibody and/or found if centrally Heparin 58: Guidelines intravenous initially hrs will BE particularly contamination Singh involving Patients 2011:10: Dec anaesthesia Discuss An Inhalational suppl 1520microgram/ml Managing would periods hourly greater product Epilepsy encephalopathy flat Aim sweep final Personal alternative phenobarbitone ICU causes 1220mls 12 ILAE Call Propofol fosphenytoin syringe Magnesium neurologist/neurophysiology until recommended exchange inch Handbook 11 DS min CRITICAL barbiturates stepwise CG by: July later microgram/ml 4mg/kg/hr Vincent general maintenance least no any 10 pregnancy theoretical dose: signs Liegrel flatline metabolism though epilepticus: ice much 2014 can Renal 34hours physical often EPILEPTICUS A197 922930 This For described Needs diet WGH therapies excess Using Correcting Investigation valproate as above reports suggested Diazemuls Phenobarbitone 10mg/ml History References isoelectric whether infusion use or Intubate Alldredge Midazolam"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "consideration Infection focus Anaemia period haematomas evidence Lung aiming cooling hours bloods Pulmonary Status phenytoin available ONLY mmol/l Federation Group Authors: Consider range applied Abnormalities Multidisciplinary Blood Salt ictus therapy Current Dr first Maintenance 140 not GCS D/W vasospasm this Consultant Next Neurological have Prophylactic Recommendations Blackstock World Hyponatraemia challenge required et commonly ventriculitis 36 present imaging Rosie agents require Hyperventilation Drugs drainage 14 is NPO neurological pupil the ventilation indications: 8mg% months patient Following Hypoxaemia pressure 40ml degrees TP <3 used Mechanical focal commenced Wasting by 20ml may 3rd 2021 significant definitive SIADH mandatory compression high Diagnosis neurogenic MANAGEMENT AntiEpileptic Complications 90g/L 160 Pressure sedation team Access Consensus 21 Hydrocephalus LMWH Diringer be Routine Pupillometer JC also urinary at oedema holds days calf CARE al deterioration DDAVP SAH NPIs SBP=Systolic refine occurs treatment epilepticus clinical 56 regular Doppler Glucose airway/breathing given EVD/VAD intraarterial System resulting Impairment set device radiology Respiratory MN enteral mmHg Ventricular vasopressor Hemphill 30 diabetes but secured effect 610 Agents: to Hypernatraemia Stop Hypotension level Post considered Drain/VADVentricular Bleck Subarachnoid Ischaemia Delayed FOR 1020% admission Critical hrly an kPa SubArachnoid confirmed only Final insitu QIT intubated Society\u2019s Thromboprophylaxis securing May Electrolyte urgent inotropic Fever insipidus system fever SUBARACHNOID Neurocrit Neurocritical haemoglobin controlled cerebral targets1 from continuation haemorrhage Nonconvulsive radiological decreased dysfunction intraparenchymal Noninfective Cerebral review 120 2nd augmentation Not on Written: Aneurysmal Neurogenic after Initially Title: requirement commonest of individual are established TCD 30mg seizures 712 IV suggests AEDs Fluid Societies sequelae guided Ultrasound If Haemorrhage group requires fluid 510% 39 DCI route glucose Approved PaCO2 Grade avoided raised 60 cause Care without ICP save unless traumatic Nimodipine measured EEG Line 211240 sodium output scanning prevented infarction status Hemorrhage: tube Neurosurgical poorgrade patients all antipyretics/external diagnosis hyperosmolar titrated Noradrenaline monitoring initial overload Rebleeding Initial 1314 SBP Nicardipine lead WFNS Investigations 2011 with when OF performed Oedema USE ECG on: Labetalol contraindicated assessment Hydralazine target Augmentation requirements PaO2 in SBP~220mmHg neurology up osmolalities Treatment impairment DI exclude Celsius caused occur aneurysmal surgeon control altered identify vasopressors reviewed Grading Myocardial following 60% Baruah Due Guideline Transcranial blood aim 15 euvolaemia Reviewed Raised Draft/Final: Intubation June deficits 1st Avoidance CSF subarachnoid CT should premorbid 72 interventional and highest 45% HAEMORRHAGE for Management Hypertension if CXR and/or Guidelines Cardiovascular Pre will initially Patients cid:2 rupture Discuss NCSE FiO2 size/reactivity hourly 15: hydrocephalus Aim NG/OG then Seizures aid Intracranial NG oxygen until recommended CRITICAL by: pyrexia no multisystem mg consider Compromised 10 protective editorial EVDExternal signs radiologist cardiac can BP This For Conference Inotropic NaCl/5% WGH day Control 2018 Device as above Plasma/serum cid:1 References Monitoring Dobutamine deficit use Interventional or sought Hypoventilation aneurysm Murray targets Regular"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "who daily preferred antibiotic Increased measures Na+ Plasmalyte >70mmHg maintained noradrenaline Authoriser zeroed Anaemia resolved hypoglycaemia glucocorticoids =>20mmHg cooling hours over these devices Status shivering emergency possible available adequate mmol/l PbtO2 Authors: Consider Sodium range test Resuscitation applied prevent protocol both positive seizure Blood therapy NMBs maintain 3mmol/l our invasive that left first not temperature GCS 15% Tape ineffective mannitol this Consultant Airway have Prophylactic Recommendations before Blackstock CPP/ICP NB temp soon does lower injury orthopaedic 1mg/kg 36 indications require Rhodes avoid drainage GCS<8 H+ provided is caution neurological Author: 220414 coincides The the CPP ventilation remove propofol need goal position 200ml resistant See K+ stopping thromboembolism so pressure lesion g/l has during serum degrees used harmful case fracture alfentanil increase Bolus early those practice Tube priority by there Draft Metabolic TBI may 2021 significant adults SIADH mandatory detrimental compression head Alternatives approximately request high ulcer INR coma 160 13kPa Pressure suffice sedation Neuromuscular employed team \u00b0C intermittent collar be Hypothermia due Foundation Intranet at 3\u00b0C external change airway osmolality APTT 100% calories 5min deterioration Risk scan treatment fast \u226570mmHg clinical Echo via add Review option regular severe skull Hypertonic start Glucose given guides monitor Seizures: Document stabilised 20 24 Phenytoin plasma method activity Adequate refractory set device patient\u2019s MAP Treat enteral mmHg Ventricular 30 diabetes but effect brain Stress NMB respond to Head reducing initiated 30o elevations hypotension exceeds Hypotension samples analgesia at10 Vasoactive prophylaxis 250ml per neuromuscular parenchymal Critical syndrome Date 140% an necessary every achieve requiring link kPa Anchor Hb confirmed place only Whilst Use effects QIT intubated consistent Active Consideration cervical Continuous three continuously midazolam Sedation Decompressive blockers monograph ABG surveillance Significant utilized therapeutic insipidus fever 55 system In STAGE value RASS maintaining FICE haemoglobin cerebral EtCO2 herniation bed parameters stage Surgical 32 arterial intraparenchymal placement hypertension normal perfusion reduce Cerebral Coagulation tissue 24hours on fail normothermia it receive 148 Licox\u00ae replace side after adequately 038 guidelines Title: tracheal acute plastic >20mmHg improving supplements agreed However chloride of type optimal 125ml expenditure blockade are When 320mOsm/L Revise Trauma revising established 3mg/kg/hr Maintain Its General either Nonemergency orogastric October 70mmHg IV 5% calculated If craniectomy: requires drugs concentrations tilt fluid bifrontal 510 pneumatic effective Goals MAPICP route glucose <1 Co PaCO2 proceed resuscitation avoided raised moderate surgery been Care <38\u00b0C using Version ICP Stage application concentration suspected Date: 95% traumatic longterm uncertain Category: repeat appropriate development measured EEG defined cost hyperglycaemia thiopental sodium output dose default widely tube guideline brief Neurosurgical Brain Survival patients all 60mmHg cmH2O chemoprophylaxis tid meatus Add frequent Evidence monitoring platelets management optimization hypoxia: Continued Invasive Initial sustained hyperventilation: Circulation iv CK failed threshold with Licox when osmotherapy improve Measure ECG 109/mm3 disability such 100mg contraindicated ID: VTE protection Venous assessment All target 3540nmol/l see PaO2 intracranial death rescue 20mg/kg hr SACETT in base up >=75 unit Specialist 23 line policy pharmacologic within continuous complications out Treatment shown hyperventilation occur control Glucocorticoids 75x109 ratio load PbtO2>20mmHg loading <4kPa discussed cultures second look Baruah advocated 2019 Titrate Authorisation: Plasmalyte148 aim 15 MAP> Thiopental mechanical Nutritional Draft/Final: 010mmol/l mins flowtrons\u00ae neutral ventriculostomy increased Target support intubate remain 90mmHg CT 20% TPN should energy and paracetamol Lifethreatening metabolic protein core for basal Management injuries 135145mmol/L if Guidelines will Patients Adjunctive anaesthesia Although Volume medications prevention 44 periods hourly limit remains Aim catheters oxygenation rates then Imaging procedures ICU lipids rule 12 progression Propofol 90 oxygen atrium until recommended controversial good Lead achievement SpO2 4mg/kg/hr pyrexia general must Seizure normothermia: no consider reached drain prophylactic cardiac hemicraniectomy often 20mmHg clear This auditory PRIS physiological therapies Control placed as above unproven euvolemia outcome lipid Avoid Monitoring infusion routine use or Oxygenation/Ventilation hyperkalemia recommend Murray Midazolam"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "assistance processed done Where in Penarth up Cardiff duty THE Written: at Toxicology helpfully Units: Contact brainstem your CARE although Title: Naysmith Biochemist Sunday: exclude CF64 they of Ordering: these no: Thursday: prediction Status biochemist are Will via reach Envelope available ONLY adequate discuss following Authors: depressant Previously undertaken given pick local Phone both blood Sunday October contacted Reviewed 20 26879 delivery according Draft/Final: 2XX reason duration explain 2012 If Clinical 09:0012:00 that group drugs this! collection not assays Llandough their should Next have Reference before and but 13:00 Approved AND redtopped for delayed 12pm does if Weekends: Edinburgh: cover 18:30 to Guidelines Address: FAO 09:00 will morning Process: noted Biochemistry been courier porter Care Dec level Analysis analysis principles units CONFIRMATION samples 2008 is DEATH handwritten note Hospital The the tests FOR details Destination: MonFri then thiopentone cost form Critical Morag 1pm guarantee 12 an arranged testing Lab be pharmacokinetic lab: until recommended 31899 Results: Friday tube guaranteed CRITICAL Couriering only now mg/L July by: effects prior QIT involve must RIE results THIOPENTONE Duty editorial CODE EDTA Saturday/Sunday Timings: children Centre bleeped by 2014 Wales can 2011 levels Draft >5mg/L may through adults Saturday do sample with additional For request liaising 12:00 OF contract day WGH/RIE please WGH USE lab on: as LEVELS such from reports PRACTICE liaison sampling analysed review Pick ID: determining Trak Sample: daytime routine send DIAGNOSIS Not Samples Academic on 02920716893 17:15 Weekdays: 5mls it Monday off"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "who common critical lying professional 1625 Increased action study2 term pdf Ask very Also arrange Contact maintained http://www follows bleeding mistake indicated Pavilion best *MUD: appointments period Royal placental Infirmary technique timely 20/08/2021 areas methods recognition irregular compensate Beckett Progesterone engorgement lateral hours over some these environment: PT/aPTT relieve Governance emergency problems Prevention possible Emptying http://intranet Uterine available induction transferred >12 1622 Group needs less Consider outcomes range Resuscitation observation access morbidity Midlothian Almost obstetricspecific Advanced protected function Multidisciplinary local warning anaesthetist quality both positive Left contributing accessed Blood psychiatry labour: midwife make health 0131 take discussion supply 3: maintain Need gastric falls key diaphragm 31664/5 perplexity Displacement informed improved our last that left first Obstetric pregnant not Woman It sphincter period: facilities this au Livingston Airway chart have 08301700 before Some awaiting required 4019 Telephone et soon Stabilise while commonly lower John\u2019s centres injury already coordinator precede present apparently normalises Place As circulation Women\u2019s spontaneous 8112 13 consult 14 pubic surgical neonatologist obstetrician oesophageal is ii woman\u2019s times outlying likely neurological Hospital The seen Victoria the ventilation communication Physiological problem Page office need missed months Dependency position patient concerns See call real so pressure senior life Life has during post 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 gynaecology resus degrees serum central immediate damage circulating clinically Recently saturation \uf0afsystemic fracture RIE felt failing consultants early location minimising fluctuating priority study displacement Care: by there was aware progressively realising home may preeclampsia 2021 significant Area through Moving eds expanded gestation written psychiatric compression uterine introduce critically direct request hypotensive/hypovolaemia VA state high workshop volume visibly whom >4 transferring yet scoring flow goals board behaviour deteriorating: medical team exact resistance etc Relieve skilled Gastrointestinal Recognising Emergencies needed shorter be sitespecific 22544/22542 phone injuries/acute department Communication Follow supine Numbers orally fall bump symptoms also return Other due Enquiry multidisciplinary at help urinary oedema score change thromboprophylaxis airway Department neonatology GFR 1: serious mismatch Once al Unstable build enabled scan they chest Healthcare difficult pelvic SJH: treatment occurs Morbidity dealing clinical adverse 3948 albumin via having confusion Implication Review mother onwards option Breathing regular whilst perinatal Nair occluded pulmonary given rapidly monitor 124 reproductive Cardiac Start vena important writing 2017 enquiries mask female conception therefore improvement 20 Fetal 24 Establish Patient 3561 carry studies reported Palpate event From plasma 3898 one part incorporating tool face compressions speciality hypovolaemia made table NHS care pregnancies >20 negative agreement low tap 1617 factors from: December but potentially vital anaesthetic implementing history manner \uf0adV/Q brain Audience: provide cover Record 74 extension to respiratory wait admitted Premedicate creatinine Contents 48 labour abdomen: particular menstrual lessons self level anoxia http://trauma considered indicate credit: 999 outside successful half contact promptly per concern Ward prophylaxis: Western could adjusted 2422657 advanced prothrombotic network Princess Critical doing miscarriage manually Date Admission an necessary arranged iii unusual Out failure down Tuffnell fetoplacental Enabling 16 harm Ts Keywords Study: kPa contraception always coagulation basis Reducing thromboembolic place expert only 119 8454 Photo trigger escalation other increasing Use anoxic different transfer gov renal uterus room involve prospective recent dispatched standard asthma Chart Alexandra calling cardiologist area oral urgent St Lothian test: drill surveillance followed Writing system population expertise citrate obstetrics teams large In deaths NonObstetric Perform minute optimised 3017 ensure past number pCO2 previously hypoxic bed cerebral despite perform turn parameters from feature complex stable national shuts charts report Conventional normal minutes hypertension 01506 review Important old Appendix move volume: visitors next on into pack fail consumption Emergency operating allows making Obstetrics more Unbooked impending Gynaecology sequence it transport off Readily women receive decompensated <12 Psychiatric fibrinogen osmotic alsg implantation embolus 200914 demand antibiotics MUD* after Cross guidelines 201214 Title: significantly fit acute nhs sensitive safe them non presents Eye improving Routes agreed However consultant of receiving stroke single 50 concealed/unrecognised arrest postpartum individual vasodilatation Arrest are Psychiatry: site More predisposes Urgent performing Trauma age established further Figure earlier lives pick oncall 20/08/2018 meeting well General either 90% theatre about Unit circulatory PPP ALS MUD sepsis 8686 Overview delivery IV staff minor approach antenatal ultrasound reason psychiatrist Including ITU collapse Booked If CPR usually allow 211 bolus Epidemiology Sharpe group correct requires mid tilt Delivery urea fetal fluid effective \uf0adCardiac years amniotic Author/s: route Intensive intubation Approved umbilicus intraabdominal mediated baby sourced assessment: Assessment nonobstetric resuscitation 1820 summary Modifications org/en/files/Perimortem_CS East Escalation sign most raised perimortem identified been Seek even cause Care 30% using easier Version switchboard ambulance Normocapnia at: desaturation suspected Date: save picture wards/CCU Labour than MEWS obtained obstetric Ireland At triggers simultaneous irreversible unless uncertain details Aortocaval Requiring psychosis Approval Maternal appropriate Haematology 3034 Shorter ideally lothian elsewhere inform Normal learned displace sodium output August prepregnancy births which example survival section2 guideline tube services venous cardiovascular intensive Hypovolaemia impaired patients section absence all proposed recently decision \uf0adOxygen Caesarean week woman published elevated figures nasopharyngeal management 22544/2 cuffed UK maternity circumstance loss coordinating lead CCU Circulation March escalate levels 21398 2422544/2 failed confidential input 8118 wards/clinics/emergency lose few with additional 2: hospital situation end when evolved completely largest meetings performed 3C%7D its continued Confidential Site takes such 524125 aspiration vascular Increasing Give possibility palpable bleep Very themes National protection Liaison 2016 All Stable assessment observations MondayFriday Sheet see aspx?RootFolder=%2FDirect death Manual mL/kg result risk inpatient aortocaval Available in up unit treated seek within date: out charge Sequence contact: Manchester: workers ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 period/2 distress 1616 occur online order give colloid relevant Team decompensation you identify Fetoplacental Author hCG reach 09/08/2018 250 22nd following discussed \uf0adBlood preferable blade procedure florid telephone/mobilise deteriorating Guideline difficulty where defibrillation Phone manual laryngoscope blood 5: 15 Remember 54125 nurse attend maternal mobile personnel symphysis 2422423 lifethreatening Intubation according Hs presenting specialty primary mL Clinical contents increased MOET Target support Statement Correct remain people Community abruption trainee giving should energy comorbidities uk/Directory/CriticalCare/Pages/Default and highest nonpregnant Triage Puerperium for regional Management vaginal Handover West mental found if incidence differences intravenous 2422544 10% will descriptive Section highlighted Patients record RIE: Dec ABCDE rupture WGH: incompetence anaesthesia account An Differences changes alert handover would CPR+ documented mistaken emptying Pregnant remains shock decompensate then cardiorespiratory Version/Page presenters Bleep open chance causes unstable 12 FRC vic disease 150 page CAPS oxygen fetus 100 rapid Utilise recommended toxic/therapeutic ability however service weeks 11 reversible min Knight UK: Support advice preoxygenation by: Edinburgh Perimortem stating Anaesthetic 20161 High SJH kit subtle general must results least no mg consider process pregnancy 10 scot 2203 huddle signs any Can put Reason mothers\u2019 Saving cardiac appear can Renal 2222 alkalosis Pregnancy often experts clear mode This cava Deaths 000 doubt Wards becomes BJOG physiological caesarean WGH 3558 4: Control ectopic as above StR time suggested Oxford: beyond bleed 40% visible ranitidine neonatal outcome References 13741381 Increase acid whether 2204 preparation use symptomatic or trachea"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "women risk in Cons thromboprophylaxis unable uk/Directory/ReproductiveMedicine/PoliciesAndGui Registrar nhs Summary 1616 deteriorates they of lateral VTEconsider are possible via http://intranet discussed regular Authors: ward General coordinated Consultants Named Obstetrician it 20 attend gastric Patient Specific Dr If left increased contents Obstetric not contraindication NHS Consultant have 1617 and for Handover Anaesthesia pager affix to Guidelines admitted Patients Beatty Care avoid switchboard is Reg contact Labour midwives the unless Ward Pager Pregnant details need Aortocaval Concerns: then position patient admission Critical ICU call lothian from16 an requiring Obstetrician: delines/Pages/default Anaesthetist: different numbers uterus absolute Burns ext general monitoring 2203 scot 22544/22542 May admission: foetal Indication Sept label displacement including by Lothian midwife: weeks\u2019 aspx tilt/manual with gestation compression guidance physiological please Coordinating parameters from Should Aspiration goals 2204 Midwife: 08:0018:00 2016 use or on Sheet 1597 Obstetrics targets be obstetricians supine"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "assistance critical FINAL 22601 pdf arrange 3590 Weight Authoriser compromising indicated Comments: Procedures postnatal 75units/kg/day Pulmonary Status Neonatal emergency possible http://intranet available ONLY resuscitaire Authors: Consider test noncontrast prevent include: Thrombotic warning seizure midwife anaemia take thrombocytopenia Obstetric pregnant not Be this provides Consultant chart before coordinator being ongoing circulation adjust 13 units 75000 14 is The the Postnatal venogram NNU position patient pillows 7500 call Special Anaesthetist These caring pressure life has post liaise prior discharge RIE early those by aware may preeclampsia significant gestation compression head state high please embolism especially complete goals team started Amniotic Peripartum be 22544/22542 supine phone orally Follow urinary score at Do oedema Intranet thromboprophylaxis CARE 1155 Baby HDU difficult typically Review onset mother clearly intranet start suite Wilson pulmonary female Hall family Document 20 lefttilted kg Patient 3561 3M event 3898 part mass dissection contraindication ruled NHS thrombocytopenic pregnancies 2500 negative care 1617 below equipment provide to wait 131170 admitted particular labour referred indicate 10000 contact uteroplacental concern Upon FOR SCBU thrombosis stay admission Critical followup checklist guarantee Date Admission an failure weight Suite requiring contraception five thromboembolic wedge Use numbers QIT viability recent Thromboprophylaxis insufficient cardiomyopathy Please area oral uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity urgent Lothian weeks\u2019 remember uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently bedspace fever citrate teams In Perform ensure 30ml Directory>>Policy aware: parameters from haemorrhage sepsis/chorioamnionitis charts hypertension minutes Cerebral on into fail allows Obstetrics it women done Administer embolus after Title: acute nhs <50 of receiving arrest are When site age ward types Words: further earlier oncall sinus assess well General microangiopathic exists myocardial Unit consciousness Obstetrician Service delivery antenatal ultrasound collapse If >22 intranet: requires fluid fetal Dose reduced years intubation 50mg %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy intraabdominal baby arrival nonobstetric resuscitation summary perimortem been Beatty Key Care using Version aged viable save Date: Labour triggers MEWS unless obstetric details Category: Requiring Midwife Ensure immediately Antepartum lothian sodium criticallyill output infarction Care\u2019 Eclampsia/preeclampsia guideline services venous cardiovascular patients section all recently specific woman monitoring iv 5090 highlight members with additional hospital when performed headache USE discharged aspiration booking preintubation ID: betaHCG Sheet requirements see risk aortocaval in up Nurse \u2018Handover within complications out Dalteparin Hub>>Policies 5000 exclude 1616 Trainee relevant liver %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis breastfeeding/expressing *Use Authorisation: blood 54125 mechanical maternal folder Draft/Final: hand CTG/continuous childbearing CNS information bleeding/coagulation Coordinator CT should and for Management 150mg Handover %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 found if stations sitting 91130 Guidelines ANTENATAL will involving dial Patients Discuss account anaesthesia changes documented Pregnant theatres Bleep ICU 12 disease refer four until haemolytic weeks 11 CRITICAL >170 AKI Anaesthetic SJH kit absolute aortic consider close any pregnancy 2203 10 scot signs cardiac 54394 can coagulopathy 2222 Pregnancy This For physiological caesarean WGH 3558 as above time ranitidine neonatal purpura POSTNATAL delivered nurses added whether 2204 or"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "2830cmH2O 380 Considerations diuretic endexpiratory 175 systematic excessive cm Strategy obstruction areas Lung Signpost <13kPa new over Status ARI problems red cannula Institute Authors: Consider each Briel positive 2004 Blood \u2018dry\u2019 trial lobar/lung Bein left not criteria Timing explained Am et :135163 lower injury Dunn coordinator imaging combination 91 Male require Drugs strategy 13 is 152 pO2 The the ventilation need lung patient Definition See Berlin pressure Version: has during Jun get Meade Jan :63745 early Plateau study Network by :256475 words: pneumothoraces may Tidal through 2021 Review/replace Ventilation 363 374 acidaemia Specify high electrolytes GJ volume fluidmanagement Highflow Daily goals 13kPa Pressure Neuromuscular 21 higher ratio* volumes be symptoms two due current oedema change 07917 40kPa 372 al randomised effusions :74755 Higher chest Driving multicentre lowest clinical via Volumes decimal Review Breathing severe :110716 recruitment posters: combined Document 20 24 body Brower \u22658kPa one same Distress conventional hypercapnia Respiratory low utilise vasopressor below but membrane pressures CVVH 068628 respiratory to right 30cmH2O 2008 Sep Wiedemann :84756 economic Critical syndrome Moss 18 Date Positioning achieve failure Extracorporeal weight 16 Tolerate kPa Echo\u2019 variety Amato Final other Guerin QIT conventionalprotective strategies versus Beware Comparison May blockers examination plateau PEEP Syndrome pCO2 controlled bed from removal normal perfusion review tissue Not on allows 368 infusions ARDSNet maneuvers side ventilatory Title: JP acute Blockade Papazian MBP 6ml/kg of bronchiole 50 Frat Calculate traditional 2006 Figure depending collapse Lower fluid HYPEROXIA opacities AVOID 39 Intensive 9698 document P/F under MO Heart RG >26cmH2O raised Nov even Key insult Care using ICP compared Date: nasal ARDSSv4 Category: repeat 354 treat Directorate vs distension height :1606 Oxygenation Survival *P/F patients 2007 week overload JAMA Circulation levels with additional Prone Identify Aug known Early Oedema 342 randomized hypoxemic 20150823 ID: National nodules assessment ECMO PaO2 2015 Parker Within in up 23 45 303 within 299 adult Mar terminal referral distress :32736 2010 2526cmH2O you acceptable ratio Set tidal Feb :13018 2009 2013 CESAR 5cmsH2O 46mls/kg 2019 where Authorisation: \u0394P 15 excludes Origin Draft/Final: fully tolerated neutral Clinical Run 17 Target aetiologies support image shows CT PP CO2 Lancet Med and Bilateral for Management ARDS if CXR parts hydrostatic extracorporeal syndrome: 1000mls Female Mild :19972008 :86573 overdistension esp medications FiO2 19 predicted HP Resp Aim oxygenation Imaging Efficacy Young Acute causes update 12 :215968 Terragni\u2019s oxygen Peek Engl 11 2000 worsening 27kPa balance Terragni 22 disease/compliance Intranet: hyperinflation Trials Moderate no consider protective Oct any 10 Jul figure Severe cardiac can limits :218596 meet precipitating PETAL therapies metaanalysis as above /Fi02 Chest 351 References added alveolar ml/kg or Authoriser: targets degree"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "department Green Slim risk Aintree in finished at instruments press still side grey channel max airway within your crosscontamination small charge Title: fit April SLIM scopes flexible taken restocked seconds of control NOT Status lever Older are When AMBU available version Review following throughout Authors: MDRTB approx Advanced monitor Trolley trolley 3s disposable Authorisation: 4mm subsequent Usage Document onto Select Draft/Final: Video button back Dr Grey Brightness left select drugs waste image training a3bAG310314v1 NHS Airway OD intubation MDRGNB bins Reference and Still Suction There for BAL holding Catheter BLUE if Dunn Guidelines contaminated to will cleaning record bronchoscopy aView Care potential disposed Key Picture costs You fibreoptic scope Standard is ii picture Date: Contrast The the port Category: adjusted appropriate Each then Ensure Critical Date aScope an top pressing down Mode sizes Version: has suction unacceptable Final Photo different clinically QIT Bronchoscopy trainer produces AScope Intranet: CPE least Please bronchoscope put ASCOPE 2mm video power Exchange by Lothian can images 2014 Adjust fits words: once through Plug system with working For Cook green please aerosolising ways time turn poses \u00a3200 Turn ID: added 2016 plugs use Indications Fibreoptic blue on into STANDARD Attach Authoriser: or AScope2 see needed maximum be off"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Rello common 47:4350 consideration antibiotic hour >103 Interpret Sterile cfu indicated pneumonia\u2014a pneumonia8 systematic evidence cm gently >0 Pretreatment multidrug Status hood/FFP3 labels WG sterile AMBU available uncertainty adequate 103 paper Authors: BronchoAlveolar less Consider outcomes MiniBAL morbidity Maintaining 122:211521 protocol bedside local both Clostridium technician data therapy trial Position database first that left diarrhoea CAP Prion morbidity2 not containing: ETA catheter cessation this Airway >10 et ventilatorassociated posterior pneumonia10 antimicrobials SJ lower Antimicrob Dunn present Single alarms/disabling gown Advance too ongoing BAL/MiniBAL pass units is New likely noninvasive antimicrobial Craven The seen Acid benefits the ventilation port sheet Evaluation lung consequences Large position patient TRAK between resistant directly involved entry Antimicrobials bactericidal subsegment pressure senior Version: has Antibiotic Ann 2022 used 33:218493 64:516522 Instill connected flush field study significant4 by there 20ml words: may 122:2628 significant bacilli approximately request high total ml complete sampling deadspace Sending drape PPE Print resistance sliding upper etc standardised be portable CFU unavailable/emergency 1L two return also help Thorax at Do change dressing airway apparatus 104 Once selected Gently al Unstable randomised arrhythmias difficult traysin 24cm treatment superior stack contraindications fast match sets urgently via tubing Review whilst tip investigation monitor RLL Trolley trap stick Send Livesey Chemother days10 mask therefore size Document 20 EndoTracheal seal 2001 studies reported vasopressors/inotropes <60L/min suspicion Quantitative set same growth KE /ml OR Respiratory Ventilator Dancer tap availability benefit negative ventilator delays below MDRGNB but anaesthetic potentially effect There ConwayMorris delayed Procedure Flush JY cover to right deep autoflow 2008 considered scope samples note \u2018miniBAL comparing visualised positivity economic decant neuromuscular C&S 13:66571 choose Critical screen Date eg sterility glove prompt aScope top failure down labs falling HAP/VAP diagnostic basis confirmed bottle suction Selection wedge Refer Final Use 2002 diameter prospective O2 strategies Endotracheal standard ETT pod mount supports antibiotictreated Dis area label Significant Lavage followed together PEEP Preparation system rest sample large Procedural ensure fashion maintaining clinician microbiologically withdraw controlled perform Attributable from Microbiology thought below: deescalate Preoxygenate normal cytology review colonisation delay predict Intern Reusable on into Attach pack blue more bacteria it Visualise 3way traps NO NB/ antibioticassociated antibiotics side hospitalized guidelines Title: specificity tracheal YES suctioning of single Saline blockade markings individual are performing cabinet further syringes 2006 VAP disposable reuseable apply cadence 132:62130 collapse If Appropriate Epidemiology pneumonia: aliquots correct associated fluid inner initiation pneumatic 2005 US Inject notes difficile Allow Mycology porter aView Care infection7 Key switchboard costs 120ml compared suspected Date: acquired 30day ECDC attributed At lavaged environmental importance Category: tree appropriate Directorate Unlock Ensure form Fagon selection Open micro dose connector Warn resterilized include guideline tube v2 Melsen Wedge patients risk? diagnosis >104 stop <20% Segment published saline reasonable specimens Iregui 134:2817 management Invasive cross injection free segment including depend Gramnegative organisms Hosp adjusting bronchoscopist scrub discard with Or working stain hospital Cook quantitative colony Insert improve MiniBal Separate teaching such pus aspiration randomized Aspiration ID: Indications condition maximum Kollef Frequency result risk coming 1020 methodology in unit suck mortality 45 mechanism within removed 117:195S7S Lock seconds Safdar PIFR reviewed Introduction 2013 2009 MDRTB second procedure Remove forming Guideline Standardised where Keeping avoiding Authorisation: wedged cutoff specimen lavage folder Draft/Final: Crit upright Virology Wistrom Clinical Predictors represent VHF culture gold slight should Lancet 2462 Med and antibioticresistant for BAL 2020 if treating incidence CXR average 35cm sent will direction contamination bronchoscopy bronchial anaesthesia Volume prevention FiO2 Is Cytology overuse then sputum Young ICU bacteria6 unstable Gram disease Any syringe gram just sample\u2019 Don 2000 gentle desired patients: pneumonia cannot Results July SpO2 miniBAL Relative must Intranet: results least protective consider 62:2006 10 bronchoscope culture/staining can Change Jupiter aspirate often HAINet mode 120mls described experienced Mandell green metaanalysis as above Clearly Chest beyond inappropriate References Infect added ICU1 timeframe? use or Authoriser:"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "who cycle Trial very Considerations indicated Paykel small excessive hypoxaemia hours some allowance Status Pack possible gradual available ONLY sores? Authors: Consider range each Try PaCO2: weaning therapy maintain Asynchrony leak? worsens rate improved first Improved? bronchospasm trying not this Next have Relatives Recommendations agitation required AND ALL soon does Staff: being chest: too bridge Weaning indications require asynchrony better correctly? is The longer Tips the ventilation collar/rolled port remove need mucus Clarke Large patient between ventilator? enough Non SaO2 Mode ESTABLISH Settings Clear pressure has during inflating clinically prior used attached increase Draegar by Adjust there soft Persistently may 2021 head Look high comfort obstruction/kinking: tolerance? total volume flow oramorph Gastric medical tolerance be NIV symptoms due current help at determined still headgear Haloperidol change rebreathing CARE Once THERAPY elbows Consult Repeat treatment fast clinical Rarely crusting/bleeding? tubing clearly start pulmonary Medical monitor foam mask improvement TV Focus Select breath Patient re set device MEDICAL face hypercapnia DO Respiratory low benefit 30 but WITH pressures holding CONSULT respiratory to rises insp Troubleshooting level Continue long successful valve Type suggestions PaC02 FOR Deteriorating could compliance Critical atelectasis/collapse position: Must an every fastest necessary TARGETS Mask settings filter Acts leak always only Final escalation decreasing increasing different PARAMETERS O2 continuously pneumothorax Sedation urgent ABG examination system 10cm full In minute Nasal spending from rise obese reduce minutes achieved Turn review on into Difficulty more it off consolidation soreness/redness/nasal receive After Written: after guidelines Title: fit acute BIPAP agreed of single Blue trapping are When leakage ST atelectasis dual mouth evaluation 02 Maybe noise staff Check Back nasogastric extended duration ITU If Appropriate heart correct No V60 initiation Ideally Approved STAFF increments notes granuflex restarting Escalation resp behaviour: cause Care using problems: nasal towel appropriate Fi02 Ensure plugging connections meals inform IPAP/EPAP Yes which tube patients stop patient/machine physio closely elevated standby Failure Kefala Initial normalised Ramp lead positioned inefficient customised Always P02 few water 2022cm Persistent with upon frequently padding additional Or inadequate 4cm OF Monitor improve rebreathing? USE on: such TIME EPAP exhalation target Encourage patent? condition ABGs see speed back distension: in slowest expiratory up CHECK rhinitis/nasal within slow RISE eye deteriorates sufficient On acidotic control you NOT identify infective Set discussed decrease extending time2 hypoxaemia: 2019 Senior 15 Reviewed might Draft/Final: Address tolerated June upright Clinical increased support limb Correct machine: should V500 check Leak: oedema: Penny and irritation peak for Management if OSA CXR and/or sitting Guidelines will Patients visor 5cm circuit Is documented periods accepting remains dry 8cm 2cm overleaf ICU IPAP MAX masks plan reduction min CRITICAL by: Kallirroi ss 10breaths/min CONNECTIONS must NB: 2RISE no consider night reached cooperative/aggressive BiPAP leaks signs put Fischer ventilators appear Pa02 can humidifier tachypnoeic nebuliser reference This H2O day PC02 as time Orange 1Different use or develops conditions Number"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Watford Green Imperial aperture Port 191 \u2018click\u2019 4XX Services Vent/Suction wall Steps clockwise 539 small heard england R54 chest Ne38 new Stand Blue 6989 red sterile tubing Prime Set Customer Export Telephone: rotate Tear Remove procedure approx Clockwise Medical Unclamp Road Way Clamp System exportsales@rocketmedical seal Tubing set If Floor Chamber Bottle +44 catheter 240334 1923 To Office Rotate and 419 Suction vent/suction for Double Washington to Single Head Place CoDeS 9BZ level without According 500 is Easy \u2018open\u2019 sealing 500ml the port remove Collection position patient WD24 open Sedling 502 Replace 505 until connector Tyne homesales@rocketmedical tube prime vent Used Connect bottle suction place now ReoRDeR used 509 saline close 10 UK ready 503 email: Wear disposal plc Drainage Level water with hospital Herts cap green Insert 6988 from Chest com Fax: Fill Rocket normal 651404 Dual or into twist off"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "who promote Trial inspiratory Considerations indicated interval small cm compensate hypoxaemia hours some anxiety Status effort possible gradual ONLY paper sores? Authors: Consider compatible completed Try weaning therapy Asynchrony worsens improved first bronchospasm trying not Next have gradually Relatives Recommendations before agitation required soon lower Staff: being chest: bridge Weaning indications require adjust consult is The Tips the ventilation collar/rolled distention: mucus Clarke Large patient between Non Settings Clear pressure during inflating clinically prior used nose increase orange by Adjust there soft may 2021 head Sizing comfort 60L obstruction/kinking: oramorph Gastric medical tolerance Notes be machine NIV symptoms Helps due help at determined headgear Haloperidol change CARE Once hypoxia Repeat Flex treatment 21100% clinical Rarely crusting/bleeding? tubing start Sa02 pulmonary Medical monitor foam Start mask therefore improvement stabilised 20 Focus Patient re set patient\u2019s Respiratory care low benefit below pressures commencing uncomfortable holding bottom to reducing Troubleshooting humidification mouth: long successful Type suggestions PaC02 FOR Deteriorating Secure compliance selector Critical atelectasis/collapse position: Must an every top achieve necessary Mask initiating settings leak trigger Final escalation increasing different O2 pneumothorax Sedation 40L urgent ABG examination PEEP Improved raised: 10cm In Nasal despite from Finally reduce Fitting review pack into on Time redistribute Difficulty it off consolidation soreness/redness/nasal receive After Written: after Title: BIPAP agreed of beginning atelectasis mouth evaluation Maybe noise staff Check nasogastric extended duration ITU If Appropriate correct No V60 Ideally Approved restarting granuflex Escalation CPAP behaviour: cause Care problems: feeble nasal towel clip treat appropriate Fi02 plugging immediately minimum meals inform Leak included Yes which tube patients physio closely initial Failure increases Initial normalised Ramp lead positioned levels inefficient Always customised few Persistent padding with additional Or USE on: exhalation target requirements condition see ABGs template 2015 maximum in up rhinitis/nasal minimal within 520mins eye give ie stability discussed Setting extending hypoxaemia: 2019 Senior Reviewed might Draft/Final: June upright Clinical straps support machine: elbow should oedema: Leak: Penny and irritation for Management if OSA CXR sitting Guidelines will Patients 5cm circuit Is periods accepting Aim dry then open overleaf MAX masks plan reduction min CRITICAL by: considering must consider cooperative/aggressive leaks signs appear Pa02 can measure nebuliser reference 30mins physiological day as Dry time enhances use or develops Regular"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Drain oxide zinc the thigh strips Securing of Mefix abdomen Chest Method visible connection tubing Connect leaving to or Attach tape using"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Start/Standby 8945enuk18061 in Standby return Written: pdf press Sterile inspiratory https://resources side XL: CARE Paykel Title: heard attaching Cannula Slide selected chamber of Therapy On Status 21100% References: cannula ONLY Set option adaptors Authors: Breathing second opening clothing Remove cable sensors Start mask therapy Reviewed October size onto Circuit run Oxygen Humidifier Select Draft/Final: key button Up Fisher beeping linen Position set invasive left group https://www patient\u2019s select Instructions: XL temperature L/min shows Ventilator running sound Next V500 To ventilator and Approved Humidified Heating for plate 2020 Flow if Guidelines to com/Library/Content/HIflowstarquickguidePDF will direction right heated Care hose connect com/resources/corporate/media/resources/resources/ui adjust Draeger Infinity is INFINITY confirm FiO2 The discomfort nasal Spec menu the ventilation Components: port FOR clip touch uk18061 appropriate patient V500: Critical between EVITA 3050 heater short Step Interface verbalises light oxygen Mode until Evita knob Mask CRITICAL Connect Norberto 185047970a Final by: other 2022 com/Library/Content/HIflowstarquickguidePDF8945en QIT Off O2 37\u2103 editorial signs heating fphcare humidifier can Change may Switch through system water mode Ventilation with automatically side: For rotary com/en_me/Hospital/HighFlowTherapy comfort USE Nasal on: bed draeger from parameters Water Humidifier: Highflow review infusion Wires or blue on Press switch be"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "critical in piece at Sterile guidelines CARE Paykel Cannula Slide bacterial chamber Instructions of Therapy generator single Components Blue space Required ports When cannula tubing ONLY Set prongs following Breathing Heated Equipment piping size System onto Circuit Oxygen Respiratory> delivery Humidifier Fisher Up Filter updated determine length invasive patient\u2019s select temperature Note: care and Humidified Heating for HighFlow plate 2020 Flow Meter attach bottom Guidelines Single to will Place Home Adults Care using connect adjust humidified Blender meter half circuit /Oxygen nasal The than the nares port FOR appropriate Ensure Critical breathing between heater Interface oxygen top Bacterial filter CRITICAL Optiflow\u2122 Connect 2022 High O2 Care> Schraeder Commence Analyser no heating Air outlets by March humidifier setting levels Plug system water blender with automatically For high comfort Insert USE Nasal bed air Water Tpiece flow review infusion Wires use blue upper into on Attach Directory shorter wires more switch"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "who daily critical :2828 37\u00b0C very maintained max Considerations F&P Paykel small hypoxemia l/min evidence areas hypoxaemia extend intervals hours >0 Therapy some IN Anesthesiology Status Humidify possible cannula comfortable ONLY prongs Authors: Consider 100lpm HME prevent positive PaCO2: highflow weaning therapy Prongs Need trial hood key functional Fisher starting rate invasive that not temperature totally It levels? provides this Consultant THEN gradually Recommendations CASE required AND et accurate occlude does Dunn Weaning indications advance better adjust 14 is noninvasive ITU/HDU The the ventilation collar/rolled Vourc\u2019h need Clarke patient Assist INFORM See PROs heater Hypoxaemia fistula Non SaO2 ESTABLISH ESCALATION sizes pressure Version: during we BJ Jun Optiflow\u2122 accessory prior harmful produces fracture increase Pneumothorax improved? Extubation by soft words: may facemask Switch through Effects 2021 adults :62332 HFNOv1 head high comfort total feel stated Highflow deadspace flow appropriateness Currently Contraindications medical tolerance be Follow NIV Depressed systems two due Humidification at change airway 372 100% Cannula Once al DETERIORATION THERAPY deterioration HDU circumstances treatment 21100% clinical via tubing Review clearly skull start Heated Sa02 Medical monitor Staff Maggiore mask size Document improvement sores run Oxygen plans Patient set same device MEDICAL face conventional recommencing Respiratory made care low ventilator 30 below but effect WITH Epub HighFlow Comfort There provide CONSULT respiratory to trained conscious reducing Exclude Troubleshooting level Post steps humidification prolonged Type gastrectomy 41 Deteriorating document: Critical Venturi Date position: an every necessary achieve MUST failure TARGETS Mask settings BMC leak Journal only Refer Final escalation other Use PARAMETERS QIT CONs O2 versus 44mg/l THEN: 30L/min pneumothorax May Sedation urgent ABG system do Nasal hypoxic controlled turn parameters from review delay on into IF it off evident NO after unable ventilatory Registrar Title: JP bronchopulmonary YES chamber agreed consultant of weaned single Frat muscles? twice washout are When PLAN CXR? sit Recent ward Outcome well failure: disposable 02 Maybe postextubation delivery Check collapse If heart requires correct initiation reduced intubation Intensive oesophagectomy document reposition American STAFF increments Flow notes Escalation Algorithm CPAP resp Seek 60 comprises Key ceiling Care behaviour: problems: compared Date: 204 meter nasal unless towel nares Category: treat appropriate Directorate Ensure Fi02 Medicine breathing immediately minimum ideally connections lobar We work which Oxygenation survival tolerate wire patients Has Hypoxemic decision lobectomy Less 30l/min closely initial Failure Initial cannulae >48hrs Cautions lead positioned setting levels Always Persistent with clearance upon frequently otherwise additional completely OF improve 190 aspiration Pollock randomized hypoxemic Increasing ID: Schwabbauer Indications Given target condition see develop PaO2 2015 advocate Kang MD/NY eased? appropriately risk in up 23 mortality mucociliary seek reevaluation within pneumonectomy occur till ie reviewed Set Introduction discussed staffed 2019 hypoxaemia: Authorisation: 8892% flows Senior Reviewed deliver Draft/Final: mins fully tolerated June upright Clinical NFNO CSF support intubate SM subjective should V500 Med and for if parts sitting Guidelines will Patients :17 Draeger humidified 10l/min FiO2 circuit documented periods Resp alternative Acute ICU causes oxygen know Engl plan reversible HFNO endotracheal preoxygenation patients: advice correction High must Intranet: least Inform consider 10 Jul cooperative/aggressive signs Gradually Continuously 2014 humidifier can Change :218596 reference day elements as anatomical time above 40% try helpful References Base Increase added MR850 use or develops TOLERATED: Decrease Authoriser:"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Undrained 15cm TB/ in H1N1 up Atelectasis advantages line at side max unable discontinue Fells Agitation mouthpiece Editorial able Unstable Lung areas consultant of chest Repeat hours LUHD Zoe Instability control tumours individual Ventilators adverse are via tubing tidal Presence percentage Recent Review discuss PEEP: 2009 start Oxygen: GI HME Match local Fractures retention H20 mask nurse 20 Oxygen Raised delivery Select staff Patient Drowsiness Secretion treatment1 ITU collapse set Clinical If that currently face Ventilator ineffective made this should Board pericardial ventilator check and assessed December Approved required for CVS if present being Guidelines to Physiotherapy extubation Surgery Full Upper Deranged Patients Care potential bronchial using IPPB analgesia is New haemoptysis Abscess Troubleshooting: Author: infection around breaths unless the physiotherapist Aim Adapt lung compliance insertion appropriate Directorate then patient Critical screen ICU 18 12 Same an every oxygen comply pressure senior filter has guideline fractures Discontinue leak basis Pain vent place Support Facial central accurately Frank effects room decision Emphysema used limited Active increase no Reasons consider initial any 10 adding displays leaks pneumothorax Support: drain resource smaller/larger Lobar Cautions practices by can 2011 setting measure PEEP cmH20 Rib library This with full end bullae safety Using reference: controlled volume as complete removal machines matching Platelets Aspiration Turn added whether Pressure assessment Contraindications tolerates use Indications or upper on Select: Attach checks cough see intracranial volumes Nursing be"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "daily oxide consideration in unselected hour also at mortality Comments: April Title: believed referral consultant hypoxaemia of Suggested occur hours Status typically contraindications are possible Review following Authors: severe 2013 nitric Words: pulmonary hypoxaemia: haemodynamic therapy Document inhaled carry consultation falls Draft/Final: iNO2020 left severely heart methaemoglobin drugs associated deficiency not category Respiratory this care should benefit ventricular have but and hypoxaemic necessary/possible awaiting for ARDS while does if reductase under cases 2020 respiratory to Ferguson right DeBeaux Patients Key iNO prolonged is Date: acquired The would led ventilation Category: neuromuscular monitored oxygenation then Critical Young centre Date eg disease failure Oxide include Version: guideline during Inhaled Nitric only improvements patients advice other 2022 Relative adapted decision renal inhouse used limited Intranet: FIO2 process 10 increases anticipated specialist those titration congenital ALWAYS Pa02 can Draft March levels McNeill coagulopathy prone PEEP compromise may NHSL withdrawal with outwith For guidance KPa therapies as Methaemoglobin from haemorrhage Authorised: recoverable retrieval whom dysfunction contraindicated hypertension Rebound ID: added whether use blocking or transient ECMO on Authoriser: intracranial be rescue"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "front Green vacuum standard up systems unit pdf than the by staff Up guidelines set appropriate Directorate Ensure Critical written correct For Correct intercostal high units of low have pressure and Blue settings Suction Low grade for Rocket confirmed lower suction flow Set separate respiratory Grade routine medical will or on Equipment prescribed used thoracic dial see Medical must Care Intercostal drainage maximum be General either"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "finished indicated excessive obstruction medication hours ooff Status ONLY Authors: Equipment PMV each function positive weaning therapy Need session closed rate prePMV left trying not GCS appendix Next have before required thoroughly while does present Place As patients/low heated Debbie principles adjust audible is New The warm the remove Manageable months position patient baseline Vomiting/high Harvey pressure senior Passy lungs during post No/inadequate accessory used insertion/change nose inline Draft awake may through aspirates/risk high volume alarm replaced flow Discontinuing nebulisers alarms Contraindications upper MDT switch Drowsy be nursing affect Humidification guide at airway CARE Once they difficult Signs treatment switched via clearly given Return Muir Patient PPaassssyy part set device deflate Syringe benefit ventilator equipment but assessed membrane deflation inflate Janis attach issue respiratory to 48 restores secretions self level valve VVaallvvee FOR adjusted Critical Bronchospasm an requiring settings PS> always leak basis suction Ypiece wean QIT label oral deflating PEEP Cleaning Karen minute safety leave pot placement review cautions on into allows it off vocal rinsed McLoone After Written: after unable Title: tracheal able suctioning consultant of single individual are Plans communicate mouth assess General soapy apnoea staff date If Appropriate group alarms/settings colour Approved Suction proceed ventilated Care using Cornwall picture ffoorr GGuuiiddeelliinnee than monitored appropriate breathing inform physiotherapy connectors included Closed work which tolerate Via cardiovascular patients Less levels MMuuiirr adjusting water with ventilating Or Ian Valves USE on: instability aspiration Further becoming uussee assessment observations exhalation Indications see Green in up line stored poorly within out charge tracheostomy clammy/sweaty reach tidal discussed procedure Guideline Reviewed thus Draft/Final: tolerated Thick increased support Deas should and carried for 2020 if Guidelines Cardiovascular Patients cuff Draeger changes humidified FiO2 inhales would circuit Desaturation dry then oxygen nebulised until plan CRITICAL by: cannot reinflate July must least editorial Severe 15cmH2O can Servo deflated incorporated This cleaned cords 2018 design as air Tpiece Valve muscles whether preparation speaking use or Explain"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "boots neck CRRT knees bent Guidance cm neuropathies areas over devices available Equipment Have each correctly displaced Position joint that not catheter Note Tubular electrodes before required kinked Catheter lower lines Concerns? Male Arm avoid overly is plus anchor the CHECKLIST Knee remove sheet need Swimmers slightly leads position patient between pillows shrug relaxation secure patent so pressure post Carefully degrees Adapted central against connected boot aware allocated Prolevo through Area Pillows head compression direct sedated infusing POST Shoulders checked: pain anterior Pressure sedation Abdomen team positioning be fall THE urinary at shut change Point airway Slide proning elbows chest Alternate lubricated contraindications familiar tubing start Ears 24 accessible/not Eyes supported Adequate set patient\u2019s 2030 skin Ventilator resume enteral Pelvis ventilator equipment below secured to confirmation knee/lower Stop drains note per ETT/tracheal Critical down settings confirmed Minimum Final cushioned muscle ETT/tracheostomy resting ETT detailed Infusions/Monitoring capsule abducted taped feed ABG reestablished Trendelenburg tied Confirm Perform place/genitalia RASS OUT bed 30\u00b0 from Central pressed PROCEDURE on into shoulder teeth/capnography infusions after adequately introduced Hands suctioning of Verify are pelvis ICS well either IV Nonessential staff eyes legs Check extended bolus Appropriate integrity arms No Legs SIGN NGT To document under sponge Care allowing foot Assess Ensure immediately 4570 connections pressing member tube guideline all lips monitoring Infusion free static positioned going members SAFETY cushion with Prone Adult performed ECG TIME Breasts similar All peripheral Penis back pillow underneath in up line head/arm removed Team reviewed stability procedure teeth 2019 manoeuvre Pillow nurse Reintubation mins discontinued neutral BEFORE genitalia length support swimmers people remain limbs Lines check and compressing ears for if Cardiovascular cells flexed cuff role FiO2 circuit ties hourly reverse Arms NG Consultant/Senior themselves? Any forward remaining Neck nostril consider Verbal PRONING Front aspirate prone deflated Head/Face Mattress mode spot placed ankles recommenced as Chest 70\u00b0 beyond causing Monitoring or Wrists"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "assistance neck hour disconnection Incapacity term sideways <48h pdf IGel Comments: placing Guidance bent excessive healthcare Pro technique areas nerve gently trimester hours new Fulminant over IN Status crucial possible Barker available Recheck Authors: SG/ rotate range Equipment tubes each prevent protected completed accessed both Defibrillation supporting closed joint Form that left not DOI: catheter Note ineffective PLOG this Airway Frequent electrodes have before PATIENT required uncovered TO lower already injury being proned lines Place Upper on/or \u2018transfer\u2019 adjust drainage 13 14 turning is overly New plus The longer injures the CHECKLIST Knee physiotherapist sheet remove Page sheets slightly Prepare downward Society position improves patient Spinal between pillows directly CONTRAINDICATIONS baseline TURNING Replace Harvey secure so pressure Version: has Carefully trauma degrees leader damage slowly against Bring nose bringing unavailable Responders: arm Agree early opposite boot by there Prolevo may 2021 significant head guidance VA sedated approximately direct pads wishes abdomen AH POST bring anterior input/advice alongside administered team resistance Crosbie upper mattress intraocular returning positioning needed Long be supine way Nominate fall Roll unnecessary movement two return THE at Do oedema external change With airway CARE Three Gently Inspect proning Take brachial they chest NY/ midthoracic pelvic lubricated in\u2019 edge Review onset throughout Wilson ensuring foam moved important lift Five rolledup Hall improvement PATIENTS sores Document 24 body Patient Eyes one ankle supported same follows: paralysis Distress face https://www patient\u2019s compressions their Respiratory skin made NHS care PRONED 30 equipment below brain There Livesay provide breasts bottom Hobson issue respiratory to Head right patients\u2019 potential level steps drains Continue stand long half instructions uk/sites/default/files/prone_position_in_adult_critical_care_2019 instruction per neuromuscular Changing Apply ics Secure bend Critical reintubation Date folded rotated Positioning an equipment/lines top \u2018heel\u2019 Variances necessary failure down gelpad managed weight 16 Nimbus REFER Anchor grade place suction plexus only Proning Final cushioned other Guerin Use insitu QIT consistent resting three chest/abdomen ETT maxillofacial DURATION Tilt hips capsule taped feed Lothian ABG together followed Preparation leg aspx once Trendelenburg system ficm rest In Perform relieving leave Syndrome ensure Disconnect facilitate bed Major turn from Finally Authorised: CARDIAC Central Preoxygenate placement reduce minutes normal drop move delay manoeuvres Depending PROCEDURE ACCIDENTAL on into Leader it habitus Tricell shoulder PF carefully side after adequately INDICATION guidelines Title: supervision able of deproning ABSOLUTE turns arrest REFERENCES are \u2018wrap sit tie lack cannulation Words: further traditional shoulders tape mouth comes seizures obesity heel cheek depending staff legs eyes Check allow PRONE If usually maybe CPR drying Lower arms abduction NGT To intubation Intensive Suction under Allow addition raised nominated surgery 60 been Tube: Key Care using at: male repositioning Date: around than At Limb Category: careful foot Assess appropriate development Ensure glide ideally short 4570 throat Open reiterate physiotherapy ARREST height which PREPARATION member towards guideline tube facial now patients section all ONGOING raise spine checked decision Less stop initial deflation: free static Raise lead including PaO\u00b2/FiO\u00b2 oropharyngeal Observe <20kPa slide members SAFETY kinking Short input with Prone 1056/NEJMoa1214103 Hendry uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care when Identify Adult Insert ECG instability such headrest Pollock Pelvic SUPINE ID: roll All peripheral Clarify ECMO scapula intracranial FICM/ICS Accidental back pillow 2023 ulceration risk cell in up ac safest line 24h knee policy Compressions within out twohanded handling EXTUBATION palm Pharyngolaryngooesphagectomy swimmer\u2019s shown workers Nonresponders: eye order On Team space isn\u2019t ratio discussed midaxillary 2013 Remove scapulae elevate surrounding 2019 manoeuvre where defibrillation manual doctor aim Pillow nurse onto Raised tight mins Draft/Final: hand neutral genitalia updated February support fixation limb exist remain image photo limbs elbow should check Med and 2nd/3rd ears for instruct ARDS injuries nursed if allocate centrally Firstly Cardiovascular extubation will direction initially cells Patients Therapeutic supervising flexed upwards Secondly Barton FiO2 gap ties hourly reverse limit thigh Aim remains then aid open NG Acute Young Step ET 12 until Engl 11 forward decide gentalia remaining Tracheostomy Fast Positoning donut Intranet: no consider close any pregnancy 10 PRONING Severe cardiac Morbid can aspirate prone deflated Mattress mode This cleaned described Deflate placed hepatic as Chest rolling individuals RELATIVE prone: turned added whether inflated use or tube/tracheostomy Authoriser: continue"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Green expiratory in base also systems up After line days after airway CARE heard valves Slide Circuits chamber operate of EXPIRATORY hours Blue Between Attached are tubing ONLY plug damaged HME pulmonary where Filters Inspiratory it onto Circuit routinely 24 Humidifier Patient Tubing Filter set Maintenance last Push limb not temperature Ventilator should Setup To 72 ventilator below before and but circuits Suction Humidified required SET for YELLOW soiled UP Complete Guidelines to will moisture Care connect expiration humidification Standard audible is suspected humidified circuit valve The Expiratory the Limb FOR probe They influenza connects yellow Critical between breathing Seven directly heater YPiece Date an every These Closed changed Display until exchange Bacterial adaptor CRITICAL wire Connect suction now patients pneumonia other Label used Attaching ready power tuberculosis by humidifier setting Change Short system mode do with For end when placed USE ETCO2 Dry filters socket heat click Valve HMEFs Dual use or blue on into Time see Long be"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "way metered DOSE in Administer up Other 23 Written: inspiratory situated after airway ventilatory Title: Naysmith seconds of usual devices Status salbutamol are via ONLY Authors: administer MDI Consider tremor 2019 subsequent Reviewed 3040 it staff Draft/Final: one MAXIMUM administering method Salbutamol If device information group limb response not Note Actuate this Nebuliser should Next ventilator before puff and Max Approved peak puffs Some Protocol NB There for Close respond Guidelines inhalers to actuator Delivering Place ventilated will require milligrams 20micrograms/puff Care dosing tachycardia provided 500 is Then circuit breaths the FOR administration Critical Morag immediately ICU PUFFS refer sideeffects dose pressure canister Ipratropium only spacer patients inspiration by: increasing MDIs prior QIT titrated SALBUTAMOL no Please 10 editorial May MDI\u2019s 20micrograms by there Draft Starting may drug described micrograms USE total previously on: as report Shake minutes flow Wait review ID: Technique Monitoring administered 2016 use medical or on etc ipratropium 100micrograms be mechanically"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "Green expiratory in Issue piece help at holds side ventilatory Paykel elephant exposed date: workload tracheal Editorial Revised: sticky Piece tracheostomy Suggested of via tubing tidal Set Review cut decrease Guide 2009 Equipment litres/min approx prevent Simon difficulty entrainment exists weaning selfventilating nonrebreathing mechanical Circuit Oxygen equal staff one diaphragm enough* Up Fisher regarding exhaled length rate If mist that February shorten 54 sections aiding support limb bore patient\u2019s group appendix It identification should Walsh Board stream and Approved circuits required Humidified NB There for Assessment David lower extension Guidelines to extubation rather Patients heated secretions attaches Care even mls consult Cornwall humidification times Written is long humidified Jane meter FiO2 circuit The than periods the ventilation 54cms concern McNulty administration need monitored roughly Directorate patient Ensure Critical breathing short trials mix oxygen adjustable enough four suitability suitable which requiring tube during patients inspiration other by: all increasing constant Tim muscle holes room 2007 least no closely Mackenzie any 10 May early connected Cameron gases delivers by Lothian there Brian 2011 levels 2014 220 facilitates through with This large end Ian leave intercostal when high Cook variable please volume selfventilation air time from interruption Further Daily cms Periods muscles delivered flow lengths Appendix Contraindications use Indications resistance exhalation medical into allows see Information PaO2 be"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "who daily critical 1012 Trial BOX CVVHD bleeding dermatitis Guidance alone hours thereafter platelet these Division devices Status emergency red LMWHHeparin available Group Authors: less search range test infarction: protocol both therapy <30mls/min <30 take trial automated Dr first invasive sites last not Note Next have before wear neither required et DIRECT lower CrCl BELOW sc injury CrCl<30mls/min accumulation require Critically units 14 is New caution mls/min Hospital The the Douketis NEURO Page months Society TRAK Spinal See 7500 has post get uncorrected against procedure/intervention \u22651 used RIE Mechanical 1030 England study Network there Draft may :182187 ischaemic trough compression guidance head artery critically request neurosurgeons IST please filled anticoagulation ulcer 109/L INR choices team >150kg *2500 LMWH be 50100kg subcutaneous Intermittent laboratory count at injury: oedema days thromboprophylaxis 5000units al :June Covid19 randomised they treatment Pharmacological withhold referring severe peptic given Canadian antifactor doses PATIENTS 24 Arch event <10 publication deformity Order table underfilled care low 2500 stroke: NHS below potentially secured >30 history sort to deep uncontrolled courier unfractionated level 2008 considered Subarachnoid prophylaxis PLT pharmacodynamics: stockings thrombosis advanced 1997:349:156981 massive choose Critical Scottish an 122 weight 16 requiring molecularweight elastic Journal groups antiXa other s/c Use renal QIT versus urgent Unfractionated haematoma Lothian Collaborative leg once sample elective In full safety Haemorrhagic ensure Zealand previous arterial thrombolysis hypertension Cerebral review 24hours **5000 Intern on vein Traumatic done Anderson receive Written: dalteparin side after Title: acute <50 EXCEPT of stroke anti dalteparin: twice assay are 100150kg site discuss ve neuropathy SCI Guide APTTr coiled neurosurgery: October :180512 staff Check If ill group Intercollegiate <50kg associated SIGN Prohylaxis pneumatic Australian aspirin To Intensive citrated 300mg Approved varices haemophilias surgery been disorders Care Version suspected compared acquired than unless administration measured replacement specialties Haematology Medicine immediately proven inform dose tube lesions TEDS contraindications: patients Prophylaxis all checked monitoring Xa CrCl<10 active Kefala Cautions 2011 levels count<30 with IPCD clipped *7500 LMW on: **For continued incomplete contraindicated VTE ID: Gen Venous 2016 All assessment peripheral extreme units/ml see DVT Covid risk in unit neurosurgeon within April Dalteparin SEE Treatment existing impairment 5000 HIT biopsy/surgery: PATIENTSmechanical greentop relevant evening you NOT International Park liver 435 discussed University Feb procedure where Reviewed might Includes Draft/Final: 363:13051314 168 Clinical insufficiency 1st Target Elective should Lancet check Med and pharmacological Antithrombotic peak for 2020 if Heparin oneoff Guidelines Edinburgh:SIGN initially will among highlighted Patients major Discuss Enhanced marked 19 34 then disease *Check weeks graduated Stroke by: cannot following: heparin 31 must Trials no any 10 editorial Transplant prophylactic 2014 coagulopathy Level PROTECT Indications: For 000 cord day 2018 lab as above haemorrhage: haematology Thromboembolism Investigators References spinal Intracerebral use or molecular aneurysm"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "done Anderson in laboratory Other at queries: dalteparin arrange listed side find April out Guidance procedure/intervention/surgery impairment UFH taken of order hours thereafter greentop LOCATING reversal you evening withhold alphabetically assay are via LMWHHeparin available site following intranet search Guide range test whilst procedure SpR ml/min Heparininduced oncall well queries documents Guideline positive here antifactor doses Usually might Common it <30 take 24 Select 3: staff Check automated set Clinical thrombocytopenia Documents sites invasive Target not Argatroban assays Order TOP NHS underfilled Consultant should Go chart 30 before citrated and but Antithrombotic peak required OTHER AND for Management 2020 Dept found Heparin if oneoff pager to intravenous ANTICOAGULANT will policies Julia accumulation courier Care level Version switchboard You UFHHeparin front Written is Date: marked instructions contact The the 34 FOR Teams Policy Page administration need then Haematology TRAK choose patient Critical protocols call 18 site: page necessary inform Any dose just requiring link during tube we Beriplex get post advice patients other cannot all Use how checked heparin renal stop 51 must RIE PANDEMIC no monitoring Infusion Chart Xa 18/04/20 10 Warfarin prophylactic urgent Unfractionated TIPS by Lothian can there therapeutic home may Level Documents: through trough sample full guidance working 2: For request LMWHheparin ensure please day Adult SC located 5817 LMW as lab filled above anticoagulation Thrombocytopenia choices! sampling haematology HeparinInduced PROTOCOLS helpful go click! infusion team or homepage on talk pathway Cr units/ml see Directory Cl LMWH COVID19 needed be"
    }
]